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1. The	  personal	  health	  budget	  initiative	  is	  a	  key	  aspect	  of	  personalisation	  across	  health	  care	  services	  in	  
England.	  Its	  aim	  is	  to	  improve	  patient	  outcomes,	  by	  placing	  patients	  at	  the	  centre	  of	  decisions	  about	  
their	  care.	  Giving	  people	  greater	  choice	  and	  control,	  with	  patients	  working	  alongside	  health	  service	  
professionals	  to	  develop	  and	  execute	  a	  care	  plan,	  given	  a	  known	  budget,	  is	  intended	  to	  encourage	  
more	  responsiveness	  of	  the	  health	  and	  care	  system.	  	  
2. The	  personal	  health	  budget	  programme	  was	  launched	  by	  the	  Department	  of	  Health	  in	  2009	  after	  the	  
publication	  of	  the	  2008	  Next	  Stage	  Review.	  An	  independent	  evaluation	  was	  commissioned	  alongside	  
the	  pilot	  programme	  with	  the	  aim	  of	  identifying	  whether	  personal	  health	  budgets	  ensured	  better	  
health	  and	  care	  outcomes	  when	  compared	  to	  conventional	  service	  delivery	  and,	  if	  so,	  the	  best	  way	  for	  
personal	  health	  budgets	  to	  be	  implemented.	  	  
Study	  design	  and	  methodology	  
3. The	  evaluation	  took	  a	  longitudinal	  approach	  and	  included	  people	  with	  any	  of	  six	  conditions:	  chronic	  
obstructive	  pulmonary	  disease,	  diabetes	  and	  long-­‐term	  neurological	  conditions;	  mental	  health;	  stroke;	  
and	  patients	  eligible	  for	  NHS	  Continuing	  Healthcare.	  	  
4. Of	  the	  64	  sites	  in	  the	  personal	  health	  budgets	  pilot	  at	  onset,	  20	  sites	  were	  selected	  to	  be	  in-­‐depth	  
evaluation	  sites,	  with	  the	  remainder	  being	  wider	  cohort	  sites.	  Sites	  implemented	  personal	  health	  
budgets	  in	  different	  ways,	  varying	  the	  choice	  people	  had	  about	  what	  services	  could	  be	  purchased	  with	  
the	  budget,	  flexibility	  as	  to	  how	  the	  budget	  could	  be	  managed,	  how	  explicit	  the	  budget	  size	  was	  and	  
how	  the	  size	  of	  the	  budget	  was	  calculated.	  	  
5. The	  evaluation	  used	  a	  controlled	  trial	  to	  compare	  the	  experiences	  of	  people	  selected	  to	  receive	  
personal	  health	  budgets	  with	  those	  of	  people	  continuing	  with	  conventional	  support	  arrangements.	  A	  
pragmatic	  design	  was	  used.	  After	  applying	  initial	  selection	  criteria,	  in	  some	  sites	  people	  were	  
randomised	  into	  the	  personal	  health	  budget	  group	  or	  a	  control	  group.	  In	  other	  sites,	  the	  personal	  
health	  budget	  group	  was	  recruited	  from	  patients	  of	  those	  health	  care	  professionals	  in	  the	  pilot	  offering	  
budgets	  and	  a	  control	  group	  from	  patients	  of	  non-­‐participating	  health	  care	  professionals.	  	  
6. The	  evaluation	  followed	  a	  mixed	  design,	  using	  both	  quantitative	  and	  qualitative	  methodologies	  to	  
explore	  patient	  outcomes,	  experiences,	  service	  use	  and	  costs.	  Just	  over	  1000	  individuals	  were	  recruited	  
into	  each	  arm	  of	  the	  study	  in	  order	  to	  give	  the	  analysis	  sufficient	  statistical	  power.	  The	  study	  used	  
methods	  to	  deal	  with	  a	  range	  of	  issues,	  including:	  attribution	  of	  effect	  (addressed	  using	  a	  difference-­‐in-­‐
difference	  approach	  and	  testing	  with	  confounding	  factors);	  missing	  data	  (multiple	  imputation);	  
allocation	  of	  costs	  (a	  costing	  model);	  and	  statistical	  inference	  regarding	  the	  significance	  of	  sample	  
results	  (parametric	  and	  bootstrap	  estimators,	  powered	  sample	  sizes).	  Limitations	  with	  respect	  to	  these	  
methods	  should	  be	  noted.	  	  
7. Cost	  effectiveness	  was	  assessed	  by	  estimating	  whether	  the	  personal	  health	  budgets	  group	  experienced	  
greater	  benefits	  than	  the	  control	  group	  who	  received	  conventional	  service	  delivery,	  after	  netting	  off	  
the	  difference	  in	  service	  and	  support	  costs	  between	  the	  groups.	  Net	  benefits	  were	  expressed	  in	  
monetary	  terms	  for	  this	  purpose,	  using	  willingness-­‐to-­‐pay	  thresholds.	  The	  groups	  were	  compared	  at	  a	  
target	  12-­‐month	  after	  initial	  recruitment,	  with	  any	  baseline	  differences	  (in	  net	  benefit	  levels)	  between	  
the	  groups	  subtracted	  from	  the	  follow-­‐up	  difference	  to	  reduce	  attribution	  bias.	  	  
8. The	  qualitative	  analysis	  involved	  interviews	  with	  organisational	  representatives,	  personal	  health	  
budget	  holders	  and	  carers	  of	  budget	  holders.	  The	  framework	  approach	  was	  used	  for	  the	  analysis,	  with	  
the	  data	  organised	  by	  themes	  according	  to	  the	  topic	  guides	  used	  in	  the	  interviews.	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The	  impact	  of	  PHBs	  on	  quality	  of	  life	  and	  care-­‐related	  outcomes	  
9. A	  personal	  health	  budget	  might	  have	  an	  impact	  on	  outcomes	  in	  three	  different	  ways:	  
 Through	  the	  direct	  benefits	  of	  having	  more	  choice	  and	  control	  on	  quality	  of	  life;	  	  
 From	  the	  change	  in	  the	  services	  and	  support	  people	  fund	  using	  their	  personal	  health	  budgets,	  
allowing	  them	  to	  tailor	  care	  and	  support	  to	  their	  own	  needs	  and	  preferences.	  This	  process	  could	  
improve	  the	  recipients’	  health	  and	  functioning	  and,	  in	  turn,	  their	  quality	  of	  life.	  There	  might,	  
conversely,	  be	  a	  negative	  effect	  if	  people	  make	  ill-­‐informed	  choices	  about	  their	  care;	  and	  	  
 From	  any	  change	  in	  the	  overall	  level	  of	  funding	  of	  people’s	  personal	  health	  budgets	  as	  compared	  
to	  what	  they	  would	  have	  received	  under	  conventional	  service	  arrangements.	  	  
10. A	  range	  of	  ‘impact’	  indicators	  were	  assessed,	  including	  clinical	  effectiveness	  measures;	  mortality	  rates;	  
care	  and	  health-­‐related	  quality	  of	  life	  measures;	  psychological	  health	  scales	  and	  overall	  wellbeing	  
indicators.	  Changes	  in	  these	  impact	  indicators	  between	  the	  personal	  health	  budget	  and	  control	  groups	  
indicated	  the	  benefits	  consequences	  of	  the	  initiative.	  
11. People’s	  use	  of	  a	  wide	  range	  of	  services	  and	  support	  was	  assessed	  between	  the	  groups,	  including:	  
community	  health;	  therapy	  and	  nursing	  services;	  social	  care	  services	  aimed	  at	  meeting	  health	  and	  care	  
needs;	  well-­‐being	  services;	  and	  also,	  primary	  and	  secondary	  services	  (which	  might	  be	  affected	  
indirectly	  from	  the	  use	  of	  a	  personal	  health	  budget).	  Changes	  in	  service	  expenditure	  between	  the	  
personal	  health	  budget	  and	  control	  groups	  indicated	  the	  cost	  consequences	  of	  the	  initiative.	  	  
Findings	  
12. The	  main	  benefit-­‐related	  implications	  of	  personal	  health	  budgets	  were	  as	  follows	  (unless	  otherwise	  
noted,	  significance	  is	  assessed	  at	  the	  95%	  confidence	  level):	  
 The	  use	  of	  personal	  health	  budgets	  was	  associated	  with	  a	  significant	  improvement	  in	  the	  care-­‐
related	  quality	  of	  life	  (ASCOT)	  and	  psychological	  well-­‐being	  (GHQ-­‐12)	  of	  patients	  (at	  90%	  
confidence).	  
 Personal	  health	  budgets	  did	  not	  appear	  to	  have	  an	  impact	  on	  health	  status	  per	  se	  over	  the	  12	  
month	  follow-­‐up	  period.	  No	  significant	  effects	  were	  found	  with	  regard	  to	  two	  clinical	  measures	  
(HbA1C	  and	  lung-­‐function	  tests,	  used	  where	  relevant)	  and	  there	  was	  no	  significant	  difference	  in	  
mortality	  rates	  between	  the	  groups.	  Consistent	  with	  these	  results,	  the	  study	  did	  not	  find	  that	  
personal	  health	  budgets	  had	  a	  significant	  effect	  on	  EQ-­‐5D	  compared	  to	  the	  control	  group.	  
13. The	  configuration	  of	  personal	  health	  budgets	  also	  appeared	  to	  be	  important.	  Generally,	  a	  more	  
positive	  effect	  on	  outcome	  indicators	  was	  seen	  where	  sites:	  choose	  to	  be	  explicit	  in	  informing	  the	  
patients	  about	  the	  budget	  amount;	  provided	  a	  degree	  of	  flexibility	  as	  to	  what	  services	  could	  be	  
purchased;	  and	  provided	  greater	  choice	  as	  to	  how	  the	  budget	  could	  be	  managed.	  Some	  negative	  
impacts	  were	  found	  for	  sites	  using	  configurations	  with	  less	  flexibility	  and	  choice	  than	  other	  sites.	  	  
14. Separating	  personal	  health	  budgets	  into	  high-­‐value	  (i.e.	  a	  budget	  of	  more	  than	  £1,000	  per	  year)	  and	  
low-­‐value,	  it	  was	  the	  former	  that	  showed	  a	  significant	  positive	  impact	  on	  care-­‐related	  quality	  of	  life	  
(ASCOT)	  and	  psychological	  well-­‐being	  (GHQ-­‐12).	  High-­‐value	  budgets	  were	  more	  likely	  for	  people	  with	  
greater	  levels	  of	  need	  or	  where	  sites	  opted	  to	  be	  more	  inclusive	  about	  what	  budgets	  could	  cover.	  
15. Sub-­‐group	  analyses	  for	  individual	  patient	  groups	  were	  limited	  by	  the	  relatively	  small	  sample	  sizes	  for	  
individual	  groups	  (hence	  low	  statistical	  power).	  Nonetheless,	  a	  number	  of	  effects	  were	  strong	  enough	  
to	  emerge	  in	  these	  analyses:	  personal	  health	  budgets	  were	  associated	  with	  improvements	  regarding	  
ASCOT-­‐measured	  outcome	  change	  (at	  90%),	  psychological	  well-­‐being	  (GHQ-­‐12)	  and	  subjective	  well-­‐
being,	  for	  the	  COPD	  cohort.	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16. The	  main	  findings	  of	  the	  cost	  analysis	  were:	  
 The	  cost	  of	  inpatient	  care	  (an	  ‘indirect’	  cost)	  was	  significantly	  lower	  for	  the	  personal	  health	  budget	  
group	  compared	  to	  the	  control	  group	  after	  accounting	  for	  baseline	  differences.	  	  
 The	  (‘direct’)	  costs	  of	  well-­‐being	  and	  other	  health	  services	  were	  both	  significantly	  higher	  for	  the	  
personal	  health	  budget	  group	  compared	  to	  controls.	  
 Other	  categories	  of	  direct	  and	  indirect	  cost	  showed	  no	  difference	  between	  the	  groups.	  
 The	  difference	  in	  direct	  and	  indirect	  total	  costs	  between	  personal	  health	  budget	  and	  control	  
groups	  after	  accounting	  for	  baseline	  differences	  were	  not	  statistically	  significant.	  	  
17. The	  cost	  analyses	  for	  the	  individual	  health	  condition	  groups	  were	  mostly	  inconclusive	  as	  a	  result	  of	  the	  
modest	  sub-­‐sample	  sizes.	  However,	  indirect	  costs	  were	  found	  to	  be	  lower	  for	  personal	  health	  budget-­‐
holders	  in	  the	  mental	  health	  and	  NHS	  Continuing	  Healthcare	  sub-­‐groups	  (at	  the	  90%	  confidence	  level).	  
Total	  costs	  were	  also	  lower	  in	  the	  group	  of	  people	  with	  high-­‐value	  personal	  health	  budgets	  compared	  
to	  the	  controls	  (significant	  at	  the	  90%	  confidence	  level).	  
18. The	  change	  in	  the	  balance	  of	  services	  that	  budget-­‐holders	  used	  also	  suggested	  that	  more	  of	  their	  
services	  were	  secured	  from	  outside	  conventional	  NHS	  providers	  than	  the	  control	  group.	  
19. Personal	  health	  budgets	  were	  assessed	  to	  be	  cost-­‐effective	  relative	  to	  conventional	  service	  delivery	  if	  
they	  produced	  greater	  net	  benefits	  than	  this	  usual	  care	  comparator.	  Key	  findings	  were:	  
 Using	  care-­‐related	  quality	  of	  life	  (ASCOT)	  measured	  net	  benefits,	  personal	  health	  budgets	  were	  
cost-­‐effective	  relative	  to	  conventional	  service	  delivery	  (at	  the	  90%	  confidence	  level).	  
 There	  was	  no	  significant	  difference	  in	  the	  net	  benefit	  between	  the	  groups	  using	  health-­‐related	  
quality	  of	  life	  (EQ-­‐5D)	  measured	  benefits.	  
 Notwithstanding	  the	  small	  sample	  sizes	  in	  the	  sub-­‐group	  analyses,	  personal	  health	  budgets	  
showed	  higher	  ASCOT-­‐measured	  net	  benefits	  than	  conventional	  services	  for	  the	  CHC	  and	  mental	  
health	  sub-­‐groups	  (at	  the	  90%	  confidence	  level).	  
 Personal	  health	  budgets	  implemented	  following	  the	  main	  ethos	  of	  the	  policy	  (greater	  choice	  and	  
control)	  were	  cost-­‐effective	  at	  the	  95%	  confidence	  level,	  as	  were	  those	  with	  high-­‐value	  budgets.	  	  
20. Sensitivity	  analysis	  was	  used	  to	  explore	  whether	  the	  main	  results	  changed	  if	  some	  of	  the	  assumptions	  
in	  the	  analysis	  were	  altered	  (regarding	  missing	  data	  imputation	  and	  the	  costing	  of	  personal	  health	  
budgets).	  These	  analyses	  substantiated	  our	  main	  results	  in	  almost	  all	  cases.	  With	  the	  main	  alternative	  
assumptions,	  personal	  health	  budgets	  were	  cost-­‐effective	  (with	  ASCOT-­‐measured	  benefits)	  at	  the	  95%	  
confidence	  level,	  rather	  than	  the	  90%	  level.	  
21. Personal	  health	  budgets	  were	  cost-­‐effective	  using	  the	  ASCOT	  quality	  of	  life	  measure.	  Although	  this	  
measure	  was	  developed	  originally	  to	  assess	  the	  consequences	  of	  social	  care	  services,	  its	  focus	  on	  care-­‐
related	  quality	  of	  life	  implications	  makes	  it	  highly	  relevant	  for	  general	  use	  with	  people	  managing	  long-­‐
term	  conditions.	  Other	  studies	  have	  shown	  that	  people	  value	  care-­‐related	  quality	  of	  life	  as	  measured	  
by	  ASCOT	  in	  that	  they	  are	  willing	  to	  exchange	  shorter	  life	  expectancy	  for	  better	  ASCOT-­‐measured	  
quality	  of	  life.	  Improvement	  in	  ASCOT	  quality	  of	  life	  was	  found	  for	  people	  who	  were	  not	  using	  social	  
care	  at	  baseline	  as	  well	  as	  for	  those	  people	  who	  were	  in	  receipt	  of	  these	  services.	  	  
The	  impact	  of	  personal	  health	  budgets	  on	  the	  caring	  role	  and	  quality	  of	  life	  
22. Difference-­‐in-­‐difference	  multivariate	  analysis	  revealed	  no	  significant	  differences	  in	  the	  reported	  use	  of	  
informal	  care	  between	  personal	  health	  budget	  and	  control	  groups	  overall.	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23. Analysis	  of	  a	  more	  limited	  sample	  of	  carers	  of	  people	  with	  personal	  health	  budgets	  suggested	  that	  they	  
were	  more	  likely	  to	  report	  better	  quality	  of	  life	  and	  perceived	  health	  than	  carers	  of	  people	  in	  the	  
control	  group.	  Carers	  seemed	  to	  be	  satisfied	  with	  the	  personal	  health	  budget	  process	  in	  terms	  of	  
support	  planning,	  the	  amount	  of	  the	  budget	  and	  the	  amount	  of	  help	  that	  was	  offered	  when	  deciding	  
what	  services	  or	  support	  to	  purchase	  from	  the	  personal	  health	  budget.	  The	  small	  sample	  (147)	  in	  this	  
case	  restricted	  the	  extent	  to	  which	  confounding	  factors	  could	  be	  accounted	  for	  in	  this	  analysis.	  	  
User	  and	  carer	  perspectives	  on	  PHBs	  
24. At	  around	  three	  months	  after	  the	  offer	  of	  the	  personal	  health	  budget	  58	  personal	  health	  budget	  
holders	  were	  interviewed	  to	  discuss	  their	  experiences	  of	  the	  process.	  Fifty-­‐two	  took	  part	  in	  a	  follow-­‐up	  
interview	  nine	  months	  after	  the	  offer	  of	  the	  personal	  health	  budgets.	  Nineteen	  carers	  providing	  
assistance	  to	  a	  personal	  health	  budget	  holder	  were	  interviewed	  at	  three	  months	  after	  the	  offer;	  of	  
which	  13	  carers	  were	  interviewed	  at	  nine	  months	  after	  the	  offer	  of	  the	  budget.	  	  
25. At	  nine	  months	  after	  study	  recruitment,	  the	  majority	  of	  budget-­‐holders	  and	  carers	  reported	  positive	  
impacts	  of	  the	  personal	  health	  budget	  –	  on	  their	  health	  and	  well-­‐being,	  health	  care	  and	  other	  support	  
arrangements	  and	  for	  other	  family	  members.	  Effect	  on	  their	  use	  of	  health	  services	  or	  changes	  in	  
relationships	  with	  health	  professionals	  were	  less	  likely	  to	  be	  reported.	  Most	  interviewees	  appreciated	  
the	  increased	  choice,	  control	  and	  flexibility	  of	  the	  personal	  health	  budget,	  although	  some	  thought	  the	  
benefits	  were	  curtailed	  by	  restrictions	  on	  what	  the	  budget	  could	  be	  used	  for,	  lack	  of	  services	  and	  
budgets	  being	  too	  small	  for	  their	  needs.	  	  
Recommendations	  for	  policy	  and	  practice	  	  
26. The	  findings	  from	  the	  study	  suggest	  a	  number	  of	  recommendations	  regarding	  the	  possible	  roll-­‐out	  of	  
personal	  health	  budgets:	  	  
 The	  study	  concludes	  that	  personal	  health	  budgets	  were	  cost-­‐effective,	  given	  the	  assumptions	  
made	  (esp.	  regarding	  the	  value	  of	  ASCOT	  quality	  of	  life)	  and	  thus	  support	  a	  wider	  roll	  out.	  	  
 High-­‐value	  personal	  health	  budgets	  were	  most	  cost-­‐effective,	  suggesting	  that	  personal	  health	  
budgets	  should	  be	  initially	  targeted	  at	  people	  with	  greater	  need,	  to	  act	  as	  substitute	  for	  
conventional	  service	  delivery.	  
 Personal	  health	  budgets	  were	  cost-­‐effective	  for	  people	  with	  mental	  health	  problems	  and	  those	  
receiving	  NHS	  continuing	  healthcare	  but	  the	  analyses	  for	  other	  health	  conditions	  were	  inconclusive	  
due	  to	  small	  sub-­‐samples	  sizes.	  
 The	  budget-­‐holders	  that	  were	  interviewed	  emphasised	  the	  value	  of	  information	  and	  guidance	  from	  
sites	  about	  the	  size	  and	  operation	  of	  their	  budgets,	  including	  what	  services	  were	  covered.	  	  
 The	  use	  of	  personal	  health	  budgets	  is	  likely	  to	  result	  in	  greater	  use	  of	  ‘non-­‐conventional’	  providers.	  






1.2 Policy	  Background	  
In	  England,	  the	  personal	  health	  budget	  initiative	  is	  an	  important	  part	  of	  the	  current	  personalisation	  
agenda	  for	  health	  care	  services,	  with	  the	  aim	  of	  placing	  patients	  at	  the	  heart	  of	  decisions	  about	  the	  
care	  and	  services	  they	  receive	  (Department	  of	  Health,	  2009).	  The	  aim	  of	  the	  initiative	  is	  to	  encourage	  
the	  NHS	  to	  become	  more	  responsive	  to	  the	  needs	  of	  patients	  by	  providing	  greater	  choice	  (HM	  
Government,	  2010b),	  which	  could	  in	  turn	  lead	  to	  improved	  efficiency	  within	  the	  NHS.	  Both	  aims	  are	  
high	  on	  the	  political	  agenda	  at	  a	  time	  when	  demand	  on	  the	  health	  care	  system	  is	  increasing,	  with	  
greater	  numbers	  of	  people	  living	  with	  one	  or	  more	  complex	  long-­‐term	  conditions,	  and	  within	  the	  
current	  climate	  of	  constrained	  finances.	  As	  context	  for	  these	  aims,	  around	  15.4	  million	  people	  in	  
In	  England,	  the	  personal	  health	  budget	  initiative	  is	  an	  important	  part	  of	  the	  current	  personalisation	  
agenda	  for	  health	  care	  services.	  Its	  aim	  is	  to	  place	  patients	  at	  the	  heart	  of	  decisions	  about	  services	  they	  
receive.	  	  
The	  personal	  health	  budget	  initiative	  was	  first	  proposed	  in	  the	  2008	  NHS	  Next	  Stage	  Review	  as	  a	  
process	  of	  giving	  patients	  greater	  control	  over	  services	  they	  receive	  and	  how	  their	  support	  is	  managed.	  
A	  number	  of	  design	  principles	  underlie	  personal	  health	  budgets,	  including:	  	  
1. Patients	  should	  know	  the	  resource	  level	  available	  within	  the	  budget;	  
2. Patients	  should	  be	  encouraged	  to	  develop	  a	  support/care	  plan	  that	  details	  how	  the	  resource	  
will	  be	  used	  to	  meet	  their	  identified	  needs;	  
3. Patients	  should	  decide	  how	  they	  would	  like	  the	  budget	  to	  be	  managed.	  	  
	  
In	  2009,	  the	  Department	  of	  Health	  invited	  PCTs	  to	  become	  pilot	  sites	  for	  the	  personal	  health	  budget	  
pilot	  programme.	  An	  evaluation	  was	  commissioned	  to	  run	  alongside	  in	  order	  to	  provide	  an	  account	  of	  
the	  personal	  health	  budget	  process	  from	  the	  system	  and	  from	  the	  view	  of	  budget	  holders	  and	  carers.	  	  
	  
Initially,	  64	  pilot	  sites	  were	  involved	  in	  piloting	  personal	  health	  budgets	  and	  contributing	  to	  the	  
evaluation.	  During	  the	  evaluation	  period,	  the	  pilot	  programme	  remained	  open	  and	  now	  there	  are	  75	  
pilot	  sites	  implementing	  personal	  health	  budgets.	  	  
Twenty	  sites	  from	  across	  the	  pilots	  were	  selected	  to	  be	  in-­‐depth	  evaluation	  sites,	  with	  the	  remainder	  
being	  wider	  cohort	  sites.	  
	  
The	  overarching	  aim	  of	  the	  evaluation	  was	  to	  identify	  whether	  personal	  health	  budgets	  ensured	  better	  
health	  and	  care-­‐related	  outcomes	  when	  compared	  to	  conventional	  service	  delivery	  and,	  if	  so,	  the	  best	  




England	  have	  at	  least	  one	  long-­‐term	  health	  condition,	  accounting	  for	  70	  per	  cent	  of	  the	  health	  and	  
social	  care	  budget1.	  	  
The	  personal	  health	  budget	  initiative	  was	  proposed	  in	  the	  2008	  NHS	  Next	  Stage	  Review	  as	  a	  way	  of	  
giving	  patients	  greater	  choice	  and	  control	  over	  services	  they	  receive	  and	  how	  their	  support	  is	  
managed.	  However,	  the	  idea	  was	  not	  new,	  as	  in	  2009	  Glasby	  and	  colleagues	  reported	  a	  growing	  
impetus	  around	  personalisation	  within	  the	  NHS	  among	  academics	  (Glasby	  et	  al.,	  2009;	  Glendinning	  et	  
al.,	  2008;	  Leadbeater	  et	  al.,	  2008;	  Alakeson,	  2007;	  Glasby	  and	  Hasler,	  2004;	  Glendinning	  et	  al.,	  2000a;	  
Glendinning	  et	  al.,	  2000b),	  from	  a	  previous	  health	  policy	  advisor	  to	  Tony	  Blair	  (Le	  Grand,	  2007)	  and	  
from	  Government	  (Brown,	  2008;	  Milburn,	  2007)	  (Glasby	  et	  al.,	  2009).	  The	  Coalition	  Government	  re-­‐
affirmed	  the	  importance	  of	  offering	  personalised	  services	  and	  actively	  involving	  individuals,	  carers	  
and	  families	  in	  all	  decisions	  concerning	  services	  and	  support	  within	  the	  NHS	  in	  a	  number	  of	  policy	  
documents.	  The	  2010	  White	  Paper	  Equity	  and	  Excellence:	  Liberating	  the	  NHS	  highlighted	  the	  need	  for	  
patients	  to	  be	  involved	  in	  all	  decision	  making:	  “Shared	  decision-­‐making	  will	  become	  the	  norm:	  no	  
decision	  about	  me	  without	  me”	  (HM	  Government,	  2010b).	  Following	  the	  White	  Paper,	  the	  
Department	  of	  Health	  published	  two	  consultations	  outlining	  proposals	  to	  secure	  shared	  decision-­‐
making	  over	  care	  and	  treatment.	  It	  was	  proposed	  that	  personalised	  care	  planning	  would	  be	  the	  main	  
way	  to	  encourage	  choice	  and	  control	  among	  patients	  (Department	  of	  Health,	  2012;	  Department	  of	  
Health,	  2010).	  In	  2011,	  the	  Government	  response	  to	  the	  NHS	  Future	  Forum	  report	  repeated	  and	  
emphasised	  the	  importance	  of	  public	  involvement:	  “A	  health	  system	  where	  patients	  and	  the	  public	  
have	  a	  stronger	  voice	  and	  more	  control	  –	  no	  decision	  about	  me	  without	  me”	  (HM	  Government,	  2011).	  	  
There	  are	  a	  number	  of	  principles	  underlying	  the	  personal	  health	  budget	  initiative	  (Department	  of	  
Health,	  2009),	  including:	  	  
1. Recipients	  knowing	  the	  resource	  level	  available	  within	  the	  budget	  following	  an	  initial	  
assessment	  and	  the	  identification	  of	  outcomes.	  
2. Encouraging	  patients	  to	  develop	  a	  support/care	  plan	  that	  details	  how	  the	  resource	  will	  be	  
used	  to	  meet	  their	  identified	  needs.	  This	  should	  include	  flexibility	  in	  the	  services	  and	  support	  
that	  can	  be	  purchased,	  but	  contains	  a	  number	  of	  restrictions	  on	  the	  use	  of	  personal	  health	  
budgets.	  The	  following	  are	  excluded:	  	  
 Part-­‐funding	  treatment	  alongside	  patients’	  own	  money;	  
 Primary	  medical	  services	  (i.e.	  GP	  services)	  and	  emergency	  services;	  
 Anything	  illegal,	  gambling,	  debt	  repayment,	  tobacco	  and	  alcohol.	  
3. Patients	  deciding	  how	  they	  would	  like	  the	  budget	  to	  be	  managed.	  There	  are	  three	  options	  (or	  
potentially	  a	  combination	  of	  them):	  notionally,	  where	  the	  budget	  is	  held	  by	  the	  
commissioner,	  but	  the	  budget	  holder	  is	  aware	  of	  the	  treatment/service	  options	  and	  their	  






financial	  implications;	  managed	  by	  a	  third	  party;	  or	  as	  a	  direct	  payment	  (in	  certain	  approved	  
sites	  only).	  
	  
It	  is	  clear	  from	  the	  underlying	  principles	  that	  co-­‐production	  is	  central	  to	  the	  personal	  health	  budget	  
initiative.	  Co-­‐production	  can	  be	  traced	  back	  to	  the	  1970s,	  when	  the	  term	  was	  introduced	  as	  a	  way	  of	  
improving	  service	  efficiency	  by	  actively	  involving	  people	  who	  use	  services	  (Needham	  and	  Carr,	  2009).	  
In	  support	  of	  this	  view,	  a	  number	  of	  recent	  policy	  documents	  have	  provided	  a	  strong	  direction	  for	  co-­‐
production	  within	  the	  personalisation	  agenda,	  including	  the	  2010	  White	  Paper,	  Equity	  and	  
Excellence:	  Liberating	  the	  NHS	  that	  outlined	  the	  importance	  of	  actively	  involving	  individuals,	  carers	  
and	  families	  in	  all	  decisions	  in	  the	  delivery	  of	  health	  care	  services	  to	  ensure	  that	  personalised	  support	  
is	  being	  offered	  (HM	  Government,	  2010b).	  	  
The	  premise	  of	  co-­‐production	  can	  be	  found	  within	  policy	  documents	  related	  to	  the	  introduction	  of	  
three	  previous	  initiatives	  (direct	  payments;	  In	  Control	  approach	  and	  Individual	  Budgets)	  within	  social	  
care	  in	  England.	  All	  three	  initiatives	  focused	  on	  placing	  more	  choice	  and	  control	  in	  the	  hands	  of	  
service	  users	  in	  terms	  of	  how	  and	  when	  their	  services	  and	  support	  are	  delivered.	  	  
1.2.1 Direct	  payments	  
Local	  authorities	  were	  permitted	  to	  make	  cash	  payments	  to	  people	  with	  a	  disability	  in	  lieu	  of	  
community	  care	  services	  following	  the	  implementation	  of	  the	  Community	  Care	  (Direct	  Payments)	  Act	  
(1996).	  In	  2003,	  after	  the	  implementation	  of	  the	  Health	  and	  Social	  Care	  Act	  2001,	  local	  authorities	  
were	  required	  to	  offer	  direct	  payments	  to	  all	  people	  eligible	  for	  social	  care	  services,	  to	  be	  mainly	  
spent	  on	  personal	  and	  domestic	  support,	  through	  the	  employment	  of	  personal	  assistants	  
(Department	  of	  Health,	  2003).	  
1.2.2 In	  Control	  approach	  
Following	  the	  direct	  payment	  initiative,	  the	  White	  Paper	  Valuing	  People	  (Department	  of	  Health,	  
2001)	  set	  out	  the	  Government’s	  vision	  for	  providing	  new	  opportunities	  for	  people	  with	  learning	  
disabilities.	  Building	  on	  the	  strategy,	  the	  social	  enterprise	  organisation	  In	  Control	  combined	  both	  
person-­‐centred	  and	  direct	  payments,	  with	  the	  introduction	  of	  the	  term	  ‘self-­‐directed’	  support	  
(Needham,	  2011).	  In	  Control	  developed	  a	  system	  of	  seven-­‐stage	  self-­‐directed	  support	  with	  the	  aim	  of	  
replacing	  the	  conventional	  care	  management	  arrangements.	  The	  approach	  encouraged	  greater	  
flexibility,	  and	  the	  use	  of	  a	  wide	  range	  of	  services	  and	  support,	  rather	  than	  solely	  personal	  care	  
(Duffy,	  2005).	  
1.2.3 Individual	  (personal)	  budgets	  
Building	  on	  direct	  payments	  (DPs)	  and	  the	  In	  Control	  approach,	  individual	  budgets	  (IBs)	  were	  first	  
proposed	  within	  the	  Cabinet	  Office	  Strategy	  Unit	  report	  Improving	  the	  Life	  Chances	  of	  Disabled	  
People	  (Cabinet	  Office,	  2005)	  that	  emphasised	  the	  importance	  of	  reducing	  fragmentation	  and	  
multiple	  assessments	  by	  combining	  funding	  streams.	  This	  proposal	  went	  further	  than	  previous	  
initiatives	  concerning	  DPs,	  by	  offering	  greater	  transparency	  over	  the	  level	  of	  the	  budget	  and	  how	  it	  is	  
calculated;	  achieving	  greater	  flexibility	  over	  how	  the	  resource	  is	  used;	  and	  avoiding	  some	  of	  the	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responsibilities	  believed	  to	  have	  had	  an	  impact	  on	  the	  take-­‐up	  of	  direct	  payments.	  Budget	  holders	  
were	  given	  a	  choice	  in	  how	  the	  resource	  was	  deployed:	  they	  could	  receive	  the	  money	  directly;	  have	  a	  
managed	  budget	  via	  the	  local	  authority,	  third	  party	  or	  a	  service	  provider;	  establish	  a	  trust	  fund;	  or	  a	  
combination	  of	  these	  options.	  Furthermore,	  individual	  budgets	  combined	  a	  number	  of	  funding	  
sources	  other	  than	  social	  care,	  including	  independent	  living	  and	  supporting	  people	  funds,	  access	  to	  
work,	  and	  disabled	  facilities	  grants.	  Since	  the	  individual	  budget	  pilot	  programme,	  personalisation	  has	  
continued	  to	  be	  stated	  in	  recent	  key	  policy	  documents	  in	  England,	  including	  the	  White	  Paper	  Building	  
the	  National	  Care	  Service	  (HM	  Government,	  2010a)	  which	  anticipated	  that,	  by	  the	  time	  the	  service	  is	  
introduced,	  every	  eligible	  person	  will	  be	  offered	  a	  personal	  budget.	  Unlike	  individual	  budgets,	  
personal	  budgets	  consist	  of	  only	  social	  care	  funds	  given	  to	  service	  users	  after	  an	  assessment	  to	  meet	  
their	  social	  care	  needs.	  Budget	  holders	  should	  be	  given	  a	  transparent	  allocation	  of	  money,	  and	  they	  
are	  given	  choice	  on	  how	  to	  manage	  the	  resource	  and	  what	  services	  are	  purchased.	  
The	  importance	  placed	  on	  greater	  choice	  and	  control	  in	  service	  delivery	  is	  not	  focused	  solely	  in	  
England,	  with	  a	  number	  of	  reviews	  (The	  Health	  Foundation,	  2010;	  Alakeson,	  2010a;	  Alakeson,	  2010b;	  
Arksey	  and	  Kemp,	  2008;	  Timonen	  et	  al.,	  2006;	  Ungerson	  and	  Yeandle,	  2007;	  Alakeson,	  2007;	  Pavolini	  
and	  Ranci,	  2006)	  highlighting	  the	  development	  of	  self-­‐directed	  support	  initiatives	  in	  various	  
countries,	  including	  Austria,	  Belgium,	  Denmark,	  Italy,	  Finland,	  Austria,	  France,	  Sweden,	  Germany,	  
Australia	  and	  the	  USA.	  The	  research	  scan	  carried	  out	  by	  The	  Health	  Foundation	  (2010)	  outlined	  that	  
the	  focus	  of	  most	  programmes	  was	  to	  reduce	  the	  cost	  of	  health	  and	  social	  care	  budgets,	  although	  it	  
was	  highlighted	  that	  the	  motivations	  for	  introducing	  personal	  budgets	  differed	  between	  countries.	  
For	  example,	  in	  Belgium	  the	  initiative	  was	  designed	  to	  reduce	  the	  use	  of	  residential	  care,	  while	  in	  
Australia	  the	  focus	  was	  on	  reducing	  the	  fragmentation	  of	  services	  in	  remote	  rural	  areas.	  
Furthermore,	  there	  were	  differences	  between	  the	  initiatives	  as	  to	  the	  target	  population.	  In	  the	  USA,	  
the	  ‘cash	  and	  counselling	  system’	  is	  only	  available	  for	  people	  eligible	  for	  Medicaid,	  while	  in	  the	  
Netherlands	  elderly	  and	  disabled	  people	  in	  need	  of	  care	  can	  apply	  to	  a	  special	  municipal	  agency	  for	  
care	  services.	  In	  contrast,	  Germany	  has	  tested	  the	  impact	  of	  using	  personal	  budgets	  for	  people	  in	  
need	  of	  nursing	  care	  (The	  Health	  Foundation,	  2010).	  	  
1.3 Research	  evidence	  
A	  number	  of	  reviews	  have	  provided	  an	  overview	  of	  the	  social	  care	  initiatives	  outlined	  above	  and	  have	  
found	  generally	  a	  positive	  impact	  on	  people’s	  satisfaction	  with	  services	  and	  quality	  of	  life	  (Carr,	  2011;	  
Carr	  and	  Robbins,	  2009;	  Needham	  and	  Carr,	  2009;	  Needham,	  2011;	  Glasby	  and	  Littlechild,	  2009;	  The	  
Health	  Foundation,	  2010;	  Alakeson,	  2010b;	  Glasby	  et	  al.,	  2009).	  	  
Research	  focusing	  on	  the	  impact	  of	  personalised	  support	  within	  the	  health	  care	  system	  in	  England	  is	  
limited	  and	  is	  often	  based	  on	  qualitative	  or	  non-­‐controlled	  studies	  (NHS	  Confederation	  and	  National	  
Mental	  Health	  Development	  Unit,	  2011;	  NHS	  Confederation	  and	  National	  Mental	  Health	  
Development	  Unit,	  2009;	  Cole,	  2009;	  Macmillan	  Cancer	  Support,	  2008).	  Although	  the	  examples	  of	  
previous	  research	  are	  of	  great	  interest	  and	  provide	  valuable	  evidence,	  the	  studies	  were	  not	  designed	  
to	  answer	  questions	  such	  as	  whether	  personalised	  support	  can	  ensure	  better	  outcomes	  when	  
compared	  to	  conventional	  service	  delivery.	  From	  a	  number	  of	  reviews	  of	  the	  existing	  evidence	  
(Alakeson,	  2010a;	  Alakeson,	  2007;	  Alakeson,	  2010b)	  it	  has	  been	  suggested	  that	  the	  evidence	  from	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the	  US	  (particularly	  from	  randomised	  controlled	  trials)	  provides	  support	  for	  the	  notion	  that	  giving	  
patients	  more	  choice	  and	  control	  could	  have	  a	  positive	  impact	  on	  patients’	  experiences	  of	  NHS	  
services	  in	  England.	  Alakeson	  (2007)	  provides	  an	  example	  of	  a	  controlled	  experimental	  study	  that	  
explored	  the	  impact	  of	  a	  Cash	  and	  Counselling	  programme	  in	  the	  US	  on	  costs	  and	  outcomes.	  This	  
programme	  offers	  Medicaid	  patients	  more	  choice	  about	  how	  to	  get	  help	  at	  home.	  The	  initiative	  was	  
first	  launched	  as	  a	  demonstration	  project	  in	  Arkansas,	  Florida	  and	  New	  Jersey.	  According	  to	  the	  
evaluation	  of	  the	  demonstration	  projects	  that	  was	  carried	  out	  between	  1998	  and	  2002,	  consumers	  
were	  overwhelmingly	  satisfied	  with	  the	  Cash	  and	  Counselling	  programme	  (Robert	  Wood	  Johnson	  
Foundation,	  2006).	  The	  evaluation	  found	  that,	  compared	  to	  a	  control	  group,	  Cash	  and	  Counselling	  
reduced	  participants’	  unmet	  needs	  for	  care	  and	  helped	  them	  maintain	  their	  health.	  It	  also	  
significantly	  improved	  the	  lives	  of	  carers.	  The	  three	  states	  found	  that	  the	  programme	  could	  be	  
implemented	  without	  costing	  substantially	  more	  than	  traditional	  services.	  	  
1.3.1 Evaluation	  of	  the	  personal	  health	  budget	  pilot	  programme	  
Following	  the	  publication	  of	  the	  NHS	  Next	  Stage	  Review	  (Department	  for	  Health,	  2008),	  the	  personal	  
health	  budget	  pilot	  programme	  was	  launched	  by	  the	  Department	  of	  Health	  in	  2009	  (Department	  of	  
Health,	  2009).	  The	  Department	  of	  Health	  invited	  PCTs	  to	  become	  pilot	  sites	  and	  to	  join	  a	  three-­‐year	  
programme	  to	  explore	  the	  opportunities	  offered	  by	  personal	  health	  budgets;	  and	  an	  independent	  
evaluation	  was	  commissioned	  to	  run	  alongside	  the	  pilot	  programme.	  The	  2010	  White	  Paper	  Equity	  
and	  Excellence	  –	  Liberating	  the	  NHS	  (HM	  Government,	  2010b)	  and	  the	  Government	  response	  to	  the	  
NHS	  Future	  Forum	  report	  (Department	  of	  Health,	  2011)	  outlined	  that	  the	  Government	  intended	  to	  
use	  the	  results	  from	  the	  evaluation	  of	  the	  personal	  health	  budget	  pilot	  programme	  to	  inform	  a	  wider,	  
more	  general	  roll-­‐out	  of	  the	  initiative	  after	  2012.	  	  
However,	  for	  a	  national	  roll-­‐out	  to	  be	  successful,	  robust,	  systematic	  evidence	  is	  required.	  It	  is	  
essential	  that	  the	  various	  implementation	  possibilities	  for	  personal	  health	  budgets	  and	  the	  impact	  for	  
different	  individuals	  be	  fully	  explored;	  personal	  health	  budgets	  cannot	  be	  viewed	  as	  a	  one-­‐size-­‐fits-­‐all	  
policy.	  The	  various	  complexities	  within	  the	  personal	  health	  budget	  process	  need	  to	  be	  fully	  
understood	  if	  the	  potential	  of	  personal	  health	  budgets	  is	  to	  be	  realised	  after	  the	  pilot	  programme.	  	  
As	  noted	  above,	  much	  of	  the	  previous	  evidence	  exploring	  the	  impact	  of	  personalised	  support	  on	  
health	  outcomes	  and	  on	  the	  system	  has	  involved	  qualitative	  or	  non-­‐controlled	  research.	  This	  study	  
took	  a	  longitudinal	  approach	  combining	  both	  quantitative	  and	  qualitative	  data	  collection	  points	  not	  
only	  to	  bridge	  the	  gap	  in	  the	  evidence	  but	  also	  to	  be	  able	  to	  provide	  a	  complete	  account	  of	  the	  
personal	  health	  budget	  process	  from	  the	  system,	  and	  from	  patients	  and	  carers	  perspectives.	  	  
Initially,	  64	  pilot	  sites	  were	  involved	  in	  piloting	  personal	  health	  budgets	  and	  contributing	  to	  the	  
evaluation.	  During	  the	  evaluation	  period,	  the	  pilot	  programme	  remained	  open;	  75	  pilot	  sites	  were	  
implementing	  personal	  health	  budgets	  at	  the	  time	  of	  writing.	  Most	  of	  the	  pilot	  sites	  were	  based	  
within	  an	  individual	  PCT,	  although	  some	  worked	  across	  a	  number	  of	  PCTs.	  
Twenty	  sites	  from	  across	  the	  pilots	  were	  selected	  to	  be	  in-­‐depth	  evaluation	  sites,	  with	  the	  remainder	  
being	  wider	  cohort	  sites.	  The	  20	  in-­‐depth	  pilot	  sites	  each	  received	  funding	  of	  £100,000	  per	  year	  (for	  
18	  
	  
three	  years	  in	  total)	  to	  ensure	  that	  the	  requirements	  of	  the	  evaluation	  were	  met.	  The	  wider	  cohort	  
received	  lower	  levels	  of	  funding	  per	  year	  as	  the	  evaluation	  demands	  on	  them	  were	  less	  onerous.	  	  
The	  20	  in-­‐depth	  pilot	  sites	  were	  selected	  using	  the	  following	  criteria:	  
 Pilot	  sites	  offering	  personal	  health	  budgets	  to	  a	  large	  enough	  group	  of	  patients	  aged	  18	  and	  
over;	  
 Pilot	  sites	  offering	  budgets	  to	  patient	  groups	  where	  there	  were	  enough	  patients	  in	  total	  for	  
the	  evaluation	  to	  provide	  useful	  information;	  
 Pilot	  sites	  offering	  a	  mixture	  of	  deployment	  options;	  
 Pilot	  sites	  enabling	  inclusion	  of	  a	  range	  of	  socio-­‐economic	  groups,	  age	  groups,	  ethnic	  groups	  
and	  urban/rural	  populations;	  and	  
 Pilot	  sites	  implementing	  personal	  health	  budgets	  quickly	  enough	  to	  contribute	  information	  to	  
the	  evaluation.	  
Based	  on	  the	  plans	  submitted	  by	  pilot	  sites,	  the	  in-­‐depth	  pilot	  sites	  offered	  personal	  health	  budgets	  
to	  individuals	  with	  the	  following	  health	  conditions:	  long-­‐term	  conditions	  (including	  chronic	  
obstructive	  pulmonary	  disease,	  diabetes	  and	  long-­‐term	  neurological	  conditions);	  mental	  health;	  NHS	  
Continuing	  Healthcare;	  and	  stroke.	  Table	  1-­‐1	  below	  outlines	  the	  characteristics	  of	  the	  pilot	  sites.	  
Table	  1-­‐2	  outlines	  the	  models	  of	  how	  personal	  health	  budgets	  were	  implemented	  among	  the	  in-­‐
depth	  pilot	  sites.	  A	  range	  of	  implementation	  methods	  were	  used	  for	  personal	  health	  budgets,	  varying	  
according	  to:	  whether	  the	  budget	  is	  known	  before	  support	  planning;	  what	  flexibility	  there	  is	  in	  terms	  
of	  what	  help	  can	  be	  purchased;	  and	  the	  choice	  of	  deployment	  (including	  direct	  payment).	  The	  range	  
of	  specification	  options	  were	  condensed	  into	  five	  models	  by	  the	  evaluation	  team.	  Model	  1	  is	  
regarded	  as	  the	  most	  ambitious	  being	  nearest	  to	  policy	  intentions	  for	  personal	  health	  budgets.	  
Model	  5	  is	  a	  combination	  of	  models	  1	  and	  2.	  The	  only	  difference	  between	  these	  models	  is	  the	  
existence	  of	  a	  menu	  of	  services	  for	  the	  budget	  holder	  to	  choose	  from,	  which	  was	  as	  wide	  as	  possible	  
to	  provide	  flexibility	  to	  the	  budget	  holder.	  Nineteen	  of	  the	  20	  in-­‐depth	  pilot	  sites	  were	  classified	  
within	  one	  of	  the	  models.	  Quotations	  from	  the	  qualitative	  interviews	  with	  organisational	  
representatives	  following	  each	  implementation	  model	  can	  be	  found	  in	  Appendix	  D.	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Table	  1-­‐1	  Characteristics	  of	  pilot	  sites	  
Pilot	  
sites	  




Health	  condition	  initially	  chosen	  for	  the	  personal	  
health	  budget	  pilot	  
	  
1	   Metropolitan	   Yorkshire	  and	  Humber	   Mental	  health;	  NHS	  Continuing	  Healthcare	  
2	   London	   London	   COPD;	  Diabetes	  
3	   Unitary	   Yorkshire	  and	  Humber	   COPD;	  Diabetes;	  Long-­‐term	  neurological;	  NHS	  
Continuing	  Healthcare;	  End	  of	  Life	  
4	   Unitary	   West	  Midlands	   COPD;	  Diabetes;	  Mental	  health	  
5	   Shire	   South	  Central	   NHS	  Continuing	  Healthcare	  
6	   Shire	   South	  East	  Coast	   Mental	  health;	  NHS	  Continuing	  Healthcare;	  End	  of	  
life;	  Maternity	  
7	   Shire	   East	  Midlands	   Long-­‐term	  neurological;	  NHS	  Continuing	  healthcare;	  
Stroke	  
8	   London	   London	   COPD;	  Diabetes;	  Stroke	  
9	   Shire	   South	  West	   COPD;	  Long-­‐term	  neurological;	  NHS	  Continuing	  
Healthcare;	  End	  of	  life	  
10	   Unitary	   South	  East	  Coast	   COPD;	  Long-­‐term	  neurological;	  Mental	  health;	  
Stroke	  
11	   Unitary	   North	  East	   COPD;	  Long-­‐term	  neurological;	  NHS	  Continuing	  
Healthcare	  
12	   Metropolitan	   West	  Midlands	   COPD;	  Diabetes	  
13	   Unitary	   East	  Midlands	   Long-­‐term	  neurological;	  Mental	  health;	  NHS	  
Continuing	  Healthcare	  
14	   Shire	   East	  of	  England	   COPD;	  Long-­‐term	  neurological;	  Mental	  health;	  NHS	  
Continuing	  Healthcare	  
15	   Unitary	   South	  West	   Long-­‐term	  neurological;	  Mental	  health	  
16	   Unitary	   South	  West	   Stroke;	  NHS	  Continuing	  Healthcare	  
17	   Metropolitan	   North	  West	   Mental	  health	  
18	   Metropolitan	   North	  West	   NHS	  Continuing	  Healthcare	  
19	   Unitary	   East	  of	  England	   Long-­‐term	  neurological;	  Stroke	  
20	   London	   London	   COPD;	  Diabetes;	  Long-­‐term	  neurological;	  NHS	  





Table	  1-­‐2	  Implementation	  models	  
Implementation	  models	   In-­‐depth	  pilot	  sites	  
Model	  1	  
Personalised	  budget	  is	  known	  before	  support	  planning	  
Flexibility	  in	  what	  help	  can	  be	  purchased	  
Deployment	  choice	  (including	  DP)	  
8	  pilot	  sites	  	  
Model	  2	  
Budget	  is	  known	  before	  support	  planning	  (but	  may	  not	  be	  
personalised	  –	  a	  set	  amount)	  
Service	  directory	  
Deployment	  choice	  (including	  DP)	  
4	  pilot	  sites	  
Model	  3	  
Budget	  is	  known	  before	  support	  planning	  (but	  may	  not	  be	  
personalised	  –	  a	  set	  amount)	  
Lack	  of	  flexibility	  in	  the	  help	  that	  can	  be	  purchased	  
No	  deployment	  choice	  	  
3	  pilot	  sites	  
Model	  4	  
Budget	  is	  not	  known	  before	  support	  planning	  
Flexibility	  in	  what	  help	  can	  be	  purchased	  
Variation	  in	  the	  degree	  of	  deployment	  choice	  
4	  pilot	  sites	  
Model	  5	  
Model	  1	  and	  2	  combined	  
12	  pilot	  sites	  
	  
1.3.1.1 Aims	  of	  the	  national	  evaluation	  
The	  overarching	  aim	  of	  the	  evaluation	  is	  to	  identify	  whether	  personal	  health	  budgets	  ensured	  better	  
health	  and	  social	  care	  outcomes	  when	  compared	  to	  conventional	  service	  delivery	  and,	  if	  so,	  the	  best	  
way	  they	  should	  be	  implemented.	  The	  evaluation	  explores:	  
1. The	  process	  of	  implementing	  personal	  health	  budgets	  for	  individuals	  and	  carers;	  
2. The	  short-­‐	  and	  longer-­‐term	  impacts	  of	  personal	  health	  budgets	  on	  different	  groups	  of	  people	  
and	  their	  carers	  (including	  the	  effects	  of	  demographic	  and	  socio-­‐demographic	  factors);	  
3. The	  cost-­‐effectiveness	  of	  implementing	  personal	  health	  budgets	  for	  different	  health	  conditions,	  
compared	  to	  conventional	  service	  delivery;	  and	  the	  costs	  and	  benefits	  of	  different	  models	  of	  
personal	  health	  budgets	  for	  different	  groups	  of	  people;	  
4. The	  short-­‐	  and	  longer-­‐term	  impact	  of	  implementing	  personal	  health	  budgets	  on	  NHS	  
organisations,	  staff	  and	  the	  wider	  health	  and	  social	  care	  system;	  
5. The	  fit	  of	  personal	  health	  budgets	  with	  the	  broader	  context	  of	  the	  NHS	  and	  NHS	  values;	  and	  
6. The	  longer-­‐term	  effects	  if	  personal	  health	  budgets	  were	  to	  be	  further	  rolled	  out.	  
21	  
	  
1.4 Structure	  of	  the	  report	  
This	  report	  is	  structured	  as	  follows.	  Chapter	  2	  outlines	  the	  methods	  used	  in	  the	  evaluation.	  Chapter	  3	  
describes	  the	  sample	  of	  participants	  recruited	  to	  the	  study.	  Chapter	  4	  provides	  a	  description	  of	  how	  
people	  were	  using	  their	  personal	  health	  budget.	  Chapter	  5	  reports	  the	  analysis	  of	  the	  impact	  of	  
personal	  health	  budgets	  on	  a	  range	  of	  outcome	  indicators.	  Costs	  and	  cost-­‐effectiveness	  analysis	  are	  
reported	  in	  chapter	  6,	  while	  chapter	  7	  describes	  the	  analysis	  of	  the	  impact	  of	  receiving	  personal	  
health	  budgets	  on	  carers.	  Chapter	  8	  discusses	  the	  main	  analysis	  to	  infer	  the	  successes	  and	  challenges	  
of	  the	  personal	  health	  budget	  pilot.	  Finally,	  chapter	  9	  draws	  together	  the	  evidence	  to	  provide	  a	  series	  
of	  recommendations	  about	  whether,	  and	  how,	  personal	  health	  budgets	  should	  be	  implemented	  

















2.1 Summary	  	  
	  
2.2 Overall	  research	  design	  
The	  evaluation	  within	  the	  in-­‐depth	  pilot	  sites	  used	  a	  controlled	  trial	  with	  a	  pragmatic	  design	  
(depending	  on	  pilot	  site	  arrangements)	  to	  compare	  the	  experiences	  of	  people	  selected	  to	  receive	  
personal	  health	  budgets	  with	  the	  experiences	  of	  people	  continuing	  under	  the	  current	  support	  
arrangements	  for	  their	  condition.	  	  
To	  best	  fit	  with	  the	  specific	  local	  configuration	  of	  the	  personal	  health	  budget	  pilot	  in	  each	  site,	  
selection	  of	  individuals	  into	  either	  the	  personal	  health	  budget	  group	  or	  the	  control	  group	  occurred	  in	  
one	  of	  two	  ways.	  The	  first	  option	  applied	  to	  sites	  where	  the	  pilot	  was	  set	  up	  so	  that	  personal	  health	  
budgets	  were	  potentially	  offered	  by	  any	  health	  professional	  in	  the	  site.	  In	  this	  case,	  people	  under	  the	  
care	  of	  the	  health	  professional	  who	  were	  judged	  as	  potentially	  eligible	  for	  a	  personal	  health	  budget	  
were	  randomised	  into	  either	  the	  personal	  health	  budget	  group	  or	  the	  control	  group.	  People	  selected	  
to	  the	  personal	  health	  budget	  group	  were	  offered	  a	  budget	  and	  were	  asked	  to	  participate	  in	  the	  
evaluation.	  The	  offer	  of	  the	  personal	  health	  budget	  was	  not	  dependent	  on	  participating	  in	  the	  
research.	  People	  selected	  into	  the	  control	  group	  were	  also	  asked	  to	  participate	  in	  the	  evaluation.	  
The	  second	  option	  was	  where	  pilots	  were	  set	  up	  so	  that	  separate	  health	  professional	  groups	  either	  
offered	  personal	  health	  budgets	  or	  recruited	  patients	  to	  the	  control	  group.	  This	  meant	  that	  all	  
potential	  personal	  health	  budget	  patients,	  up	  to	  a	  quota,	  were	  selected	  into	  the	  PHB	  group	  by	  
participating	  health	  professionals.	  Non-­‐participating	  health	  professionals	  in	  that	  site	  were	  asked	  to	  
select	  a	  control	  group	  from	  people	  who	  would	  potentially	  be	  eligible	  for	  a	  personal	  health	  budget.	  A	  
cluster	  randomisation	  design	  was	  considered,	  with	  GP	  practices	  forming	  clusters	  of	  patients.	  
The	  evaluation	  used	  a	  controlled	  trial	  with	  a	  pragmatic	  design	  (depending	  on	  pilot	  site	  arrangements)	  
to	  compare	  the	  experiences	  of	  people	  selected	  to	  receive	  personal	  health	  budgets	  with	  the	  
experiences	  of	  people	  continuing	  under	  the	  current	  support	  arrangements	  for	  their	  condition.	  
The	  quantitative	  and	  qualitative	  data	  collection	  points	  are	  outlined	  in	  this	  chapter	  that	  were	  followed	  
to	  explore:	  	  
 Patient	  outcome	  and	  experiences	  
o Individual	  outcome	  data;	  
o Primary	  and	  secondary	  care	  service	  use;	  
o Information	  about	  care/support	  plans;	  
o Qualitative	  data	  on	  patient	  outcomes	  and	  experiences;	  
 Implementation	  experiences	  and	  costs	  
o Pilot	  sites’	  experiences	  of	  implementing	  personal	  health	  budget.	  





However,	  although	  the	  number	  of	  GP	  practices	  across	  the	  20	  in-­‐depth	  pilot	  sites	  was	  sufficiently	  
large,	  the	  numbers	  within	  each	  pilot	  site	  were	  not.	  Given	  the	  different	  implementations	  of	  personal	  
health	  budgets	  by	  site,	  selection	  needed	  to	  occur	  within	  each	  pilot	  site.	  Instead,	  comparator	  
practices	  were	  chosen	  according	  to	  local	  selection	  criteria.	  In	  the	  main,	  personal	  health	  budget	  
patients	  were	  drawn	  from	  practices	  in	  one	  patch	  within	  the	  pilot	  site	  and	  the	  control	  patients	  from	  
practices	  in	  a	  different	  patch	  (chosen	  to	  be	  a	  similar	  as	  possible).	  Where	  this	  was	  not	  possible,	  for	  
example	  because	  local	  GPs	  refused	  to	  offer	  personal	  health	  budgets	  or	  where	  equivalent	  patches	  
could	  not	  be	  easily	  found,	  control	  patients	  were	  drawn	  from	  practices	  selected	  on	  a	  more	  
opportunistic	  basis.	  
For	  people	  who	  did	  not	  have	  the	  capacity	  to	  consent,	  (for	  example	  where	  an	  individual	  lacks	  capacity	  
to	  make	  a	  decision	  or	  take	  a	  particular	  action	  for	  themselves	  at	  the	  time	  the	  decision	  needs	  to	  be	  
taken),	  a	  representative	  was	  approached	  and	  asked	  if	  they	  would	  like	  to	  participate	  in	  the	  evaluation	  
on	  behalf	  of	  the	  patient.	  The	  representative	  was	  asked	  to	  give	  consent	  for	  the	  potential	  participant	  
to	  take	  part	  only	  if	  they	  believed	  this	  would	  be	  their	  wish.	  The	  decision	  about	  capacity	  to	  consent	  
was	  initially	  made	  by	  the	  identified	  health	  professional	  in	  the	  pilot	  site.	  
The	  allocation	  into	  either	  the	  personal	  health	  budget	  group	  or	  the	  control	  group	  was	  followed	  by	  a	  
number	  of	  quantitative	  and	  qualitative	  data	  collection	  points	  over	  a	  12-­‐month	  period.	  
2.3 Data	  collection	  for	  in-­‐depth	  sites	  
Figure	  2-­‐1	  outlines	  both	  quantitative	  and	  qualitative	  data	  collection	  that	  was	  followed	  to	  explore	  
both:	  
 Patient	  outcome	  and	  experiences;	  
 Implementation	  experiences	  and	  costs.	  
Figure	  2-­‐1	  provides	  further	  detail	  on	  the	  different	  data	  collection	  points	  and	  the	  outcome	  measures.	  
2.3.1 Patient	  outcome	  and	  experiences	  
2.3.1.1 Individual	  outcome	  data	  
Within	  the	  quantitative	  data	  collection,	  outcome	  data	  were	  collected	  on	  four	  occasions:	  at	  the	  time	  
of	  consent	  (baseline);	  six	  months	  after	  date	  of	  consent	  (initial	  follow-­‐up);	  12	  months	  after	  date	  of	  
consent	  (main	  follow-­‐up);	  and	  up	  to	  24	  months	  after	  date	  of	  consent	  (second	  follow-­‐up).	  
Organisational	  representatives	  working	  within	  the	  pilot	  sites	  carried	  out	  the	  baseline	  outcome	  
interviews	  between	  April	  2010	  and	  June	  2011.	  
The	  six-­‐month	  data	  collection	  was	  via	  postal	  questionnaires	  which	  were	  sent	  out	  from	  October	  2010	  
and	  continued	  until	  December	  2011.	  The	  follow-­‐up	  interviews	  began	  12	  months	  later,	  in	  April	  2011	  
and	  continued	  until	  June	  2012;	  these	  interviews	  were	  conducted	  by	  a	  research	  fieldwork	  agency.	  
Finally,	  the	  second	  follow-­‐up	  outcome	  data	  collection	  was	  via	  a	  postal	  questionnaire	  which	  was	  sent	  
out	  between	  17	  and	  24	  months	  later,	  starting	  in	  September	  2011	  and	  continuing	  until	  May	  2012.	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The	  questionnaires	  included	  the	  following	  outcome	  measures:	  
 Health-­‐related	  quality	  of	  life	  (EQ-­‐5D	  –	  Euro-­‐QoL)2;	  
 Care-­‐related	  quality	  of	  life	  (ASCOT);	  
 Psychological	  well-­‐being	  (GHQ-­‐12);	  
 Subjective	  well-­‐being	  scale;	  	  
 Perceived	  quality	  of	  life	  (a	  seven-­‐point	  scale);	  
 Perceived	  health	  (a	  five-­‐point	  scale).	  
	  
Further	  details	  can	  be	  found	  below	  (section	  2.5.5)	  and	  in	  Appendix	  A.	  The	  outcome	  questionnaire	  
also	  collected	  information	  around	  social	  care	  and	  primary	  care	  service	  use.	  In	  addition,	  demographic	  
and	  socio-­‐economic	  information	  was	  collected,	  as	  well	  as	  information	  about	  current	  circumstances.	  
Table	  2-­‐1	  lists	  the	  variables	  that	  were	  included	  in	  the	  outcome	  questionnaires.	  	  
Table	  2-­‐1	  List	  of	  variables	  included	  in	  the	  outcome	  questionnaire	  
Demographic	  information	   Socio-­‐demographic	  information	  
Age	   Highest	  education	  level	  	  
Ethnicity	   Type	  of	  income	  
Sexual	  orientation	   	  
Gender	  (including	  trans-­‐gender)	   Current	  circumstances	  
Religion	   Activities	  of	  daily	  living	  
Household	  composition	  and	  accommodation	   Receipt	  of	  informal	  care	  support	  
Marital	  status	   Employment	  status	  
	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
2	  ©	  1990	  EuroQol	  Group.	  EQ-­‐5D™	  is	  a	  trade	  mark	  of	  the	  EuroQol	  Group.	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Care/support	  plan	  (PHB	  Group)	  
	  
Sample	  selection	  
 Potential	  participants	  identified	  








2.3.1.2 Primary	  and	  secondary	  care	  service	  use	  
A	  medical	  record	  template	  was	  designed	  by	  the	  evaluation	  team	  to	  gather	  information	  from	  GP	  
records	  concerning	  participants’	  health	  status	  and	  their	  use	  of	  primary	  and	  secondary	  health	  care	  
services.	  
This	  information	  was	  collected	  at	  two-­‐time	  points	  during	  the	  study	  period:	  first,	  around	  the	  time	  of	  
consent	  to	  explore	  the	  previous	  12	  months	  activity;	  second,	  around	  12	  months	  after	  participants	  
agreed	  to	  take	  part	  to	  gather	  information	  for	  the	  year	  following	  consent.	  Information	  about	  
secondary	  health	  care	  service	  use	  was	  also	  gathered	  from	  Hospital	  Episodes	  Statistics	  (HES)	  during	  
2008	  and	  2012.	  
2.3.1.3 Information	  about	  the	  care	  plan	  and	  personal	  health	  budget	  
For	  the	  personal	  health	  budget	  holders,	  the	  evaluation	  team	  asked	  for	  a	  copy	  of	  the	  support/care	  
plan	  that	  outlined	  the	  following	  information:	  
 The	  budget	  per	  year,	  and	  the	  total	  level	  of	  funding	  in	  terms	  of	  health	  service	  expenditure,	  
recurrent	  annual	  and	  one-­‐off	  payments	  (where	  applicable);	  
 The	  cost	  of	  planning	  health	  support;	  
 The	  formal	  organisation	  of	  the	  budget	  in	  terms	  of	  deployment	  options;	  
 The	  activities	  in	  the	  care	  plan	  that	  the	  budget	  was	  to	  be	  spent	  on;	  and	  
 The	  cost	  of	  the	  individual	  services	  identified	  within	  the	  care	  plan.	  
2.3.1.4 Qualitative	  data	  on	  patient	  outcomes	  and	  experiences	  
The	  quantitative	  arm	  of	  the	  study	  was	  supplemented	  with	  qualitative	  data	  derived	  from	  semi-­‐
structured	  interviews	  with	  a	  sub-­‐sample	  of	  personal	  health	  budget	  holders.	  These	  interviews	  were	  
conducted	  three	  and	  nine	  months	  after	  the	  offer	  of	  a	  personal	  health	  budget.	  Budget	  holders	  were	  
recruited	  for	  these	  interviews	  from	  amongst	  those	  who	  had	  already	  consented	  to	  take	  part	  in	  the	  
quantitative	  strand	  of	  the	  evaluation.	  The	  aim	  was	  to	  recruit	  this	  sub-­‐sample	  from	  at	  least	  half	  of	  the	  
20	  pilot	  sites	  involved	  in	  the	  in-­‐depth	  evaluation;	  to	  include	  budget	  holders	  with	  each	  of	  the	  health	  
conditions	  for	  which	  personal	  health	  budgets	  were	  offered;	  and	  to	  include	  a	  spread	  of	  ages	  and	  a	  
roughly	  equal	  gender	  balance.	  Sampling	  also	  aimed	  to	  include	  budget	  holders	  from	  a	  range	  of	  ethnic	  
groups.	  However,	  this	  depended	  on	  the	  wider	  sample	  and,	  as	  only	  small	  numbers	  of	  non-­‐White	  
British	  budget	  holders	  had	  been	  recruited	  to	  the	  wider	  evaluation	  at	  the	  time	  the	  sub-­‐sample	  was	  
selected,	  the	  number	  of	  interviewees	  from	  minority	  ethnic	  communities	  in	  the	  sub-­‐sample	  was	  
similarly	  limited.	  Inclusion	  of	  the	  full	  range	  of	  deployment	  options	  for	  personal	  health	  budgets	  in	  the	  
qualitative	  sub-­‐sample	  was	  similarly	  determined	  by	  progress	  with	  implementation	  in	  the	  pilot	  sites	  
and	  by	  recruitment	  to	  the	  wider	  evaluation.	  
The	  aim	  was	  to	  recruit	  a	  sub-­‐sample	  of	  55	  budget	  holders	  to	  take	  part	  in	  the	  semi-­‐structured	  
interviews.	  In	  fact,	  58	  budget	  holders	  were	  recruited	  initially	  and	  took	  part	  in	  the	  three	  month	  
interviews;	  52	  of	  these	  were	  re-­‐interviewed	  at	  nine	  months.	  Five	  of	  the	  initial	  sample	  withdrew	  
27	  
	  
before	  the	  nine-­‐month	  interview,	  and	  a	  sixth	  who	  had	  been	  interviewed	  at	  three	  months	  could	  not	  
be	  re-­‐contacted	  at	  nine	  months.	  
The	  interviews	  at	  three	  months	  explored	  how	  people	  found	  out	  about	  personal	  health	  budgets	  and	  
their	  initial	  impressions;	  their	  knowledge	  of	  the	  amount	  of	  the	  budget	  and	  how	  this	  had	  been	  
calculated;	  their	  decisions	  about	  how	  to	  use	  the	  budget	  and	  the	  help	  received	  with	  this;	  and	  options	  
for	  managing	  the	  budget.	  The	  nine-­‐month	  interviews	  focused	  on	  the	  perceived	  impacts	  of	  the	  
personal	  health	  budget	  on	  budget	  holders’	  health,	  well-­‐being	  and	  quality	  of	  life;	  reflections	  on	  their	  
chosen	  uses	  for	  the	  budget;	  satisfaction	  with	  the	  amount	  of	  the	  budget;	  reflections	  on	  the	  way	  the	  
budget	  had	  been	  managed;	  and	  experiences	  of	  the	  implementation	  of	  personal	  health	  budgets.	  
Interviews	  were	  digitally	  recorded,	  with	  interviewees’	  consent,	  and	  subsequently	  transcribed.	  
2.3.1.5 Carers	  
Personal	  health	  budgets	  may	  have	  an	  impact	  not	  only	  on	  patients	  but	  also	  on	  their	  family	  carers.	  We	  
asked	  study	  participants	  to	  say	  whether	  they	  had	  a	  carer	  and,	  if	  so,	  whether	  they	  were	  happy	  for	  us	  
to	  approach	  them.	  Twelve	  months	  after	  the	  patient	  gave	  consent,	  a	  questionnaire	  was	  made	  
available	  to	  those	  carers	  in	  both	  the	  personal	  health	  budget	  group	  and	  the	  control	  group.	  This	  data	  
collection	  began	  in	  April	  2011	  and	  continued	  until	  June	  2012.	  The	  questionnaire	  included	  the	  
following	  outcome	  measures	  to	  explore	  whether	  personal	  health	  budgets	  had	  an	  impact	  on	  carers’	  
quality	  of	  life	  and	  the	  caring	  role:	  
 Health-­‐related	  quality	  of	  life	  (EQ-­‐5D	  –	  Euro-­‐QoL);	  
 Perceived	  quality	  of	  life	  (a	  seven-­‐point	  scale);	  
 Perceived	  health	  (a	  five-­‐point	  scale).	  
The	  questionnaire	  also	  contained	  questions	  from	  the	  first	  national	  survey	  of	  adult	  carers’	  
experiences,	  views	  and	  outcomes	  conducted	  in	  England	  by	  councils	  with	  social	  services	  
responsibilities	  (Malley	  et	  al.,	  2010;	  Fox	  et	  al.,	  2010;	  Holder	  et	  al.,	  2009).	  
2.3.2 Implementation	  experiences	  and	  costs	  
2.3.2.1 Pilot	  sites’	  experiences	  of	  implementing	  personal	  health	  budgets	  
Both	  quantitative	  and	  qualitative	  data	  collection	  techniques	  were	  used	  to	  explore	  pilot	  sites’	  
experiences	  of	  implementing	  personal	  health	  budgets.	  
The	  quantitative	  data	  collection	  involved	  key	  front-­‐line	  operational	  staff	  completing	  a	  web-­‐based	  
questionnaire	  in	  month	  3	  and	  month	  24	  of	  the	  evaluation.	  The	  questionnaires	  focused	  on	  whether	  
the	  implementation	  of	  personal	  health	  budgets	  had	  an	  impact	  on	  the	  workplace	  environment.	  The	  
quantitative	  data	  also	  included	  various	  relevant	  measures,	  such	  as	  ‘propensity	  to	  leave’,	  job	  
satisfaction	  and	  occupational	  stress.	  
In	  addition,	  to	  ensure	  as	  far	  as	  possible	  that	  the	  costs	  reported	  reflected	  only	  the	  resources	  required	  
for	  the	  implementation	  of	  personal	  health	  budgets	  rather	  than	  being	  associated	  with	  being	  a	  pilot	  
site,	  a	  template	  was	  designed	  (see	  Appendix	  E).	  The	  data	  collection	  explored	  the	  costs	  associated	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with	  implementing	  personal	  health	  budgets	  during	  the	  first	  and	  second	  year	  of	  the	  local	  pilot	  
programme.	  Project	  leads	  were	  asked	  to	  complete	  the	  template	  at	  two	  time-­‐points:	  during	  month	  12	  
and	  month	  24	  of	  the	  evaluation.	  
It	  was	  anticipated	  that	  the	  implementation	  of	  personal	  health	  budgets	  would	  create	  many	  challenges	  
for	  the	  pilot	  areas.	  It	  was	  vitally	  important	  to	  explore	  in	  detail	  the	  processes	  of	  implementing	  
personal	  health	  budgets;	  the	  challenges	  and	  barriers	  encountered	  and	  how	  these	  were	  overcome;	  
and	  the	  impact	  of	  personal	  health	  budgets	  on	  the	  wider	  local	  health	  and	  social	  care	  economy	  and	  
patterns	  of	  service	  provision.	  This	  area	  of	  the	  evaluation	  relied	  on	  qualitative	  interviews	  from	  project	  
leads;	  operational	  staff;	  front-­‐line	  professionals;	  third-­‐party	  budget	  holders;	  and	  commissioning	  
managers	  at	  three	  points	  of	  the	  study	  period:	  months	  3,	  15	  and	  24.	  Interviews	  with	  service	  providers	  
and	  managers	  of	  user/carer	  organisations	  were	  carried	  out	  within	  month	  24	  of	  the	  evaluation.	  	  
2.4 Data	  collection	  for	  the	  wider	  cohort	  pilot	  sites	  
The	  wider	  cohort	  of	  pilot	  sites	  was	  asked	  to	  recruit	  personal	  health	  budget	  holders	  to	  the	  main	  
evaluation	  between	  April	  2010	  and	  April	  2011.	  Recruitment	  to	  the	  personal	  health	  budget	  group	  
followed	  the	  process	  outlined	  for	  the	  in-­‐depth	  pilot	  sites.	  
Upon	  receipt	  of	  the	  consent	  form,	  the	  baseline	  outcome	  questionnaire	  was	  posted	  directly	  to	  the	  
individual	  for	  completion.	  An	  outcome	  questionnaire	  was	  sent	  again	  at	  12	  months	  after	  the	  person	  
consented	  to	  participate	  in	  the	  evaluation.	  The	  questionnaire	  covered	  the	  same	  measures	  as	  
described	  above.	  As	  with	  the	  data	  collection	  in	  the	  in-­‐depth	  sites,	  a	  copy	  of	  the	  care	  plan	  was	  
requested,	  and	  information	  about	  the	  budget	  holder’s	  use	  of	  secondary	  care	  services	  was	  extracted	  
from	  the	  hospital	  episode	  statistics	  (HES).	  
To	  provide	  further	  understanding	  of	  the	  implementation	  issues	  within	  the	  local	  wider	  cohort	  pilot,	  a	  
web-­‐based	  questionnaire	  was	  developed	  for	  project	  leads	  to	  complete	  during	  month	  17	  of	  the	  study	  
period.	  A	  further	  web-­‐based	  questionnaire	  was	  developed	  to	  capture	  the	  views	  of	  project	  leads	  
around	  the	  perceived	  success	  of	  the	  local	  pilot.	  
2.5 Quantitative	  data	  analysis	  
2.5.1 Sample	  size	  and	  power	  
Based	  on	  initial	  power	  calculations,	  the	  aim	  was	  to	  achieve	  a	  final	  sample	  size	  of	  2,000	  individuals	  
into	  the	  evaluation:	  1,000	  to	  the	  personal	  health	  budget	  group	  and	  1,000	  to	  the	  control	  group.	  Power	  
calculations	  for	  minimum	  sample	  sizes	  were	  computed	  using	  data	  from	  the	  evaluation	  of	  individual	  
budget	  pilot	  programme	  (IBSEN)	  (Glendinning	  et	  al.,	  2008).	  In	  common	  with	  the	  measures	  used	  for	  
this	  study,	  the	  IBSEN	  evaluation	  used	  both	  the	  GHQ-­‐12	  measure	  and	  the	  ASCOT	  measure3.	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
3	  A	  slightly	  different	  version	  of	  ASCOT	  was	  available	  at	  the	  time.	  
29	  
	  
Based	  on	  the	  mean	  and	  standard	  deviation	  scores	  for	  the	  comparison	  sample	  in	  the	  IBSEN	  study,	  and	  
assuming	  a	  power	  of	  0.8,	  a	  minimum	  sample	  of	  1,474	  (737	  participants	  recruited	  to	  the	  ‘personal	  
health	  budget	  group’	  and	  737	  to	  the	  ‘control	  group’)	  would	  be	  required	  to	  detect	  an	  overall	  one-­‐
point	  increase	  in	  GHQ-­‐12	  in	  a	  two-­‐sample	  comparison.4	  	  
As	  regards	  ASCOT,	  the	  IBSEN	  study	  detected	  an	  improvement	  of	  just	  over	  0.03	  (significant	  at	  the	  5%	  
level)	  when	  expressed	  on	  a	  0	  to	  1	  range.	  To	  detect	  this	  change	  in	  a	  two-­‐sample	  comparison	  based	  on	  
the	  IBSEN	  comparison	  group	  mean	  and	  standard	  deviation	  would	  require	  each	  sample	  to	  have	  at	  
least	  635	  observations	  or	  1,270	  in	  total.	  
Given	  that	  we	  expected	  some	  loss	  at	  follow-­‐up	  and	  also	  missing	  data	  within	  records	  that	  would	  
require	  imputation	  (see	  section	  2.5.4	  below),	  we	  aimed	  to	  achieve	  a	  sample	  size	  of	  1,000	  for	  each	  
group	  (personal	  health	  budget	  and	  control)	  by	  having	  an	  initial	  target	  sample	  of	  3,000	  participants	  to	  
account	  for	  attrition	  rates.	  Ideally	  a	  larger	  sample	  would	  have	  been	  collected	  to	  allow	  sub-­‐group	  
analyses	  to	  be	  powered,	  but	  there	  were	  limits	  on	  the	  resources	  available	  in	  the	  study.	  As	  a	  
consequence,	  for	  sub-­‐group	  analyses	  with	  fewer	  cases	  than	  indicated	  by	  our	  power	  calculation	  a	  
non-­‐significant	  result	  could	  stem	  from	  the	  estimation	  being	  under-­‐powered.	  
2.5.2 Evaluating	  impact	  within	  the	  in-­‐depth	  pilot	  sites	  
To	  assess	  the	  impact	  of	  any	  intervention	  –	  such	  as	  a	  personal	  health	  budget	  or	  a	  new	  drug	  –	  on	  an	  
outcome	  indicator	  we	  need	  to	  establish	  the	  counterfactual:	  i.e.	  what	  would	  have	  happened	  if	  the	  
person	  had	  not	  received	  the	  intervention.	  The	  difference	  between	  the	  indicator	  with	  the	  intervention	  
and	  the	  indicator	  without	  the	  intervention	  is	  a	  measure	  of	  its	  effectiveness.	  One	  way	  to	  do	  this	  is	  a	  
before-­‐and-­‐after	  study:	  that	  is,	  to	  assume	  that	  the	  person’s	  situation/status	  before	  the	  intervention	  
is	  a	  good	  indication	  of	  what	  their	  situation	  would	  be	  in	  the	  future	  had	  they	  not	  had	  the	  intervention.	  
However,	  this	  is	  a	  strong	  assumption:	  that	  over	  the	  course	  of	  the	  intervention	  nothing	  else	  affects	  
people’s	  situation.	  This	  assumption	  is	  particularly	  hard	  to	  defend	  when	  the	  intervention	  takes	  place	  
over	  a	  long	  period	  of	  time,	  e.g.	  a	  year,	  and	  where	  it	  involves	  people	  with	  one	  or	  more	  long-­‐term	  
health	  conditions	  which	  could	  deteriorate	  during	  the	  study	  period.	  	  
An	  alternative	  is	  to	  use	  a	  control	  group	  and	  to	  compare	  the	  experiences	  of	  people	  who	  had	  the	  new	  
intervention	  with	  those	  who	  continued	  to	  receive	  their	  usual	  support.	  A	  comparison-­‐after-­‐use	  study	  
measures	  the	  outcome	  indicator	  of	  interest	  in	  both	  groups	  after	  the	  intervention	  and	  takes	  the	  
difference	  as	  a	  measure	  of	  effectiveness	  of	  the	  new	  intervention.	  This	  approach	  assumes	  that	  the	  
situation	  of	  people	  before	  the	  intervention	  is	  the	  same	  between	  the	  personal	  health	  budget	  and	  
control	  groups.	  In	  a	  randomised	  controlled	  trial	  we	  can	  be	  confident	  that	  this	  is	  the	  case,	  especially	  if	  
the	  trial	  is	  ‘blind’:	  i.e.	  that	  patients	  and	  practitioners	  do	  not	  know	  which	  group	  they	  are	  in	  during	  the	  
study.	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
4	  The	  36-­‐range	  GHQ-­‐12	  score	  in	  IBSEN	  had	  a	  mean	  of	  13.8	  and	  a	  standard	  deviation	  of	  6.85	  for	  the	  comparison	  group.	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In	  many	  cases	  a	  double-­‐blind	  randomised	  controlled	  trial	  is	  not	  possible,	  and	  it	  was	  not	  possible	  in	  
this	  evaluation.	  Without	  blinding	  there	  was	  the	  potential	  problem	  that	  local	  patients	  and	  
practitioners	  could	  change	  their	  behaviour	  with	  regard	  to	  the	  control	  group,	  thus	  potentially	  biasing	  
the	  experiences	  of	  participants	  in	  providing	  a	  counterfactual.	  This	  problem	  is	  particularly	  significant	  
for	  evaluation	  of	  more	  systemic	  interventions	  such	  as	  personal	  health	  budgets	  rather	  than,	  say,	  a	  
new	  drug	  therapy.	  
In	  this	  study	  we	  chose	  a	  mixed	  methodology,	  with	  some	  in-­‐depth	  sites	  using	  (non-­‐blind)	  
randomisation	  and	  others	  using	  a	  control	  between	  localities,	  as	  described	  above.	  This	  mixing	  gave	  us	  
some	  opportunity	  to	  compare	  results	  produced	  by	  these	  different	  methods.	  In	  any	  case,	  it	  was	  
difficult	  to	  defend	  the	  assumption	  that	  the	  characteristics	  and	  situation	  of	  people	  in	  the	  personal	  
health	  budget	  group	  were	  the	  same	  (on	  average)	  as	  those	  people	  in	  the	  control	  group.	  To	  address	  
this	  potential	  limitation,	  we	  opted	  to	  use	  a	  method	  that	  required	  the	  weakest	  assumptions:	  the	  
difference-­‐in-­‐difference	  approach.	  This	  approach	  recognises	  that	  both	  intervention	  and	  control	  
groups	  could	  differ	  at	  baseline	  and	  that	  other	  influences	  may	  apply	  during	  the	  course	  of	  the	  
intervention.	  Rather	  than	  compare	  post-­‐intervention	  outcome	  indicators	  between	  groups,	  we	  
compared	  the	  changes	  in	  the	  outcome	  indicator	  between	  baseline	  and	  follow-­‐up	  between	  the	  two	  
groups.	  In	  particular,	  effectiveness	  was	  measured	  by	  subtracting	  the	  change	  (follow-­‐up	  score	  minus	  
the	  baseline)	  in	  the	  outcome	  indictor	  for	  the	  control	  group	  from	  the	  same	  change	  in	  the	  outcome	  
indicator	  for	  the	  intervention	  group.	  In	  other	  words,	  we	  were	  assuming	  that,	  without	  the	  
intervention,	  the	  situation	  of	  the	  intervention	  group	  would	  change	  (on	  average)	  by	  the	  same	  amount	  
as	  the	  control	  group.	  The	  counterfactual	  is	  therefore	  the	  change	  in	  outcome	  indicator	  between	  the	  
groups.	  Arguably,	  this	  assumption	  –	  that	  external	  influences	  affect	  people	  in	  both	  groups	  in	  the	  same	  
way	  –	  is	  less	  demanding	  than	  the	  assumptions	  required	  for	  the	  above	  methods.	  
The	  difference-­‐in-­‐difference	  (DiD)	  measure	  was:	  
Δ𝑦𝑦 = 𝑦𝑦 − 𝑦𝑦 − (𝑦𝑦 − 𝑦𝑦)	  
where:	  
𝑦𝑦	  is	  the	  measured	  indicator	  for	  the	  personal	  health	  budget	  group	  at	  follow-­‐up	  
𝑦𝑦	  is	  the	  measured	  indicator	  for	  the	  personal	  health	  budget	  group	  at	  baseline	  
𝑦𝑦	  is	  the	  measured	  indicator	  for	  the	  control	  group	  at	  follow-­‐up	  
𝑦𝑦	  is	  the	  measured	  indicator	  for	  the	  control	  group	  at	  baseline	  
The	  method	  for	  deriving	  this	  difference-­‐in-­‐difference	  measure	  is	  described	  in	  Box	  2-­‐1.	  Further	  




The	  difference-­‐in-­‐difference	  method	  can	  be	  used	  for	  any	  indicator	  that	  has	  been	  measured	  both	  at	  
baseline	  and	  follow-­‐up.	  In	  particular,	  we	  used	  it	  for	  our	  effectiveness	  measures,	  where	  we	  have	  𝑦𝑦	  as	  
an	  effect	  indicator,	  E,	  such	  as	  health	  or	  care-­‐related	  quality	  of	  life.	  The	  difference-­‐in-­‐difference	  
Box	  2-­‐1.	  Difference-­‐in-­‐Difference	  methods	  
Suppose	  that	  𝑦𝑦	  is	  the	  outcome	  indicator	  in	  question	  (e.g.	  care-­‐related	  quality	  of	  life	  
(SCRQOL).	  The	  subscript	  i	  refers	  to	  the	  patient	  group:	  𝑖𝑖 = 1	  for	  the	  personal	  health	  budget	  
group	  and	  𝑖𝑖 = 0	  for	  the	  control	  group.	  The	  subscript	  t	  refers	  to	  the	  time	  point:	  𝑡𝑡 = 0	  is	  the	  
pre-­‐intervention	  baseline	  time	  and	  𝑡𝑡 = 1	  is	  the	  post-­‐intervention	  follow-­‐up	  time	  (e.g.	  the	  12-­‐
month	  follow-­‐up).	  In	  the	  figure	  below	  ()	  we	  have	  illustrated	  a	  situation	  where	  the	  personal	  
health	  budget	  group	  has	  higher	  (better)	  SCRQOL	  than	  the	  control	  group	  i.e.	  𝑦𝑦 > 𝑦𝑦,	  
perhaps	  because	  slightly	  healthier	  people	  were	  selected	  into	  the	  PHB	  group.	  In	  fact,	  the	  
difference	  in	  SCRQOL	  is	  𝑦𝑦 − 𝑦𝑦 = β.	  By	  the	  follow-­‐up	  time,	  the	  measured	  difference	  
between	  groups	  is	  𝑦𝑦 − 𝑦𝑦,	  but	  on	  its	  own	  this	  difference	  would	  over-­‐estimate	  the	  impact	  of	  
personal	  health	  budgets	  because	  it	  does	  not	  account	  for	  the	  difference	  in	  SCRQOL	  at	  baseline.	  
If	  we	  assume	  that	  the	  personal	  health	  budget	  group	  of	  people	  would	  have	  deteriorated	  in	  
terms	  of	  their	  SCRQOL	  at	  the	  same	  rate	  as	  the	  control	  group,	  i.e.	  by	  an	  amount	  β,	  then	  
without	  the	  intervention	  they	  would	  have	  averaged	  SCRQOL	  of	  𝑦𝑦,	  not	  𝑦𝑦,	  and	  therefore	  the	  
‘true’	  improvement	  is	  the	  amount	  β.	  Another	  way	  of	  thinking	  about	  this	  approach	  is	  to	  
compare	  measured	  SCRQOL	  for	  the	  personal	  health	  budget	  group	  between	  baseline	  (𝑦𝑦)	  and	  
follow-­‐up	  (𝑦𝑦).	  This	  difference	  would	  under-­‐estimate	  the	  effect	  of	  the	  intervention	  in	  this	  
example	  because	  without	  the	  intervention,	  and	  taking	  a	  lead	  from	  the	  control	  group,	  we	  
would	  have	  expected	  SCRQOL	  to	  have	  fallen	  by	  β	  to	  a	  level	  𝑦𝑦.	  So	  again,	  the	  ‘true’	  
effectiveness	  is	  𝑦𝑦 − 𝑦𝑦 = β.	  As	  can	  been	  seen,	  this	  is	  equivalent	  to	  the	  calculation  
Δ𝑦𝑦 = (𝑦𝑦 − 𝑦𝑦) − (𝑦𝑦 − 𝑦𝑦)	  as	  set	  out	  in	  the	  text.	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estimate	  is	  then	  change	  in	  effect	  Δ𝐸𝐸.	  Also,	  the	  same	  method	  could	  be	  used	  for	  the	  cost	  of	  the	  care,	  
services	  and	  support	  a	  person	  receives,	  so	  therefore	  we	  measured	  change	  in	  cost:	  Δ𝐶𝐶.	  
2.5.2.1 Sub-­‐groups	  
The	  evaluation	  concerned	  a	  number	  of	  patient	  groups	  as	  potential	  beneficiaries	  of	  personal	  health	  
budgets	  as	  outlined	  in	  Chapters	  1	  and	  3.	  In	  each	  case	  we	  had	  the	  option	  to	  separate	  out	  these	  sub-­‐
samples	  completely	  and	  run	  the	  analysis	  for	  these	  groups	  on	  a	  stand-­‐alone	  basis.	  This	  approach	  
clearly	  meant	  smaller	  sample	  sizes	  for	  the	  sub-­‐samples.	  Moreover,	  it	  did	  not	  account	  for	  any	  
similarity	  of	  effect	  (of	  personal	  health	  budgets)	  that	  applied	  for	  each	  sub-­‐sample.	  The	  alternative	  was	  
to	  analyse	  the	  whole	  sample	  but	  with	  dummy	  variables	  to	  distinguish	  patient	  groups.	  These	  dummy	  
variables	  could	  be	  used	  to	  account	  for	  any	  differences	  at	  baseline	  (intercept	  dummies)	  and	  also	  
differences	  in	  effect	  through	  time	  (interaction	  dummies).	  
2.5.3 Confounding	  factors	  on	  outcome	  indicator	  changes	  
In	  using	  a	  difference-­‐in-­‐difference	  approach	  we	  effectively	  remove	  any	  differences	  between	  the	  
groups	  in	  the	  level	  of	  the	  outcome	  indicator	  at	  baseline.	  Whilst	  this	  method	  is	  an	  effective	  way	  to	  
control	  for	  any	  differences	  in	  the	  characteristics	  of	  the	  personal	  health	  budget	  and	  control	  groups	  
affecting	  the	  outcome	  indicator	  at	  baseline,	  there	  remains	  a	  possibility	  that	  differences	  between	  the	  
groups	  might	  cause	  differences	  in	  the	  rate	  of	  change	  of	  the	  indicator,	  beyond	  any	  true	  effect	  of	  
personal	  health	  budgets	  –	  see	  Appendix	  C.	  To	  safeguard	  against	  the	  possibility	  of	  bias	  of	  this	  kind,	  we	  
also	  estimated	  multivariate	  difference-­‐in-­‐difference	  models.	  These	  allow	  us	  to	  identify	  and	  remove	  
the	  effects	  of	  differences	  in	  baseline	  characteristics	  between	  the	  groups	  on	  change	  in	  the	  outcome	  
measure.	  A	  number	  of	  baseline	  characteristics	  were	  explored	  in	  these	  ‘controlled’	  analyses,	  including	  
socio-­‐demographic	  factors	  (for	  example,	  gender,	  age,	  baseline	  dependency,	  accommodation,	  
ethnicity);	  socio-­‐economic	  factors	  (for	  example,	  education,	  benefit	  receipt);	  and	  health	  status	  (for	  
example,	  health	  condition	  and	  comorbidities)	  (see	  Appendix	  C	  for	  the	  full	  list	  of	  confounding	  
variables).	  
2.5.3.1 Mortality	  
Mortality	  rates	  are	  an	  important	  outcome	  measure	  and	  we	  investigated	  whether	  mortality	  was	  
higher	  in	  the	  personal	  health	  budget	  group	  compared	  to	  the	  control	  group.	  In	  theory,	  a	  difference-­‐in-­‐
difference	  method	  can	  be	  applied,	  but	  in	  this	  case	  there	  is	  no	  difference	  in	  mortality	  at	  baseline	  
between	  the	  groups.	  A	  simple	  comparison	  of	  mortality	  rates	  is	  unlikely	  to	  be	  sufficient,	  however,	  for	  
the	  reasons	  outlined	  above.	  Indeed,	  the	  chance	  that	  differences	  in	  baseline	  characteristics	  will	  
introduce	  spurious	  change	  bias	  is	  particularly	  important	  for	  mortality	  rate	  analysis.	  The	  lack	  of	  
difference	  at	  baseline	  can	  mask	  significant	  differences	  in	  the	  probability	  of	  death	  immediately	  after	  
baseline.	  
For	  these	  reasons,	  we	  estimated	  the	  probability	  of	  dying,	  controlling	  for	  a	  range	  of	  baseline	  
characteristics,	  particularly	  morbidity	  indicators	  and	  also	  study	  timings.	  As	  regards	  the	  latter,	  and	  
discussed	  in	  more	  detail	  below,	  for	  practical	  reasons	  the	  time	  between	  consent	  and	  baseline	  and	  
between	  baseline	  and	  follow-­‐up	  was	  not	  always	  the	  same	  for	  each	  study	  participant.	  Elapsed	  time	  is	  
33	  
	  
highly	  relevant	  for	  analysis	  of	  mortality,	  so	  for	  this	  analysis	  we	  selected	  a	  sample	  where	  time	  frames	  
were	  comparable.	  
2.5.4 Missing	  values	  and	  loss	  to	  follow-­‐up	  
In	  highly	  complex	  evaluations,	  such	  as	  PHBE,	  we	  will	  always	  have	  at	  least	  some	  missing	  data	  for	  
individuals	  in	  the	  study.	  In	  some	  cases,	  these	  missing	  data	  are	  where	  respondents	  overlook	  or	  fail	  to	  
answer	  particular	  questions	  but	  manage	  to	  complete	  many	  others.	  Where	  these	  responses	  could	  be	  
considered	  to	  be	  missing	  at	  random	  (to	  a	  reasonable	  extent),	  we	  were	  able	  to	  ‘impute’	  values	  for	  
missing	  data	  with	  techniques	  that	  use	  the	  underlying	  patterns	  in	  the	  whole	  dataset.	  The	  Technical	  
Annex	  (Appendix	  C)	  has	  more	  details	  of	  these	  multiple	  imputation	  techniques.	  
After	  the	  baseline	  period,	  some	  original	  participants	  withdrew	  from	  the	  study	  or	  were	  unable	  to	  
continue	  to	  participate,	  or	  died.	  The	  number	  of	  people	  in	  the	  study	  at	  follow-­‐up	  (e.g.	  12	  months)	  was	  
lower	  than	  at	  baseline.	  We	  were	  unable	  for	  ethical	  reasons	  to	  ask	  people	  why	  they	  had	  withdrawn	  if	  
they	  had	  rescinded	  consent.	  We	  could	  assume	  in	  some	  cases	  that	  this	  withdrawal	  was	  at	  random	  and	  
therefore	  use	  multiple	  imputations	  to	  infer	  characteristics	  at	  follow-­‐up.	  
In	  Chapter	  3	  we	  describe	  the	  sample	  and	  the	  numbers	  of	  records	  used	  in	  the	  main	  analyses.	  Our	  
overall	  approach	  was	  to	  include	  all	  participants	  in	  the	  analysis	  where	  we	  had	  either	  baseline	  outcome	  
information	  or	  any	  form	  of	  outcome	  follow-­‐up	  data.	  A	  number	  of	  study	  participants	  were	  in	  
residential	  care	  at	  baseline.	  Since	  residential	  care	  is	  not	  included	  in	  the	  personal	  health	  budget	  pilot	  
programme,	  we	  excluded	  these	  cases.	  With	  this	  definition	  of	  the	  active	  sample,	  multiple	  imputation	  
was	  used	  to	  address	  missing	  values	  on	  all	  major	  variables	  in	  the	  dataset.	  
Following	  imputation,	  we	  excluded	  anyone	  below	  the	  age	  of	  18.	  For	  the	  main	  outcomes,	  cost	  and	  
cost-­‐effectiveness	  analyses	  we	  also	  excluded	  people	  that	  had	  died	  at	  follow-­‐up.	  Although	  in	  theory	  
we	  might	  assign	  them	  outcome	  indicator	  and	  costs	  of	  zero	  at	  that	  point,	  this	  would	  not	  be	  a	  good	  
guide	  to	  their	  experience	  between	  baseline	  and	  follow-­‐up.	  We	  instead	  conducted	  a	  separate	  analysis	  
of	  death	  rates.	  
2.5.4.1 Variable	  follow-­‐up	  periods	  
Due	  to	  the	  different	  timing	  of	  local	  implementation	  between	  sites,	  delays	  in	  recruitment	  and	  
workload	  at	  follow-­‐up,	  there	  was	  some	  variation	  in	  the	  follow-­‐up	  periods	  for	  participants	  in	  relation	  
to	  our	  12-­‐month	  target	  duration.	  The	  follow-­‐up	  data	  collection	  period	  in	  the	  study	  was	  between	  9	  
and	  18	  months.	  Without	  prior	  knowledge	  about	  the	  timing	  of	  the	  actual	  impact	  of	  personal	  health	  
budgets	  on	  people’s	  outcomes,	  we	  could	  not	  specifically	  adjust	  for	  these	  differences,	  although	  we	  
did	  include	  the	  time	  elapsed	  between	  baseline	  and	  follow-­‐up	  as	  a	  variable	  in	  the	  statistical	  models.	  
On	  average,	  follow-­‐up	  periods	  were	  similar	  between	  the	  personal	  health	  budget	  and	  control	  groups.	  
It	  might	  nonetheless	  be	  the	  case	  that	  where	  follow-­‐up	  was	  less	  than	  12	  months,	  this	  gave	  less	  
opportunity	  for	  personal	  health	  budgets	  to	  show	  differential	  outcomes	  for	  patients	  (if	  such	  
differences	  existed).	  We	  flag	  this	  issue	  as	  a	  possible	  limitation	  of	  the	  evaluation.	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2.5.5 Outcome	  indicators	  
We	  used	  a	  range	  of	  validated	  measures	  of	  impact	  or	  effectiveness	  as	  outlined	  above	  and	  in	  Appendix	  
A.	  The	  intention	  was	  to	  measure	  impact	  in	  the	  following	  categories:	  
 Clinical	  outcomes:	  The	  aim	  was	  to	  assess	  the	  impact	  of	  personal	  health	  budgets	  on	  the	  
health	  of	  study	  participants	  in	  terms	  of	  standard	  clinical	  markers.	  To	  this	  end,	  we	  measured	  
HbA1c	  for	  diabetes	  sufferers	  and	  lung	  function	  (forced	  expiratory	  volume,	  FEV1)	  for	  COPD	  
sufferers.	  Following	  advice	  from	  a	  medical	  professional,	  there	  wasn’t	  an	  appropriate	  clinical	  
outcome	  measure	  for	  the	  other	  health	  conditions.	  	  
 Health-­‐related	  quality	  of	  life:	  We	  used	  the	  EQ-­‐5D	  measure,	  which	  aims	  to	  measure	  a	  
person’s	  quality	  of	  life	  in	  domains	  that	  are	  likely	  to	  be	  related	  to	  their	  underlying	  health	  
status.	  This	  measure	  is	  well	  established	  in	  research	  and	  offers	  significant	  potential	  for	  
comparison	  of	  the	  results	  with	  those	  of	  other	  studies.	  EQ-­‐5D	  can	  be	  summarised	  as	  
measuring	  personal	  functioning	  (as	  potentially	  constrained	  by	  poor	  health)	  such	  as	  mobility,	  
being	  free	  of	  pain	  and	  depression,	  and	  in	  order	  to	  achieve	  everyday	  activities	  (e.g.	  self-­‐care,	  
usual	  activities	  and	  mobility).	  	  
 Care-­‐related	  quality	  of	  life:	  We	  also	  used	  another	  care-­‐related	  quality	  of	  life	  measure	  with	  a	  
focus	  on	  the	  achievement	  of	  everyday	  activities	  that	  might	  come	  from	  the	  support	  of	  
services	  and	  interventions,	  as	  well	  as	  from	  personal	  functioning.	  Arguably,	  quality	  of	  life	  
improvements	  for	  people	  with	  long-­‐term	  conditions	  come	  mainly	  from	  a	  management	  of	  
those	  conditions	  rather	  than	  any	  prospect	  that	  the	  underlying	  condition	  can	  be	  cured.	  There	  
are	  a	  number	  of	  indicators	  that	  might	  be	  appropriate	  but	  we	  wanted	  a	  measure	  that	  was	  
utility	  weighted	  in	  order	  to	  undertake	  comparative	  cost-­‐effectiveness	  analyses.	  For	  these	  
reasons	  we	  used	  the	  ASCOT	  measure	  (Adult	  Social	  Care	  Outcomes	  Toolkit)	  which	  aims	  to	  
measure	  people’s	  achievement	  of	  everyday	  activities,	  including	  basic	  capabilities	  such	  as	  
dressing	  and	  feeding,	  as	  well	  as	  more	  complex	  capabilities	  such	  as	  feeling	  safe,	  being	  
occupied	  and	  having	  a	  sense	  of	  control.	  ASCOT	  recognises	  that	  achievement	  of	  these	  
activities	  may	  come	  from	  the	  support	  of	  services	  and	  interventions,	  as	  well	  as	  personal	  
functioning.	  Whilst	  it	  was	  developed	  for	  people	  using	  long-­‐term	  social	  care,	  many	  of	  the	  
indicators	  are	  highly	  relevant	  for	  people	  with	  long-­‐term	  conditions	  in	  general.	  For	  example,	  it	  
would	  be	  expected	  that	  having	  a	  sense	  of	  control	  over	  daily	  living	  would	  be	  equally	  
important	  for	  patients	  with	  a	  long-­‐term	  health	  condition	  as	  well	  as	  for	  services	  users	  with	  
social	  care	  needs.	  
 Subjective	  well-­‐being:	  We	  used	  a	  subjective	  global	  measure	  based	  on	  the	  measure	  used	  by	  
ONS	  in	  the	  Integrated	  Household	  Survey	  (IHS).	  This	  measure	  used	  in	  this	  study	  seeks	  to	  
capture	  general	  life	  happiness	  and	  satisfaction.	  We	  used	  a	  scale	  that	  considers	  satisfaction	  
with	  life,	  happiness	  and	  satisfaction/worry	  about	  the	  person’s	  health.	  
 Perceived	  quality	  of	  life:	  The	  seven-­‐point	  scale	  with	  categories	  ranging	  from	  ‘So	  good,	  it	  
could	  not	  be	  better’	  to	  ‘So	  bad,	  it	  could	  not	  be	  worse’.	  
 Perceived	  health:	  The	  five-­‐point	  scale	  asks	  respondents	  to	  rate	  their	  health	  in	  general	  
according	  to	  five	  categories	  ranging	  from	  ‘Very	  good’	  to	  ‘Very	  bad’.	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 Mortality:	  As	  well	  as	  the	  above	  morbidity	  and	  quality	  of	  life	  measures,	  we	  also	  assessed	  
whether	  there	  were	  differences	  in	  mortality	  rates	  between	  the	  personal	  health	  budget	  and	  
control	  groups.	  
The	  range	  of	  measures	  used	  was	  intended	  to	  capture	  the	  broader	  ramifications	  of	  use	  of	  personal	  
health	  budgets.	  As	  a	  process	  intervention,	  we	  expected	  that	  personal	  health	  budgets	  would	  have	  a	  
direct	  impact	  on	  quality	  of	  life	  and	  rather	  more	  indirect	  impact	  (through	  people’s	  choice	  of	  service	  
and	  support)	  on	  clinical	  aspects	  of	  their	  life.	  
The	  measures	  used	  take	  the	  form	  of	  numerical	  scales	  or	  dummy	  variables.	  They	  were	  also	  measured	  
at	  multiple	  time	  points	  in	  the	  study.	  The	  exception	  is	  mortality,	  where	  there	  was	  no	  difference	  
between	  personal	  health	  budget	  and	  control	  groups	  in	  this	  outcome	  (all	  people	  were	  alive),	  and	  
therefore	  change	  in	  mortality	  is	  the	  same	  as	  mortality	  at	  follow-­‐up.	  For	  this	  reason	  we	  had	  to	  use	  
mortality-­‐related	  characteristics	  at	  baseline	  to	  control	  for	  any	  differences	  between	  the	  groups	  prior	  
to	  the	  study,	  rather	  than	  the	  value	  of	  the	  respective	  outcome	  (on	  the	  above	  scales)	  at	  baseline.	  
2.5.6 Costs	  
Personal	  health	  budgets	  give	  recipients	  the	  opportunity	  to	  buy	  services	  and	  support	  that	  would	  not	  
be	  ordinarily	  available,	  or	  to	  use	  services	  and	  support	  to	  a	  different	  intensity	  than	  would	  otherwise	  
be	  provided.	  
Table	  2-­‐2	  lists	  a	  range	  of	  services	  and	  other	  forms	  of	  support	  (column	  1).	  Some	  of	  these	  are	  ordinarily	  
available	  without	  a	  personal	  health	  budget	  and	  some	  are	  not	  (column	  2).	  Depending	  on	  their	  local	  
configuration,	  personal	  health	  budgets	  can	  be	  used	  to	  purchase	  a	  sub-­‐set	  of	  these	  services	  (column	  
3).	  In	  some	  cases,	  services	  might	  be	  funded	  from	  the	  personal	  health	  budget	  or	  provided	  
conventionally.	  Moreover,	  a	  person	  may	  have	  some	  of	  their	  services	  conventionally	  funded	  and	  
others	  secured	  from	  their	  personal	  health	  budget.	  In	  other	  cases,	  support	  might	  only	  be	  available	  
using	  a	  personal	  health	  budget	  –	  e.g.	  ‘well-­‐being’	  services	  such	  as	  art	  classes	  or	  holidays	  –	  or	  only	  
conventionally-­‐funded	  –	  e.g.	  secondary	  care.	  
In	  column	  4	  we	  distinguish	  direct,	  indirect	  and	  neutral	  services.	  Direct	  services	  are	  those	  where	  a	  
personal	  health	  budget	  holder	  can	  use	  their	  budget	  to	  buy	  the	  service	  and	  so	  directly	  determine	  the	  
amount	  of	  that	  service	  they	  use.	  Indirect	  services	  are	  those	  which	  cannot	  by	  secured	  using	  a	  budget	  
but	  where	  it	  has	  been	  assumed	  that	  the	  use	  of	  these	  services	  might	  be	  affected	  as	  a	  result	  of	  a	  
person	  having	  a	  personal	  health	  budget	  and	  the	  direct	  service	  choices	  that	  person	  makes	  with	  their	  
budget.	  These	  could	  be	  preventative	  effects:	  for	  example,	  the	  use	  of	  particular	  well-­‐being	  services	  
secured	  using	  a	  personal	  health	  budget	  might	  reduce	  people’s	  need	  for	  primary	  care	  (GP	  visits).	  
Alternatively,	  a	  change	  in	  the	  use	  of	  direct	  services	  might	  increase	  the	  need	  for	  indirect	  services.	  
Finally,	  we	  have	  neutral	  services	  where	  we	  expect	  a	  personal	  health	  budget	  to	  have	  very	  little	  or	  no	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effect	  on	  their	  use.	  For	  example,	  we	  would	  not	  expect	  the	  use	  of	  a	  personal	  health	  budget	  to	  affect	  
the	  medicines	  a	  person	  might	  need,	  at	  least	  in	  the	  short	  term.5	  
Table	  2-­‐2.	  Services	  and	  support	  –	  by	  availability	  and	  personal	  health	  budget	  coverage	  





Affected	  by	  PHB?	  
Secondary	  care	   Yes	   No	   Indirect	  
Primary	  care	   Yes	   No	   Indirect	  
Drugs	  	   Yes	   No	   Neutral	  (excluded)	  
Social	  care	  (residential)	   Yes	   No	   Neutral	  (excluded)	  
Specialist	  nursing	  and	  other	  health	  	   Yes	   Yes	   Direct	  &	  Indirect	  
Community	  nursing	  and	  AHPs*	   Yes	   Yes	   Direct	  &	  Indirect	  
Social	  care	  (community)*	   Yes	   Yes	   Direct	  &	  Indirect	  
Respite	  care	   Yes	   Yes	   Direct	  &	  Indirect	  
Equipment	  	   Yes	   Yes	   Direct	  &	  Indirect	  
Well-­‐being	  support	   No	   Yes	   Direct	  
Informal	  care	  (payment)	   No	   Yes	   Direct	  
	  *	  Includes	  personal	  assistants	  
	  
The	  total	  cost	  of	  the	  services	  and	  support	  that	  people	  might	  use	  is	  calculated	  by	  applying	  a	  unit	  cost	  
to	  the	  intensity	  measure	  of	  each	  service.	  In	  practice,	  measuring	  the	  use	  of	  any	  service	  across	  each	  of	  
the	  above	  11	  categories	  is	  demanding	  for	  study	  participants.	  We	  simplified	  this	  requirement	  by	  using	  
existing	  service	  datasets	  where	  possible,	  such	  as	  the	  hospital	  episodes	  statistics	  (HES)	  database	  and	  
by	  using	  a	  costing	  methodology	  that	  places	  the	  lowest	  demand	  on	  respondents	  (but	  does	  require	  us	  
to	  make	  a	  number	  of	  assumptions).	  
With	  regard	  to	  costing,	  we	  identified	  two	  ways	  in	  which	  personal	  health	  budgets	  were	  implemented	  
by	  sites	  (see	  also	  Chapter	  4):	  
 first,	  where	  the	  personal	  health	  budget	  funded	  services	  in	  a	  given	  category	  in	  addition	  to	  
what	  was	  usually	  provided;	  
 second,	  where	  the	  personal	  health	  budget	  substituted	  for	  services	  in	  a	  given	  service	  
category.	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
5	  Potentially,	  we	  have	  assumed	  that	  having	  a	  personal	  health	  budget	  might	  lead	  to	  improved	  outcomes	  that	  reduce	  the	  
need	  for	  some	  drugs	  (e.g.	  anti-­‐depressants)	  and	  have	  an	  impact	  on	  pain	  management,	  although	  we	  expect	  the	  effect	  will	  be	  
small	  in	  magnitude.	  As	  a	  result,	  we	  do	  not	  measure	  the	  impact	  on	  drug	  use	  and	  assume	  this	  is	  not	  different	  between	  the	  
personal	  health	  budget	  group	  and	  control	  group.	  However	  we	  do	  collect	  information	  on	  prescriptions	  and	  therefore	  
potentially	  additional	  analysis	  could	  be	  carried	  out	  in	  the	  future.	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It	  was	  possible	  for	  a	  personal	  health	  budget	  to	  mix	  these	  two	  options	  for	  different	  categories	  of	  
service:	  e.g.	  the	  personal	  health	  budget	  substituted	  for	  social	  care	  services	  but	  was	  used	  to	  augment	  
provision	  of	  physiotherapy.	  
These	  distinctions	  were	  used	  in	  our	  comparison	  of	  costs	  for	  people	  in	  the	  personal	  health	  budget	  
group	  and	  those	  in	  the	  control	  group.	  Our	  approach	  to	  costing	  was	  to	  include	  all	  health	  and	  social	  
care	  service	  costs	  as	  listed	  in	  the	  above	  table.	  The	  exception	  was	  to	  exclude	  services	  for	  which	  we	  
strongly	  anticipated	  a	  neutral	  effect,	  e.g.	  for	  drug	  medications.	  
As	  suggested	  by	  their	  description,	  in	  our	  costing	  method	  the	  value	  of	  in-­‐addition	  services	  covered	  in	  
the	  personal	  health	  budget	  were	  added	  to	  the	  cost	  of	  conventional	  services	  in	  that	  category	  to	  
calculate	  the	  total	  cost	  in	  each	  category.	  For	  substitute	  services,	  their	  value	  in	  the	  personal	  health	  
budget	  was	  used	  as	  the	  total	  cost	  of	  services	  in	  that	  service	  category.	  The	  overall	  total	  cost	  for	  each	  
person	  at	  any	  given	  time	  was	  the	  summation	  of	  the	  sub-­‐totals	  for	  each	  service	  category.	  
On	  this	  basis,	  the	  costs	  for	  a	  personal	  health	  budget	  holder	  are	  as	  follows:	  
Sub-­‐total	  cost	  for	  each	  service	  category	  =	   Cost	  of	  conventional	  services	  +	  value	  in	  personal	  health	  
budget	  of	  in-­‐addition	  services	  
	   	  Or	  
	   =	  value	  in	  personal	  health	  budget	  of	  substitute	  services	  
	  
Total	  cost	  for	  personal	  health	  budget	  holder	  (at	  follow-­‐up)	  =	  sum	  of	  sub-­‐total	  cost	  for	  each	  service	  
category	  
Where	  all	  of	  a	  person’s	  direct	  services	  are	  covered	  by	  the	  budget,	  then	  the	  total	  cost	  is	  equal	  to	  the	  
value	  of	  the	  personal	  health	  budget	  (plus	  the	  cost	  of	  indirect	  services).	  Where	  budgets	  are	  purely	  
additional,	  then	  the	  total	  cost	  is	  equal	  to	  the	  value	  of	  the	  personal	  health	  budget	  plus	  the	  cost	  of	  the	  
conventionally-­‐funded	  direct	  services	  they	  receive	  (plus	  the	  cost	  of	  indirect	  services).	  
In	  practice,	  there	  were	  a	  number	  of	  data	  limitations	  that	  needed	  to	  be	  addressed.	  First,	  we	  had	  to	  
identify	  which	  services	  were	  in	  addition	  and	  which	  substitute	  for	  each	  service	  category	  based	  on	  the	  
personal	  health	  budget	  value.	  In	  the	  main	  analysis	  we	  assumed	  a	  threshold	  of	  £1000	  per	  annum:	  that	  
is,	  personal	  health	  budgets	  of	  £1000	  or	  less	  in	  each	  service	  category	  were	  provided	  in	  addition	  to	  
conventional	  services	  in	  that	  category.	  Budgets	  over	  £1000	  for	  each	  category	  of	  service	  were	  
provided	  as	  a	  substitute	  for	  conventional	  service	  in	  that	  category.	  
Second,	  although	  we	  had	  direct	  measures	  of	  the	  cost	  of	  services	  covered	  by	  the	  personal	  health	  
budget	  (from	  the	  personal	  health	  budget	  care	  plan),	  we	  had	  a	  mix	  of	  data	  sources	  and	  observations	  
of	  service	  intensity	  for	  costing	  the	  level	  of	  conventional	  services.	  In	  particular,	  for	  the	  direct	  and	  
indirect	  service	  categories	  –	  i.e.	  social	  care,	  respite,	  community	  nursing	  and	  AHPs/therapy	  service	  
categories	  –	  we	  collected	  data	  on	  total	  use	  of	  conventional	  services	  in	  these	  categories.	  The	  difficulty	  
was	  that	  we	  could	  not	  be	  sure	  whether	  respondents	  had	  included	  any	  amount	  of	  these	  services	  that	  
was	  personal	  health	  budget-­‐funded	  in	  addition	  to	  that	  funded	  in	  the	  usual	  way.	  This	  difficulty	  only	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affects	  in-­‐addition	  services	  where	  usual	  and	  personal	  health	  budget	  funding	  can	  be	  used	  in	  the	  same	  
service	  category.	  
Third,	  we	  could	  not	  collect	  service-­‐use	  data	  on	  all	  conceivable,	  conventionally-­‐funded	  health	  and	  
social	  care	  services	  used	  by	  study	  participants.	  Since	  all	  types	  of	  service	  use	  that	  are	  funded	  by	  the	  
personal	  health	  budget	  are	  recorded	  in	  the	  support	  plan,	  this	  created	  a	  problem	  when	  making	  like-­‐
with-­‐like	  comparisons	  between	  costing	  people	  using	  a	  personal	  health	  budget	  and	  those	  using	  
conventional	  funding	  (this	  includes	  people	  in	  the	  control	  group	  and	  those	  people	  in	  the	  personal	  
health	  budget	  group	  at	  baseline	  before	  they	  received	  their	  budget).	  An	  example	  was	  where	  non-­‐
personal	  health	  budget	  holders	  reported	  having	  a	  social	  care	  personal	  budget	  but	  where	  we	  did	  not	  
know	  its	  value.	  
These	  issues	  were	  tackled	  by	  making	  certain	  assumptions	  based	  on	  our	  understanding	  of	  how	  sites	  
had	  implemented	  the	  funding	  and	  allocation	  of	  personal	  health	  budgets.	  As	  regards	  the	  first	  issue,	  in	  
most	  sites	  budgets	  provided	  over-­‐and-­‐above	  conventionally-­‐funded	  services	  were	  valued	  at	  less	  than	  
£1000	  per	  annum.	  On	  this	  basis	  we	  assumed	  that	  services	  costed	  in	  the	  personal	  health	  budget	  care	  
plan	  at	  a	  value	  of	  less	  than	  £1000	  were	  in-­‐addition	  services.	  Accordingly,	  services	  funded	  in	  the	  
personal	  health	  budget	  in	  an	  amount	  greater	  than	  £1000	  were	  regarded	  as	  substitutes.	  
Regarding	  the	  second	  issue,	  we	  proceeded	  by	  estimating	  the	  proportion	  of	  the	  total	  reported	  use	  of	  
conventional	  services	  that	  was	  covered	  by	  the	  personal	  health	  budget.	  This	  estimation	  involved	  
comparing	  the	  reported	  total	  levels	  of	  use	  of	  substitute	  services	  against	  the	  amount	  costed	  in	  the	  
care	  plan.	  As	  these	  are	  substitutes,	  there	  should	  not	  have	  been	  any	  non-­‐personal	  health	  budget	  
funding.	  Therefore,	  the	  amount	  of	  these	  services	  reported	  as	  the	  total	  use	  gives	  us	  an	  indication	  
across	  the	  sample	  of	  the	  proportion	  of	  people	  that	  were	  including	  personal	  health	  budget-­‐funded	  
services	  in	  the	  total	  against	  those	  who	  were	  not.	  This	  sample	  average	  proportion	  was	  used	  to	  reduce	  
the	  value	  of	  total	  use	  of	  conventional	  services	  when	  it	  was	  added	  to	  the	  value	  of	  personal	  health	  
budget-­‐funded	  services	  in	  each	  category	  to	  calculate	  total	  cost.	  For	  example,	  take	  the	  community	  
social	  care	  service	  category.	  If	  25%	  of	  the	  sample	  with	  budgets	  of	  over	  £1000	  for	  that	  category	  had	  
included	  personal	  health	  budget-­‐funded	  amounts	  in	  their	  reporting	  of	  the	  total	  use	  of	  (conventional)	  
services,	  then	  we	  would	  use	  this	  25%	  figure	  as	  a	  deflator	  when	  costing	  in-­‐addition	  community	  social	  
care	  (i.e.	  for	  those	  with	  a	  personal	  health	  budget	  cost	  of	  less	  than	  £1000	  on	  community	  social	  care).	  
Full	  details	  of	  this	  method	  are	  provided	  in	  Appendix	  C.	  
We	  had	  two	  options	  for	  tackling	  the	  third	  data	  limitation.	  We	  could	  remove	  the	  cost	  of	  these	  services	  
covered	  by	  the	  personal	  health	  budget	  from	  the	  total.	  Alternatively,	  we	  could	  predict	  the	  amount	  of	  
these	  services	  that	  would	  have	  been	  used	  by	  non-­‐personal	  health	  budget	  holders	  and	  use	  this	  cost	  in	  
the	  total.	  We	  chose	  the	  latter	  option	  because	  it	  allowed	  us	  to	  gauge	  any	  change	  in	  costs	  in	  this	  
category	  over	  time	  (where	  the	  main	  analysis	  is	  in	  change	  in	  total	  cost).	  The	  predicted	  value	  was	  
estimated	  using	  the	  correlation	  between	  the	  amount	  of	  these	  services	  in	  the	  personal	  health	  budget	  
and	  some	  predictor	  variables	  such	  as	  health	  condition,	  dependency	  level,	  informal	  care	  and	  other	  
personal	  characteristics.	  




Sub-­‐total	  cost	  for	  each	  service	  category	  	   =	  Cost	  of	  main	  conventional	  services	  +	  predicted	  value	  of	  
other	  services	  
	  
Total	  cost	  for	  control	  group	  (at	  each	  time)	  	   =	  sum	  of	  sub-­‐total	  cost	  for	  each	  service	  category	  
Also	  
Total	  cost	  for	  PHB	  group	  at	  baseline	  	   	   =	  sum	  of	  sub-­‐total	  cost	  for	  each	  service	  category	  
The	  main	  analyses	  used	  changes	  in	  total	  costs	  for	  each	  person	  between	  the	  amount	  at	  baseline	  and	  
amount	  at	  follow-­‐up:	  
Change	  in	  total	  cost	  =	  Total	  cost	  at	  follow-­‐up	  –	  Total	  cost	  at	  baseline	  
Using	  change	  controls	  for	  any	  difference	  in	  cost	  between	  the	  personal	  health	  budget	  and	  control	  
groups	  at	  baseline	  before	  the	  budget	  were	  used	  and	  therefore	  reduce	  the	  potential	  to	  wrongly	  
conclude	  that	  an	  effect	  was	  due	  to	  the	  intervention	  when	  it	  was	  due	  to	  chance.	  Specifically,	  this	  
analysis	  controls	  for	  the	  potential	  occurrence	  of	  participants	  being	  recruited	  at	  a	  high	  service	  use	  
that	  subsequently	  reduces	  to	  more	  normal	  levels:	  that	  is	  the	  analysis	  controls	  for	  the	  potential	  of	  
‘regression	  to	  the	  mean’.	  Any	  impact	  of	  using	  personal	  health	  budgets	  on	  costs	  is	  best	  indicated	  by	  
the	  difference	  between	  groups	  of	  the	  change	  in	  total	  costs.	  	  
Full	  details	  of	  our	  costing	  methodology	  are	  available	  in	  Appendix	  C.	  
2.5.7 Cost-­‐effectiveness	  analysis	  
To	  judge	  the	  merits	  of	  a	  new	  intervention	  like	  personal	  health	  budgets,	  it	  is	  now	  a	  standard	  approach	  
to	  consider	  how	  cost-­‐effectively	  the	  intervention	  would	  utilise	  scarce	  resources	  (e.g.	  the	  NHS	  and	  
social	  care	  budgets)	  (Drummond,	  2005;	  Weinstein,	  1990).	  Interventions	  that	  produce	  greater	  
effect/benefits	  for	  the	  same	  cost	  are	  favoured	  over	  alternatives	  with	  poorer	  cost-­‐effectiveness.	  Cost-­‐
effectiveness	  (CE)	  ratio	  can	  be	  calculated	  for	  this	  purpose.	  They	  are	  normally	  expressed	  in	  terms	  of	  
the	  annual	  (additional)	  cost	  of	  producing	  a	  standardised	  effect	  –	  an	  improvement	  in	  outcomes.	  
Quality-­‐adjusted	  life	  years	  (QALYs)	  have	  become	  the	  conventional	  way	  to	  measure	  the	  effect,	  a	  
method	  that	  allows	  comparison	  across	  interventions	  that	  have	  different	  types	  of	  impact.	  Any	  given	  
intervention	  is	  therefore	  evaluated	  to	  determine	  the	  additional	  cost	  of	  producing,	  on	  average,	  a	  gain	  
of	  one	  QALY.	  
The	  approach	  used	  in	  England	  is	  to	  establish	  a	  cost-­‐effectiveness	  threshold,	  based	  on	  the	  idea	  that	  
the	  threshold	  represents	  the	  least	  cost-­‐effective	  intervention	  currently	  being	  provided	  in	  the	  NHS	  
(Raftery,	  2009;	  NICE,	  2007).	  In	  other	  words,	  any	  new	  intervention	  with	  an	  (incremental)	  cost	  per	  
QALY	  less	  than	  this	  threshold	  should	  be	  implemented.	  The	  value	  of	  the	  threshold	  –	  expressed	  as	  the	  
additional	  cost	  to	  achieve	  an	  extra	  QALY	  e.g.	  £20,000	  per	  QALY	  gained	  –	  can	  change,	  increasing	  when	  
society	  places	  a	  greater	  value	  on	  health	  (gain)	  and	  reducing	  when	  there	  is	  a	  lesser	  willingness	  to	  pay	  
for	  health.	  This	  is	  the	  approach	  used	  by	  the	  National	  Institute	  for	  Health	  and	  Clinical	  Excellence	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(NICE).	  Following	  convention,	  the	  threshold	  value	  is	  denoted	  by	  𝜆𝜆.	  An	  intervention	  (personal	  health	  




In	  theory,	  the	  new	  intervention	  would	  displace	  a	  less	  cost-­‐effective	  intervention	  to	  cover	  its	  total	  
cost	  within	  the	  overall	  budget	  available	  (assuming	  it	  is	  reasonably	  divisible).	  
Re-­‐arranging	  the	  above	  ratio,	  we	  can	  define	  the	  net	  monetary	  benefit	  (NMB)	  of	  any	  intervention	  as	  
Δ𝑁𝑁𝑁𝑁𝑁𝑁 = 𝜆𝜆Δ𝐸𝐸 − Δ𝐶𝐶.	  A	  cost-­‐effective	  intervention	  is	  one	  where	  the	  change	  in	  NMB	  is	  greater	  than	  
zero:	  
Δ𝑁𝑁𝑁𝑁𝑁𝑁 = 𝜆𝜆Δ𝐸𝐸 − Δ𝐶𝐶 > 0	  
Both	  the	  EQ-­‐5D	  health-­‐related	  quality	  of	  life	  measure	  and	  the	  ASCOT	  social	  care-­‐related	  quality	  of	  life	  
measure,	  which	  were	  included	  in	  the	  study,	  are	  preference	  weighted	  so	  that	  any	  particular	  state	  is	  
valued	  by	  respondents	  in	  comparison	  to	  the	  implicit	  value	  of	  being	  dead.	  NICE	  are	  currently	  
operating	  with	  a	  guideline	  cost-­‐effectiveness	  threshold	  for	  EQ-­‐5D	  of	  around	  £30,000	  per	  QALY.	  There	  
is	  no	  cost-­‐effectiveness	  threshold	  for	  ASCOT	  at	  present,	  although	  given	  the	  equivalent	  anchoring	  to	  
death	  as	  for	  EQ-­‐5D,	  we	  might	  infer	  a	  similar	  threshold	  value.	  
2.5.8 Outcomes,	  cost-­‐effectiveness	  and	  statistical	  error	  
We	  estimated	  the	  impact	  of	  personal	  health	  budgets	  using	  a	  sample	  of	  patients	  and	  therefore	  
needed	  to	  account	  for	  the	  statistical	  uncertainty	  inherent	  in	  our	  measures.	  To	  this	  end,	  we	  estimated	  
confidence	  intervals	  –	  i.e.	  the	  range	  of	  values	  for	  the	  estimate	  in	  question	  which	  have	  a	  95%	  chance	  
of	  containing	  the	  true	  effect.	  For	  the	  cost-­‐effectiveness	  analysis	  we	  also	  calculated	  the	  probability	  
that	  estimated	  NMB	  was	  greater	  than	  zero	  for	  a	  range	  of	  CE	  threshold	   𝜆𝜆 .	  We	  used	  both	  parametric	  
and	  non-­‐parametric	  approaches,	  and	  this	  is	  explored	  further	  in	  Appendix	  C.6	  
2.5.9 Carers	  
This	  study	  was	  organised	  around	  the	  patient,	  with	  that	  patient	  as	  the	  main	  point	  of	  contact.	  We	  did	  
not	  undertake	  a	  separate	  carers’	  study	  and	  instead	  sampled	  carers	  via	  the	  cared-­‐for	  person.	  
Originally,	  the	  cared-­‐for	  people	  were	  asked	  if	  we	  could	  contact	  their	  carer	  and,	  if	  they	  agreed,	  a	  
‘permission	  to	  contact	  carer’	  form	  was	  completed.	  Around	  12	  months	  after	  the	  consent	  date	  we	  
contacted	  the	  carer	  and	  asked	  if	  they	  would	  be	  willing	  to	  complete	  the	  outcome	  questionnaire.	  This	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
6	  It	  is	  important	  to	  be	  clear	  that	  this	  statistical	  uncertainty	  relative	  to	  the	  ‘true	  effect’	  is	  a	  consequence	  of	  sampling	  and	  is	  
distinct	  from	  any	  misrepresentation	  of	  the	  true	  effect	  of	  personal	  health	  budgets	  when	  in	  routine	  operation	  rather	  than	  the	  
true	  effect	  that	  applies	  in	  the	  piloting	  process.	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design	  meant	  that	  we	  only	  had	  carer	  outcomes	  information	  at	  follow-­‐up	  and	  for	  only	  those	  study	  
participants	  who	  identified	  a	  main	  carer	  and	  who	  also	  consented	  for	  us	  to	  contact	  that	  carer.	  
Without	  a	  baseline	  measure	  for	  carers,	  we	  were	  unable	  to	  use	  a	  difference-­‐in-­‐difference	  estimator.	  
Instead,	  we	  followed	  the	  approach	  used	  for	  mortality	  and	  used	  a	  range	  of	  (baseline)	  factors	  that	  
were	  anticipated	  to	  be	  correlated	  with	  carer	  outcomes.	  In	  this	  case,	  the	  objective	  was	  to	  assess	  how	  
the	  use	  of	  personal	  health	  budgets	  by	  the	  cared-­‐for	  person	  impacted	  on	  carer	  outcomes.	  As	  such,	  it	  
was	  important	  to	  include	  baseline	  outcomes	  and	  need	  characteristics	  for	  the	  cared-­‐for	  person	  in	  the	  
follow-­‐up	  estimate	  of	  carer	  outcomes.	  
2.6 Qualitative	  data	  analysis	  
All	  interviews	  with	  organisational	  representatives,	  personal	  health	  budget	  holders	  and	  carers	  of	  
budget	  holders	  were	  digitally	  recorded,	  with	  the	  participants’	  consent.	  The	  completed	  interviews	  
were	  transcribed	  in	  full.	  
Analysis	  of	  the	  data	  followed	  the	  framework	  approach	  (Ritchie	  and	  Spencer,	  1994).	  This	  involved	  
summarising	  the	  data	  and	  extracting	  quotations	  from	  each	  transcript.	  These	  summaries	  were	  placed	  
in	  a	  template	  organised	  by	  themes.	  The	  themes	  were	  based	  on	  the	  topics	  included	  in	  the	  interview	  
topic	  guides.	  The	  template	  enabled	  the	  comparison	  of	  themes	  across	  participants.	  
2.7 Challenges	  to	  implementing	  the	  evaluation	  design	  
As	  with	  all	  new	  national	  initiatives,	  the	  implementation	  of	  personal	  health	  budgets	  presented	  various	  
challenges,	  and	  modifications	  to	  the	  planned	  evaluation	  structure	  and	  the	  process	  had	  to	  be	  made	  in	  
the	  course	  of	  the	  study.	  We	  have	  highlighted	  these	  challenges	  as	  limitations	  in	  Chapter	  8.	  
2.7.1 Demands	  on	  organisational	  representatives	  working	  within	  the	  pilot	  sites	  
The	  evaluation	  team	  relied	  heavily	  on	  the	  support	  from	  organisational	  representatives	  working	  
within	  pilot	  sites.	  Project	  leads	  were	  asked	  to:	  
 Organise	  the	  recruitment	  of	  participants	  and	  ensure	  patients	  were	  fully	  informed	  about	  the	  
study;	  	  
 Organise	  baseline	  outcome	  interviews	  to	  be	  done	  within	  one	  month	  of	  the	  consent	  date;	  
 Organise	  the	  completion	  of	  the	  medical	  record	  templates	  at	  baseline	  and	  at	  12	  months	  after	  
the	  consent	  date;	  
 Ensure	  delivery	  of	  the	  personal	  health	  budget	  support	  plans	  to	  the	  research	  team.	  	  
Furthermore,	  the	  research	  team	  relied	  on	  project	  leads	  and	  organisational	  representatives	  to	  inform	  
them	  when	  participants	  had	  withdrawn	  from	  the	  study	  and	  also	  they	  were	  approached	  on	  a	  monthly	  
basis	  to	  clarify	  whether	  it	  remained	  appropriate	  to	  make	  contact	  with	  participants	  who	  continued	  to	  
be	  involved	  in	  the	  study.	  	  
The	  demands	  were	  being	  made	  at	  the	  same	  time	  as	  organisational	  representatives	  were	  changing	  
how	  they	  were	  delivering	  health	  care	  services.	  Furthermore,	  staff	  were	  also	  dealing	  with	  significant	  
42	  
	  
challenges	  within	  the	  pilot	  sites,	  such	  as	  the	  abolishment	  of	  Strategic	  Health	  Authorities	  and	  Primary	  
Care	  Trusts	  by	  2013.	  These	  changes	  would	  have	  had	  an	  impact	  on	  the	  implementation	  of	  personal	  
health	  budgets	  within	  the	  pilot	  programme.	  
2.7.2 Implementation	  delays	  
A	  number	  of	  implementation	  delays	  had	  a	  substantial	  impact	  on	  the	  evaluation.	  The	  initial	  
recruitment	  period	  was	  between	  April	  2010	  and	  April	  2011.	  However,	  challenges	  in	  implementing	  
the	  initiative	  led	  to	  pilot	  sites	  not	  being	  in	  a	  position	  to	  begin	  offering	  personal	  health	  budgets	  and	  
recruiting	  to	  the	  evaluation.	  Originally,	  recruitment	  was	  planned	  to	  cover	  the	  whole	  period,	  which	  
would	  have	  meant	  an	  even	  spread	  of	  participants	  across	  the	  12	  months.	  However,	  the	  delays	  
resulted	  in	  the	  recruitment	  period	  being	  extended	  to	  the	  end	  of	  June	  2011	  to	  achieve	  the	  aim	  of	  the	  
study	  to	  recruit	  3,000	  participants.	  	  
Chapter	  5	  reports	  on	  the	  delays	  in	  the	  deployment	  of	  personal	  health	  budgets.	  Chapter	  6	  reports	  on	  
the	  impact	  that	  recruitment	  delays	  and	  the	  time	  lag	  in	  the	  reports	  of	  activity	  becoming	  available	  in	  
HES.	  This	  delay	  resulted	  in	  not	  being	  able	  to	  collect	  secondary	  service	  use	  information	  for	  the	  full	  12-­‐
month	  follow-­‐up	  study	  period	  for	  a	  sample	  of	  participants7.	  	  
2.7.3 Changing	  nature	  of	  the	  intervention	  
There	  are	  reasonable	  arguments	  one	  way	  and	  the	  other	  about	  whether	  evaluations	  should	  be	  
conducted	  on	  the	  implementation	  of	  new	  interventions	  or	  after	  some	  transition	  period	  when	  
processes	  have	  had	  a	  chance	  to	  ‘settle	  down’.	  In	  this	  study	  the	  former	  was	  the	  case,	  which	  meant	  
that	  the	  evaluation	  was	  of	  a	  developing	  intervention.	  During	  the	  course	  of	  the	  pilot	  programme	  and	  
evaluation,	  some	  key	  design	  features	  of	  personal	  health	  budgets	  were	  being	  modified	  and	  improved	  
locally.	  This	  also	  meant	  that	  sites	  were	  using	  a	  range	  of	  methods	  to	  implement	  personal	  health	  
budgets.	  The	  benefit	  of	  this,	  from	  an	  evaluation	  perspective,	  is	  that	  we	  have	  the	  opportunity	  to	  
compare	  different	  models	  of	  personal	  health	  budget	  to	  assess	  which	  ones	  work	  the	  best.	  The	  
downside	  is	  the	  significant	  extra	  complexity	  of	  evaluating	  essentially	  not	  one	  but	  multiple	  new	  
interventions.	  The	  challenges	  for	  costing	  as	  outlined	  above	  were	  particularly	  acute	  as	  a	  result.	  
2.7.4 Changes	  to	  the	  policy	  during	  the	  evaluation	  period	  	  
Part	  of	  the	  evaluation	  is	  to	  inform	  the	  national	  roll-­‐out	  of	  personal	  health	  budgets	  by	  providing	  
information	  about	  how	  the	  initiative	  should	  be	  implemented.	  During	  the	  evaluation	  period	  there	  was	  
a	  growing	  emphasis	  on	  the	  roll-­‐out	  of	  the	  initiative,	  although	  it	  was	  repeatedly	  highlighted	  that	  any	  
decision	  would	  be	  subject	  to	  the	  research	  findings.	  On	  4	  October	  2011	  the	  Secretary	  of	  State	  for	  
Health	  announced	  that,	  subject	  to	  the	  evaluation,	  by	  April	  2014	  everyone	  in	  receipt	  of	  NHS	  
Continuing	  Healthcare	  (NHS	  CHC)	  will	  have	  the	  right	  to	  ask	  for	  a	  personal	  health	  budget,	  including	  a	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
7	  There	  is	  potential	  that	  additional	  analysis	  could	  be	  carried	  out	  on	  the	  full	  12-­‐month	  period.	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direct	  payment.	  Within	  the	  same	  time,	  it	  is	  planned	  that	  the	  new	  Clinical	  Commissioning	  Groups	  
(CCGs)	  will	  be	  able	  to	  offer	  personal	  health	  budgets	  on	  a	  voluntary	  basis	  more	  widely.	  
2.8 Research	  ethics	  and	  the	  PHBE	  steering	  group	  
The	  National	  Research	  Ethics	  Service	  conferred	  a	  favourable	  ethical	  opinion	  for	  the	  evaluation.	  
Subsequently,	  the	  research	  was	  given	  Research	  Governance	  management	  authorisation	  to	  
commence	  the	  study	  in	  each	  pilot	  site.	  
A	  steering	  group	  was	  set-­‐up	  that	  included	  the	  full	  project	  team	  and	  a	  number	  of	  key	  stakeholders	  
across	  the	  pilot	  sites,	  including	  a	  general	  practitioner	  and	  two	  service	  users.	  The	  group	  convened	  at	  








This	  chapter	  introduces	  the	  evaluation	  sample	  to	  inform	  interpretation	  and	  understanding	  of	  the	  
analysis	  in	  Chapters	  5	  –	  7.	  All	  results	  in	  this	  chapter	  were	  based	  on	  the	  non-­‐imputed	  dataset.	  
3.3 Recruitment,	  consent	  and	  attrition	  
3.3.1 Quantitative	  data	  collection	  
Figure	  3-­‐1	  shows	  the	  sequencing	  of	  the	  main	  quantitative	  and	  qualitative	  data	  collection	  within	  the	  
in-­‐depth	  pilot	  sites.	  Study	  consent	  was	  gained	  from	  2,700	  people,	  with	  2,235	  participants	  included	  in	  
the	  active	  study	  sample.	  The	  active	  sample	  excludes	  participants	  for	  whom	  we	  did	  not	  receive	  
Overall,	  2,700	  patients	  were	  recruited	  to	  the	  evaluation	  of	  personal	  health	  budget	  pilot	  
programme,	  of	  whom	  2,235	  were	  included	  in	  the	  active	  sample.	  	  
The	  active	  sample	  excluded	  participants:	  
 for	  whom	  we	  did	  not	  receive	  baseline	  or	  follow-­‐up	  outcome	  information;	  
 in	  residential	  care	  at	  baseline;	  
 under	  the	  age	  of	  18	  years	  of	  age;	  and	  
 who	  had	  died	  before	  follow-­‐up.	  
Within	  the	  active	  sample	  we	  received:	  	  
 2,168	  completed	  baseline	  questionnaires:	  1,141	  in	  the	  personal	  health	  budget	  group	  and	  
1,	  027	  in	  the	  control	  group;	  
 1,341	  participants	  were	  interviewed	  for	  the	  main	  follow-­‐up	  outcome	  data	  collection;	  	  
 1,807	  (81%)	  completed	  baseline	  medical	  record	  templates;	  
 1,278	  (57%)	  completed	  follow-­‐up	  medical	  record	  templates;	  
 1,678	  baseline	  secondary	  care	  service	  use	  information;	  	  
 1,400	  follow-­‐up	  secondary	  care	  service	  use	  information;	  
 147	  carers	  completed	  and	  returned	  the	  outcome	  questionnaire.	  	  
Fifty-­‐eight	  personal	  health	  budget	  holders	  were	  interviewed	  three	  months	  after	  being	  offered	  a	  
budget.	  Fifty-­‐two	  took	  part	  in	  a	  follow-­‐up	  interview,	  nine	  months	  after	  being	  offered	  a	  budget.	  
Nineteen	  carers	  of	  personal	  health	  budget	  holders	  were	  interviewed	  at	  three	  months	  after	  the	  
offer	  of	  the	  budget	  and	  13	  were	  interviewed	  nine-­‐months	  after	  the	  offer.	  	  
The	  chapter	  provides	  an	  overview	  of	  the	  sample	  characteristics	  of	  patients	  taking	  part	  in	  both	  the	  
quantitative	  and	  qualitative	  data	  collection.	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baseline	  or	  follow-­‐up	  outcome	  information,	  participants	  in	  residential	  care	  at	  baseline8,	  participants	  
under	  the	  age	  of	  18	  years	  of	  age	  or	  who	  had	  died	  before	  follow-­‐up.	  Within	  the	  active	  study	  sample,	  
453	  participants	  withdrew	  from	  the	  study.	  Of	  these,	  158	  (35%)	  participants	  died.	  In	  comparison,	  31%	  
(N=40)	  of	  the	  withdrawn	  sample	  in	  the	  evaluation	  of	  individual	  budgets	  pilot	  programme	  died	  during	  
the	  study	  period	  (Glendinning	  et	  al.,	  2008)9.	  	  
Within	  the	  active	  study	  sample,	  we	  received	  2,168	  completed	  baseline	  questionnaires:	  1,141	  in	  the	  
personal	  health	  budget	  group	  and	  1,027	  in	  the	  control	  group.	  Within	  the	  active	  study	  sample,	  the	  
fieldwork	  agency	  interviewed	  1,341	  participants	  (60%	  response	  rate):	  663	  in	  the	  personal	  health	  
budget	  group	  and	  678	  in	  the	  control	  group.	  
Within	  the	  active	  sample,	  the	  baseline	  medical	  record	  template10	  was	  completed	  for	  1,807	  (81%)	  
participants:	  957	  in	  the	  personal	  health	  budget	  group	  and	  850	  in	  the	  control	  group.	  At	  12	  months,	  
the	  medical	  record	  template11	  was	  completed	  for	  1,278	  (57%	  of	  the	  active	  sample)	  participants:	  673	  
in	  the	  personal	  health	  budget	  group	  and	  605	  in	  the	  control	  group.	  In	  terms	  of	  extracting	  secondary	  
care	  service	  use	  data	  from	  the	  hospital	  episodes	  statistics	  database	  (HES),	  we	  received	  secondary	  
care	  service	  use	  information	  for	  1,678	  participants	  at	  baseline	  and	  1,400	  at	  follow-­‐up.	  The	  lower	  
sample	  was	  the	  result	  of	  a	  number	  of	  factors	  including:	  	  
 Participants	  not	  giving	  consent	  for	  data	  to	  be	  extracted	  from	  the	  database;	  
 NHS	  numbers	  not	  being	  supplied	  by	  the	  pilot	  site;	  
 The	  NHS	  Information	  Centre	  being	  unable	  to	  match	  the	  NHS	  number.	  	  
Postal	  outcome	  questionnaires	  were	  sent	  out	  to	  282	  carers,	  of	  which	  147	  (57%	  response	  rate)	  were	  
returned.	  Chapter	  7	  explores	  whether	  personal	  health	  budgets	  had	  an	  impact	  on	  the	  caring	  role	  and	  
carers’	  quality	  of	  life.	  
3.4 Qualitative	  data	  collection	  
Figure	  3-­‐1	  shows	  that	  58	  budget	  holders	  were	  interviewed	  around	  three	  months	  after	  the	  offer	  of	  
the	  personal	  health	  budget	  to	  discuss	  their	  experiences	  of	  the	  process.	  	  
Nineteen	  carers	  providing	  assistance	  to	  personal	  health	  budget	  holders	  were	  also	  interviewed	  
around	  three	  months	  after	  the	  offer	  of	  the	  budget	  to	  explore	  their	  experiences	  of	  the	  process.	  	  
	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
8	  Patients	  in	  residential	  care	  at	  baseline	  should	  not	  have	  been	  invited	  to	  participate	  in	  the	  study.	  	  
9	  The	  attrition	  rate	  was	  expected	  due	  to	  the	  sample	  of	  patients	  participating	  in	  the	  evaluation.	  	  
10	  Medical	  record	  information	  collected	  for	  the	  year	  before	  consent	  date.	  
11	  Medical	  record	  information	  collected	  for	  the	  year	  after	  consent	  date.	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Figure	  3-­‐1.	  The	  sample.	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3.5 An	  overview	  of	  the	  sample	  characteristics	  
3.5.1 Completed	  main	  outcome	  questionnaires	  by	  health	  condition	  
We	  gathered	  information	  concerning	  health	  conditions	  from	  participants’	  medical	  records.	  Table	  3-­‐1	  
shows	  the	  primary	  health	  condition	  breakdown	  by	  personal	  health	  budget	  group	  and	  control	  group	  
at	  baseline	  and	  at	  12	  months	  within	  the	  active	  sample.	  	  
Table	  3-­‐1	  Completed	  main	  outcome	  questionnaires	  by	  health	  condition	  
	   Baseline	   Main	  follow-­‐up	  
Personal	  health	  budget	  group	   1,14112	   663	  
NHS	  Continuing	  Healthcare	   153	   94	  
Diabetes	   170	   97	  
Stroke	   116	   71	  
Mental	  health	   228	   105	  
COPD	   192	   140	  
Neurological	   284	   159	  
Control	  group	   1,027	   678	  
NHS	  Continuing	  Healthcare	   86	   61	  
Diabetes	   235	   165	  
Stroke	   116	   83	  
Mental	  health	   184	   92	  
COPD	   152	   111	  
Neurological	   262	   173	  
	  
Within	  the	  medical	  records,	  it	  was	  reported	  that	  overall	  one	  per	  cent	  of	  participants	  (n=27)	  had	  a	  
learning	  disability	  and	  six	  per	  cent	  (n=132)	  had	  some	  form	  of	  disability,	  such	  as	  poor	  mobility,	  hearing	  
or	  sight	  problems.	  However,	  we	  cannot	  assume	  that	  all	  disability	  information	  was	  included	  in	  
returned	  medical	  record	  templates.	  	  
3.6 An	  overview	  of	  the	  sample	  characteristics	  
In	  determining	  the	  validity	  of	  subsequent	  multivariate	  analysis,	  it	  is	  crucial	  initially	  to	  explore	  
whether	  the	  sample	  within	  the	  personal	  health	  budget	  and	  control	  groups	  were	  similar.	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
12	  The	  sample	  for	  each	  health	  condition	  does	  not	  add	  up	  to	  the	  total	  overall	  sample	  because	  a	  group	  of	  participants	  were	  
eligible	  for	  NHS	  Continuing	  Healthcare	  and	  were	  classified	  within	  one	  of	  the	  health	  condition	  cohorts.	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3.6.1 Completed	  baseline	  outcome	  questionnaire	  by	  age,	  gender	  and	  ethnicity	  
Table	  3-­‐2	  combines	  information	  on	  age,	  gender	  and	  ethnicity	  and	  health	  conditions.	  The	  table	  shows	  
that	  participants	  in	  the	  personal	  health	  budget	  group	  were	  significantly	  younger	  (mean	  =	  56	  years)	  
compared	  to	  the	  control	  group	  (mean	  =	  61	  years).	  Overall,	  17%	  (n=369)	  of	  participants	  were	  aged	  75	  
years	  of	  age	  or	  older.	  	  
Fifty-­‐three	  per	  cent	  (n=588)	  of	  the	  personal	  health	  budget	  sample	  were	  female	  and	  52%	  (n=521)	  
were	  female	  in	  the	  control	  group.	  Overall,	  7%	  (n=150)	  of	  the	  sample	  was	  from	  a	  black	  and	  minority	  
ethnic	  community.	  
Table	  3-­‐2	  Completed	  baseline	  outcome	  questionnaire	  by	  age,	  gender	  and	  ethnicity	  
	   Mean	  age	   75	  and	  over	   Female	  	   BME	  
	   	   %	  (N)	   %	  (N)	   %	  (N)	  
Overall	  	   59	  years	   17	  (369)	   51	  (1,109)	   7	  (150)	  
	   	   	   	   	  
PHB	  Group	   56	  years***	   15	  (167)	   53	  (588)	   7	  (82)	  
NHS	  CHC	   49	  years***	   13	  (20)	   54	  (82)	   6	  (9)	  
Diabetes	   60	  years	   15	  (25)	   53	  (89)	   13	  (22)	  
Stroke	   65	  years	  	   26	  (30)	   41	  (47)	   3	  (4)	  
Mental	  health	   45	  years***	  	   11	  (24)	   49	  (111)	   10	  (22)	  
COPD	   66	  years***	  	   17	  (32)	   57	  (109)	   4	  (7)	  
Neurological	   55	  years***	  	   13	  (36)	   53	  (151)	   6	  (18)	  
	   	   	   	   	  
Control	  Group	   61	  years	  	   20	  (202)	   52	  (521)	   7	  (68)	  
NHS	  CHC	   59	  years	  	   21	  (18)	   49	  (42)	   5	  (4)	  
Diabetes	   61	  years	  	   19	  (44)	   52	  (123)	   15	  (36)	  
Stroke	   67	  years	  	   31	  (36)	   47	  (54)	   4	  (5)	  
Mental	  health	   53	  years	  	   10	  (18)	   50	  (92)	   3	  (6)	  
COPD	   70	  years	  	   31	  (47)	   49	  (74)	   0	  (0)	  
Neurological	   61	  years	  	   16	  (41)	   53	  (140)	   6	  (17)	  
Significance	  levels:	  *	  p<0.10	  **	  p<0.05***	  p<	  0.001	  	  
Note	  1:	  NHS	  CHC	  refers	  to	  participants	  eligible	  for	  NHS	  Continuing	  Healthcare	  
	  
Table	  3-­‐3	  shows	  sexual	  orientation	  information	  from	  the	  baseline	  questionnaire.	  As	  the	  overall	  
sample	  classified	  themselves	  as	  heterosexual.	  	  
Table	  3-­‐3	  Sexual	  orientation	  
	   PHB	  Group	   Control	  Group	  
	   N=719	   N=734	  
Heterosexual	   96	  (687)	   95	  (700)	  
Homosexual	   3	  (21)	   3	  (21)	  
Bisexual	   1	  (10)	   2	  (13)	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3.6.2 Household	  composition	  and	  informal	  carers	  
Table	  3-­‐4	  shows	  that	  people	  in	  the	  personal	  health	  budget	  group	  were	  significantly	  more	  likely	  to	  be	  
single	  (26%)	  compared	  to	  the	  control	  group	  (19%)	  and	  were	  more	  likely	  to	  have	  help	  from	  a	  carer	  
inside	  (57%)	  or	  outside	  (41%)	  the	  household.	  People	  in	  the	  control	  group	  were	  significantly	  more	  
likely	  to	  be	  married	  (50%)	  compared	  to	  people	  in	  the	  personal	  health	  budget	  group	  (45%).	  
Table	  3-­‐4	  Household	  composition	  and	  informal	  carers	  
	   PHB	  Group	   Control	  Group	  
	   %	  (n)	   %	  (n)	  
Married/cohabiting	   45	  (506)	   50	  (511)*	  
Single	   25	  (288)	   19	  (196)***	  
Lives	  alone	   27	  (310)	   31	  (314)	  
University/college	  graduate	   27	  (297)	   25	  (256)	  
Secondary	  school	  education	   52	  (572)	   55	  (540)	  
Help	  from	  a	  carer	  inside	  the	  household	   57	  (644)	   48	  (488)***	  
Help	  from	  a	  carer	  outside	  the	  household	   41	  (471)	   36	  (373)**	  
Significance	  levels:	  *	  p<0.10	  **	  p<0.05***	  p<	  0.001	  	  
3.6.3 Activities	  of	  daily	  living	  (ADLs)	  
Table	  3-­‐5	  shows	  the	  level	  of	  dependency	  of	  participants.	  People	  in	  the	  personal	  health	  budget	  group	  
were	  significantly	  more	  likely	  to	  be	  unable	  to	  perform	  a	  number	  of	  activities	  of	  daily	  living	  compared	  
to	  the	  control	  group.	  	  
Table	  3-­‐5	  Level	  of	  need	  at	  baseline	  




get	  up	  or	  down	  stairs	   29	  (330)	   22	  (222)***	  
get	  outdoors	  and	  walk	  down	  the	  road	   32	  (362)	   23	  (239)***	  
get	  around	  indoors	   14	  (161)	   10	  (98)**	  
get	  in	  or	  out	  of	  bed	  or	  chair	   11	  (128)	   6	  (62)	  
use	  the	  WC	   13	  (142)	   7	  (73)	  
wash	  face	  and	  hands	   10	  (108)	   6	  (57)	  
bath,	  shower	  or	  wash	  all	  over	   12	  (132)	   7	  (70)	  
get	  dressed/undressed	   10	  (111)	   6	  (63)	  
feed	  self	   7	  (83)	   4	  (46)	  







3.7 The	  sub-­‐sample	  of	  qualitative	  interviews	  
3.7.1 Personal	  health	  budget	  holders	  
	  
Fifty	  eight	  personal	  health	  budget	  holders	  were	  interviewed	  three	  months	  after	  being	  offered	  a	  
budget.	  Fifty	  two	  took	  part	  in	  a	  follow-­‐up	  interview	  nine	  months	  after	  being	  offered	  a	  budget.	  Table	  
3-­‐6	  gives	  the	  number	  of	  budget	  holders	  interviewed	  at	  three	  and	  nine	  months	  by	  condition	  group.	  
	  
Table	  3-­‐6	  Number	  of	  budget	  holders	  interviewed	  by	  condition	  group	  
Condition	  group	   3-­‐month	  interview	   9-­‐month	  interview	  
COPD	   7	  (12%)	   6	  (12%)	  
Diabetes	   6	  (10%)	   5	  (10%)	  
Long-­‐term	  neurological	  condition	   13	  (22%)	   10	  (19%)	  
Mental	  health	   9	  (16%)	   8	  (15%)	  
NHS	  Continuing	  Healthcare	   15	  (26%)	   15	  (29%)	  
Stroke	   8	  (14%)	   8	  (15%)	  
Total	   58	  (100%)	   52	  (100%)	  
	  
Table	  3-­‐7	  shows	  the	  gender	  and	  age	  groups	  of	  budget	  holders	  interviewed.	  
	  
Table	  3-­‐7	  Characteristics	  of	  budget	  holders	  




Male	  	   27	  (47%)	   25	  (48%)	  




Under	  20	  years	   1	  (2%)	   1	  (2%)	  
20-­‐29	  years	   8	  (14%)	   7	  (13%)	  
30-­‐39	  years	   11	  (19%)	   10	  (19%)	  
40-­‐49	  years	   7	  (12%)	   6	  (12%)	  
50-­‐59	  years	   10	  (17%)	   9	  (17%)	  
60-­‐69	  years	   13	  (22%)	   13	  (25%)	  
70-­‐79	  years	   4	  (7%)	   3	  (6%)	  
80-­‐89	  years	   3	  (5%)	   2	  (4%)	  
Not	  known	   1	  (2%)	   1	  (2%)	  
Total	   58	  (100%)	   52	  (100%)	  
	  
The	  52	  budget	  holders	  interviewed	  at	  nine	  months	  were	  at	  different	  stages	  with	  their	  personal	  
health	  budgets.	  Table	  3-­‐8	  shows	  that	  about	  a	  fifth	  had	  no	  budget	  in	  place	  at	  the	  time	  of	  the	  nine-­‐
month	  interviews;	  around	  two-­‐thirds	  had	  had	  services	  and	  support	  funded	  through	  the	  budget	  in	  
place	  for	  at	  least	  three	  months.	  
51	  
	  
Table	  3-­‐8	  Length	  of	  time	  personal	  health	  budget	  in	  place	  
Length	  of	  time	  budget	  in	  place	   Number	  of	  budget	  
holders	  
No	  personal	  health	  budget	  in	  place	   9	  (17%)	  
Less	  than	  3	  months	   5	  (10%)	  
Between	  3	  and	  6	  months	   11	  (21%)	  
More	  than	  6	  months	   25	  (48%)	  
Budget	  terminated	  by	  budget	  holder	  because	  health	  improved	   1	  (2%)	  
Budget	  holder	  not	  sure	  if	  personal	  health	  budget	  in	  place	   1	  (2%)	  
Total	   52	  (100%)	  
	  
3.7.2 Carers	  of	  personal	  health	  budget	  holders	  
The	  initial	  aim	  was	  to	  conduct	  semi-­‐structured	  interviews	  with	  20	  carers	  of	  personal	  health	  budget	  
holders,	  at	  three	  and	  nine	  months	  after	  the	  offer	  of	  a	  budget.	  Table	  3-­‐9	  shows	  that	  nineteen	  carers	  
were	  recruited	  within	  the	  available	  timeframe.	  Five	  of	  these	  carers	  withdrew	  before	  the	  nine-­‐month	  
interview,	  and	  a	  sixth	  who	  had	  been	  interviewed	  at	  three	  months	  could	  not	  be	  re-­‐contacted	  at	  nine	  
months.	  The	  interviews	  were	  digitally	  recorded,	  with	  interviewees’	  consent,	  and	  subsequently	  fully	  
transcribed.	  
Table	  3-­‐9	  Number	  of	  carers	  interviewed	  by	  condition	  group	  	  
Carers	  who	  were	  supporting	  relatives	  with:	  	   3-­‐month	  interview	   9-­‐month	  interview	  
Stroke	  1	   3	   1	  
COPD	  2	   2	   1	  
Long-­‐term	  neurological	  condition3	   7	   4	  
NHS	  Continuing	  Healthcare	  	   7	   7	  
Total	   19	   13	  
1. One	  person	  had	  a	  long-­‐term	  neurological	  condition	  as	  well	  as	  stroke.	  
2. One	  person	  had	  multiple	  health	  problems,	  including	  arthritis,	  as	  well	  as	  COPD.	  
3. Two	  people	  had	  additional	  health	  problems,	  including	  diabetes	  and	  Asperger’s	  Syndrome.	  
	  
Table	  3-­‐10	  shows	  the	  gender	  and	  range	  of	  ages	  of	  interviewees.	  The	  carers	  were,	  in	  the	  main,	  caring	  




Table	  3-­‐10	  Characteristics	  of	  carers	  interviewed	  




Male	  	   5	   3	  
Female	  	   14	   10	  
	   	  
	  
Age	  group	   	  
40-­‐49	  years	   8	   4	  
50-­‐59	  years	   3	   3	  
60-­‐69	  years	   5	   4	  
70-­‐79	  years	   3	   2	  
Total	   19	   13	  
	  
3.8 Sample	  representativeness	  
The	  results	  in	  this	  chapter	  provide	  an	  understanding	  of	  the	  potential	  bias	  in	  terms	  of	  both	  internal	  
and	  external	  validity	  that	  will	  need	  to	  be	  controlled	  for	  in	  the	  difference-­‐in-­‐difference	  multivariate	  
analysis.	  In	  terms	  of	  internal	  validity,	  the	  results	  highlight	  that	  there	  were	  significant	  baseline	  
differences	  between	  the	  personal	  health	  budget	  and	  control	  groups	  in	  terms	  of	  dependency	  levels	  
and	  socio-­‐demographic	  factors	  (such	  as	  age,	  and	  receiving	  informal	  care	  from	  someone	  inside	  or	  
outside	  the	  household).	  In	  terms	  of	  external	  validity,	  the	  results	  demonstrate	  potentially	  that	  pilot	  
sites	  were	  selecting	  or	  excluding	  specific	  groups	  of	  patients	  to	  be	  put	  forward	  for	  this	  study	  which	  
will	  need	  to	  be	  controlled	  for	  in	  the	  multivariate	  analysis.	  	  
	  	   	  
53	  
	  















A	  number	  of	  principles	  underlying	  the	  personal	  health	  budget	  policy	  were	  outlined	  in	  Chapter	  1	  
(Department	  of	  Health,	  2009).	  To	  recap,	  personal	  health	  budget	  holders	  should	  be:	  
1. Aware	  of	  the	  level	  of	  resources	  available	  to	  them	  before	  support	  planning.	  
2. Encouraged	  to	  develop	  a	  support	  plan	  which	  details	  how	  the	  resources	  will	  be	  used	  to	  meet	  
identified	  needs	  and	  outcomes.	  There	  should	  be	  a	  degree	  of	  flexibility	  on	  what	  support	  and	  
services	  are	  paid	  for	  through	  the	  personal	  health	  budget.	  
3. Given	  the	  choice	  on	  how	  the	  budget	  is	  managed.	  There	  are	  three	  different	  ways	  that	  
personal	  health	  budgets	  can	  be	  managed	  (or	  potentially	  a	  combination	  of	  them):	  notionally,	  
where	  the	  budget	  is	  held	  by	  the	  commissioner	  but	  the	  budget	  holder	  is	  aware	  of	  the	  
treatment/service	  options	  and	  their	  financial	  implications;	  managed	  by	  a	  third	  party;	  or	  as	  a	  
direct	  payment	  (in	  certain	  approved	  sites	  only),	  where	  the	  patient	  receives	  a	  cash	  payment	  
to	  buy	  services.	  
In	  this	  chapter	  we	  describe	  the	  level	  of	  the	  personal	  health	  budget	  funding,	  the	  content	  of	  
support/care	  plans,	  and	  the	  degree	  to	  which	  individuals	  are	  taking	  advantage	  of	  the	  flexibility	  in	  
deciding	  how	  to	  manage	  the	  budget	  and	  the	  innovative	  services/support	  that	  can	  be	  purchased.	  We	  
also	  compare	  spending	  patterns	  within	  and	  between	  health	  condition	  cohorts	  and	  deployment	  
1,171	  care/support	  plans	  were	  received	  which	  identified	  an	  average	  of	  approximately	  £10,400	  
was	  included	  in	  the	  personal	  health	  budgets.	  	  
71%	  (n=828)	  of	  support/care	  plans	  included	  deployment	  information;	  of	  these	  around	  34%	  
(n=283)	  were	  managed	  as	  a	  direct	  payment.	  
Personal	  health	  budgets	  for	  the	  NHS	  Continuing	  Healthcare	  cohort	  had	  a	  higher	  value	  (£37,418	  
per	  year)	  compared	  with	  the	  other	  health	  condition	  cohorts	  such	  as	  the	  stroke	  cohort	  (£1,837	  
per	  year).	  The	  size	  of	  budget	  will	  inevitably	  be	  linked	  to	  the	  degree	  of	  need	  and	  may	  also	  give	  
an	  indication	  of	  the	  level	  of	  control	  transferred	  to	  the	  individual.	  
53%	  (N=625)	  of	  budgets	  were	  worth	  less	  than	  £1,000,	  which	  indicates	  that	  pilot	  sites	  were	  
either	  restricting	  recruitment	  to	  patients	  with	  less	  complex	  needs	  or	  were	  only	  using	  personal	  
health	  budgets	  to	  cover	  specific	  elements	  of	  the	  care	  package	  (for	  example,	  well-­‐being	  support	  
and	  informal	  care,	  or	  modest	  health	  services	  or	  equipment).	  
47%	  (N=545)	  of	  personal	  health	  budgets	  were	  worth	  more	  than	  £1,000,	  with	  seven	  budgets	  




options.	  Throughout	  this	  chapter	  we	  will	  also	  draw	  from	  evidence	  that	  has	  been	  gathered	  within	  the	  
in-­‐depth	  interviews	  with	  budget	  holders,	  carers	  and	  organisational	  representatives.	  
4.3 Method	  
All	  the	  information	  about	  the	  level	  and	  use	  of	  personal	  health	  budgets	  was	  drawn	  from	  the	  
support/care	  plans.	  A	  copy	  of	  the	  care/support	  plan	  was	  requested	  by	  the	  evaluation	  team	  for	  all	  
personal	  health	  budget	  holders	  participating	  in	  the	  study.	  Within	  the	  active	  sample,	  as	  outlined	  in	  
Chapter	  3,	  1,171	  care/support	  plans	  were	  received	  which	  identified	  the	  size	  of	  the	  personal	  health	  
budget	  and	  the	  request	  for	  support/services	  that	  would	  meet	  the	  desired	  outcomes.	  
4.4 Size	  of	  the	  personal	  health	  budget	  
Table	  4-­‐1	  shows	  that	  53%	  (N=625)	  of	  budgets	  were	  worth	  less	  than	  £1,000,	  which	  indicates	  that	  pilot	  
sites	  were	  either	  restricting	  recruitment	  to	  patients	  with	  less	  complex	  needs	  or	  were	  only	  using	  
personal	  health	  budgets	  to	  cover	  specific	  elements	  of	  the	  care	  package	  (for	  example,	  well-­‐being	  
support	  and	  informal	  care,	  or	  modest	  health	  or	  social	  care	  services	  or	  equipment).	  Chapter	  5	  will	  
explore	  whether	  participants	  in	  the	  12-­‐month	  outcome	  interview	  felt	  the	  level	  of	  budget	  was	  
adequate	  to	  meet	  their	  needs.	  However,	  there	  was	  some	  evidence	  in	  the	  in-­‐depth	  interviews	  that	  
were	  carried	  out	  around	  nine	  months	  after	  the	  offer	  of	  the	  budget	  to	  suggest	  that	  budget	  holders	  
felt	  that	  the	  level	  was	  sometimes	  inadequate	  (Davidson	  et	  al.,	  2012).	  It	  was	  found	  that,	  while	  most	  
interviewees	  appreciated	  the	  increased	  choice,	  control	  and	  flexibility	  of	  the	  personal	  health	  budget,	  
some	  thought	  the	  benefits	  had	  been	  curtailed	  by	  restrictions	  on	  what	  the	  budget	  could	  be	  used	  for	  
or	  lack	  of	  services.	  The	  lack	  of	  flexibility	  with	  what	  services/support	  could	  be	  purchased	  through	  the	  
personal	  health	  budgets	  was	  echoed	  during	  the	  interviews	  with	  organisational	  representatives.	  A	  
number	  of	  pilot	  sites	  offered	  a	  menu	  of	  approved	  services	  that	  budget	  holders	  could	  choose	  from	  
rather	  than	  allowing	  total	  service	  flexibility.	  
Table	  4-­‐1	  also	  shows	  that	  47%	  (N=546)	  of	  personal	  health	  budgets	  were	  worth	  more	  than	  £1,000,	  
with	  seven	  budgets	  worth	  more	  than	  £150,000.	  As	  highlighted	  in	  Chapter	  2,	  for	  budgets	  over	  £1,000	  
it	  was	  assumed	  that	  the	  resource	  would	  be	  used	  to	  substitute	  for	  existing	  services	  and	  the	  money	  
would	  have	  been	  transferred	  from	  conventional	  service	  budgets.	  We	  will	  explore	  whether	  the	  level	  
of	  budget	  had	  an	  impact	  on	  outcomes	  and	  costs	  in	  Chapters	  5	  and	  6.	  	  
Table	  4-­‐2	  shows	  that,	  unsurprisingly,	  people	  receiving	  NHS	  Continuing	  Healthcare	  received	  a	  
significantly	  higher	  level	  of	  resource	  (mean	  £37,418)	  in	  their	  personal	  health	  budget	  compared	  with	  
the	  other	  health	  condition	  cohorts.	  Furthermore,	  budget	  holders	  with	  a	  neurological	  problem	  also	  
received	  a	  higher	  level	  of	  resource	  (mean	  £13,055	  per	  year)	  compared	  with	  the	  other	  health	  
conditions,	  such	  as	  people	  in	  the	  stroke	  cohort	  who	  received	  on	  average	  £1,837	  per	  year.	  The	  size	  of	  




Table	  4-­‐1	  Size	  of	  the	  personal	  health	  budget	  
	   N	   Mean	   Min	   Max	  
Overall	  budget	  (yearly)	   1,171	   £10,402	   £0	   £378,524	  
Budget	  breakdown	   	   	   	   	  
Less	  than	  £500	   359	   £267	   £0	   £500	  
£501	  -­‐	  £1000	   266	   £680	   £500	   £1,000	  
£1001	  -­‐	  £5000	   273	   £2,092	   £1,000	   £4,987	  
£5001-­‐	  £10,000	   67	   £6,820	   £5,011	   £9,996	  
£10,001-­‐	  £50,000	   128	   £25,302	   £10,067	   £49,904	  
£50,001-­‐	  £100,000	   55	   £71,554	   £50,567	   £99,984	  
£100,001-­‐	  £150,000	   16	   £122,172	   £101,470	   £147,702	  
More	  than	  £150,000	   7	   £245,294	   £163,422	   £378,524	  
	  
Table	  4-­‐2:	  Average	  personal	  health	  budget	  by	  health	  condition,	  demographic	  and	  socio-­‐economic	  
status	  
	   N	   Mean	   Min	   Max	  
Health	  condition	   	   	   	   	  
NHS	  Continuing	  Healthcare	   155	   £37,418	   £0	   £378,524	  
Diabetes	   174	   £5,286	   £1	   £263,970	  
COPD	   197	   £3,257	   £0	   £121,566	  
Stroke	   119	   £1,837	   £1	   £68,171	  
Long-­‐term	  neurological	  	   295	   £13,055	   £0	   £308,255	  
Mental	  health	   234	   £3,602	   £0	   £92,302	  
	   	   	   	   	  
Age	   	   	   	   	  
Above	  75	  years	  of	  age	   173	   £11,011	   £0	   £263,251	  
Below	  75	  years	  of	  age	   998	   £10,296	   £0	   £378,524	  
	   	   	   	   	  
Ethnicity	   	   	   	   	  
White	  population	   1,085	   £10,626	   £0	   £378,524	  
BME	  population	   86	   £7,581	   £0	   £137,635	  
	   	   	   	   	  
Benefit	  receipt	   	   	   	   	  
Received	  benefits	   397	   £8,187	   £0	   £255,212	  
No	  benefits	   774	   £11,538	   £0	   £378,524	  
	   	   	   	   	  
Highest	  education	  level	   	   	   	   	  
University/college	  education	   	   	   	   	  
Yes	   318	   £14,408	   £0	   £378,524	  
No	   853	   £8,907	   £0	   £308,255	  
Intermediate	  education	   	   	   	   	  
Yes	   171	   £10,945	   £0	   £223,117	  




4.5 Personal	  health	  budget	  deployment	  mechanisms	  
Seventy-­‐one	  per	  cent	  (n=828)	  of	  support/care	  plans	  included	  deployment	  information;	  of	  these,	  
around	  34%	  of	  personal	  health	  budgets	  were	  being	  managed	  as	  a	  direct	  payment	  (n=283)	  and	  36%	  
were	  managed	  notionally	  (n=298).	  Despite	  one	  of	  the	  main	  aims	  of	  the	  initiative	  being	  centred	  
around	  choice,	  there	  is	  a	  varying	  picture	  between	  pilot	  sites	  as	  to	  whether	  budget	  holders	  were	  given	  
the	  option	  to	  choose	  the	  deployment	  that	  best	  met	  their	  needs.	  From	  the	  interviews	  with	  
organisational	  representatives,	  only	  half	  of	  the	  20	  in-­‐depth	  pilot	  sites	  reported	  that	  all	  three	  
deployment	  options	  were	  offered.	  Five	  of	  the	  pilot	  sites	  only	  offered	  the	  notional	  deployment	  option	  
to	  their	  budget	  holders.	  The	  lack	  of	  choice	  given	  to	  budget	  holders	  was	  highlighted	  to	  some	  extent	  
within	  the	  in-­‐depth	  interviews	  carried	  out	  nine-­‐months	  after	  the	  offer	  of	  the	  budget	  (Davidson	  et	  al.,	  
2012).	  During	  the	  interviews,	  one	  interviewee	  reported	  that	  she	  would	  have	  preferred	  it	  if	  someone	  
else	  had	  managed	  the	  budget	  rather	  than	  having	  a	  direct	  payment,	  but	  she	  was	  not	  given	  that	  
option.	  We	  will	  continue	  to	  explore	  the	  impact	  of	  choice	  and	  flexibility	  on	  outcome	  and	  costs	  in	  the	  
personal	  health	  budget	  process	  in	  Chapters	  5	  and	  6.	  
Table	  4-­‐3	  shows	  that	  personal	  health	  budgets	  that	  were	  managed	  as	  a	  direct	  payment	  received	  a	  
significantly	  higher	  level	  of	  resource	  (mean	  £13,712)	  compared	  with	  a	  notional	  budget	  (mean	  £4,523)	  
or	  a	  third-­‐party	  arrangement	  (mean	  £1,556).	  	  
Table	  4-­‐3:	  Description	  of	  deployment	  options	  by	  health	  condition	  
	   DP	   Notional	   3rd-­‐party	   Combination	  
	   Mean	  (N)	   Mean	  (N)	   Mean	  (N)	   Mean	  (N)	  
Overall	   £13,712	  (283)	   £4,523	  (298)	   £1,556	  (190)	   £15,226	  (57)	  
NHS	  Cont.	  Healthcare	   £38,972	  (79)	   £26,216	  (23)	   £17,955	  (9)	   £47,019	  (12)	  
Diabetes	   £998	  (36)	   £1,376	  (43)	   £517	  (25)	   £0	  (0)	  
COPD	   £493	  (31)	   £1,329	  (64)	   £499	  (38)	   £2,044	  (18)	  
Stroke	   £664	  (27)	   £1,602	  (65)	   £300	  (1)	   £720	  (1)	  
Neurological	  	   £7,851	  (65)	   £4,011	  (89)	   £1,926	  (4)	   £10,325	  (22)	  
Mental	  health	   £6,568	  (48)	   £9,969	  (14)	   £833	  (113)	   £9,741	  (4)	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4.6 Patterns	  of	  expenditure	  
In	  order	  to	  provide	  an	  overall	  picture	  of	  the	  use	  of	  personal	  health	  budgets,	  Table	  4-­‐4	  shows	  the	  
pattern	  of	  expenditure	  per	  year	  included	  in	  the	  personal	  health	  budgets.	  The	  expenditure	  was	  
divided	  into	  four	  categories:	  
 Social	  care	  service-­‐related	  service	  required	  to	  meet	  both	  health	  and	  social	  care	  needs	  –	  for	  
example	  home	  care,	  day	  care,	  meal	  services;	  
 Well-­‐being-­‐related	  services	  –	  for	  example	  complementary	  therapies,	  leisure,	  and	  
equipment;	  
 Therapy	  and	  nursing	  services	  –	  for	  example,	  nurse	  and	  physiotherapy	  visits;	  
 Other	  health	  services	  –	  for	  example,	  specialist	  NHS	  Continuing	  Healthcare.	  
Table	  4-­‐4	  shows	  the	  overall	  pattern	  of	  expenditure.	  	  
Table	  4-­‐4:	  Overall	  patterns	  of	  expenditure	  funded	  in	  personal	  health	  budgets,	  whole	  PHB	  sample	  
	   Mean	   SD	   Min	   Max	  
Total	  budget	   £10,402	   £28,834	   £0	   £378,524	  
Social	  care	   £5,712	   £18,627	   £0	   £235,855	  
Well-­‐being	   £560	   £1,289	   £0	   £23,135	  
Therapy	  	   £111	   £545	   £0	   £5,492	  
Other	  health	   £1,947	   £10,226	   £0	   £147,207	  
	  
A	  varying	  picture	  was	  uncovered	  when	  the	  level	  of	  resource	  was	  explored	  within	  each	  health	  
condition	  cohort.	  Unsurprisingly,	  Table	  4-­‐5	  shows	  that	  individuals	  in	  the	  NHS	  Continuing	  Healthcare	  
cohort	  received	  a	  higher	  level	  of	  resource	  for	  social	  care-­‐related	  services	  such	  as	  home	  care	  which	  is	  
health	  –funded	  (mean	  £30,913)	  and	  well-­‐being	  related	  services	  (mean	  £843),	  while	  individuals	  in	  the	  
stroke	  cohort	  received	  a	  higher	  level	  of	  resource	  for	  therapy-­‐related	  services	  (mean	  £358).	  
Individuals	  in	  the	  neurological	  cohort	  received	  a	  significantly	  higher	  level	  of	  resource	  for	  the	  ‘other	  




Table	  4-­‐5:	  Overall	  patterns	  of	  expenditure	  with	  the	  personal	  health	  budgets	  
	   N	   Mean	   SD	   Min	   Max	  
NHS	  CHC	   	   	   	   	   	  
Total	  Budget	   155	   £37,418	   £47,672	   £0	   £378,524	  
Social	  care	   155	   £30,913	   £35,274	   £0	   £235,855	  
Well-­‐being	   155	   £843	   £2,749	   £0	   £23,136	  
Therapy	  and	  
other	  nursing	  
155	   £61	   £472	   £0	   £5,492	  
Other	  health	   155	   £2,713	   £14,351	   £0	   £123,609	  
	   	   	   	   	   	  
Diabetes	   	   	   	   	   	  
Total	  Budget	   174	   £5,286	   £23,000	   £1	   £263,251	  
Social	  care	   174	   £583	   £7,495	   £0	   £179,790	  
Well-­‐being	   174	   £590	   £520	   £0	   £4,103	  
Therapy	  and	  
other	  nursing	  
174	   £29	   £257	   £0	   £5,492	  
Other	  health	   174	   £1,978	   £10,554	   £0	   £127,284	  
	   	   	   	   	   	  
Stroke	   	   	   	   	   	  
Total	  Budget	   119	   £1,836	   £4,162	   £1	   £68,171	  
Social	  care	   119	   £225	   £1,149	   £0	   £15,788	  
Well-­‐being	   119	   £292	   £437	   £0	   £2,347	  
Therapy	  and	  
other	  nursing	  
119	   £358	   £914	   £0	   £5,492	  
Other	  health	   119	   £466	   £1,887	   £0	   £33,010	  
	   	   	   	   	   	  
Mental	  health	   	   	   	   	   	  
Total	  Budget	   234	   £3,602	   £9,663	   £0	   £92,132	  
Social	  care	   234	   £2,198	   £8,894	   £0	   £91,950	  
Well-­‐being	   234	   £598	   £1,130	   £0	   £11,799	  
Therapy	  and	  
other	  nursing	  
234	   £34	   £244	   £0	   £2,533	  
Other	  health	   234	   £374	   £1,319	   £0	   £22,100	  
	   	   	   	   	   	  
COPD	   	   	   	   	   	  
Total	  Budget	   197	   £3,257	   £12,217	   £0	   £121,566	  
Social	  care	   197	   £387	   £3,579	   £0	   £102,444	  
Well-­‐being	   197	   £488	   £611	   £0	   £3,557	  
Therapy	  and	  
other	  nursing	  
197	   £65	   £403	   £0	   £5,492	  
Other	  health	   197	   £1,123	   £5,614	   £0	   £57,352	  
	   	   	   	   	   	  
Neurological	  	   	   	   	   	   	  
Total	  Budget	   295	   £13,055	   £33,414	   £0	   £308,255	  
Social	  care	   295	   £4,242	   £15,225	   £0	   £123,346	  
Well-­‐being	   295	   £585	   £1,471	   £0	   £18,506	  
Therapy	  and	  
other	  nursing	  
295	   £175	   £700	   £0	   £5,492	  
Other	  health	   295	   £3,901	   £14,501	   £0	   £147,201	  
	  
Exploring	  the	  breakdown	  of	  costs,	  individuals	  in	  the	  NHS	  Continuing	  Healthcare	  cohort	  received	  a	  
higher	  level	  of	  resource	  for	  social	  care-­‐related	  services	  such	  as	  home	  care	  which	  is	  health–funded	  for	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this	  cohort	  (mean	  £30,913)	  and	  well-­‐being	  related	  services	  (mean	  £843),	  while	  individuals	  in	  the	  
stroke	  cohort	  received	  a	  higher	  level	  of	  resource	  for	  therapy-­‐related	  services	  (mean	  £358).	  
Individuals	  in	  the	  neurological	  cohort	  received	  a	  significantly	  higher	  level	  of	  resource	  for	  the	  ‘other	  
health	  service’	  category	  (mean	  £3,901).	  
Table	  4-­‐6	  highlights	  specific	  services	  and	  support	  that	  were	  purchased	  with	  the	  personal	  health	  
budget.	  As	  mentioned	  above,	  the	  majority	  of	  the	  budgets	  were	  being	  spent	  on	  social	  care-­‐related	  
services,	  although	  there	  were	  signs	  that	  budget	  holders	  were	  choosing	  more	  innovative	  services	  to	  
support	  their	  outcomes	  and	  needs,	  such	  as	  complementary	  therapies,	  leisure	  and	  education.	  
Table	  4-­‐6:	  Specific	  expenditure	  examples	  
Social	  care-­‐related	  	   Well-­‐being	  related	  	   Nursing	  and	  
Therapy	  	  
Other	  health	  
Day	  centre	  placements	   Complementary	  therapies	  	   Physiotherapy	  	   Chiropody	  
Respite	   Sport	  membership	   Occupational	  
therapy	  	  
Dentistry	  
Home	  care	   Equipment	  	   Counselling	   Psychiatric	  
appointments	  
Meal	  services	   Holidays	  	   Stroke	  therapy	   Specialised	  CHC	  nursing	  
Autism	  support	  	   Talking	  therapies	  	   Nurse	  
appointments	  
	  
Transport	  	   Swimming	  	   	   	  
	   Horse-­‐riding	  	   	   	  
	   Education	  	   	   	  
Note	  1:	  CHC	  refers	  to	  NHS	  Continuing	  Healthcare	  
4.7 Discussion	  
Of	  significant	  importance	  is	  the	  finding	  that	  around	  50%	  of	  the	  budgets	  were	  worth	  less	  than	  £1,000	  
per	  year,	  suggesting	  that	  pilot	  sites	  were	  either	  restricting	  recruitment	  to	  the	  evaluation	  to	  patients	  
with	  less	  complex	  care	  packages,	  concentrating	  on	  specific	  elements	  of	  packages	  or	  providing	  a	  small	  
additional	  resource	  on	  top	  of	  what	  would	  have	  been	  conventionally	  provided.	  Within	  this	  group	  of	  
budgets,	  pilot	  sites	  may	  have	  incurred	  double	  running	  costs	  that	  may	  not	  be	  sustainable	  in	  the	  event	  
of	  a	  national	  roll-­‐out	  of	  the	  initiative.	  It	  seems	  that	  where	  personal	  health	  budgets	  were	  sufficiently	  
high	  enough	  to	  substitute	  for	  existing	  services,	  pilot	  sites	  tended	  to	  transfer	  money	  from	  
conventional	  service	  budgets.	  In	  terms	  of	  the	  evaluation	  guiding	  the	  roll-­‐out	  of	  the	  initiative,	  
personal	  health	  budgets	  substituting	  existing	  services	  will	  be	  of	  central	  importance	  and	  will	  be	  the	  
focus	  within	  subsequent	  multivariate	  analyses	  in	  Chapters	  5	  and	  6.	  
This	  chapter	  also	  highlighted	  that	  there	  were	  clear	  resource	  differences	  between	  the	  health	  
condition	  cohorts,	  deployment	  options	  and	  expenditure	  patterns.	  To	  some	  extent	  these	  differences	  
may	  reflect	  the	  policies	  within	  pilot	  sites	  rather	  than	  decisions	  made	  by	  budget	  holders.	  This	  
assumption	  is	  supported	  by	  the	  interviews	  with	  both	  organisational	  staff	  and	  budget	  holders	  that	  
highlighted	  varying	  degrees	  of	  choice	  and	  control	  given	  to	  budget	  holders	  during	  the	  personal	  health	  
budgets	  process,	  which	  will	  be	  explored	  in	  subsequent	  multivariate	  analysis.	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A	  key	  objective	  of	  the	  evaluation	  was	  to	  identify	  whether	  personal	  health	  budgets	  improved	  
outcomes	  from	  the	  health	  and	  care	  system	  for	  people	  by	  giving	  them	  greater	  choice	  and	  control	  over	  
Chapter	  5	  explores	  the	  impact	  that	  personal	  health	  budgets	  had	  on	  both	  clinical	  and	  subjective	  
outcomes	  between	  baseline	  and	  the	  main	  follow-­‐up	  12	  month	  period.	  	  
For	  the	  clinical	  outcomes	  we	  explored	  whether	  personal	  health	  budgets	  had	  an	  impact	  on	  mortality	  
rates,	  and	  health-­‐specific	  measures	  for	  diabetes	  (HbA1C)	  and	  COPD	  (forced	  expiratory	  volume	  in	  1	  
second	  –	  FEV1).	  For	  the	  more	  subjective	  measures,	  we	  used	  validated	  measures:	  health-­‐related	  
quality	  of	  life;	  care-­‐related	  quality	  of	  life;	  psychological	  well-­‐being;	  and	  subjective	  well-­‐being.	  
To	  account	  for	  possible	  selection	  bias	  we	  used	  the	  difference-­‐in-­‐difference	  approach.	  
Key	  overall	  findings	  were:	  	  
 Personal	  health	  budgets	  had	  a	  significant	  impact	  on	  well-­‐being	  and	  quality	  of	  life	  rather	  
than	  health	  per	  se.	  Although,	  as	  the	  follow-­‐up	  period	  was	  for	  one	  year	  we	  may	  not	  expect	  
that	  personal	  health	  budgets	  would	  have	  an	  impact	  on	  health	  status.	  Personal	  health	  
budgets	  had	  a	  significant	  positive	  impact	  on	  care-­‐related	  quality	  of	  life,	  psychological	  well-­‐
being	  and	  subjective	  well-­‐being	  compared	  to	  individuals	  in	  the	  control	  group.	  
 Personal	  health	  budgets	  had	  little	  impact	  on	  health	  status	  as	  measured	  by	  the	  clinical	  
effect	  indicators	  such	  as	  HbA1c	  and	  FEV1.	  Furthermore,	  personal	  health	  budgets	  didn’t	  
have	  an	  effect	  on	  mortality	  rates.	  	  
 People	  in	  the	  personal	  health	  budget	  group	  did	  not	  report	  significant	  improvements	  in	  
health-­‐related	  quality	  of	  life	  (EQ-­‐5D)	  compared	  to	  those	  in	  the	  control	  group.	  	  
Key	  sub-­‐group	  findings	  were:	  	  
First,	  there	  were	  significant	  improvements	  associated	  with	  the	  personal	  health	  budget	  group	  
relative	  to	  the	  control	  group	  for:	  
 COPD	  sub-­‐group	  on	  ASCOT,	  GHQ-­‐12	  and	  subjective	  well-­‐being;	  
 People	  aged	  under	  75	  years	  of	  age	  on	  ASCOT;	  
 University	  or	  college	  education	  on	  ASCOT	  and	  GHQ-­‐12;	  
 Those	  not	  receiving	  benefits	  at	  baseline	  on	  ASCOT,	  GHQ-­‐12	  and	  subjective	  well-­‐being.	  
Second,	  implementation	  model	  4	  and	  5	  had	  a	  significant	  positive	  impact	  on	  outcome	  change,	  while	  
model	  3	  had	  a	  significant	  negative	  impact.	  	  
Third,	  high-­‐budget	  personal	  health	  budgets	  (£1,000+)	  had	  a	  significant	  positive	  impact	  on	  care-­‐
related	  quality	  of	  life	  (ASCOT)	  and	  psychological	  well-­‐being	  (GHQ-­‐12).	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the	  type	  of	  support	  they	  accessed	  and	  the	  way	  that	  support	  was	  organised	  and	  delivered.	  The	  
purpose	  of	  this	  chapter	  is	  to	  describe	  the	  change	  in	  outcomes	  for	  individuals	  in	  the	  personal	  health	  
budget	  and	  control	  groups	  between	  baseline	  (before	  the	  intervention	  began)	  and	  12	  months	  after	  
the	  consent	  date	  (follow-­‐up).	  Three	  questions	  will	  be	  addressed	  in	  this	  chapter:	  
 Is	  there	  evidence	  that	  personal	  health	  budgets	  lead	  to	  better	  outcomes	  as	  compared	  with	  
conventional	  service	  delivery?	  
 Is	  there	  evidence	  to	  suggest	  that	  specific	  implementation	  models	  lead	  to	  comparatively	  
better	  outcomes	  for	  budget	  holders?	  
 What	  other	  factors	  are	  associated	  with	  outcome	  changes?	  
This	  chapter	  is	  structured	  as	  follows.	  In	  the	  next	  section	  we	  briefly	  review	  the	  methods	  relevant	  to	  
this	  chapter	  that	  we	  used	  to	  assess	  the	  effects	  of	  using	  personal	  health	  budgets.	  Section	  5.4	  reports	  
the	  results	  and	  we	  end	  with	  a	  discussion	  of	  those	  results	  in	  Section	  5.5.	  
5.3 Method	  
The	  effectiveness	  or	  outcome	  of	  an	  intervention	  like	  personal	  health	  budgets	  can	  be	  measured	  in	  a	  
number	  of	  ways.	  We	  used	  clinical	  outcome	  measures	  to	  assess	  consequences	  for	  health	  state.	  A	  
range	  of	  subjective	  measures	  were	  used	  to	  assess	  the	  impact	  of	  personal	  health	  budgets	  on	  health-­‐
related	  quality	  of	  life	  and	  care-­‐related	  quality	  of	  life,	  and	  also	  on	  subjective	  global	  well-­‐being	  and	  
psychological	  well-­‐being.	  
The	  impact	  of	  personal	  health	  budgets	  can	  also	  be	  inferred	  from	  peoples’	  experiences	  of	  the	  process	  
of	  using	  the	  budget	  and	  the	  satisfaction	  or	  otherwise	  they	  expressed	  regarding	  that	  process.	  These	  
measures	  are	  useful	  for	  understanding	  how	  well	  budget	  holders	  felt	  the	  process	  was	  working.	  There	  
is	  often	  a	  presumption	  that	  well-­‐operating	  processes	  lead	  to	  improved	  outcomes	  of	  personal	  health	  
budget	  use	  compared	  to	  alternatives.	  
5.3.1 Outcome	  measures	  
5.3.1.1 Clinical	  outcomes	  
To	  explore	  whether	  personal	  health	  budgets	  had	  an	  impact	  on	  health	  status	  we	  collected	  information	  
from	  medical	  records.	  The	  template	  included	  health-­‐specific	  measures	  for	  diabetes	  (HbA1c	  measure)	  
and	  COPD	  (forced	  expiratory	  volume	  in	  1	  second	  –	  FEV1).	  The	  template	  can	  be	  found	  in	  Appendix	  G.	  
HbA1c	  occurs	  when	  haemoglobin	  joins	  with	  glucose	  in	  the	  blood.	  The	  more	  glucose	  found	  in	  the	  
blood,	  the	  more	  glycated	  haemoglobin	  (HbA1c)	  will	  be	  present.	  The	  HbA1c	  test	  is	  in	  widespread	  use	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as	  a	  way	  to	  check	  whether	  diabetes	  is	  under	  control,	  and	  current	  HbA1c	  target	  is	  between	  6.5%	  
(good	  control)	  and	  7.5%	  (greater	  risk	  of	  hypoglycaemia).13	  	  
The	  pulmonary	  function	  test	  (FEV1)	  is	  performed	  to	  assess	  lung	  function	  and	  determine	  the	  degree	  
of	  damage	  to	  the	  lungs.	  FEV1-­‐Forced	  Expiratory	  Volume	  in	  One	  Second	  is	  the	  amount	  of	  air	  which	  
can	  be	  forcibly	  exhaled	  from	  the	  lungs	  in	  the	  first	  second	  of	  a	  forced	  exhalation.14	  
We	  also	  tracked	  mortality	  rates	  in	  the	  sample	  between	  groups.	  
5.3.1.2 Subjective	  well-­‐being	  outcomes	  
As	  described	  in	  Chapter	  2,	  we	  sought	  to	  capture	  some	  over-­‐arching	  aspects	  of	  well-­‐being	  by	  using	  
well-­‐validated	  global	  indicators,	  and	  also	  measures	  that	  picked	  up	  key	  areas	  of	  people’s	  lives,	  
specifically	  relevant	  to	  social	  care.	  Chapter	  2	  and	  Appendix	  A	  describes	  the	  measures	  used	  in	  more	  
detail,	  and	  here	  we	  briefly	  summarise	  them.	  
 Clinical	  outcomes:	  The	  aim	  was	  to	  assess	  the	  impact	  of	  personal	  health	  budgets	  on	  the	  
health	  of	  study	  participants	  in	  terms	  of	  standard	  clinical	  markers.	  To	  this	  end,	  we	  measured	  
HbA1c	  for	  diabetes	  sufferers	  and	  lung	  function	  (forced	  expiratory	  volume,	  FEV1)	  for	  COPD	  
sufferers. 
 Health-­‐related	  quality	  of	  life:	  The	  EQ-­‐5D	  utility	  scale	  aims	  to	  measure	  a	  person’s	  quality	  of	  
life	  in	  domains	  likely	  to	  be	  related	  to	  their	  underlying	  health	  status.	  It	  measures	  personal	  
functioning	  (as	  potentially	  constrained	  by	  poor	  health).	  We	  use	  the	  three-­‐level	  version	  in	  this	  
study.	  
 Care-­‐related	  quality	  of	  life:	  The	  care-­‐related	  quality	  of	  life	  measure	  (ASCOT)	  focused	  on	  the	  
achievement	  of	  everyday	  activities	  that	  might	  come	  from	  the	  support	  of	  services	  and	  
interventions,	  as	  well	  as	  from	  personal	  functioning.	  	  
 Subjective	  well-­‐being:	  The	  measure	  used	  in	  this	  study	  seeks	  to	  capture	  general	  life	  happiness	  
and	  satisfaction.	  We	  used	  a	  scale	  that	  considers	  satisfaction	  with	  life,	  and	  happiness	  and	  
satisfaction/worry	  about	  the	  person’s	  health.	  
The	  outcome	  questionnaire	  also	  contained	  a	  number	  of	  socio-­‐demographic	  and	  socio-­‐economic	  
questions	  which	  will	  be	  controlled	  in	  the	  multivariate	  analysis.	  Quantitative	  outcome	  data	  was	  
collected	  on	  four	  occasions:	  at	  baseline;	  six	  months	  after	  date	  of	  consent;	  at	  the	  main	  follow-­‐up	  time	  
(12	  months	  after	  date	  of	  consent);	  and	  up	  to	  24	  months	  after	  date	  of	  consent.	  For	  the	  purpose	  of	  this	  
chapter,	  change	  in	  outcome	  measures	  will	  be	  explored	  between	  baseline	  and	  main	  follow-­‐up	  (12-­‐
months	  after	  consent).	  






5.3.1.3 Process	  and	  experience	  measures	  
Interviews	  with	  budget	  holders	  at	  three	  and	  nine	  months	  after	  the	  offer	  of	  the	  personal	  health	  
budget	  provided	  us	  with	  a	  further	  insight	  into	  the	  experiences	  and	  impact	  of	  the	  process	  on	  
individuals	  and	  carers	  that	  could	  help	  explain	  change	  in	  outcome.	  We	  asked	  about	  their	  perceptions	  
of	  the	  process	  of	  using,	  and	  their	  understanding	  of	  personal	  health	  budgets.	  We	  also	  asked	  about	  the	  
overall	  levels	  of	  satisfaction	  they	  felt	  in	  using	  a	  personal	  health	  budget.	  
5.3.2 Analyses	  of	  responses	  
As	  outlined	  in	  Chapter	  2,	  we	  aimed	  to	  assess	  the	  effect	  of	  personal	  health	  budgets	  by	  measuring	  
whether	  the	  average	  change	  in	  the	  relevant	  outcome	  indicator	  in	  the	  personal	  health	  budget	  group	  
was	  higher	  than	  the	  average	  change	  in	  that	  indicator	  for	  the	  control	  group.	  In	  other	  words,	  relative	  
to	  the	  control	  group,	  had	  people	  in	  the	  personal	  health	  budget	  group	  improved	  at	  a	  faster	  rate	  (or	  
declined	  at	  a	  slower	  rate)	  on	  the	  measured	  indicator?	  
In	  using	  a	  difference-­‐in-­‐difference	  approach,	  we	  effectively	  removed	  any	  differences	  between	  the	  
groups	  in	  the	  level	  of	  the	  outcome	  indicator	  at	  baseline.	  So,	  if	  one	  group	  happened	  to	  have	  higher	  
measured	  well-­‐being	  or	  health	  status	  at	  baseline	  than	  the	  other,	  this	  baseline	  difference	  will	  not	  
have	  a	  bearing	  on	  the	  follow-­‐up	  analysis	  –	  as	  we	  are	  measuring	  relative	  improvement.	  Whilst	  this	  
method	  is	  an	  effective	  way	  to	  control	  for	  any	  differences	  in	  the	  characteristics	  of	  the	  personal	  health	  
budget	  and	  control	  groups	  affecting	  the	  outcome	  indicator	  at	  baseline,	  there	  remains	  a	  possibility	  
that	  differences	  between	  the	  groups	  might	  cause	  differences	  in	  the	  rate	  of	  change	  of	  the	  indicator,	  
beyond	  any	  true	  effect	  of	  PHBs–	  see	  Appendix	  C.	  A	  list	  of	  all	  confounding	  variables	  explored	  in	  the	  
analysis	  can	  be	  found	  in	  Appendix	  C.	  
To	  safeguard	  against	  the	  possibility	  of	  bias	  of	  this	  kind,	  we	  also	  estimated	  multivariate	  difference-­‐in-­‐
difference	  models.	  These	  allow	  us	  to	  identify	  and	  remove	  the	  effects	  of	  differences	  in	  baseline	  
characteristics	  between	  the	  groups	  on	  any	  changes	  in	  the	  outcome	  measures	  (see	  also	  Chapter	  6	  for	  
an	  interpretation	  of	  these	  methods).	  A	  number	  of	  baseline	  characteristics	  were	  explored	  in	  these	  
‘controlled’	  analyses	  including	  socio-­‐demographic	  factors	  (for	  example,	  gender,	  age,	  baseline	  
dependency,	  accommodation,	  ethnicity),	  socio-­‐economic	  factors	  (for	  example,	  education,	  benefit	  
receipt);	  and	  health	  status	  (for	  example,	  health	  condition	  and	  comorbidities).	  The	  possibility	  of	  
differences	  in	  baseline	  characteristics	  introduces	  spurious	  change	  bias	  which	  is	  particularly	  important	  
for	  mortality	  rate	  analysis.	  Clearly,	  at	  baseline	  there	  were	  no	  differences	  between	  the	  groups	  in	  
mortality	  rates	  (all	  were	  alive)	  but	  this	  can	  mask	  significant	  differences	  in	  the	  probability	  of	  death	  
immediately	  after	  baseline.	  The	  confounding	  variables	  that	  contributed	  to	  explaining	  the	  change	  on	  
outcomes	  at	  follow-­‐up	  were	  included	  in	  the	  models.	  	  
As	  anticipated	  and	  discussed	  in	  Chapter	  2	  (and	  Appendix	  C,	  section	  C.	  7),	  in	  highly	  complex	  
evaluations	  such	  as	  this	  one,	  we	  will	  always	  have	  at	  least	  some	  missing	  data	  for	  individuals.	  Where	  
these	  responses	  could	  be	  considered	  to	  be	  missing	  at	  random	  (to	  a	  reasonable	  extent),	  we	  were	  able	  
to	  ‘impute’	  values	  for	  missing	  data	  with	  techniques	  that	  use	  the	  underlying	  patterns	  in	  the	  whole	  
dataset.	  Appendix	  C	  provides	  a	  detailed	  account	  of	  these	  multiple	  imputation	  techniques.	  The	  main	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multivariate	  outcome	  analyses	  were	  run	  on	  the	  imputed	  datasets.	  The	  imputed	  dataset	  consists	  of	  
2,235	  cases,	  with	  1,171	  in	  the	  personal	  health	  budget	  group	  and	  1,064	  in	  the	  control	  group.	  	  
The	  quantitative	  analyses	  were	  also	  supplemented	  by	  evidence	  from	  the	  in-­‐depth	  qualitative	  analysis	  
with	  budget	  holders	  at	  nine	  months	  after	  the	  offer	  of	  the	  budget	  and	  organisational	  representatives.	  
5.3.2.1 Sub-­‐group	  effects	  
The	  in-­‐depth	  interviews	  with	  organisational	  representatives	  provided	  us	  with	  information	  around	  
how	  personal	  health	  budgets	  had	  been	  implemented	  within	  the	  in-­‐depth	  pilot	  sites	  and	  the	  views	  
held	  by	  the	  staff	  offering	  personal	  health	  budgets.	  The	  interviews	  also	  provided	  the	  opportunity	  to	  
classify	  pilot	  sites	  into	  five	  different	  implementation	  models	  based	  on	  the	  local	  processes	  that	  were	  
followed	  during	  the	  pilot	  programme	  (see	  Table	  1-­‐2).	  
5.4 Results	  
5.4.1 Personal	  health	  budget	  process	  
The	  original	  evaluation	  design	  anticipated	  that	  all	  personal	  health	  budget	  holders	  would	  be	  using	  
their	  budget	  at	  the	  time	  of	  the	  12-­‐month	  outcome	  interview.	  However,	  similar	  to	  the	  social	  care	  
experience	  within	  the	  evaluation	  of	  individual	  budgets	  pilot	  programme	  (Glendinning	  et	  al.,	  2008),	  
the	  process	  took	  significantly	  longer	  to	  be	  put	  in	  place.	  According	  to	  the	  in-­‐depth	  interviews	  with	  
organisational	  representatives,	  the	  delays	  were	  caused	  by	  various	  issues	  including	  challenges	  faced	  
within	  the	  pilot	  sites,	  lack	  of	  guidance	  and	  the	  required	  cultural	  shift	  to	  implement	  a	  new	  way	  of	  
service	  delivery.	  
	  “Too	  slowly,	  too	  slowly,	  because	  of	  the	  challenges	  our	  PCT	  is	  having	  in	  terms	  of	  administering	  and	  
assessing	  for	  the	  personal	  health	  budgets”	  (Operational	  staff	  member).	  
	  “We	  need	  training	  about	  packages	  of	  choice,	  how	  to	  facilitate	  choice,	  we	  don’t	  know	  this	  at	  the	  
minute”	  (Health	  professional).	  
Despite	  the	  delays	  within	  the	  system,	  it	  was	  anticipated	  that	  a	  year	  between	  consent	  and	  follow-­‐up	  
outcome	  interviews	  would	  have	  been	  sufficient	  for	  the	  personal	  health	  budget	  process.	  At	  the	  time	  
of	  the	  outcome	  interview,	  around	  two-­‐thirds	  of	  individuals	  reported	  that	  they	  had	  received	  help	  paid	  
for	  by	  their	  personal	  health	  budget	  (65%,	  N	  =	  766).15	  Just	  under	  half	  of	  people	  with	  personal	  health	  
budgets	  received	  help	  paid	  for	  by	  the	  budget	  for	  more	  than	  6	  months	  (46%,	  N	  =	  544).	  The	  limited	  
amount	  of	  time	  that	  budget	  holders	  were	  in	  receipt	  of	  the	  personal	  health	  budget	  will	  have	  an	  
impact	  on	  the	  extent	  to	  which	  the	  study	  can	  explore	  the	  impact	  on	  longer-­‐term	  outcomes.	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  




We	  were	  able	  to	  collect	  further	  information	  on	  people’s	  view	  of	  the	  personal	  health	  budget	  for	  the	  
sub-­‐sample	  of	  non-­‐imputed	  data.	  Among	  personal	  health	  budget	  holders,	  around	  40%	  (n=217)	  had	  
some	  understanding	  of	  how	  the	  resource	  level	  was	  calculated	  and	  around	  50%	  (n=285)	  were	  
extremely	  or	  very	  satisfied	  with	  the	  support	  planning	  process.	  However,	  around	  15%	  (n=98)	  of	  
individuals	  in	  the	  personal	  health	  budget	  group	  expressed	  a	  degree	  of	  dissatisfaction	  with	  the	  
support	  planning	  process,	  the	  knowledge	  that	  the	  support	  planner	  had	  around	  the	  initiative	  and	  
financial	  arrangements.	  
The	  mixed	  views	  among	  budget	  holders	  is	  supported	  by	  the	  findings	  from	  the	  in-­‐depth	  interviews	  
among	  budget	  holders	  as	  it	  was	  found	  that,	  while	  many	  people	  were	  satisfied	  with	  the	  help	  and	  
advice	  that	  they	  received	  in	  support	  planning,	  others	  did	  not	  feel	  that	  they	  had	  been	  given	  a	  chance	  
to	  be	  involved	  in	  the	  process.	  	  
However,	  despite	  the	  somewhat	  negative	  views	  held	  by	  some	  budget	  holders,	  38%	  (n=201)	  reported	  
that	  their	  view	  of	  what	  could	  be	  achieved	  in	  their	  lives	  had	  changed	  a	  lot	  and	  a	  further	  32%	  (N=172)	  
reported	  that	  it	  had	  changed	  a	  little.	  This	  picture	  is	  consistent	  with	  the	  interviews	  carried	  out	  among	  
the	  sub-­‐sample	  of	  budget	  holders	  that	  found	  a	  number	  of	  participants	  expressing	  the	  view	  that	  the	  
personal	  health	  budget	  had	  been	  life-­‐changing:	  by	  improving	  their	  health	  and	  outlook	  on	  life.	  For	  
example,	  one	  man	  with	  a	  mental	  health	  issue	  said	  that,	  in	  planning	  for	  its	  use,	  he	  had	  been	  
encouraged	  to	  focus	  on	  what	  would	  make	  him	  feel	  better:	  “I	  just	  think	  it	  encourages	  me	  to	  look	  more	  
positively	  at	  my	  health	  condition	  than	  otherwise	  I	  would	  have	  done”.	  
A	  few	  budget	  holders	  felt	  that	  the	  personal	  health	  budget	  had	  given	  them	  motivation	  to	  do	  more	  for	  
themselves	  to	  increase	  their	  well-­‐being,	  while	  others	  thought	  that	  their	  confidence	  had	  improved.	  
However,	  similar	  to	  the	  in-­‐depth	  qualitative	  interviews,	  a	  sample	  of	  budget	  holders	  within	  the	  
quantitative	  analysis	  (29%,	  N=151)	  did	  not	  believe	  that	  the	  personal	  health	  budget	  process	  had	  
changed	  their	  view	  on	  what	  could	  be	  achieved.	  
5.4.2 Variations	  in	  clinical	  outcomes	  
5.4.2.1 Mortality	  rates	  
Mortality	  rates	  after	  baseline	  characteristics	  averaged	  8.7%	  in	  the	  personal	  health	  budget	  group	  and	  
6.6%	  in	  the	  control	  group,	  or	  around	  33%	  higher	  in	  the	  personal	  health	  budget	  than	  the	  control	  
group,	  but	  this	  difference	  was	  not	  statistically	  significant	  (p	  =	  0.109).	  As	  noted	  above,	  the	  case	  for	  
using	  control	  factors	  is	  strong	  for	  the	  analysis	  of	  mortality.	  Table	  5-­‐1	  presents	  the	  results	  of	  the	  
control	  estimations	  and	  highlight	  that	  older	  and	  more	  dependent	  participants	  were	  more	  likely	  to	  die	  
within	  the	  study	  period.	  The	  base	  model	  compared	  personal	  health	  budget	  and	  control	  groups	  for	  
the	  whole	  sample.	  An	  odds	  ratio16	  of	  +27.1%	  greater	  mortality	  in	  the	  personal	  health	  budget	  group	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
16	  The	  odd	  ratios	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  a	  measure	  of	  effect	  size	  and	  reflect	  how	  likely	  an	  event	  (death)	  will	  occur.	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compared	  to	  the	  control	  group	  was	  estimated,	  but	  again	  not	  significant	  (p	  =	  0.252).	  The	  control	  
factors	  were	  strongly	  significant	  in	  accounting	  for	  variation	  in	  mortality	  rates	  after	  baseline	  (F	  =	  4.55,	  
p	  <	  0.001).	  Specifically,	  the	  results	  suggest	  that	  older	  and	  more	  dependent	  participants	  (as	  measured	  
by	  ADLs	  scores	  at	  baseline)	  were	  more	  likely	  to	  die	  within	  the	  study	  period.	  
Table	  5-­‐1.	  Mortality	  rates	  
	   Base	  model	   Interaction	  model	  
	   Odds	  Ratio	   Prob	   Odds	  Ratio	   Prob	  
PHB	  Group	   1.271	   0.252	   1.213	   0.426	  
PHB	  Group*NHS	  Continuing	  Healthcare	  
	   	  
1.286	   0.629	  
NHS	  Continuing	  Healthcare	   1.457	   0.373	   1.229	   0.701	  
Age	   1.032	   <0.001***	   1.032	   <0.001***	  
Married	   0.867	   0.614	   0.872	   0.624	  
Informal	  care	  –	  inside	  household	  at	  baseline	   0.972	   0.912	   0.968	   0.900	  
Informal	  care	  –	  inside	  household	  at	  baseline	   1.250	   0.291	   1.252	   0.287	  
ADL	  score	  level	  at	  baseline	   0.923	   <0.001***	   0.923	   <0.001***	  
Gender	   1.064	   0.734	   1.067	   0.721	  
Help	  with	  outcome	  questionnaire	   0.781	   0.271	   0.780	   0.269	  
Receiving	  benefits	  at	  baseline	   0.810	   0.415	   0.813	   0.421	  
University	  or	  college	  education	   1.066	   0.824	   1.070	   0.815	  
Intermediate	  education	   0.644	   0.417	   0.647	   0.425	  
BME	  	   1.019	   0.965	   1.025	   0.955	  
Health-­‐related	  quality	  of	  life	  at	  baseline	   1.383	   0.625	   1.400	   0.614	  
Psychological	  well-­‐being	  at	  baseline	   0.988	   0.559	   0.988	   0.557	  
Subjective	  well-­‐being	  at	  baseline	   0.995	   0.740	   0.995	   0.723	  
Social	  care-­‐related	  quality	  of	  life	  at	  baseline	   1.796	   0.322	   1.803	   0.315	  
Perceived	  quality	  of	  life	  at	  baseline	   1.098	   0.444	   1.101	   0.430	  
Perceived	  health	  at	  baseline	  
	   	   	   	  




Good	   1.006	   0.994	   1.012	   0.988	  
Fair	   1.639	   0.532	   1.646	   0.529	  
Bad	   1.633	   0.566	   1.646	   0.561	  
Very	  bad	   2.544	   0.291	   2.550	   0.290	  
Constant	   0.014	   0.001***	   0.014	   0.001***	  








Significance	  levels:	  *	  p<0.10	  **	  p<0.05***	  p<	  0.001	  	  
Mortality	  rates	  were	  higher	  overall	  for	  the	  NHS	  Continuing	  Healthcare	  sub-­‐group	  than	  the	  rest	  of	  the	  
sample,	  at	  15.43%	  overall	  (12.42%	  control	  and	  16.97%	  personal	  health	  budget).	  The	  results	  of	  the	  
interaction	  model	  indicated	  that	  the	  impact	  of	  personal	  health	  budget	  use	  on	  mortality	  rates	  in	  the	  
NHS	  Continuing	  Healthcare	  cohort	  was	  not	  significantly	  different	  from	  the	  rest	  of	  the	  sample	  (and	  
not	  significant	  compared	  to	  controls	  in	  the	  NHS	  Continuing	  Healthcare	  cohort:	  p	  =	  0.329).	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Table	  5-­‐2	  shows	  that	  personal	  health	  budgets	  did	  not	  a	  have	  significant	  impact	  on	  the	  clinical	  
measures	  for	  diabetes	  and	  COPD	  compared	  to	  conventional	  service	  delivery.	  Control	  factors	  did	  not	  
have	  a	  significant	  impact	  on	  clinical	  outcome	  change	  (p	  =	  0.755	  for	  COPD	  and	  p	  =	  0.449	  for	  diabetes).	  
However,	  due	  to	  the	  one-­‐year	  follow-­‐up	  period	  used	  in	  this	  study,	  it	  may	  be	  expected	  that	  using	  a	  
personal	  health	  budget	  wouldn’t	  have	  an	  impact	  on	  health	  status.	  	  
Table	  5-­‐2.	  Change	  in	  clinical	  outcomes	  between	  baseline	  and	  follow-­‐up	  	  
	   Coef	   P>t	  
HbA1c	  –	  Diabetes	  health	  cohort	  	   -­‐0.481	   0.449	  
FEV1	  –	  COPD	  health	  cohort	  	   0.069	   0.755	  
Significance	  levels:	  *	  p<0.10	  **	  p<0.05***	  p<	  0.001	  	  
5.4.3 Variations	  in	  subjective	  outcomes	  
This	  section	  explores	  whether	  personal	  health	  budgets	  had	  a	  significant	  impact	  on	  subjective	  
outcome	  measures	  compared	  to	  the	  control	  group.	  A	  description	  of	  the	  outcome	  measures	  used	  can	  
be	  found	  in	  Chapter	  2	  and	  Appendix	  A.	  	  
5.4.3.1 Main	  effect	  analyses	  
On	  average,	  the	  study	  showed	  that	  there	  were	  relative	  improvements	  in	  care-­‐related	  quality	  of	  life	  
(ASCOT),	  psychological	  well-­‐being	  (GHQ-­‐12)	  and	  subjective	  well-­‐being	  for	  individuals	  in	  the	  personal	  
health	  budget	  group	  compared	  to	  those	  in	  the	  control	  group.	  Table	  5-­‐3	  shows	  baseline	  and	  follow-­‐up	  
averages	  for	  the	  listed	  outcome	  measures,	  distinguishing	  between	  the	  personal	  health	  budget	  and	  
control	  group,	  and	  the	  size	  of	  their	  change	  without	  accounting	  for	  baseline	  characteristics.	  The	  right-­‐
hand	  column	  reports	  the	  differences	  between	  the	  personal	  health	  budget	  and	  control	  group,	  and,	  in	  
particular,	  the	  difference	  in	  the	  change	  amounts.	  At	  baseline,	  we	  found	  significant	  differences	  
between	  outcome	  measures,	  the	  size	  of	  which	  had	  reduced	  in	  all	  cases	  except	  EQ-­‐5D	  by	  follow-­‐up.	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Table	  5-­‐3	  Outcome	  measures	  –	  means	  and	  differences,	  baseline	  and	  follow-­‐up	  
	   	   PHB	   Control	   Diff	  
	   	   Mean	   SD	   Mean	   SD	   Mean	  
ASCOT	  	   Baseline	   0.526	   0.239	   0.610	   0.230	   -­‐0.084***	  
Follow-­‐up	   0.584	   0.239	   0.628	   0.235	   -­‐0.045***	  
Change	   0.057	   0.233	   0.018	   0.221	   0.039***	  
EQ-­‐5D	   Baseline	   0.489	   0.278	   0.549	   0.265	   -­‐0.059***	  
Follow-­‐up	   0.479	   0.284	   0.549	   0.271	   -­‐0.070***	  
Change	   -­‐0.011	   0.221	   0.000	   0.207	   -­‐0.011NS	  
GHQ-­‐12	   Baseline	   17.274	   7.480	   15.549	   7.267	   1.726***	  
Follow-­‐up	   15.056	   7.219	   14.496	   7.006	   0.560	  NS	  
Change	   -­‐2.218	   7.940	   -­‐1.053	   7.173	   -­‐1.165**a	  
Subjective	  
well-­‐being	  
Baseline	   24.780	   10.310	   26.870	   10.558	   -­‐2.090***	  
Follow-­‐up	   27.336	   9.724	   28.293	   9.913	   -­‐0.956*	  
Change	   2.556	   10.017	   1.423	   9.654	   1.133*	  
NB	  	   a	  A	  negative	  change	  denotes	  an	  improvement	  on	  GHQ-­‐12	  
	   Significance	  levels:	  *	  p<0.10	  **	  p<0.05***	  p<	  0.001	  	  
However,	  because	  we	  also	  found	  significant	  differences	  at	  baseline,	  the	  possibility	  that	  those	  
differences	  might	  account	  for	  some	  of	  the	  difference	  in	  change,	  rather	  than	  the	  use	  of	  a	  personal	  
health	  budget,	  needed	  to	  be	  considered.	  For	  this	  reason	  we	  also	  estimated	  the	  difference	  in	  the	  
change	  over	  time	  when	  controlling	  for	  a	  range	  of	  baseline	  characteristics.	  
The	  results	  are	  listed	  in	  Table	  5-­‐4	  for	  ASCOT	  and	  EQ-­‐5D	  and	  in	  Table	  5-­‐5	  for	  GHQ-­‐12	  and	  subjective	  
well-­‐being.	  In	  all	  cases	  the	  control	  factors	  were	  jointly	  significant	  at	  the	  10%	  level	  or	  higher.	  The	  
introduction	  of	  control	  factors	  somewhat	  reduced	  the	  difference-­‐in-­‐difference	  estimates	  compared	  
to	  the	  mean	  values	  in	  Table	  5-­‐3	  above.	  For	  example,	  rather	  than	  an	  average	  difference	  in	  ASCOT	  
change	  of	  0.039,	  the	  new	  estimate	  is	  reduced	  to	  0.028.	  The	  differences	  remained	  statistically	  
significant	  at	  5%	  for	  ASCOT	  and	  10%	  for	  GHQ-­‐12.	  The	  subjective	  well-­‐being	  measure	  did	  not	  show	  a	  
significant	  difference	  after	  control	  factors	  were	  introduced.	  
The	  difference-­‐in-­‐difference	  analyses	  highlight	  that,	  after	  accounting	  for	  confounding	  factors,	  people	  
in	  the	  personal	  health	  budget	  group	  reported	  statistically	  significantly	  better	  ASCOT	  and	  GHQ-­‐12	  
outcomes	  compared	  with	  people	  in	  the	  control	  group.	  In	  other	  words,	  we	  found	  significant	  positive	  
effects	  of	  using	  personal	  health	  budgets	  on	  care-­‐related	  quality	  of	  life	  and	  psychological	  well-­‐being.	  
The	  results	  highlight	  that	  there	  is	  good	  probability	  that	  personal	  health	  budgets	  improve	  people’s	  
perceptions	  of	  quality	  of	  life	  compared	  with	  conventional	  service	  delivery.	  
Despite	  these	  positive	  effects	  on	  ASCOT	  and	  GHQ-­‐12	  outcomes,	  this	  result	  was	  not	  repeated	  for	  
health	  care-­‐related	  quality	  of	  life	  (EQ-­‐5D).	  After	  accounting	  for	  confounding	  factors,	  people	  in	  the	  
personal	  health	  budget	  group	  did	  not	  report	  a	  greater	  change	  in	  health-­‐related	  quality	  of	  life	  
compared	  to	  those	  in	  the	  control	  group.	  As	  outlined	  above,	  there	  is	  both	  quantitative	  and	  qualitative	  
evidence	  to	  suggest	  that	  personal	  health	  budgets	  did	  not	  have	  an	  impact	  on	  health	  status	  when	  
clinical	  outcomes	  were	  explored.	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Exploring	  the	  controlling	  factors,	  the	  analysis	  indicated	  that	  improvement	  in	  outcome	  measures	  was	  
consistently	  associated	  with	  younger	  participants	  and	  baseline	  dependency	  levels.	  The	  age	  effect	  is	  
consistent	  with	  the	  findings	  from	  the	  evaluation	  of	  individual	  budgets	  (Glendinning	  et	  al.,	  2008),	  
which	  raised	  questions	  about	  the	  benefits	  of	  IBs	  for	  older	  people.	  However,	  the	  main	  effects	  
disappeared	  once	  we	  controlled	  for	  whether	  participants	  were	  in	  the	  personal	  health	  budget	  or	  
control	  group.	  	  
Table	  5-­‐4	  ASCOT	  and	  EQ-­‐5D	  outcome	  Difference-­‐in-­‐Difference,	  personal	  health	  budget	  group,	  with	  
control	  factors	  
	   Care-­‐related	  quality	  of	  life	  
(ASCOT)	  
Health-­‐related	  quality	  of	  life	  
(EQ-­‐5D)	  
	   Coeff	   Prob	   Coeff	   Prob	  
PHB	  group	   0.028	   0.047**	   -­‐0.018	   0.167	  
Age	   -­‐0.002	   <0.001***	   -­‐0.001	   0.023**	  
Male	   -­‐0.004	   0.741	   0.011	   0.432	  
ADL	  score	   2.11E-­‐04	   0.813	   -­‐0.004	   <0.001***	  
Receives	  benefits	   -­‐0.014	   0.420	   0.011	   0.427	  
Uni/college	  educ.	   0.010	   0.701	   0.019	   0.175	  
Intermediate	  educ.	   -­‐0.004	   0.840	   0.022	   0.198	  
Health	  condition	   	   	   	   	  
Continuing	  Healthcare	   0.009	   0.656	   -­‐0.074	   0.001**	  
Stroke	   -­‐0.004	   0.873	   -­‐0.001	   0.977	  
Diabetes	   0.044	   0.146	   -­‐3.18E-­‐04	   0.988	  
Mental	  health	   0.042	   0.176	   -­‐0.012	   0.635	  
COPD	   0.040	   0.140	   0.016	   0.514	  
Neurological	   0.043	   0.215	   -­‐0.022	   0.298	  
Follow-­‐up	  period	   2.90E-­‐04	   0.319	   2.95E-­‐05	   0.889	  
Consent	  date	   -­‐2.71E-­‐05	   0.810	   7.55E-­‐05	   0.473	  
Area	  cost	  adjust	   0.079	   0.564	   0.193	   0.186	  
Area	   	   	   	   	  
Town	  &	  Fringe	   0.026	   0.310	   0.014	   0.639	  
Rural	   0.019	   0.578	   0.036	   0.114	  
Constant	   0.385	   0.858	   -­‐1.501	   0.456	  
N	   2235	   	   2235	   	  
Model	  F	   2.010	   0.011**	   2.000	   0.011**	  
Controls	  -­‐	  Joint	  sig	   1.670	   0.052*	   2.110	   0.008**	  





Table	  5-­‐5.	  GHQ-­‐12	  and	  Subjective	  well-­‐being	  Difference-­‐in-­‐Difference,	  personal	  health	  budget	  
group,	  with	  control	  factors	  
	   Psychological	  well-­‐being	  
(GHQ-­‐12)	  
Subjective	  well-­‐being	  
	   Coeff	   Prob	   Coeff	   Prob	  
PHB	  group	   -­‐0.852	   0.096*	   0.762	   0.213	  
Age	   0.027	   0.028**	   -­‐0.042	   0.022**	  
Male	   1.030	   0.059*	   -­‐0.669	   0.110	  
ADL	  score	   0.113	   0.013**	   -­‐0.041	   0.306	  
Receives	  benefits	   -­‐0.291	   0.604	   0.132	   0.865	  
Uni/college	  educ.	   -­‐0.334	   0.561	   0.446	   0.457	  
Intermediate	  educ.	   0.288	   0.648	   -­‐0.755	   0.266	  
Health	  condition	   	   	   	   	  
Continuing	  Healthcare	   1.423	   0.060*	   -­‐1.391	   0.165	  
Stroke	   -­‐1.801	   0.033**	   0.569	   0.633	  
Diabetes	   -­‐1.891	   0.047*	   1.563	   0.101	  
Mental	  health	   -­‐0.459	   0.653	   2.233	   0.066*	  
COPD	   -­‐1.278	   0.136	   1.141	   0.350	  
Neurological	   -­‐1.119	   0.153	   1.015	   0.410	  
Follow-­‐up	  period	   -­‐0.003	   0.663	   0.014	   0.062*	  
Consent	  date	   -­‐1.57E-­‐04	   0.954	   0.002	   0.611	  
Area	  cost	  adjust	   1.016	   0.842	   -­‐0.141	   0.981	  
Area	   	   	   	   	  
Town	  &	  Fringe	   -­‐0.549	   0.415	   0.947	   0.295	  
Rural	   -­‐1.048	   0.270	   1.305	   0.166	  
Constant	   -­‐1.188	   0.982	   -­‐45.595	   0.605	  
N	   2235	   	   2235	   	  
Model	  F	   2.220	   0.004**	   1.790	   0.025**	  
Controls	  -­‐	  Joint	  sig	   1.880	   0.020**	   1.590	   0.064*	  
Significance	  levels:	  *	  p<0.10	  **	  p<0.05***	  p<	  0.001	  	  
We	  can	  infer	  from	  these	  results	  that	  personal	  health	  budgets	  had	  a	  significant	  positive	  impact	  on	  
care-­‐related	  quality	  of	  life	  and	  psychological	  well-­‐being.	  The	  impact	  of	  personal	  health	  budgets	  on	  
well-­‐being/quality	  of	  life-­‐related	  outcomes	  is	  not	  surprising	  as	  it	  was	  highlighted	  in	  Chapter	  4	  that	  
there	  were	  signs	  budget	  holders	  were	  choosing	  more	  innovative	  well-­‐being	  services	  to	  support	  their	  
needs	  that	  potentially	  would	  have	  an	  impact	  on	  perceptions	  of	  quality	  of	  life.	  Furthermore,	  Chapter	  6	  
will	  be	  reporting	  that	  well-­‐being	  services	  show	  statistically	  significant	  difference	  between	  groups	  in	  
changes	  over	  time.	  The	  assumption	  that	  personal	  health	  budgets	  have	  an	  impact	  on	  well-­‐being	  was	  
further	  supported	  in	  the	  in-­‐depth	  qualitative	  interviews	  with	  budget	  holders	  at	  nine	  months	  after	  the	  
offer	  of	  the	  budget.	  Some	  budget	  holders	  felt	  that	  the	  budget	  had	  changed	  their	  lives	  by	  giving	  them	  
hope	  for	  the	  future,	  increased	  social	  participation,	  and	  improved	  mental	  health	  and	  well-­‐being;	  “well,	  
if	  anyone	  asked	  what	  it	  did	  for	  me	  I’d	  say	  it	  give	  me	  my	  life	  back;	  honest,	  it	  has	  changed	  me	  
completely”	  (mental	  health	  cohort).	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5.4.3.2 Sub-­‐group	  effects	  
We	  anticipated	  that	  personal	  health	  budgets	  would	  have	  a	  differential	  impact	  on	  outcome	  measures	  
for	  different	  sub-­‐groups	  in	  the	  sample.	  In	  particular,	  we	  investigated	  whether	  personal	  health	  
budgets	  showed	  significant	  improvements	  for	  the	  different	  health	  conditions,	  socio-­‐demographic	  
and	  socio-­‐economic	  factors	  and	  also	  in	  terms	  of	  the	  different	  implementation	  models	  for	  personal	  
health	  budgets	  (see	  Chapter	  1).	  To	  this	  end,	  we	  estimated	  controlled	  difference-­‐in-­‐difference	  models	  
with	  sub-­‐group	  interaction	  effects.	  
5.4.3.3 Health	  condition,	  socio-­‐demographic	  factors	  and	  socio-­‐economic	  factors	  	  
Table	  5-­‐6	  reports	  the	  (controlled)	  difference-­‐in-­‐difference	  results	  for	  health	  condition	  (analysis	  run	  
separately	  for	  each	  health	  condition).	  The	  analysis	  reported	  in	  this	  table	  compares	  the	  outcome	  
indicators	  for	  people	  in	  this	  study	  with	  a	  personal	  health	  budget	  against	  those	  in	  the	  control	  group	  by	  
listed	  health	  condition.	  Because	  sample	  sizes	  in	  these	  health	  condition	  sub-­‐groups	  were	  much	  
smaller	  than	  for	  the	  whole	  sample,	  confidence	  intervals	  will	  be	  wider	  (or	  significance	  probabilities	  
lower),	  other	  things	  equal.	  To	  find	  a	  significant	  result	  in	  a	  given	  health	  condition	  sub-­‐group	  means	  
that	  the	  effect	  size	  associated	  with	  personal	  health	  budgets	  will	  have	  had	  to	  have	  been	  greater	  in	  
that	  case	  than	  the	  effect	  size	  for	  the	  whole	  sample	  (at	  the	  same	  significance	  level).	  We	  found	  
significant	  improvements	  associated	  with	  the	  personal	  health	  budget	  group	  relative	  to	  the	  control	  
for	  the	  COPD	  sub-­‐group	  on	  GHQ-­‐12	  and	  subjective	  well-­‐being.	  	  
With	  regard	  to	  the	  implications,	  with	  the	  possible	  exception	  of	  COPD,	  these	  results	  do	  not	  suggest	  
that	  the	  overall	  positive	  effect	  of	  personal	  health	  budgets	  is	  strongly	  associated	  with	  particular	  
health	  conditions.	  In	  that	  the	  personal	  health	  budget	  effect	  seems	  to	  be	  focused	  around	  well-­‐being	  




Table	  5-­‐6.	  Outcome	  measures	  –	  impact	  of	  personal	  health	  budgets,	  by	  health	  condition	  	  
	   Coeff	   Prob	  
NSH	  Continuing	  Healthcare	   	   	  
ASCOT	   0.015	   0.693	  
EQ-­‐5D	   -­‐0.079	   0.112	  
GHQ-­‐12	   -­‐0.117	   0.906	  
Subjective	  well-­‐being	   -­‐0.263	   0.864	  
Stroke	   	   	  
ASCOT	   -­‐0.015	   0.619	  
EQ-­‐5D	   -­‐0.018	   0.544	  
GHQ-­‐12	   -­‐1.026	   0.329	  
Subjective	  well-­‐being	   1.123	   0.372	  
Diabetes	   	   	  
ASCOT	   0.012	   0.710	  
EQ-­‐5D	   -­‐0.015	   0.533	  
GHQ-­‐12	   -­‐1.019	   0.437	  
Subjective	  well-­‐being	   -­‐0.009	   0.994	  
Mental	  health	   	   	  
ASCOT	   0.045	   0.171	  
EQ-­‐5D	   -­‐0.040	   0.105	  
GHQ-­‐12	   0.597	   0.533	  
Subjective	  well-­‐being	   1.255	   0.289	  
COPD	   	   	  
ASCOT	   0.039	   0.098*	  
EQ-­‐5D	   0.001	   0.959	  
GHQ-­‐12	   -­‐2.313	   0.003**	  
Subjective	  well-­‐being	   2.850	   0.033**	  
Neurological	   	   	  
ASCOT	   0.025	   0.251	  
EQ-­‐5D	   -­‐0.001	   0.959	  
GHQ-­‐12	   -­‐0.931	   0.195	  
Subjective	  well-­‐being	   -­‐0.128	   0.901	  
Significance	  levels:	  *p<	  0.10	  **p<	  0.05	  ***p<	  0.001	  
The	  in-­‐depth	  interviews	  with	  budget	  holders	  support	  the	  view	  that,	  while	  personal	  health	  budgets	  
may	  provide	  greater	  choice	  and	  control,	  clinical	  health	  status	  is	  more	  difficult	  to	  improve:	  It	  certainly	  
helped	  me	  to	  maintain	  the	  status	  quo	  and,	  and	  ..	  I	  mean	  I,	  I	  would	  say	  it’s,	  it’s	  a	  positive	  achievement	  
..	  that	  I	  have	  not	  had	  any	  significant	  deterioration.	  And	  that	  is	  positive	  to	  me…	  (Long-­‐term	  
neurological	  cohort).	  
Turning	  to	  age,	  there	  was	  some	  weak	  evidence	  that	  personal	  health	  budgets	  showed	  more	  effect	  for	  
younger	  age	  groups	  –	  see	  Table	  5-­‐7.	  People	  aged	  under	  75	  in	  the	  personal	  health	  budget	  group	  were	  
significantly	  more	  likely	  than	  people	  over	  the	  age	  of	  75	  to	  report	  improved	  care-­‐related	  quality	  of	  life	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(ASCOT)	  relative	  to	  the	  control	  group.	  The	  same	  pattern	  was	  also	  evident	  for	  the	  GHQ-­‐12	  measure.	  
There	  was	  no	  observed	  change	  for	  over-­‐75s	  relative	  to	  the	  control	  group.	  
Table	  5-­‐7.Outcome	  measures	  –	  impact	  of	  personal	  health	  budgets,	  by	  socio-­‐demographic	  and	  
socio-­‐economic	  factors	  
	   Coeff	   Prob	  
Over	  75	   	   	  
ASCOT	   0.013	   0.574	  
EQ-­‐5D	   -­‐0.016	   0.511	  
GHQ-­‐12	   -­‐0.644	   0.471	  
Subjective	  well-­‐being	   0.722	   0.548	  
Under	  75	  
	   	  ASCOT	   0.031	   0.059*	  
EQ-­‐5D	   -­‐0.018	   0.221	  
GHQ-­‐12	   -­‐0.891	   0.091*	  
Subjective	  well-­‐being	   0.770	   0.250	  
University/college	  education	   	   	  
ASCOT	   0.050	   0.021**	  
EQ-­‐5D	   -­‐0.030	   0.148	  
GHQ-­‐12	   -­‐1.837	   0.008**	  
Subjective	  well-­‐being	   1.107	   0.282	  
Intermediate	  education	   	   	  
ASCOT	   -­‐0.002	   0.937	  
EQ-­‐5D	   -­‐0.035	   0.324	  
GHQ-­‐12	   -­‐0.230	   0.793	  
Subjective	  well-­‐being	   0.530	   0.695	  
Receiving	  benefits	   	   	  
ASCOT	   0.023	   0.419	  
EQ-­‐5D	   -­‐0.015	   0.423	  
GHQ-­‐12	   -­‐0.370	   0.606	  
Subjective	  well-­‐being	   -­‐0.075	   0.944	  
Not	  receiving	  benefits	   	   	  
ASCOT	   0.030	   0.087*	  
EQ-­‐5D	   -­‐0.019	   0.217	  
GHQ-­‐12	   -­‐1.054	   0.088*	  
Subjective	  well-­‐being	   1.112	   0.089*	  
Significance	  levels:	  *	  p<0.10	  **	  p<0.05***	  p<	  0.001	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People	  who	  had	  a	  university/college	  education	  in	  the	  personal	  health	  budget	  group	  were	  significantly	  
more	  likely	  to	  report	  improved	  care-­‐related	  quality	  of	  life	  and	  psychological	  well-­‐being	  (GHQ-­‐12)	  at	  
follow-­‐up	  relative	  to	  the	  control	  group.	  
People	  not	  receiving	  benefits	  at	  baseline	  in	  the	  personal	  health	  budget	  group	  were	  significantly	  more	  
likely	  to	  report	  improved	  care-­‐related	  quality	  of	  life,	  psychological	  well-­‐being	  (GHQ-­‐12)	  and	  
subjective	  well-­‐being17.	  	  
5.4.3.4 Implementation	  models	  
A	  central	  element	  of	  the	  personal	  health	  budget	  pilot	  programme	  was	  to	  allow	  flexibility	  in	  how	  the	  
initiative	  was	  implemented	  within	  the	  pilot	  sites.	  This	  flexibility	  allowed	  the	  evaluation	  to	  explore	  
what	  implementation	  models	  had	  a	  significant	  impact	  on	  outcome	  change.	  As	  reported	  earlier,	  five	  
implementation	  models	  were	  developed,	  based	  on	  the	  findings	  from	  the	  in-­‐depth	  qualitative	  
interviews	  with	  organisational	  representatives	  (see	  Table	  1.3).	  The	  models	  were	  classified	  in	  terms	  of	  
whether	  pilot	  sites	  informed	  budget	  holders	  of	  the	  amount	  in	  the	  personal	  health	  budget	  before	  
support	  planning	  began;	  the	  degree	  of	  flexibility	  in	  what	  services/help	  could	  be	  purchased	  through	  
the	  budget;	  and	  the	  degree	  to	  which	  different	  deployment	  options	  were	  offered	  when	  the	  decision	  
on	  how	  to	  manage	  the	  budget	  was	  made.	  Table	  5-­‐8	  reports	  how	  they	  varied	  across	  the	  personal	  
health	  budget	  sample.	  Note	  that	  one	  pilot	  site	  could	  not	  be	  classified	  into	  any	  of	  the	  four	  models	  but	  
had	  too	  few	  cases	  to	  form	  its	  own	  model	  type.	  
Table	  5-­‐8.	  Personal	  health	  budget	  implementation	  models	  
Model	   Number	  of	  
participants	  
%	  PHB	  group	   No	  of	  sites	  
Model	  1	   390	   33.3%	   8	  
Model	  2	   283	   24.2%	   4	  
Model	  3	   206	   17.6%	   3	  
Model	  4	   225	   19.2%	   4	  
Other	   67	   5.7%	   1	  
Model	  5	  (models	  1	  and	  2	  together)	   673	   57.5%	   12	  
	  
Table	  5-­‐9	  shows	  the	  extent	  to	  which	  implementation	  models	  had	  an	  impact	  on	  outcome	  change	  
between	  the	  personal	  health	  budget	  and	  control	  groups.	  The	  main	  effect	  analyses	  considered	  the	  
average	  net	  effect	  of	  any	  personal	  health	  budget,	  whereas	  this	  analysis	  assessed	  the	  impact	  of	  
specific	  types	  of	  budgets	  (by	  implementation	  model).	  It	  is	  clear	  from	  the	  results	  that	  the	  impact	  of	  
personal	  health	  budgets	  varied	  significantly	  according	  to	  how	  they	  were	  implemented.	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
17	  The	  analysis	  was	  carried	  out	  involving	  participants	  from	  a	  black	  and	  minority	  ethnic	  community,	  though	  the	  total	  




The	  analyses	  highlighted	  that	  all	  implementation	  models	  had	  a	  significant	  impact	  on	  outcome	  
change.	  Personal	  health	  budgets	  with	  model	  1	  implementation	  showed	  a	  significant	  effect	  relative	  to	  
controls	  on	  ASCOT.	  While	  personal	  health	  budgets	  with	  model	  2	  implementation	  were	  associated	  
with	  better	  outcomes	  than	  controls	  on	  GHQ-­‐12.	  However,	  both	  these	  effects	  were	  picked	  up	  in	  
model	  5,	  which	  combined	  models	  1	  and	  2.	  The	  common	  factor	  between	  models	  1,	  2	  and	  4	  is	  the	  level	  
of	  choice	  and	  flexibility	  in	  the	  services	  that	  can	  be	  purchased	  from	  personal	  health	  budgets.	  	  
Table	  5-­‐9.Outcome	  measures	  –	  impact	  of	  personal	  health	  budgets,	  by	  implementation	  model	  
	   Coeff	   Prob	  
Model	  1	   	   	  
ASCOT	   0.039	   0.026**	  
EQ-­‐5D	   -­‐0.024	   0.207	  
GHQ-­‐12	   -­‐1.052	   0.130	  
Subjective	  well-­‐being	   0.476	   0.593	  
Model	  2	   	   	  
ASCOT	   0.037	   0.161	  
EQ-­‐5D	   -­‐0.007	   0.790	  
GHQ-­‐12	   -­‐1.999	   0.076*	  
Subjective	  well-­‐being	   0.816	   0.367	  
Model	  3	   	   	  
ASCOT	   -­‐0.016	   0.417	  
EQ-­‐5D	   -­‐0.037	   0.062*	  
GHQ-­‐12	   2.441	   0.002**	  
Subjective	  well-­‐being	   -­‐1.573	   0.077*	  
Model	  4	   	   	  
ASCOT	   0.044	   0.027**	  
EQ-­‐5D	   0.010	   0.670	  
GHQ-­‐12	   -­‐2.445	   0.001**	  
Subjective	  well-­‐being	   3.680	   <0.001***	  
Model	  5	  (models	  1	  and	  2	  together)	   	   	  
ASCOT	   0.037	   0.028**	  
EQ-­‐5D	   -­‐0.018	   0.347	  
GHQ-­‐12	   -­‐1.384	   0.073*	  
Subjective	  well-­‐being	   0.623	   0.396	  
Significance	  levels	  *p<	  0.10	  **	  p<	  0.05	  ***p<	  0.001	  
In	  terms	  of	  care-­‐related	  quality	  of	  life,	  people	  in	  the	  personal	  health	  budget	  group	  among	  pilot	  sites	  
following	  implementation	  model	  5	  reported	  statistically	  significant	  better	  scores	  than	  the	  control	  
group.	  This	  finding	  suggests	  that	  there	  was	  an	  impact	  on	  quality	  of	  life	  when	  personal	  health	  budgets	  
were	  being	  implemented	  following	  the	  basic	  principles	  underlying	  the	  initiative:	  that	  is,	  budget	  
holders	  know	  the	  resource	  amount	  before	  support	  planning;	  there	  is	  some	  degree	  of	  flexibility	  in	  
what	  services	  can	  be	  purchased;	  and	  there	  is	  choice	  in	  deployment	  options	  as	  to	  how	  the	  budget	  
holder	  would	  like	  the	  resource	  to	  be	  managed.	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Individuals	  in	  the	  personal	  health	  budget	  group	  within	  pilot	  sites	  following	  implementation	  4	  also	  
reported	  statistically	  improved	  subjective	  well-­‐being	  compared	  to	  the	  control	  group.	  The	  only	  
difference	  between	  model	  4	  and	  5	  is	  whether	  the	  budget	  holder	  is	  informed	  of	  the	  budget	  level	  
before	  support	  planning	  begins	  (model	  5),	  suggesting	  possibly	  that	  it	  is	  the	  greater	  choice	  and	  
flexibility	  that	  is	  more	  important	  than	  knowing	  the	  budget	  level18.	  	  
This	  suggestion	  was	  echoed	  by	  budget	  holders	  during	  the	  qualitative	  interviews.	  We	  found	  that	  
personal	  health	  budgets	  had	  increased	  the	  amount	  of	  choice	  and	  flexibility	  people	  had	  over	  their	  
healthcare,	  and	  that	  choice	  was	  viewed	  positively.	  Choice	  was	  consistently	  linked	  to	  feelings	  of	  
greater	  control	  over	  health	  care	  which	  budget	  holders	  enjoyed:	  “I’ve	  been	  able	  to	  choose	  something	  
that	  I	  think	  might	  be	  beneficial,	  whether	  it	  transpires	  to	  be	  so	  or	  not	  has	  yet	  to	  be	  seen.	  But	  at	  least	  
I’ve	  been	  given	  the	  opportunity	  to	  take	  control	  of	  some	  of	  the	  health	  care	  issues	  available	  to	  me.	  I	  had	  
the	  choice”.	  However,	  the	  in-­‐depth	  interviews	  also	  indicated	  that	  knowing	  the	  budget	  meant	  that	  
budget	  holders	  had	  a	  view	  of	  whether	  the	  resource	  level	  was	  adequate	  for	  their	  needs.	  The	  majority	  
of	  budget	  holders	  appeared	  satisfied	  because	  the	  amount	  had	  allowed	  them	  to	  access	  the	  services	  or	  
items	  they	  had	  felt	  they	  needed.	  Budget	  holders	  who	  did	  not	  know	  the	  budget	  level	  could	  also	  be	  
unsure	  whether	  their	  budget	  was	  enough	  for	  their	  needs:	  “I	  think	  the	  problem	  is	  we	  don’t	  know	  how	  
much	  we’ve	  spent”.	  
The	  implied	  beneficial	  effect	  of	  choice	  is	  underlined	  by	  the	  results	  regarding	  model	  3,	  which,	  
compared	  to	  the	  other	  models	  had	  relatively	  little	  flexibility	  built	  into	  the	  personal	  health	  budget	  
process.	  In	  this	  case,	  we	  found	  that	  the	  change	  in	  EQ-­‐5D,	  GHQ-­‐12	  and	  subjective	  well-­‐being	  was	  
significantly	  worse	  among	  model	  3	  personal	  health	  budget	  holders	  than	  for	  people	  in	  the	  control	  
group.	  In	  other	  words,	  personal	  health	  budgets	  had	  a	  negative	  impact	  in	  this	  case.	  In	  addition	  to	  the	  
lack	  of	  flexibility	  and	  choice	  afforded	  in	  model	  3,	  a	  further	  explanation	  of	  this	  effect	  is	  provided	  by	  
the	  qualitative	  interviews	  with	  organisational	  representatives	  that	  hinted	  at	  differing	  attitudes	  held	  
within	  pilot	  sites	  implementing	  the	  different	  models.	  Representatives	  within	  the	  pilot	  sites	  held	  both	  
positive	  and	  negative	  attitudes	  (see	  appendix	  D).	  Some	  examples	  of	  these	  views	  are	  as	  follows:	  	  
	  “Service	  users	  know	  what	  is	  good	  for	  them	  so	  they	  know	  what	  works	  and	  it	  enables	  this	  so	  I	  think	  it	  is	  
a	  real	  positive	  in	  terms	  of	  control	  and	  choice	  and	  enabling	  them	  to	  stay	  in	  the	  community	  and	  
enabling	  them	  to	  come	  to	  their	  own	  solutions”	  (Health	  professional	  –	  model	  5).	  
“To	  be	  honest,	  when	  I’ve	  spoken	  to	  other	  people	  within	  the	  health	  service	  about	  someone	  on	  the	  
personal	  health	  budget,	  you	  know,	  making	  enquiries,	  I’ve	  received	  a	  generally	  negative	  attitude	  
towards	  it.	  I	  would	  say	  that	  the	  majority	  of	  other	  people	  I’ve	  spoken	  to	  within	  the	  health	  service	  
aren’t	  keen,	  they	  don’t	  think	  it’s	  a	  good	  idea,	  they	  don’t	  like	  it.	  I’ve	  had	  some	  people	  say	  to	  me	  that	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
18	  This	  assumption	  could	  be	  explored	  by	  combining	  implementation	  models	  1,	  2	  and	  4	  (implementation	  model	  6).	  A	  
significant	  positive	  impact	  of	  personal	  health	  budgets	  was	  found	  for	  care-­‐related	  quality	  of	  life,	  psychological	  well-­‐being	  
and	  subjective	  well-­‐being	  within	  pilot	  sites	  following	  model	  6.	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they	  think	  the	  whole	  idea’s	  a	  disgrace.	  The	  people	  who	  are	  negative	  towards	  it	  have	  come	  from	  a	  lot	  
of	  different	  camps.	  I’ve	  spoken	  to	  commissioners	  who	  don’t	  think	  it’s	  a	  good	  idea,	  I’ve	  spoken	  to	  
service	  providers	  that	  don’t	  think	  it’s	  a	  good	  idea.	  I	  would	  say	  that	  there	  isn’t	  one	  particular	  group	  
that	  has	  more	  of	  a	  dislike	  for	  it	  than	  any	  other.”	  (Operational	  staff	  –	  model	  3).	  
Another	  relevant	  factor	  in	  the	  design	  of	  personal	  health	  budgets	  was	  the	  amount	  of	  the	  budget.	  We	  
distinguished	  high-­‐amount	  personal	  health	  budgets	  as	  those	  which	  had	  an	  annual	  budget	  of	  more	  
than	  £1,000,	  and	  low-­‐amount	  PHBs	  as	  those	  which	  had	  an	  annual	  budget	  of	  less	  than	  £1,000.	  Table	  
5-­‐10	  suggests	  that	  the	  positive	  impact	  of	  personal	  health	  budgets	  was	  concentrated	  on	  those	  with	  
£1000+	  budgets.	  This	  finding	  could	  indicate	  that	  when	  a	  sufficient	  level	  of	  resource	  is	  included	  in	  the	  
budget	  to	  fully	  cover	  needs,	  budget	  holders	  feel	  that	  they	  have	  more	  choice	  in	  the	  services/support	  
that	  can	  be	  purchased	  which	  in	  turn	  had	  an	  impact	  on	  their	  perceived	  quality	  of	  life	  at	  follow-­‐up.	  	  
Table	  5-­‐10.	  Outcome	  measures	  –	  impact	  of	  personal	  health	  budgets,	  by	  budget-­‐amount	  	  
	   Coeff	   Prob	  
High-­‐budget	  PHB	   	   	  
ASCOT	   0.032	   0.046**	  
EQ-­‐5D	   -­‐0.024	   0.229	  
GHQ-­‐12	   -­‐1.378	   0.072*	  
Subjective	  well-­‐being	   0.928	   0.316	  
Low-­‐budget	  PHB	   	   	  
ASCOT	   0.025	   0.136	  
EQ-­‐5D	   -­‐0.014	   0.337	  
GHQ-­‐12	   -­‐0.557	   0.291	  
Subjective	  well-­‐being	   0.666	   0.359	  
Significance	  levels:	  *	  p<0.10	  **	  p<0.05***	  p<	  0.001	  	  
5.5 Discussion	  
A	  number	  of	  key	  findings	  have	  been	  discussed	  in	  this	  chapter	  which	  can	  be	  used	  to	  guide	  the	  national	  
roll-­‐out	  of	  personal	  health	  budgets.	  During	  the	  study	  period,	  and	  after	  controlling	  for	  baseline	  
differences	  and	  health	  conditions,	  personal	  health	  budgets	  had	  a	  significant	  positive	  impact	  on	  care-­‐
related	  quality	  of	  life,	  psychological	  well-­‐being	  and	  subjective	  well-­‐being	  compared	  to	  individuals	  in	  
the	  control	  group.	  In	  terms	  of	  socio-­‐demographic	  characteristics	  of	  individuals,	  the	  analysis	  indicated	  
that	  younger	  people	  with	  personal	  health	  budgets	  had	  higher	  ASCOT	  outcome	  scores	  at	  follow-­‐up	  
than	  younger	  people	  in	  the	  control	  group	  (after	  accounting	  for	  baseline	  differences	  in	  ASCOT	  scores	  
between	  the	  two	  groups).	  There	  was	  no	  significant	  difference	  in	  outcome	  scores	  for	  people	  over	  75	  
between	  the	  groups.	  We	  did	  not	  find	  significant	  differences	  by	  age	  using	  EQ5D-­‐measured	  outcomes.	  
By	  contrast,	  personal	  health	  budgets	  had	  very	  little	  impact	  on	  health	  status	  as	  measured	  by	  the	  
clinical	  effect	  indicators	  such	  as	  HbA1c	  and	  FEV1.	  Moreover,	  there	  was	  no	  significant	  difference	  in	  
mortality	  rates.	  This	  finding	  was	  further	  supported	  by	  the	  result	  that	  people	  in	  the	  personal	  health	  
budget	  group	  did	  not	  report	  significant	  change	  in	  the	  health-­‐related	  quality	  of	  life	  (EQ-­‐5D)	  compared	  
to	  those	  in	  the	  control	  group.	  This	  instrument	  aims	  to	  measure	  a	  person’s	  quality	  of	  life	  in	  domains	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that	  are	  likely	  to	  be	  related	  to	  their	  underlying	  health	  status.	  Although	  differences	  on	  these	  measures	  
were	  statistically	  insignificant,	  the	  average	  effect	  in	  this	  sample	  tended	  to	  be	  negative	  for	  the	  
personal	  health	  budget	  group	  compared	  to	  control	  group.	  The	  lack	  of	  statistical	  significance	  means	  
that	  we	  cannot	  reject	  the	  conjecture	  that	  this	  result	  was	  due	  to	  random	  chance	  (in	  terms	  of	  the	  
participants	  that	  happened	  to	  be	  included	  in	  this	  study),	  but	  it	  might	  merit	  further	  investigation.	  
We	  can	  interpret	  these	  findings	  to	  mean	  that	  personal	  health	  budgets	  impact	  on	  well-­‐being	  and	  
quality	  of	  life	  rather	  than	  health	  per	  se.	  Indeed,	  the	  benefits	  in	  this	  regard	  appear	  to	  stem	  from	  the	  
value	  people	  place	  on	  increased	  choice	  and	  control	  in	  their	  lives,	  and	  the	  capability	  this	  brings	  for	  
people	  to	  improve	  the	  more	  complex	  or	  higher-­‐order	  aspects	  of	  their	  quality	  of	  life	  (see	  for	  example,	  
Sen,	  1982;	  Sen,	  1993).	  
This	  finding	  is	  one	  of	  the	  implications	  for	  the	  strong	  direction	  of	  the	  national	  roll-­‐out	  of	  the	  initiative	  
after	  2012.	  	  
A	  final	  key	  message	  for	  the	  personal	  health	  budge	  programme	  is	  that	  outcome	  change	  was	  
significantly	  influenced	  by	  how	  the	  initiative	  had	  been	  implemented	  during	  the	  pilot	  programme.	  
Models	  4	  and	  5	  had	  a	  significant	  positive	  impact,	  while	  model	  3	  tended	  to	  show	  negative	  effects.	  The	  
findings	  indicate	  the	  following:	  
1.	   In	  some	  instances,	  greater	  flexibility	  and	  choice	  are	  valued	  more	  by	  budget	  holders	  and	  
families	  than	  knowing	  the	  budget	  level	  before	  support	  planning	  begins;	  
2.	   The	  management	  of	  cultural	  change,	  in	  terms	  of	  acknowledging	  concerns	  held	  by	  frontline	  
staff,	  is	  an	  important	  element	  of	  the	  implementation	  phase	  that	  can	  have	  an	  impact	  on	  the	  
experience	  of	  the	  personal	  health	  budget	  process	  and,	  in	  turn,	  on	  outcomes.	  One	  question	  
that	  was	  raised	  within	  the	  chapter	  is	  whether	  the	  success	  of	  personal	  health	  budget	  stems	  
from	  the	  views	  held	  by	  the	  staff	  members	  implementing	  the	  initiative.	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6 Costs	  and	  cost	  effectiveness	  
6.1 Summary	  
	  
In	  this	  chapter,	  we	  aim	  to	  assess	  whether	  personal	  health	  budgets	  are	  cost	  effective,	  and	  this	  requires	  us	  to	  
consider	  the	  cost	  consequences	  of	  PHBs	  as	  well	  as	  their	  effects	  on	  outcomes.	  
Cost	  effectiveness	  is	  assessed	  by	  estimating	  whether	  personal	  health	  budgets	  generate	  greater	  net	  benefit	  
than	  conventional	  service	  delivery.	  Net	  (monetary)	  benefit	  is	  (value-­‐adjusted)	  quality	  of	  life	  less	  the	  costs	  of	  
the	  services	  people	  used	  and	  this	  is	  measured	  for	  both	  personal	  health	  budget	  and	  control	  groups.	  
To	  account	  for	  possible	  selection	  bias	  we	  used	  the	  difference-­‐in-­‐difference	  approach.	  We	  also	  explored	  the	  
effect	  of	  confounding	  variables	  but	  these	  were	  not	  significant	  for	  the	  cost	  effectiveness	  analysis.	  	  
Key	  findings	  regarding	  the	  cost	  analysis	  were:	  
 Services	  such	  as	  primary	  and	  secondary	  care,	  not	  covered	  by	  personal	  health	  budgets	  (hence	  
‘indirect’),	  were	  found	  to	  be	  significantly	  lower	  for	  the	  personal	  health	  budget	  group	  compared	  to	  
the	  control	  group	  after	  accounting	  for	  baseline	  differences.	  	  
 There	  was	  no	  difference	  in	  the	  costs	  of	  services	  that	  could	  be	  directly	  secured	  using	  a	  personal	  
health	  budget	  (such	  as	  for	  nursing,	  therapy	  and	  care	  services).	  	  
 Total	  costs	  (direct	  plus	  indirect)	  were	  not	  statistically	  significantly	  different	  between	  the	  personal	  
health	  budget	  and	  control	  groups	  after	  accounting	  for	  baseline	  differences.	  	  
 The	  cost	  analyses	  for	  health	  condition	  sub-­‐samples	  did	  not	  show	  conclusive	  differences	  between	  
personal	  health	  budget	  and	  control	  groups.	  
 Total	  costs	  were	  significantly	  lower	  in	  the	  group	  of	  people	  with	  high-­‐value	  personal	  health	  budgets	  
compared	  to	  the	  controls.	  
Key	  findings	  on	  costs-­‐effectiveness	  were:	  
 Measuring	  net	  benefits	  using	  the	  care-­‐related	  quality	  of	  life	  (ASCOT)	  scale,	  personal	  health	  budgets	  
were	  found	  to	  be	  cost-­‐effective	  relative	  to	  conventional	  service	  delivery	  at	  the	  90%	  confidence	  level.	  
 There	  was	  no	  significant	  difference	  in	  the	  net	  benefit	  between	  the	  groups	  when	  benefit	  was	  
measured	  using	  the	  health-­‐related	  quality	  of	  life	  (EQ-­‐5D)	  scale.	  
 In	  the	  sub-­‐group	  analyses,	  personal	  health	  budgets	  produced	  higher	  ASCOT-­‐measured	  net	  benefits	  
than	  conditional	  services	  for	  the	  CHC	  and	  mental	  health	  sub-­‐groups	  (at	  the	  90%	  confidence	  level)	  
 Otherwise,	  the	  health	  condition	  sub-­‐group	  analyses	  were	  inconclusive.	  
 Personal	  health	  budgets	  implemented	  using	  model	  1	  were	  cost-­‐effective	  at	  the	  95%	  confidence	  
level,	  as	  were	  those	  with	  high-­‐value	  budgets.	  
 Personal	  health	  budgets	  managed	  as	  a	  direct	  payment	  were	  cost	  effective	  at	  the	  90%	  confidence	  
level.	  
 Other	  socio-­‐economic	  characteristics	  showed	  inconclusive	  impacts.	  
Sensitivity	  analysis	  supported	  the	  main	  conclusions,	  in	  many	  cases	  showing	  personal	  health	  budgets	  to	  be	  





A	  range	  of	  outcomes	  were	  improved	  for	  personal	  health	  budgets	  holders	  compared	  to	  the	  control	  
group	  as	  outlined	  in	  the	  previous	  chapter.	  In	  this	  chapter	  we	  aim	  to	  assess	  whether	  personal	  health	  
budgets	  are	  cost	  effective,	  and	  this	  requires	  us	  to	  consider	  the	  cost	  consequences	  of	  PHBs,	  as	  well	  as	  
their	  effects	  on	  outcomes.	  
As	  outlined	  in	  Chapter	  2,	  the	  use	  of	  personal	  health	  budgets	  can	  have	  potentially	  beneficial	  effects	  in	  
a	  number	  of	  ways.	  Broadly	  speaking,	  we	  might	  anticipate	  that	  personal	  health	  budgets	  allow	  
recipients:	  greater	  choice	  of	  what	  services	  and	  support	  they	  use	  to	  help	  them	  manage	  their	  
condition;	  to	  better	  tailor	  their	  care	  according	  to	  their	  own	  needs	  and	  preferences;	  and	  to	  feel	  more	  
in	  control	  of	  their	  own	  lives	  and	  empowered	  to	  make	  decisions	  for	  themselves.	  Furthermore,	  being	  
given	  a	  personal	  health	  budget	  might	  have	  implications	  for	  the	  total	  resources	  of	  the	  care	  system	  
that	  people	  receive.	  	  
In	  these	  ways,	  personal	  health	  budgets	  will	  affect	  people’s	  quality	  of	  life	  and	  other	  outcomes.	  They	  
will	  also	  affect	  the	  cost	  of	  services	  and	  support	  people	  use.	  These	  cost	  consequences	  can	  be	  direct	  in	  
that	  people	  change	  their	  use	  of	  those	  services	  and	  support	  that	  can	  be	  secured	  using	  their	  personal	  
health	  budget.	  Also,	  the	  amount	  of	  services	  and	  support	  that	  people	  can	  access	  with	  their	  personal	  
health	  budget,	  compared	  to	  conventional	  service	  delivery,	  will	  depend	  on	  how	  budgets	  resourced.	  In	  
some	  cases,	  sites	  anticipated	  the	  costs	  of	  conventional	  services	  that	  a	  person	  would	  have	  used	  and	  
provided	  a	  personal	  health	  budget	  of	  the	  same	  value.	  In	  this	  case,	  we	  might	  expect	  the	  cost	  of	  
services	  purchased	  with	  the	  personal	  health	  budget	  to	  be	  broadly	  the	  same	  as	  they	  would	  have	  been	  
without	  the	  budget	  –	  i.e.	  broadly	  cost	  neutral.	  Other	  sites,	  however,	  used	  different	  resource	  
allocation	  systems	  that	  did	  not	  necessarily	  relate	  directly	  to	  the	  costs	  of	  the	  conventional	  service	  the	  
person	  in	  question	  might	  have	  used	  otherwise.	  
The	  consequences	  for	  costs	  and	  expenditure	  can	  also	  be	  indirect	  in	  that	  the	  choices	  people	  make	  
regarding	  their	  budgets	  and	  the	  services	  and	  support	  they	  receive	  might	  change	  their	  need	  for	  
services	  not	  covered	  by	  their	  budgets.	  For	  example,	  if	  a	  personal	  health	  budget	  allows	  a	  person	  to	  
have	  greater	  control	  and	  choice	  to	  better	  manage	  their	  condition,	  their	  need	  for	  more	  intensive	  
health	  and	  care	  services	  in	  the	  future	  could	  be	  reduced.	  Similarly,	  by	  enabling	  people	  more	  scope	  to	  
act	  on	  different	  priorities	  than	  with	  conventional	  services,	  personal	  health	  budgets	  might	  lead	  to	  an	  
increase	  in	  the	  demand	  for	  some	  types	  of	  indirect	  care	  and	  support.	  
In	  keeping	  with	  the	  usual	  convention,	  we	  focused	  on	  recurrent	  production	  costs	  to	  the	  health	  and	  
social	  care	  systems.	  In	  other	  words,	  we	  do	  not	  measure	  any	  cost	  implications	  of	  using	  personal	  
health	  budgets	  that	  fall	  outside	  the	  health	  and	  social	  care	  system.	  These	  additional	  costs	  might	  
include	  family-­‐incurred	  costs	  (e.g.	  from	  a	  change	  in	  the	  amount	  of	  informal	  care	  that	  personal	  health	  
budget	  holders	  use	  compared	  to	  the	  control	  group).	  We	  assess	  the	  implications	  for	  the	  level	  of	  
informal	  care	  use	  in	  Chapter	  7,	  but	  we	  do	  not	  include	  the	  associated	  cost	  implications	  here	  (in	  part	  to	  
maintain	  consistency	  with	  other	  studies	  and	  also	  because	  there	  is	  little	  agreement	  about	  which	  
costing	  methodology	  to	  use	  for	  informal	  care).	  Furthermore,	  we	  exclude	  one-­‐off	  set	  up	  costs	  for	  
personal	  health	  budgets;	  these	  costs	  were	  explored	  in	  the	  3rd	  interim	  report	  (Jones	  et	  al.,	  2011).	  
Finally,	  we	  were	  unable	  to	  measure	  the	  ‘transaction’	  costs	  incurred	  in	  commissioning	  and	  arranging	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services	  e.g.	  in	  staff	  time	  used	  in	  the	  care	  planning	  process.	  Whilst	  it	  might	  have	  been	  possible	  to	  
cost	  some	  of	  this	  activity	  for	  personal	  health	  budgets,	  it	  would	  have	  been	  very	  difficult	  to	  undertake	  
a	  like-­‐with-­‐like	  costing	  for	  the	  care	  arrangement	  process	  for	  the	  control	  group.	  We	  would	  not	  expect	  
these	  costs	  to	  be	  significant	  relative	  to	  annual	  service	  costs	  for	  this	  population,	  but,	  nonetheless,	  
acknowledge	  that	  our	  conclusions	  could	  change	  if	  transaction	  costs	  were	  included.	  	  
The	  main	  aims	  of	  the	  chapter	  are	  to:	  
 Develop	  a	  consistent	  framework	  for	  assessing	  the	  cost	  and	  benefits	  of	  personal	  health	  
budgets.	  
 Report	  the	  costs	  of	  the	  services	  and	  support	  used	  by	  people	  in	  the	  study.	  
 Combine	  these	  findings	  with	  those	  of	  the	  last	  chapter	  in	  order	  to	  analyse	  the	  costs	  and	  
benefits	  of	  personal	  health	  budgets	  together.	  
 Analyse	  how	  net	  benefits	  compared	  between	  the	  personal	  health	  budget	  group	  and	  the	  
control	  group,	  and	  therefore	  assess	  cost-­‐effectiveness.	  
 Explore	  how	  the	  cost-­‐effectiveness	  of	  personal	  health	  budgets	  varied	  for	  different	  sub-­‐
groups	  in	  the	  study,	  such	  as	  by	  health	  condition,	  type	  of	  budget,	  budget	  level	  and	  person	  
characteristics.	  
This	  chapter	  is	  structured	  as	  follows.	  In	  the	  next	  section	  we	  briefly	  describe	  the	  methods	  used	  to	  
assess	  cost-­‐effectiveness	  and	  then,	  in	  the	  third	  section,	  we	  report	  the	  cost	  analysis.	  The	  fourth	  
section	  has	  the	  cost-­‐effectiveness	  analysis.	  Section	  five	  explores	  the	  relationship	  between	  costs	  and	  
benefits.	  The	  sixth	  part	  of	  the	  chapter	  reports	  sensitivity	  analyses.	  We	  conclude	  the	  chapter	  with	  a	  
discussion	  of	  the	  results.	  
In	  what	  follows,	  the	  analyses	  and	  results	  are	  for	  the	  imputed	  dataset	  unless	  otherwise	  stated.	  The	  
imputed	  dataset	  consists	  of	  2,235	  cases,	  with	  1,171	  in	  the	  personal	  health	  budget	  group	  and	  1,064	  in	  
the	  control	  group.	  
6.3 Methods	  
6.3.1 The	  expected	  impact	  of	  personal	  health	  budgets	  on	  costs	  and	  benefits	  
There	  are	  many	  ways	  in	  which	  the	  use	  of	  a	  personal	  health	  budget	  might	  produce	  benefits	  for	  the	  
recipient	  and	  affect	  both	  the	  service	  they	  choose	  and	  the	  costs	  of	  those	  services.	  Figure	  6-­‐1	  provides	  
a	  simple	  model	  of	  the	  three	  main	  effect	  routes.	  	  
 First,	  we	  would	  expect	  that	  personal	  health	  budgets	  have	  a	  direct	  (positive)	  effect	  on	  quality	  
of	  life	  by	  giving	  people	  more	  choice	  and	  control.	  
 Second,	  we	  would	  expect	  that	  using	  personal	  health	  budgets	  could	  lead	  to	  a	  change	  in	  the	  
types	  and	  intensities	  of	  services	  and	  support	  people	  use.	  Suppose	  personal	  health	  budgets	  
allow	  people	  to	  better	  tailor	  care	  and	  support	  to	  their	  own	  particular	  needs	  and	  preferences.	  
Their	  health	  condition	  and	  functioning	  could	  improve	  and,	  in	  turn,	  have	  positive	  effects	  on	  
quality	  of	  life.	  There	  might,	  conversely,	  be	  a	  negative	  effect	  if	  people	  make	  ill-­‐informed	  
choices	  about	  their	  care.	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 A	  third	  effect	  may	  arise	  as	  a	  consequence	  of	  the	  resource	  levels	  provided	  in	  personal	  health	  
budgets.	  In	  practice	  the	  monetary	  amount	  of	  a	  personal	  health	  budget	  need	  not	  be	  set	  at	  a	  
level	  that	  equals	  the	  cost	  of	  conventional	  services.	  Indeed,	  there	  are	  many	  examples	  where	  
the	  monetary	  value	  of	  personal	  health	  budgets	  only	  partially	  substitutes	  for	  the	  cost	  of	  
conventional	  services.	  As	  a	  result	  the	  total	  public	  resources	  available	  to	  the	  person	  might	  be	  
lower	  with	  a	  personal	  health	  budget	  than	  without	  one.	  Alternatively,	  the	  personal	  health	  
budget	  might	  be	  provided	  in	  addition	  to	  conventional	  services,	  implying	  an	  overall	  increase	  
in	  resources	  to	  that	  person.	  This	  is	  a	  policy	  decision.	  
Figure	  6-­‐1.	  The	  impact	  of	  personal	  health	  budgets	  on	  costs	  and	  benefits	  
	  
6.3.2 Assessing	  costs	  and	  cost-­‐effectiveness	  
Participants	  in	  the	  study	  had	  access	  to	  a	  very	  wide	  range	  of	  support	  and	  services,	  the	  majority	  of	  
which	  might	  have	  been	  affected,	  directly	  or	  indirectly,	  by	  whether	  the	  person	  had	  a	  personal	  health	  
budget.	  These	  could	  include:	  hospital	  inpatient,	  hospital	  outpatient,	  accident	  and	  emergency,	  
primary	  care	  doctors/GPs,	  practice,	  community	  and	  specialist	  nurses,	  a	  range	  of	  therapy	  services	  
(such	  as	  physiotherapy),	  other	  continuing	  health	  services,	  community-­‐based	  social	  care	  (including	  
home	  care,	  day	  care,	  meals,	  social	  care	  personal	  budgets),	  social	  work	  and	  respite	  care.	  Potentially,	  
study	  participants	  might	  have	  received	  equipment	  and	  other	  care-­‐related	  technology,	  and	  many	  
would	  be	  using	  a	  variety	  of	  drug	  treatments.	  Personal	  health	  budget	  holders	  could	  also	  use	  their	  
budget	  to	  purchase	  an	  array	  of	  well-­‐being,	  exercise	  and	  leisure	  services,	  equipment	  and	  other	  forms	  
of	  support	  in	  addition	  to	  their	  use	  of	  conventional	  services.	  	  
As	  outlined	  in	  Chapter	  2,	  we	  used	  a	  number	  of	  data	  collection	  methods	  to	  gather	  a	  comprehensive	  
set	  of	  information	  on	  service	  and	  support	  use.	  We	  also	  had	  to	  develop	  a	  methodology	  to	  aggregate	  
∆B	  




∆	  resource	  (3)	  
∆benefits	  =	  λ∆y	  
∆costs	  =	  ∆C	  =c∆x	  
Key:	  
∆B	   change	  in	  use	  of	  a	  PHB	  (c.f	  control	  group)	  
∆y	   change	  in	  quality	  of	  life	  
∆x	   change	  in	  services/support	  
∆m	  change	  in	  health	  condition	  and	  functioning	  
	   Direct	  effects	  
	   Feedback	  effects	  
	  
-­‐	  resource	  (3)	  
+	  need	  
(2)	  
∆	  utilisation	  (2)	   +	  need	  (2)	  
+	  PHB	  size	   -­‐	  need	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the	  costs	  in	  a	  way	  that	  constituted	  a	  like-­‐with-­‐like	  comparison	  between	  personal	  health	  budget	  and	  
control	  groups,	  avoided	  double-­‐counting	  and	  was	  sufficiently	  comprehensive.	  The	  complexity	  of	  this	  
task	  was	  compounded	  by	  the	  use	  of	  different	  processes	  between	  the	  sites	  to	  determine	  (a)	  the	  value	  
of	  the	  personal	  health	  budget	  and	  (b)	  what	  services	  were	  covered	  by	  the	  personal	  health	  budget	  and	  
what	  would	  be	  provided	  in	  the	  usual	  way.	  In	  many	  cases,	  local	  implementation	  was	  developing	  
during	  the	  course	  of	  the	  study	  so,	  to	  this	  end,	  we	  made	  a	  number	  of	  assumptions	  when	  combining	  
costs.	  We	  tested	  these	  assumptions	  as	  far	  as	  possible,	  and	  assessed	  the	  implications	  and	  sensitivity	  
of	  the	  results	  where	  different	  assumptions	  were	  made.	  
Table	  2-­‐2	  in	  Chapter	  2	  gives	  a	  broad	  classification	  of	  the	  services	  and	  support	  being	  used	  by	  people	  in	  
the	  study.	  A	  key	  distinction	  was	  made	  between	  indirect	  (only)	  services	  and	  direct	  services,	  and	  we	  
follow	  that	  approach	  in	  this	  chapter.	  
6.3.3 Costing	  methods	  
The	  activity	  levels	  of	  services	  measured	  in	  the	  study	  were	  assigned	  a	  unit	  cost.	  Primary	  and	  
community	  health	  care	  services	  were	  given	  a	  unit	  cost	  using	  the	  values	  outlined	  in	  the	  unit	  costs	  for	  
health	  and	  social	  care	  report	  published	  by	  the	  Personal	  Social	  Services	  Research	  Unit	  (Curtis,	  2010;	  
Curtis,	  2011).	  Social	  care	  services	  were	  given	  the	  unit	  cost	  using	  the	  values	  outlined	  in	  the	  Personal	  
Social	  Services	  Expenditure	  returns	  for	  2009/2010	  and	  2010/2011.19	  Activity	  data	  were	  collected	  
from	  the	  outcome	  interviews	  for	  social	  care	  and	  nursing	  care.	  GP	  visits	  (by	  type)	  and	  allied	  health	  
professional	  contacts	  (e.g.	  physiotherapy)	  were	  collected	  from	  GP	  medical	  records	  using	  the	  medical	  
record	  template	  (see	  Appendix	  E).	  Activity	  levels	  were	  grossed	  up	  to	  an	  annual	  amount,	  representing	  
total	  activity	  in	  the	  year	  before	  baseline	  and	  follow-­‐up	  (12-­‐months	  after	  consent	  date).	  	  
Secondary	  care	  costs	  were	  calculated	  by	  applying	  the	  appropriate	  national	  tariff	  rates	  to	  episodes	  
according	  to	  the	  health	  research	  group	  (HRG)	  classification	  of	  activity	  (inpatient,	  outpatient	  and	  A&E	  
tariffs).	  We	  also	  calculated	  individual	  lengths	  of	  stay	  for	  all	  episodes	  experienced	  by	  study	  
participants	  in	  order	  to	  apply	  the	  long-­‐stay	  and	  zero	  stay	  payment	  adjusters	  in	  the	  national	  tariffs.	  In	  
the	  main,	  the	  Hospital	  Episode	  Statistics	  (HES)	  dataset	  was	  used	  to	  provide	  activity	  levels	  for	  all	  study	  
participants	  who	  consented	  for	  us	  to	  download	  this	  data.	  We	  extracted	  data	  for	  all	  years	  after	  April	  
2008.	  In	  some	  cases,	  the	  last	  few	  months	  of	  hospital	  activity	  were	  missing	  due	  to	  the	  time	  lag	  in	  the	  
reports	  of	  activity	  becoming	  available	  in	  HES.20In	  those	  instances	  we	  were	  able	  to	  fill	  in	  the	  missing	  
data	  using	  secondary	  care	  information	  collected	  from	  medical	  records.	  The	  detail	  in	  the	  medical	  
record	  information	  was	  more	  limited	  than	  HES	  so	  was	  only	  used	  where	  HES	  was	  missing.	  More	  
information	  about	  this	  method	  can	  be	  found	  in	  Appendix	  C.	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
19	  http://www.ic.nhs.uk/services/social-­‐care/social-­‐care-­‐collections	  
20	  There	  is	  potential	  that	  additional	  analysis	  could	  be	  carried	  out	  on	  the	  full	  12-­‐month	  period.	  
84	  
	  
Where	  consent	  was	  granted,	  requests	  were	  made	  for	  the	  care	  plans	  for	  the	  personal	  health	  budget	  
participants	  to	  be	  sent	  to	  the	  research	  team.	  These	  plans	  included	  a	  breakdown	  of	  each	  service	  or	  
support	  item	  and	  the	  corresponding	  cost	  as	  met	  from	  the	  personal	  health	  budget.	  We	  allocated	  the	  
range	  of	  activity	  into	  the	  categories	  outlined	  in	  Chapter	  4.	  These	  categories	  were	  designed	  to	  be	  
comparable	  to	  conventional	  service	  categories	  where	  relevant	  or	  to	  new	  categories,	  such	  as	  well-­‐
being	  services.	  
In	  the	  analysis	  we	  use	  recurrent	  costs	  of	  services	  and	  support	  as	  used	  by	  study	  participants.	  We	  have	  
detailed	  the	  implementation	  costs	  in	  interim	  report	  3	  (Jones	  et	  al.,	  2011).	  
6.3.4 Net	  monetary	  benefit	  
We	  used	  the	  net	  (monetary)	  benefit	  approach	  to	  assess	  cost-­‐effectiveness.	  Personal	  health	  budgets	  
provide	  people	  with	  benefits,	  both	  from	  the	  services	  and	  support	  they	  use	  and	  in	  the	  way	  this	  help	  is	  
organised.	  Similarly,	  people	  gain	  benefits	  from	  the	  services	  and	  support	  they	  are	  provided	  under	  
conventional	  delivery	  arrangements.	  These	  benefits	  can	  be	  measured	  in	  a	  number	  of	  ways	  as	  
outlined	  in	  chapter	  5.	  The	  net	  benefit	  approach	  usually	  involves	  measuring	  the	  benefits	  in	  terms	  of	  
the	  value	  people	  associate	  with	  having	  (better)	  health	  or	  care-­‐related	  quality	  of	  life.	  In	  this	  way	  we	  
can	  gauge	  the	  benefits	  of	  personal	  health	  budgets	  compared	  to	  conventional	  service	  delivery	  by	  
comparing	  (the	  value	  of)	  people’s	  quality	  of	  life	  under	  each	  option.	  
As	  well	  as	  benefit	  implications,	  the	  use	  of	  personal	  health	  budgets	  affects	  the	  cost	  of	  services	  and	  
support	  people	  use,	  as	  compared	  to	  the	  cost	  of	  services	  and	  support	  that	  would	  be	  accrued	  under	  
conventional	  service	  delivery.	  As	  there	  can	  be	  both	  benefit	  and	  cost	  implications,	  we	  need	  a	  way	  of	  
combining	  these	  effects	  if	  we	  are	  to	  assess	  whether	  personal	  health	  budgets	  are	  cost-­‐effective	  
relative	  to	  conventional	  service	  delivery.	  The	  net	  benefit	  approach	  resolves	  this	  problem	  by	  assessing	  
benefits	  in	  £-­‐value	  terms.	  This	  allows	  a	  net	  monetary	  benefit	  amount	  to	  be	  calculated	  by	  simply	  
subtracting	  the	  cost	  associated	  with	  an	  intervention	  from	  the	  £-­‐value	  of	  the	  benefits	  (i.e.	  value-­‐
adjusted	  quality	  of	  life)	  it	  produces.	  	  
To	  make	  this	  judgement	  we	  need	  a	  method	  to	  measure	  the	  benefits	  in	  monetary	  value	  terms.	  An	  
established	  method	  is	  to	  measure	  health	  or	  care-­‐related	  quality	  of	  life	  using	  scales	  such	  as	  EQ-­‐5D	  or	  
ASCOT	  and	  then	  apply	  a	  willingness-­‐to-­‐pay	  amount	  for	  each	  unit	  gain	  on	  the	  EQ-­‐5D	  or	  ASCOT	  scales.	  
At	  present	  NICE	  ascribe	  a	  willingness-­‐to-­‐pay	  of	  between	  £20,000	  and	  £30,000	  for	  each	  unit	  gain	  in	  
EQ-­‐5D	  –	  that	  is,	  if	  an	  intervention	  improves	  a	  person’s	  quality	  of	  life	  by	  an	  amount	  corresponding	  to	  
being	  in	  full	  health	  compared	  to	  a	  state	  that	  is	  no	  better	  than	  being	  dead,	  over	  the	  course	  of	  a	  year,	  
then	  the	  value	  of	  this	  improvement	  in	  monetary	  terms	  is	  between	  £20,000	  and	  £30,000.	  
Measures	  like	  ASCOT	  or	  EQ-­‐5D	  are	  amenable	  scales	  for	  this	  purpose	  because	  they	  are	  designed	  to	  
produce	  quantitative	  ratings	  of	  experiences	  that	  people	  have	  which	  are	  relevant	  to	  their	  quality	  of	  
life	  –	  for	  example,	  being	  in	  pain,	  being	  able	  to	  conduct	  usual	  activities,	  feeling	  in	  control	  of	  their	  lives	  
etc.	  These	  measures	  place	  a	  value	  on	  each	  aspect	  of	  quality	  of	  life.	  This	  value	  is	  drawn	  from	  a	  scale	  
that	  is	  ‘anchored’	  with	  reference	  to	  the	  overall	  value	  of	  being	  in	  full	  health	  as	  opposed	  to	  being	  dead.	  
Therefore,	  when	  we	  apply	  a	  rating	  from	  these	  indicators	  –	  e.g.	  to	  rate	  a	  reduction	  in	  someone’s	  
sense	  of	  control	  over	  their	  life	  or	  their	  level	  of	  pain	  –	  this	  rating	  was	  made	  by	  asking	  people	  how	  far	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they	  would	  trade	  this	  poorer	  quality	  of	  life	  for	  having	  good	  quality	  of	  life	  but	  dying	  earlier.	  In	  other	  
words,	  these	  measures	  aim	  to	  allow	  us	  to	  describe	  the	  value	  of	  quality	  of	  life	  attributes.	  
Using	  this	  approach,	  we	  can	  assess	  whether	  personal	  health	  budgets	  are	  cost-­‐effective	  by	  measuring	  
net	  benefit	  (i.e.	  value-­‐adjusted	  quality	  of	  life	  less	  service	  cost)	  for	  people	  in	  the	  PHB	  group	  and	  
comparing	  the	  average	  with	  the	  average	  net	  benefit	  amount	  measured	  in	  the	  control	  group.	  On	  this	  
basis,	  if	  people	  in	  the	  personal	  health	  budget	  group	  experience	  greater	  net	  benefit	  than	  those	  in	  the	  
control	  group,	  we	  can	  infer	  that	  personal	  health	  budgets	  are	  cost	  effective	  relative	  to	  conventional	  
service	  options,	  and	  should	  be	  adopted.	  	  
There	  are	  two	  further	  issues	  to	  address,	  however.	  First,	  we	  need	  to	  be	  sure	  that	  the	  reason	  we	  see	  
higher	  net	  benefit	  in	  the	  personal	  health	  budget	  group	  is	  due	  to	  the	  use	  of	  the	  budget	  and	  not	  
something	  else.	  Second,	  we	  need	  to	  be	  confident	  that	  the	  difference	  we	  see	  in	  net	  benefit	  amounts	  
between	  the	  groups	  is	  a	  real	  difference	  and	  not	  just	  down	  to	  chance	  in	  the	  way	  the	  participants	  in	  
each	  group	  were	  sampled.	  	  
As	  regards	  the	  first	  problem,	  the	  two	  groups	  –	  personal	  health	  budget	  and	  control	  –	  may	  vary	  in	  ways	  
other	  than	  the	  use	  of	  a	  personal	  health	  budget.	  This	  problem	  is	  addressed	  using	  the	  difference-­‐in-­‐
difference	  design.21	  If	  the	  two	  groups	  were	  different	  in	  these	  other	  ways,	  this	  would	  show	  up	  at	  
baseline	  before	  a	  personal	  health	  budget	  was	  used.	  By	  measuring	  quality	  of	  life	  and	  service	  cost	  at	  
baseline	  we	  can	  calculate	  net	  benefit	  for	  each	  group	  prior	  to	  the	  use	  of	  a	  personal	  health	  budget.	  Any	  
difference	  in	  net	  benefit	  between	  the	  groups	  can	  then	  be	  subtracted	  from	  the	  difference	  in	  net	  
benefit	  between	  the	  groups	  at	  follow-­‐up	  to	  remove	  this	  selection	  bias.	  
The	  calculation	  is	  as	  follows,	  assuming	  a	  £30,000	  willingness	  to	  pay:	  
NMB  diff  at  baseline = £30,000×base  QoL PHB − Cost PHB − [£30,000×base  QoL CG − Cost CG 	  
NMB  diff  at  follow  up = £30,000×foll  QoL PHB − Cost PHB − [£30,000×foll  QoL CG − Cost CG 	  
The	  impact	  of	  personal	  health	  budgets	  is	  the	  difference	  between	  these	  two	  difference-­‐amounts:	  
Difference	  in	  NMB	  difference	  =	  NMB	  diff	  at	  follow-­‐up	  –	  NMB	  diff	  at	  baseline.	  
A	  positive	  value	  of	  this	  difference	  in	  NMB	  difference	  means	  that	  the	  personal	  health	  budgets	  group	  
experienced	  greater	  net	  benefit	  than	  the	  control	  group	  after	  accounting	  for	  any	  such	  difference	  at	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
21	  Regarding	  this	  attribution	  problem,	  there	  is	  always	  a	  possibility	  that	  the	  people	  in	  the	  personal	  health	  budget	  group	  had	  
some	  characteristics	  (other	  than	  the	  use	  of	  personal	  health	  budgets),	  that	  systematically	  differed	  from	  those	  in	  the	  control	  
group	  and	  which	  caused	  the	  observed	  difference	  in	  NMB	  or,	  at	  least,	  biased	  our	  estimation	  away	  from	  the	  true	  value.	  A	  
fully	  blind	  RCT	  design	  makes	  the	  odds	  of	  this	  happening	  extremely	  small.	  Without	  a	  fully	  randomised	  design,	  as	  in	  this	  case,	  
the	  odds	  are	  potentially	  greater,	  although	  a	  difference-­‐in-­‐difference	  design	  minimises	  the	  problem	  by	  controlling	  for	  
baseline	  differences	  in	  the	  sample	  (see	  Appendix	  C).	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baseline.	  By	  that	  definition,	  personal	  health	  budgets	  would	  be	  more	  cost-­‐effective	  than	  conventional	  
service	  arrangements	  (if	  the	  difference	  was	  a	  real	  difference	  –	  see	  below).	  In	  other	  words,	  personal	  
health	  budgets	  would	  have	  generated	  more	  benefit	  after	  subtracting	  costs	  than	  the	  conventional	  
approach.	  
Regarding	  the	  second	  problem,	  what	  we	  have	  are	  samples	  of	  people	  using	  personal	  health	  budgets	  
and	  conventional	  service	  delivery.	  Average	  values	  (of	  net	  benefits	  in	  this	  case)	  for	  each	  group	  
therefore	  only	  imperfectly	  reflect	  the	  true	  value:	  they	  are	  subject	  to	  statistical	  noise.	  For	  this	  reason	  
we	  need	  to	  determine	  whether	  or	  not	  the	  average	  value	  of	  net	  benefit	  difference	  is	  greater	  than	  zero	  
but	  that	  the	  difference	  is	  statistically	  significant.	  	  
In	  the	  analysis	  described	  below	  we	  started	  with	  a	  £30,000	  willingness-­‐to-­‐pay	  threshold	  and	  assessed	  
the	  probability	  and/or	  statistical	  chance	  that	  people	  in	  the	  personal	  health	  budget	  group	  would	  show	  
a	  greater	  improvement	  in	  NMB	  than	  people	  in	  the	  control	  group.	  We	  used	  this	  threshold	  for	  valuing	  
both	  EQ-­‐5D	  and	  ASCOT.	  To	  be	  clear,	  a	  willingness-­‐to-­‐pay	  convention	  for	  a	  unit	  improvement	  in	  
ASCOT	  has	  not	  yet	  been	  fully	  established.	  However,	  as	  the	  utility	  valuation	  of	  ASCOT	  was	  made	  on	  
the	  same	  basis	  as	  for	  EQ-­‐5D	  (i.e.	  both	  anchored	  at	  the	  being	  dead-­‐equivalent	  level)22,	  we	  expect	  
them	  to	  be	  broadly	  comparable	  in	  value.	  The	  impact	  of	  personal	  health	  budgets	  on	  ASCOT	  and	  EQ-­‐5D	  
outcome	  measures	  was	  described	  in	  Chapter	  5.	  
6.3.5 Adjusted	  difference-­‐in-­‐difference	  
As	  outlined	  in	  Chapter	  2	  and	  applied	  in	  the	  previous	  chapter	  on	  impact	  –	  see	  section	  5.3.2	  –	  we	  used	  
a	  difference-­‐in-­‐difference	  approach	  to	  account	  for	  any	  baseline	  differences	  between	  personal	  health	  
budget	  and	  control	  group.	  Furthermore,	  to	  safeguard	  against	  possible	  bias	  that	  could	  arise	  as	  a	  result	  
of	  differences	  in	  the	  rate	  of	  change	  of	  costs	  and	  benefits	  between	  groups,	  beyond	  any	  true	  effect	  of	  
personal	  health	  budgets,	  we	  also	  estimated	  multivariate	  difference-­‐in-­‐difference	  model	  with	  control	  
factors.	  In	  this	  case,	  unlike	  the	  results	  on	  impact	  in	  the	  last	  chapter,	  we	  found	  that	  control	  factors	  
made	  essentially	  no	  difference	  to	  the	  results	  (see	  below	  for	  details).	  In	  the	  multivariate	  analysis,	  only	  
confounding	  factors	  that	  contributed	  to	  the	  various	  models	  were	  included.	  A	  list	  of	  all	  confounding	  
variables	  initially	  explored	  in	  the	  analysis	  can	  be	  found	  in	  Appendix	  C.	  
6.4 Costs	  
Whole	  sample	  
Table	  6-­‐1	  and	  Table	  6-­‐2	  report	  the	  cost	  of	  services	  used	  by	  the	  personal	  health	  budget	  and	  control	  
groups	  respectively.	  These	  tables	  distinguish	  costs	  at	  baseline	  and	  follow-­‐up,	  and	  by	  service	  category	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
22	  using	  the	  same	  method:	  a	  time-­‐trade-­‐off	  where	  people	  exchange	  longer	  durations	  of	  lower	  quality	  of	  life	  with	  short	  
periods	  in	  full	  health.	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(see	  also	  section	  0	  for	  examples	  of	  services	  in	  these	  categories).	  For	  both	  groups	  there	  was	  a	  pattern	  
of	  increasing	  direct	  costs	  and	  falling	  indirect	  costs	  over	  the	  follow-­‐up	  period.	  
Table	  6-­‐1.	  Service	  and	  support	  costs,	  by	  type	  –	  Personal	  health	  budget	  group,	  whole	  sample	  	  
	   Follow-­‐up	   Baseline	  
	   Mean	   SD	   Min	   Max	   Mean	   SD	   Min	   Max	  
Social	  care	   15100	   23500	   0	   250800	   12800	   21500	   0	   129100	  
Well-­‐being	   600	   1300	   0	   23100	   100	   200	   0	   1800	  
Nursing	  and	  therapy	  services	   200	   700	   0	   5500	   200	   500	   0	   11000	  
Other	  health	  services	   2100	   10900	   0	   156700	   2000	   10400	   0	   149800	  
	   	   	   	   	   	   	   	   	  
Sub-­‐total:	  Direct	  costs	  	   18000	   9100	   0	   98400	   15100	   11900	   0	   137300	  
	   	   	   	   	   	   	   	   	  
Primary	  care	   740	   1140	   0	   13220	   680	   980	   0	   10960	  
Inpatient	  care	   3010	   8310	   0	   82480	   5160	   11430	   0	   118200	  
Outpatient	  and	  A&E	  care	   800	   1050	   0	   8610	   930	   1040	   0	   8610	  
	   	   	   	   	   	   	   	   	  
Sub-­‐total:	  Indirect	  costs	  	   4600	   9100	   0	   98400	   6800	   11900	   0	   137300	  
	   	   	   	   	   	   	   	   	  
Total	  cost	   22600	   28800	   0	   256000	   21900	   29500	   0	   218800	  
N	  =	  1171	  
Table	  6-­‐2.	  Service	  and	  support	  costs,	  by	  type	  –	  Control	  group,	  whole	  sample	  
	   Follow-­‐up	   Baseline	  
	   Mean	   SD	   Min	   Max	   Mean	   SD	   Min	   Max	  
Social	  care	   11200	   19300	   0	   136900	   8500	   17100	   0	   124200	  
Well-­‐being	   100	   200	   0	   1900	   100	   200	   0	   1900	  
Nursing	  and	  therapy	  services	   100	   300	   0	   3900	   100	   300	   0	   4600	  
Other	  health	  services	   2400	   5100	   0	   24200	   2300	   4900	   0	   23500	  
	  
	   	   	   	   	   	   	   	  Sub-­‐total:	  Direct	  costs	  	   13800	   7700	   0	   89800	   11000	   8900	   0	   112800	  
	   	   	   	   	   	   	   	   	  
Primary	  care	   650	   1020	   0	   10580	   590	   930	   0	   10600	  
Inpatient	  care	   2510	   7030	   0	   82480	   3340	   8340	   0	   102500	  
Outpatient	  and	  A&E	  care	   750	   940	   0	   7650	   850	   970	   0	   11030	  
	  
	   	   	   	   	   	   	   	  Sub-­‐total:	  Indirect	  costs	  	   3900	   7700	   0	   89800	   4800	   8900	   0	   112800	  
	  
	   	   	   	   	   	   	   	  Total	  cost	   17700	   22400	   0	   141400	   15800	   21800	   0	   137800	  
N	  =	  1064	  
Expenditure	  to	  meet	  direct	  costs	  (social	  care,	  well-­‐being,	  nursing	  and	  therapy,	  and	  other	  health	  
services)	  increased	  by	  25%	  over	  the	  period	  for	  the	  control	  group	  and	  20%	  for	  the	  personal	  health	  
budget	  group.	  Indirect	  costs,	  however,	  fell	  by	  33%	  for	  the	  personal	  health	  budget	  group	  compared	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with	  18%	  for	  the	  controls.	  In	  both	  cases	  the	  main	  reduction	  was	  for	  hospital	  services	  rather	  than	  in	  
primary	  care	  (GP	  services).	  	  
The	  reduction	  in	  secondary	  care	  costs	  is	  not	  unusual,	  often	  being	  the	  result	  of	  ‘regression	  to	  the	  
mean’:	  that	  is,	  where	  participants	  are	  recruited	  (meeting	  the	  recruitment	  criteria)	  at	  a	  high	  ebb	  of	  
secondary	  care	  service-­‐use	  that	  subsequently	  reduces	  to	  more	  normal	  levels.	  This	  feature	  of	  the	  data	  
is	  a	  prime	  reason	  for	  designing	  the	  study	  with	  a	  control	  group	  so	  that	  trends	  can	  be	  compared.	  
Two	  observations	  are	  important	  in	  respect	  of	  these	  cost	  results.	  First,	  the	  control	  group	  sample	  had	  
lower	  costs	  on	  average	  than	  the	  personal	  health	  budget	  group.	  Comparing	  the	  totals,	  at	  baseline	  
costs	  were	  some	  28%	  lower	  for	  the	  control	  group	  than	  for	  the	  personal	  health	  budget	  group.	  At	  
follow-­‐up,	  total	  costs	  averaged	  22%	  lower	  for	  the	  controls.	  Both	  of	  these	  were	  statistically	  significant	  
differences	  (p	  <	  0.001).	  Second,	  the	  mean	  cost	  increased	  at	  a	  slightly	  faster	  rate	  in	  the	  control	  group	  
than	  in	  the	  personal	  health	  budget	  group:	  follow-­‐up	  costs	  were	  12%	  higher,	  compared	  to	  4%	  higher	  
for	  the	  personal	  health	  budget	  group.	  
We	  can	  clearly	  infer	  that	  the	  people	  in	  the	  control	  group	  are	  healthier	  and	  have	  lower	  care	  needs	  
than	  people	  in	  the	  personal	  health	  budget	  group.	  This	  result	  underlines	  the	  difficulty	  in	  selecting	  
study	  participants	  for	  interventions,	  like	  personal	  health	  budgets,	  that	  are	  not	  ‘blind’	  and	  which	  are	  
process	  orientated.	  In	  some	  sites,	  a	  non-­‐blind	  randomisation	  method	  for	  some	  patient	  groups	  was	  
used	  for	  study	  selection	  (see	  Chapter	  2	  for	  details)	  (560	  of	  the	  2,235	  cases	  were	  selected	  using	  a	  
randomisation	  process).	  For	  the	  randomised	  sub-­‐sample,	  the	  difference	  in	  baseline	  costs	  mean	  
values	  between	  the	  two	  groups	  was	  substantially	  reduced	  compared	  to	  the	  whole-­‐sample	  difference,	  
although	  still	  significant	  at	  the	  10%	  level.23	  There	  was	  no	  significant	  difference	  in	  costs	  at	  follow-­‐up	  
for	  the	  randomisation	  sub-­‐sample.	  Due	  to	  these	  anticipated	  selection	  issues,	  we	  adopted	  a	  
difference-­‐in-­‐difference	  design	  on	  the	  basis	  that	  changes	  (in	  costs)	  through	  time	  are	  less	  affected	  by	  
differences	  in	  baseline	  characteristics.	  We	  explore	  the	  differences	  between	  the	  randomised	  and	  non-­‐
randomised	  sub-­‐samples	  as	  regards	  to	  cost-­‐effectiveness	  below	  (section	  6.5.4).	  
Costs	  in	  both	  groups	  showed	  significant	  variation	  and	  had	  the	  usual	  characteristic	  of	  a	  long	  right-­‐
hand	  tail	  of	  the	  distribution	  –	  see	  Figure	  6-­‐2.	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
23	  For	  a	  fully	  double-­‐blind	  randomised	  trial	  we	  would	  expect	  no	  difference	  in	  baseline	  costs,	  except	  by	  pure	  chance.	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Figure	  6-­‐2.	  Density	  plot	  –	  distribution	  of	  total	  costs,	  all	  participants	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Figure	  6-­‐3	  above	  shows	  the	  change	  in	  cost	  between	  baseline	  and	  follow-­‐up	  for	  both	  groups	  and	  also	  
the	  differences	  in	  these	  changes	  between	  groups	  through	  time.	  Table	  6-­‐3	  gives	  more	  detail.	  Overall,	  
total	  costs	  on	  average	  increased	  by	  £1920	  per	  person	  over	  the	  study	  period	  in	  the	  control	  group	  and	  
by	  £800	  in	  the	  personal	  health	  budget	  group	  (i.e.	  a	  difference-­‐in-­‐difference	  of	  £1120	  less	  for	  the	  
personal	  health	  budget	  group	  compared	  with	  the	  controls).	  Given	  the	  variation	  in	  total	  cost	  
differences	  between	  the	  individuals	  in	  our	  sample,	  we	  calculated	  a	  95%	  confidence	  interval	  for	  this	  
cost	  difference	  of	  -­‐£3440	  to	  £1191	  (i.e.	  we	  are	  95%	  confident	  that	  the	  true	  cost	  difference-­‐in-­‐
difference	  is	  in	  our	  confidence	  interval24).	  In	  this	  case,	  the	  confidence	  interval	  includes	  a	  zero	  cost	  
difference	  so	  we	  cannot	  say	  that	  the	  personal	  health	  budget	  group	  showed	  a	  significantly	  lower	  
change	  in	  costs	  than	  the	  control	  group.	  
The	  faster	  reduction	  in	  indirect	  costs	  was	  the	  main	  driver	  of	  this	  overall	  difference-­‐in-­‐difference	  
result,	  with	  indirect	  costs	  falling	  by	  £1360	  more	  in	  the	  personal	  health	  budget	  group	  (mainly	  in	  
respect	  to	  inpatient	  care	  costs),	  and	  this	  was	  a	  significant	  result.	  By	  contrast,	  direct	  costs	  grew	  at	  a	  
slightly	  faster	  rate	  in	  the	  personal	  health	  budget	  group,	  with	  most	  of	  this	  cost	  growth-­‐difference	  
accounted	  for	  by	  well-­‐being	  services.	  This	  result	  is	  in	  line	  with	  expectations	  and	  the	  results	  reported	  
in	  Chapter	  4	  that	  individuals	  use	  their	  personal	  health	  budgets	  to	  increase	  the	  purchase	  of	  well-­‐being	  
type	  support.	  We	  should	  also	  be	  clear	  that	  in	  the	  majority	  of	  cases	  personal	  health	  budgets	  were	  
provided	  in	  addition	  to	  usual	  funding	  and	  so	  constitute	  an	  increase	  in	  expenditure	  for	  the	  personal	  
health	  budget	  group,	  other	  things	  equal.	  We	  would,	  therefore,	  anticipate	  that	  overall	  cost	  increases	  
would	  have	  been	  even	  lower	  relative	  to	  the	  control	  group	  if	  personal	  health	  budgets	  had	  been	  used	  
to	  substitute	  for	  existing	  service	  use	  to	  a	  greater	  degree.	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  




Table	  6-­‐3.	  Differences	  in	  service	  and	  support	  costs,	  by	  type	  –	  whole	  sample	  
	   Change	  in	  cost	  between	  






	   PHB	   Control	  
Social	  care	   2310	   2720	   -­‐400	   0.635	  
Well-­‐being	   500	   0	   510	   <0.001***	  
Nursing	  and	  therapy	  services	   80	   -­‐10	   90	   0.109	  
Other	  health	  services	   120	   70	   50	   0.003**	  
Sub-­‐total:	  Direct	  costs	  	   3020	   2780	   240	   0.759	  
	   	   	   	   	  Primary	  care	   60	   70	   -­‐10	   0.830	  
Inpatient	  care	   -­‐2150	   -­‐830	   -­‐1320	   0.040**	  
Outpatient	  and	  A&E	  	   -­‐130	   -­‐100	   -­‐30	   0.427	  
Sub-­‐total:	  Indirect	  costs	   -­‐2220	   -­‐860	   -­‐1360	   0.042**	  
	   	   	   	   	  
Total	  cost	   800	   1920	   -­‐1120	   0.319	  
Significance	  levels:	  *	  p<0.10	  **	  p<0.05***	  p<	  0.001	  	  
N	  =	  2235	  
To	  sum	  up,	  statistically	  significant	  differences	  between	  the	  groups	  in	  changes	  in	  costs	  over	  time	  were	  
found	  for	  inpatient	  care,	  well-­‐being	  and	  other	  health	  services.	  The	  total	  cost	  difference-­‐in-­‐difference	  
was	  not	  significantly	  different,	  however,	  for	  the	  whole	  sample.	  
6.4.1.1 Costs	  of	  services	  by	  personal	  health	  budget	  type	  
Just	  under	  45%	  of	  personal	  health	  budgets	  in	  the	  study	  were	  deployed	  as	  direct	  payments	  (as	  
opposed	  to	  notional	  budgets	  or	  using	  third	  parties).	  The	  average	  budget	  value	  for	  recipients	  with	  
only	  direct	  payment	  personal	  health	  budgets	  was	  £12880	  compared	  to	  an	  average	  of	  £8330	  for	  all	  
types	  of	  personal	  health	  budget.	  In	  terms	  of	  expenditure	  made	  from	  budgets,	  total	  expenditure	  from	  
direct	  payment	  budgets	  in	  the	  study	  (£6.62m)25	  accounted	  for	  approximately	  two-­‐thirds	  of	  the	  total	  
expenditure	  made	  from	  all	  types	  of	  personal	  health	  budgets	  (£9.75m).	  To	  put	  these	  figures	  in	  
context,	  taking	  just	  personal	  health	  budget	  holders,	  expenditure	  from	  direct	  payment	  personal	  
health	  budgets	  accounted	  for	  31%	  of	  direct	  expenditure	  totals	  at	  follow-­‐up	  and	  25%	  of	  total	  
expenditure	  –	  see	  Table	  6-­‐1.	  
Generally	  speaking	  we	  would	  expect	  expenditure	  from	  direct	  payment	  personal	  health	  budgets	  to	  be	  
used	  to	  fund	  services	  and	  support	  provided	  by	  the	  non-­‐public	  (or	  independent)	  sector.26	  This	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
25	  In	  other	  words,	  an	  average	  of	  £5650	  over	  the	  1171	  personal	  health	  budget	  holders.	  
26	  We	  make	  this	  assumption	  because	  in	  theory	  the	  commissioning	  of	  publicly-­‐delivered	  services	  would	  not	  require	  a	  
monetary	  payment.	  Nonetheless,	  it	  might	  be	  possible	  that	  local	  arrangements	  are	  made	  to	  accommodate	  these	  sorts	  of	  
transactions	  e.g.	  netting	  off	  the	  cost	  of	  public	  services	  from	  the	  direct	  payment.	  These	  arrangements	  ought	  to	  be	  classed	  as	  
mixed	  notional	  and	  DP	  deployment	  in	  the	  data,	  but	  interpretation	  can	  differ	  between	  sites.	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assumption	  underpinned	  an	  estimation	  of	  the	  change	  in	  the	  amount	  of	  service	  secured	  outside	  the	  
NHS	  (and	  in-­‐house	  social	  care	  providers)	  as	  a	  result	  of	  the	  introduction	  of	  personal	  health	  budgets.	  
Again	  we	  estimated	  this	  outsourcing	  figure	  using	  a	  difference-­‐in-­‐difference	  approach.	  Irrespective	  of	  
the	  use	  of	  personal	  health	  budgets,	  around	  90%	  of	  social	  care	  is	  purchased	  from	  independent	  sector	  
providers	  anyway.	  Furthermore,	  well-­‐being	  services	  are	  not	  (generally)	  provided	  by	  the	  NHS.	  For	  this	  
analysis	  we	  therefore	  assumed	  that	  all	  well-­‐being	  services	  secured	  at	  follow-­‐up	  were	  outsourced.	  Of	  
the	  remaining	  services	  categorised	  as	  direct	  costs,	  e.g.	  therapy	  services,	  we	  assumed	  that	  where	  
these	  services	  were	  funded	  using	  a	  direct	  payment	  they	  were	  secured	  externally,	  and	  otherwise	  they	  
were	  supplied	  by	  internal	  providers	  (i.e.	  NHS	  and	  in-­‐house	  care	  providers).	  	  
These	  assumptions	  mean	  that	  at	  baseline,	  for	  both	  the	  control	  and	  personal	  health	  budget	  groups,	  all	  
direct	  expenditure	  went	  to	  internal	  providers	  except	  for	  the	  90%	  of	  social	  care	  that	  was	  secured	  
externally.	  At	  follow-­‐up	  the	  same	  applied	  for	  the	  control	  group.	  However,	  for	  the	  personal	  health	  
budget	  group	  all	  well-­‐being	  services	  and	  90%	  of	  social	  care	  expenditure	  were	  sourced	  externally.	  
Furthermore,	  the	  remaining	  direct	  expenditure	  (after	  well-­‐being	  service	  and	  90%	  of	  social	  care	  
expenditure	  is	  removed)	  was	  externally	  sourced	  if	  the	  person	  had	  a	  direct	  payment	  personal	  health	  
budget.	  
To	  reiterate	  the	  amount	  of	  care	  secured	  from	  external	  providers	  was:	  
Group	   Baseline	   Follow-­‐up	  
Control	   90%	  of	  social	  care	  
expenditure	  (SC)	  at	  
baseline	  (A)	  
90%	  of	  SC	  at	  follow-­‐up	  
	  
(B)	  




90%	  of	  SC	  at	  follow-­‐up	  +	  well-­‐being	  
(WB)	  +	  all	  other	  direct	  expenditure	  
by	  a	  DP27	  
(D)	  
	  
The	  difference-­‐in-­‐difference	  is	  =	  (Cell	  D	  –	  Cell	  C)	  –	  (Cell	  B	  –	  Cell	  A).	  
This	  difference-­‐in-­‐difference	  was	  calculated	  to	  be	  £2180	  per	  year	  for	  the	  sample.	  It	  was	  our	  estimate	  
of	  the	  amount	  of	  expenditure	  going	  outside	  the	  NHS	  following	  the	  use	  of	  personal	  health	  budgets.28	  
This	  amount	  was	  equivalent	  to	  just	  over	  12%	  of	  the	  £18000	  total	  direct	  expenditure	  in	  the	  personal	  
health	  budget	  group.	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
27	  This	  call	  is	  equal	  to:	  (Direct	  expenditure	  at	  follow-­‐up	  –	  90%	  of	  social	  care	  expenditure	  at	  follow-­‐up)	  x	  DP%	  +	  well-­‐being	  
expenditure	  at	  follow-­‐up	  x	  (1	  –	  DP%)	  +	  90%	  of	  SC	  at	  follow-­‐up.	  
28	  This	  value	  is	  significant	  at	  the	  90%	  confidence	  level.	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Our	  definition	  of	  social	  care	  in	  this	  study	  was	  inclusive	  and	  could	  incorporate	  services	  that	  might	  be	  
provided	  by	  the	  NHS	  for	  people	  without	  personal	  health	  budgets.	  This	  would	  mean	  less	  expenditure	  
was	  externally	  sourced	  before	  the	  introduction	  of	  personal	  health	  budgets	  and	  consequently	  the	  
change	  would	  be	  greater	  following	  their	  introduction.	  Re-­‐calculating	  on	  the	  basis	  that	  80%	  of	  social	  
care	  was	  provided	  by	  the	  independent	  sector	  increased	  the	  change	  figure	  to	  £3110	  or	  around	  17%	  of	  
direct	  expenditure.29	  
This	  outsourcing	  analysis	  gives	  some	  indication	  of	  the	  scale	  outsourcing	  associated	  with	  the	  use	  of	  
personal	  health	  budgets,	  but	  it	  relies	  on	  the	  assumptions	  detailed	  above.	  Different	  assumptions	  
would	  produce	  different	  results.	  We	  might	  have	  assumed	  that	  therapy	  and	  other	  health	  services	  
funded	  under	  notional	  personal	  health	  budgets	  could	  have	  been	  commissioned	  from	  external	  
providers.	  Also,	  we	  assumed	  that	  all	  well-­‐being	  expenditure	  went	  externally,	  but	  this	  might	  not	  be	  
the	  case.	  For	  example,	  if	  we	  assume	  that	  only	  half	  of	  well-­‐being	  expenditure	  actually	  went	  externally,	  
then	  the	  impact	  of	  personal	  health	  budgets	  would	  be	  in	  the	  order	  of	  £1900	  per	  year	  for	  the	  sample.	  
The	  wider	  implications	  of	  these	  results	  are	  considered	  in	  chapter	  9.	  
6.4.2 Costs	  for	  sub-­‐groups	  
We	  can	  further	  explore	  costs	  difference	  by	  sub-­‐samples	  of	  the	  study	  population.	  The	  following	  tables	  
present	  changes	  in	  costs	  for	  the	  different	  health	  condition	  groups,	  by	  different	  cost	  category.	  Table	  
6-­‐4	  shows	  the	  change	  to	  indirect	  service	  use	  for	  each	  health	  condition	  group.	  In	  this	  case,	  the	  
personal	  health	  budget	  group	  reduced	  their	  expenditure	  on	  indirect	  services	  to	  a	  greater	  degree	  than	  
the	  control	  group.	  The	  differences	  in	  the	  changes	  through	  time	  were	  significant	  for	  the	  mental	  health	  
and	  NHS	  Continuing	  Healthcare	  cohorts.	  The	  result	  for	  the	  NHS	  Continuing	  Healthcare	  cohort	  was	  
consistent	  with	  the	  views	  held	  by	  project	  leads	  within	  the	  in-­‐depth	  qualitative	  interviews.	  It	  was	  
consistently	  thought	  the	  personal	  health	  budgets	  would	  lead	  to	  cost-­‐savings	  within	  this	  cohort.	  
Changes	  in	  direct	  costs	  are	  shown	  in	  Table	  6-­‐5.	  There	  were	  no	  significant	  differences	  between	  the	  
personal	  health	  budget	  and	  control	  group	  in	  these	  cost	  changes.	  We	  should	  note,	  however,	  that	  
statistical	  precision	  may	  be	  limited	  by	  the	  relatively	  small	  sample	  sizes	  of	  each	  of	  the	  six	  health	  
conditions.	  	  
Table	  6-­‐6	  reports	  the	  changes	  in	  the	  total	  costs	  for	  each	  group,	  which	  is	  the	  sum	  of	  indirect	  and	  
direct	  costs.	  Overall,	  the	  difference	  in	  the	  change	  over	  time	  (third	  column)	  was	  not	  significantly	  
different	  from	  zero	  for	  any	  of	  the	  health	  conditions.	  For	  the	  NHS	  Continuing	  Healthcare	  and	  mental	  
health	  cohorts,	  the	  high	  variance	  in	  direct	  costs	  in	  the	  sub-­‐samples	  diluted	  the	  precision	  of	  the	  result	  
for	  indirect	  costs.	  Not	  finding	  significant	  total	  cost	  differences	  does	  not	  remove	  the	  significance	  of	  
the	  difference	  regarding	  indirect	  costs.	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
29	  This	  difference	  is	  significant	  at	  the	  95%	  confidence	  level.	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Table	  6-­‐4.	  Changes	  in	  indirect	  cost	  between	  baseline	  and	  follow-­‐up,	  by	  patient	  group	  
	   PHB	   Control	   Difference	  
	   Change	   Change	   Change	   Prob	   CI+	   CI-­‐	  
Diabetes	   -­‐1730	   -­‐410	   -­‐1320	   0.263	   -­‐3730	   1090	  
Stroke	   -­‐4940	   -­‐4130	   -­‐810	   0.605	   -­‐3880	   2280	  
Mental	  health	   -­‐2980	   70	   -­‐3050	   0.008**	   -­‐5290	   -­‐820	  
COPD	   -­‐930	   670	   -­‐1600	   0.109	   -­‐3560	   370	  
Neurological	   -­‐1240	   -­‐1150	   -­‐90	   0.921	   -­‐2060	   1870	  
CHC	   -­‐4570	   -­‐530	   -­‐4040	   0.058*	   -­‐8220	   140	  
Note	  1:	  CHC	  refers	  to	  NHS	  Continuing	  Healthcare	  
Significance	  levels:	  *	  p<0.10	  **	  p<0.05***	  p<	  0.001	  	  
	  
Table	  6-­‐5.	  Changes	  in	  direct	  cost	  between	  baseline	  and	  follow-­‐up,	  by	  patient	  group	  
	   PHB	   Control	   Difference	  
	   Change	   Change	   Change	   Prob	   CI+	   CI-­‐	  
Diabetes	   3610	   1900	   1710	   0.197	   -­‐900	   4320	  
Stroke	   1900	   4740	   -­‐2840	   0.146	   -­‐6680	   1000	  
Mental	  health	   980	   800	   180	   0.921	   -­‐3630	   4000	  
COPD	   4230	   2680	   1550	   0.268	   -­‐1260	   4360	  
Neurological	   4620	   3410	   1210	   0.411	   -­‐1690	   4110	  
CHC	   860	   5450	   -­‐4590	   0.301	   -­‐13560	   4390	  
Note	  1:	  CHC	  refers	  to	  NHS	  Continuing	  Healthcare	  
Significance	  levels:	  *	  p<0.10	  **	  p<0.05***	  p<	  0.001	  	  
	  
Table	  6-­‐6.	  Changes	  in	  total	  cost	  between	  baseline	  and	  follow-­‐up,	  by	  patient	  group	  
	   PHB	   Control	   Difference	  
	   Change	   Change	   Change	   Prob	   CI+	   CI-­‐	  
Diabetes	   1880	   1490	   390	   0.832	   -­‐3320	   4100	  
Stroke	   -­‐3040	   600	   -­‐3640	   0.146	   -­‐8570	   1290	  
Mental	  health	   -­‐2010	   870	   -­‐2880	   0.199	   -­‐7390	   1640	  
COPD	   3300	   3350	   -­‐50	   0.979	   -­‐3780	   3680	  
Neurological	   3380	   2260	   1120	   0.506	   -­‐2180	   4410	  
CHC	   -­‐3710	   4920	   -­‐8630	   0.112	   -­‐19520	   2270	  
Note	  1:	  CHC	  refers	  to	  NHS	  Continuing	  Healthcare	  
Significance	  levels:	  *	  p<0.10	  **	  p<0.05***	  p<	  0.001	  	  
	  
Another	  important	  distinction	  in	  the	  sample	  is	  by	  age.	  People	  aged	  over	  75	  are	  known	  to	  be	  more	  
intensive	  users	  of	  health	  and	  social	  care	  services	  than	  younger	  people.	  At	  baseline	  in	  this	  study,	  
people	  aged	  over	  75	  had	  24%	  higher	  total	  costs	  than	  people	  aged	  75	  or	  less	  (p	  =	  0.016).	  With	  a	  higher	  
capacity	  to	  benefit	  from	  cost-­‐saving	  interventions,	  we	  might	  expect	  to	  see	  differences	  in	  the	  change	  
in	  cost	  through	  time	  according	  to	  age	  group.	  	  
Table	  6-­‐7	  has	  the	  difference-­‐in-­‐difference	  results	  for	  people	  aged	  over	  75	  and,	  as	  can	  be	  seen,	  the	  
personal	  health	  budget	  group	  had	  lower	  growth	  in	  total	  cost	  than	  the	  control	  groups	  by	  -­‐£4300,	  with	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much	  of	  this	  difference	  due	  to	  the	  relative	  reductions	  in	  inpatient	  costs.	  This	  was	  a	  significant	  
difference	  at	  the	  10%	  confidence	  level.30	  
Table	  6-­‐7.	  Differences	  in	  service	  and	  support	  costs,	  by	  type	  –	  over-­‐75	  sample	  
	  
Baseline	  cost	  totals	  
Change	  in	  cost	  between	  







PHB	   Control	   PHB	   Control	  
Social	  care	   13530	   9060	   1370	   3240	   -­‐1880	   0.364	  
Well-­‐being	   60	   40	   300	   0	   300	   <0.001***	  
Nursing	  and	  therapy	  	   160	   120	   230	   40	   180	   0.210	  
Other	  health	  services	   2190	   3340	   140	   110	   30	   0.525	  
Sub-­‐total:	  Direct	  costs	  	   15940	   12560	   2030	   3390	   -­‐1360	   0.449	  
	  
	   	  
	   	   	   	  
Primary	  care	   890	   760	   -­‐60	   -­‐30	   -­‐30	   0.804	  
Inpatient	  care	   7890	   5540	   -­‐3710	   -­‐1110	   -­‐2600	   0.152	  
Outpatient	  and	  A&E	  	   1070	   880	   -­‐360	   -­‐50	   -­‐310	   0.152	  
Sub-­‐total:	  Indirect	  costs	   9840	   7180	   -­‐4130	   -­‐1190	   -­‐2940	   0.124	  
	   	   	   	   	   	   	  
Total	  cost	   25780	   19740	   -­‐2100	   2200	   -­‐4300	   0.062*	  
Significance	  levels:	  *	  p<0.10	  **	  p<0.05***	  p<	  0.001	  	  
N	  =	  383	  
As	  outlined	  in	  Chapter	  4,	  the	  value	  within	  personal	  health	  budgets	  varied	  considerably	  among	  the	  
sample.	  We	  made	  a	  qualitative	  distinction	  between	  budgets	  of	  less	  than	  and	  greater	  than	  £1000	  per	  
annum	  –	  see	  Chapter	  2	  and	  Appendix	  C	  for	  details.	  Just	  under	  40%	  of	  personal	  health	  budget	  holders	  
in	  the	  active	  (imputed)	  sample	  had	  ‘high’	  budgets	  in	  excess	  of	  £1000	  p.a.	  In	  the	  NHS	  Continuing	  
Healthcare	  cohort	  over	  80%	  had	  £1000+	  budgets,	  with	  the	  proportion	  below	  45%	  for	  the	  other	  
groups.	  We	  have	  assumed	  that	  high	  budget	  amounts	  indicate	  that	  the	  personal	  health	  budget	  was	  
funded	  in	  place	  of	  existing	  service	  delivery.	  
We	  can	  also	  compare	  costs	  for	  people	  in	  the	  personal	  health	  budget	  cohort	  with	  different	  types	  of	  
personal	  health	  budget.	  In	  particular,	  we	  can	  compare	  those	  people	  with	  high-­‐value	  budgets	  (i.e.	  
those	  worth	  more	  than	  £1000	  per	  annum)	  and	  those	  with	  low-­‐value	  budgets.	  In	  regard	  to	  our	  
assumptions	  about	  costing,	  in	  the	  latter	  case	  personal	  health	  budgets	  were	  provided	  in	  addition	  to	  
usual	  services,	  whilst	  for	  the	  former	  the	  personal	  health	  budget	  would	  substitute	  for	  conventional	  
services.	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
30	  The	  total	  cost	  difference	  can	  be	  significant	  where	  individual	  cost	  components	  are	  not	  because	  use	  of	  services	  in	  these	  
cost	  categories	  is	  likely	  to	  be	  positively	  correlated	  (i.e.	  they	  add	  up	  in	  the	  same	  direction).	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Table	  6-­‐8	  highlights	  a	  number	  of	  observations	  that	  are	  relevant.	  First,	  people	  in	  the	  sample	  with	  high-­‐
value	  personal	  health	  budgets	  (“hi	  PHB”	  in	  the	  table)	  had	  much	  higher	  expenditure	  levels	  at	  baseline	  
than	  people	  with	  low-­‐value	  personal	  health	  budgets.	  Second,	  the	  growth	  in	  direct,	  indirect	  and	  total	  
costs	  over	  the	  follow-­‐up	  period	  was	  lower,	  both	  proportionally	  and	  in	  actual	  terms,	  for	  high-­‐value	  
personal	  health	  budget	  group	  compared	  to	  the	  low-­‐value	  personal	  health	  budget	  group.	  Thirdly,	  
compared	  to	  the	  change	  in	  costs	  for	  the	  control	  group	  (as	  reported	  in	  Table	  6-­‐7),	  participants	  with	  
high-­‐value	  personal	  health	  budgets	  showed	  lower	  growth	  in	  total	  (£3,100	  less	  growth)	  whilst	  those	  
with	  low-­‐value	  personal	  health	  budgets	  showed	  a	  very	  slightly	  higher	  growth	  (+£170).31	  The	  lower	  
growth	  in	  total	  costs	  for	  high-­‐value	  personal	  health	  budgets	  in	  the	  sample	  compared	  to	  the	  control	  
group	  was	  sufficiently	  large	  for	  us	  to	  infer,	  with	  90%	  confidence,	  that	  high-­‐value	  personal	  health	  
budgets	  reduce	  total	  costs	  relative	  to	  conventional	  service	  arrangements.	  
Table	  6-­‐8.	  Differences	  in	  service	  and	  support	  costs,	  by	  personal	  health	  budget	  type	  
	  
Baseline	  cost	  totals	  





compared	  to	  the	  
control	  group	  
Significance	  of	  DiD	  
	  
Lo	  PHB	   Hi	  PHB	   Lo	  PHB	   Hi	  PHB	   Lo	  PHB	   Hi	  PHB	   Lo	  PHB	   Hi	  PHB	  
Social	  care	   5190	   24530	   3530	   450	   820	   -­‐2270	   0.464	   0.103	  
Well-­‐being	   0	   140	   390	   680	   390	   690	   <0.001***	   <0.001***	  
Nursing	  &	  therapy	  	   130	   230	   0	   190	   10	   200	   0.682	   0.044**	  
Other	  health	  	   0	   4940	   50	   230	   -­‐20	   150	   0.008**	   <0.001***	  
Sub-­‐total:	  Direct	  costs	  	   5330	   29830	   3970	   1550	   1190	   -­‐1220	   0.237	   0.349	  
	  
	   	  
	   	  
	   	   	   	  
Primary	  care	   560	   870	   20	   120	   -­‐50	   50	   0.362	   0.470	  
Inpatient	  care	   3960	   6990	   -­‐1770	   -­‐2740	   -­‐940	   -­‐1910	   0.054*	   0.132	  
Outpatient	  &	  A&E	  	   830	   1090	   -­‐140	   -­‐110	   -­‐40	   -­‐20	   0.326	   0.812	  
Sub-­‐total:	  Indirect	  costs	   5350	   8950	   -­‐1890	   -­‐2730	   -­‐1030	   -­‐1880	   0.044**	   0.144	  
	   	   	   	   	   	   	   	   	  
Total	  cost	   10680	   38790	   2090	   -­‐1180	   170	   -­‐3100	   0.883	   0.077*	  
Significance	  levels:	  *	  p<0.10	  **	  p<0.05***	  p<	  0.001	  	  
6.4.3 Control	  factors	  
As	  described	  above,	  there	  was	  no	  statistically	  significant	  difference	  in	  mean	  cost-­‐change	  between	  
personal	  health	  budget	  and	  control	  groups	  –	  see	  Table	  6-­‐3.	  We	  also	  tested	  the	  results	  to	  assess	  
whether	  the	  difference	  became	  significant	  after	  introducing	  control	  factors.	  The	  multivariate	  
estimations,	  using	  the	  same	  control	  factors	  as	  in	  chapter	  5,	  produced	  very	  similar	  results	  to	  the	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
31	  For	  low-­‐value	  personal	  health	  budgets	  ,	  direct	  costs	  in	  the	  sample	  showed	  greater	  growth	  on	  average	  compared	  to	  the	  
control	  group.	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uncontrolled	  results	  in	  Table	  6-­‐3,	  with	  almost	  the	  same	  effect	  size	  (-­‐£1125)	  and	  no	  significant	  
difference	  (p	  =	  0.26).	  
6.5 Net	  monetary	  benefit	  
Net	  (monetary)	  benefit	  (NMB)	  at	  baseline	  and	  follow-­‐up	  was	  estimated	  for	  study	  participants	  in	  both	  
the	  personal	  health	  budget	  and	  control	  groups.	  As	  outlined	  in	  section	  6.3.4,	  personal	  health	  budgets	  
would	  be	  assessed	  as	  cost-­‐effective	  if	  they	  produced	  greater	  net	  benefit	  (i.e.	  £-­‐value	  of	  benefits	  less	  
cost)	  than	  conventional	  service	  arrangements	  (to	  a	  statistically	  significant	  degree).	  We	  made	  this	  
assessment	  by	  comparing	  the	  net	  benefit	  at	  follow-­‐up	  (less	  net	  benefit	  at	  baseline)	  in	  the	  personal	  
health	  budget	  group	  with	  that	  of	  the	  control	  group.	  As	  we	  are	  controlling	  for	  baseline	  differences	  in	  
the	  net	  benefit	  of	  support	  and	  services	  received	  by	  the	  two	  groups,	  we	  refer	  to	  net	  benefit	  change	  or	  
‘NMB-­‐change’	  and	  the	  difference	  between	  the	  groups	  in	  NMB-­‐change.	  
The	  results	  are	  given	  in	  Table	  6-­‐9	  for	  ASCOT	  and	  Table	  6-­‐10	  for	  EQ-­‐5D.	  Starting	  with	  the	  ASCOT-­‐
measured	  benefits,	  Table	  6-­‐9	  shows	  that	  over	  the	  follow-­‐up	  period	  both	  personal	  health	  budget	  and	  
control	  group	  participants	  showed	  an	  improvement	  in	  their	  ASCOT	  quality	  of	  life	  scores	  (as	  also	  
described	  in	  chapter	  5).	  The	  personal	  health	  budget	  group	  showed	  the	  greater	  improvement	  –	  by	  a	  
difference	  of	  0.039.	  Seeing	  an	  improvement	  in	  the	  control	  group	  –	  albeit	  modest,	  of	  0.018	  on	  
average	  –	  it	  is	  not	  unexpected	  because	  people	  in	  the	  control	  group	  were	  getting	  an	  increased	  level	  of	  
services	  over	  the	  period	  due	  to	  an	  increase	  in	  need:	  the	  cost	  of	  their	  care	  increased	  by	  £1920.	  	  
The	  table	  shows	  the	  £-­‐value	  of	  this	  beneficial	  impact,	  by	  an	  amount	  that	  varies	  according	  to	  the	  
willingness	  to	  pay	  threshold	  we	  use.	  For	  example,	  at	  the	  £30,000	  threshold,	  the	  0.057	  improvement	  
in	  ASCOT	  quality	  of	  life	  reported	  by	  the	  personal	  health	  budget	  group	  between	  follow-­‐up	  and	  
baseline	  is	  valued	  at	  £1720	  (i.e.	  £30,000	  x	  0.057).	  For	  the	  control	  group,	  benefits	  increased	  by	  £540	  
over	  the	  follow-­‐up	  period.	  Overall,	  the	  personal	  health	  budget	  group	  were	  showing	  between	  £400	  
and	  £1570	  worth	  of	  extra	  benefit	  over	  the	  control	  group,	  depending	  on	  the	  threshold	  chosen.	  
As	  outlined	  above,	  the	  costs	  of	  services	  and	  support	  for	  people	  in	  the	  personal	  health	  budget	  group	  
increased	  at	  a	  slower	  rate	  on	  average	  than	  for	  the	  control	  group.	  Effectively,	  total	  service	  costs	  were	  
£1120	  less,	  on	  average,	  in	  the	  personal	  health	  budget	  group	  than	  the	  control	  group.	  
Taking	  both	  cost	  and	  benefits	  together,	  therefore,	  the	  personal	  health	  budget	  group	  were	  showing	  
greater	  benefit	  and	  less	  cost,	  on	  average,	  than	  the	  control	  group,	  so	  net	  benefit	  was	  between	  £1520	  
and	  £2690	  greater	  for	  the	  personal	  health	  budget	  group	  compared	  to	  the	  control	  group	  after	  
subtracting	  baseline	  differences.	  For	  example,	  at	  the	  £30,000	  threshold,	  the	  extra	  net	  benefit	  
averaged	  £2300	  (£1180	  minus	  -­‐£1120)	  more	  for	  the	  personal	  health	  budget	  group	  compared	  to	  the	  
control	  group.	  	  
Exactly	  the	  same	  calculations	  were	  undertaken	  for	  EQ5D-­‐measured	  benefits	  –	  see	  Table	  6-­‐10.	  In	  this	  
case,	  personal	  health	  budgets	  showed	  greater	  net	  benefit	  than	  controls	  on	  average	  of	  between	  
£1020	  and	  £700,	  though	  these	  were	  not	  statistically	  significant.	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Table	  6-­‐9.	  Difference	  in	  mean	  NMB-­‐change	  for	  ASCOT,	  whole	  sample,	  various	  CE	  thresholds	  





Benefits	   	   	   	   	   	   	  
ASCOT	  change	   0.057	   0.018	   0.039	   	   	   	  
£-­‐value	  of	  ASCOT	  change:	   	   	   	   	   	   	  
	   £40,000	   2290	   720	   1570	   	   	   	  
	   £30,000	   1720	   540	   1180	   	   	   	  
	   £20,000	   1150	   360	   790	   	   	   	  
	   £10,000	   580	   180	   400	   	   	   	  
Costs	   	   	   	   	   	   	  
Cost	  change	   800	   1920	   -­‐1120	   	   	   	  
Net	  benefit	   	   	   	   	   	   	  
NMB	  change:	   	   	   	   	   	   	  
	   £40,000	   1490	   -­‐1200	   2690	   0.057*	   410	   4970	  
	   £30,000	   920	   -­‐1380	   2300	   0.082*	   140	   4460	  
	   £20,000	   350	   -­‐1560	   1910	   0.124	   -­‐150	   3960	  
	   £10,000	   -­‐220	   -­‐1740	   1520	   0.198	   -­‐450	   3490	  
Significance	  levels:	  *	  p<0.10	  **	  p<0.05***	  p<	  0.001	  	  
Table	  6-­‐10.	  Difference	  in	  mean	  NMB-­‐change	  for	  EQ-­‐5D,	  whole	  sample,	  various	  CE	  thresholds	  





Benefits	   	   	   	   	   	   	  
EQ-­‐5D	  change	   -­‐0.011	   0.000	   -­‐0.011	   	   	   	  
£-­‐value	  of	  EQ-­‐5D	  change:	   	   	   	   	   	   	  
	   £40,000	   -­‐420	   0	   -­‐420	   	   	   	  
	   £30,000	   -­‐310	   0	   -­‐310	   	   	   	  
	   £20,000	   -­‐210	   0	   -­‐210	   	   	   	  
	   £10,000	   -­‐100	   0	   -­‐100	   	   	   	  
Costs	   	   	   	   	   	   	  
Cost	  change	   800	   1920	   -­‐1120	   	   	   	  
Net	  benefit	   	   	   	   	   	   	  
NMB	  change:	   	   	   	   	   	   	  
	   £40,000	   -­‐1220	   -­‐1920	   700	   0.613	   -­‐1710	   3110	  
	   £30,000	   -­‐1110	   -­‐1920	   810	   0.536	   -­‐1450	   3060	  
	   £20,000	   -­‐1010	   -­‐1920	   910	   0.459	   -­‐1200	   3030	  
	   £10,000	   -­‐900	   -­‐1920	   1020	   0.386	   -­‐980	   3020	  
Significance	  levels:	  *	  p<0.10	  **	  p<0.05***	  p<	  0.001	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As	  outlined	  above,	  although	  we	  found	  that	  the	  people	  in	  the	  personal	  health	  budget	  sample	  group	  
did	  better	  than	  the	  people	  in	  the	  control	  group	  on	  average,	  this	  sample	  difference	  is	  only	  a	  noisy	  
indicator	  of	  its	  true	  value.32	  We	  therefore	  need	  to	  consider	  the	  statistical	  significance	  of	  the	  
difference-­‐in-­‐difference	  estimator	  of	  NMB.	  Two	  methods	  are	  available	  to	  determine	  statistical	  
significance:	  the	  conventional	  method	  is	  to	  assume	  that	  variation	  in	  results	  across	  all	  participants	  in	  
the	  study	  follows	  a	  normal	  distribution	  –	  the	  parametric	  approach;	  an	  alternative	  is	  to	  use	  a	  repeated	  
sampling	  method	  –	  the	  bootstrap	  approach	  –	  which	  does	  not	  make	  the	  same	  parametric	  
assumptions	  about	  the	  shape	  of	  the	  distribution	  in	  the	  sample.	  These	  two	  methods	  produce	  the	  
same	  results	  if	  the	  underlying	  distribution	  is	  normal.	  Using	  both	  methods	  helps	  us	  determine	  
whether	  our	  results	  are	  influenced	  by	  the	  testing	  assumptions.	  
Our	  aim	  is	  to	  assess	  cost-­‐effectiveness	  of	  personal	  health	  budgets	  compared	  to	  conventional	  service	  
arrangements.	  The	  sample	  mean	  values	  of	  the	  difference	  in	  net	  benefit	  outlined	  above	  and	  the	  
corresponding	  sample	  variance	  across	  participants	  in	  the	  study	  will	  reflect	  the	  true	  value	  but	  there	  is	  
always	  a	  small	  chance	  that	  this	  sample	  gives	  a	  false	  result.	  	  
For	  ASCOT-­‐measured	  benefits,	  we	  estimated	  that	  personal	  health	  budgets	  produced	  greater	  net	  
benefit	  than	  conventional	  services	  with	  between	  a	  0.198	  and	  0.057	  probability	  of	  this	  being	  a	  false	  
positive,	  depending	  on	  the	  threshold	  used	  –	  see	  Table	  6-­‐9.	  Taking	  the	  base	  £30,000	  threshold,	  we	  
found	  that	  the	  rejection	  probability	  (of	  personal	  health	  budgets	  being	  cost-­‐effective)	  was	  0.082.	  
Another	  way	  of	  expressing	  this	  result	  is	  to	  say	  that	  personal	  health	  budgets	  are	  cost-­‐effective	  with	  a	  
better	  than	  90%	  confidence	  level.	  
For	  EQ5D-­‐measured	  benefits,	  the	  effect	  sizes	  were	  much	  smaller	  on	  average	  than	  for	  ASCOT-­‐
measured	  benefits	  and	  therefore,	  accounting	  for	  statisical	  error,	  we	  could	  not	  reasonably	  reject	  the	  
possibility	  that	  personal	  health	  budgets	  are	  not	  cost-­‐effective	  when	  benefits	  are	  measured	  this	  way.	  	  
Figure	  6-­‐4	  presents	  the	  significance	  results	  from	  the	  tables	  in	  graphical	  form	  –	  as	  confidence	  intervals	  
around	  the	  point	  estimates.	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
32	  Even	  where	  it	  is	  an	  unbiased	  estimate	  of	  the	  true	  effect	  of	  using	  a	  personal	  health	  budget.	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  Figure	  6-­‐4.	  ASCOT	  and	  EQ-­‐5D	  NMB	  Diff-­‐in-­‐Diff,	  whole	  sample,	  point	  estimates	  	  
and	  confidence	  intervals	  
	  
The	  significance	  results	  in	  the	  tables	  and	  the	  above	  chart	  are	  the	  ‘parametric’	  versions.	  We	  also	  
computed	  bootstrap	  significance	  results.	  These	  results	  were	  derived	  by	  creating	  1000	  re-­‐samples	  
from	  the	  original	  sample	  for	  each	  of	  the	  five	  imputations	  of	  the	  imputed	  dataset.	  In	  each	  case,	  we	  
calculated	  cost-­‐change	  and	  outcome-­‐change	  difference,	  and	  also	  the	  difference	  in	  the	  NMB	  change.	  
Rubin’s	  rules	  were	  applied	  to	  adjust	  the	  estimated	  standard	  errors	  to	  allow	  for	  the	  imputed	  values	  in	  
the	  data.33	  Table	  6-­‐11	  reports	  the	  results.	  Overall,	  they	  are	  very	  similar	  to	  the	  parametric	  results	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
33	  Because	  imputed	  missing	  values	  are	  estimates	  subject	  to	  statistical	  error,	  this	  additional	  source	  of	  statistical	  noise	  needs	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about	  suggesting	  that	  the	  cost,	  outcome	  and	  NMB	  change	  variables	  are	  close	  to	  normally	  distributed.	  
NMB	  using	  ASCOT	  outcomes	  is	  significant	  at	  the	  10%	  level	  for	  the	  £30,000	  threshold.	  
Table	  6-­‐11.	  Statistical	  significance	  using	  bootstrap	  results,	  ASCOT	  and	  EQ-­‐5D,	  whole	  sample	  (£30,	  
000	  threshold)	  
	   	   Mean	  
effect	  
BS	  t	  stat	   Prob	   CI-­‐	   CI+	  
ASCOT	   NMB-­‐change	   2300	   1.867	   0.082*	   135	   4464	  
	   Outcome-­‐change	   0.039	   3.017	   0.007**	   0.017	   0.062	  
	   Cost-­‐change	   -­‐1125	   1.026	   0.319	   -­‐3033	   784	  
EQ-­‐5D	   NMB-­‐change	   807	   0.634	   0.537	   -­‐1449	   3064	  
	   Outcome-­‐change	   -­‐0.011	   0.775	   0.452	   -­‐0.035	   0.014	  
	   Cost-­‐change	   -­‐1125	   1.026	   0.319	   -­‐3033	   784	  
Significance	  levels:	  *	  p<0.10	  **	  p<0.05	  ***	  p<	  0.001	  	  
6.5.1 Scatter	  plots	  
The	  significance	  results	  can	  be	  seen	  in	  the	  following	  cost-­‐effectiveness	  scatter	  plots	  (Figure	  6-­‐5	  and	  
Figure	  6-­‐6).34	  In	  addition	  to	  the	  mean	  effect	  sizes	  and	  significance	  summary	  statistics	  outlined	  above,	  
these	  charts	  give	  a	  useful	  visual	  understanding	  of	  the	  strength	  of	  effect	  that	  was	  found.	  
The	  charts	  show	  each	  combination	  of	  outcome-­‐change	  and	  cost-­‐change	  from	  each	  bootstrap	  
replication	  over	  five	  imputations.	  The	  cost-­‐effectiveness	  charts	  are	  divided	  into	  four	  quadrants.	  
Quadrant	  A	  -­‐	  for	  outcome-­‐cost	  pairs	  where	  outcomes	  (change)	  are	  higher	  for	  personal	  health	  
budgets	  compared	  to	  control	  and	  cost	  (change)	  lower	  –	  it	  is	  the	  dominant	  quadrant.	  Quadrant	  D	  is	  
the	  dominated	  quadrant	  with	  estimates	  for	  which	  personal	  health	  budgets	  are	  both	  more	  costly	  and	  
produce	  less	  quality	  of	  life	  (QoL)	  outcome	  compared	  to	  the	  controls.	  
Quadrants	  B	  and	  C	  involve	  a	  relative	  improvement	  in	  outcomes	  or	  costs,	  but	  not	  both,	  so	  our	  NMB	  
sum	  has	  both	  a	  positive	  and	  negative	  component.	  In	  these	  two	  cases,	  we	  had	  to	  calculate	  the	  
difference	  in	  NMB-­‐change	  for	  each	  group.	  Plotted	  on	  the	  chart	  below	  are	  two	  rays	  passing	  through	  
the	  origin.	  These	  lines	  are	  drawn	  through	  all	  points	  where	  NMB	  difference	  is	  zero.	  To	  the	  left	  of	  the	  
ray,	  the	  difference	  in	  NMB	  (change)	  is	  positive	  –	  personal	  health	  budgets	  are	  cost-­‐effective.	  To	  the	  
right	  of	  the	  ray,	  the	  difference	  is	  negative	  –	  personal	  health	  budgets	  are	  not	  cost-­‐effective.	  The	  angle	  
of	  the	  ray	  depends	  on	  the	  cost-­‐effectiveness	  threshold	  assumed.	  The	  solid	  ray	  corresponds	  to	  the	  
£30,000	  threshold,	  whilst	  the	  dashed	  line	  is	  the	  £20,000	  threshold.	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
34	  These	  plots	  were	  manually	  adjusted	  for	  additional	  noise	  associated	  with	  imputed	  data	  using	  the	  between	  variation	  
standard	  errors	  calculated	  for	  the	  bootstrap	  estimation.	  They	  should	  be	  taken	  as	  approximations	  to	  illustrate	  the	  overall	  
difference-­‐in-­‐difference	  by	  outcome	  and	  cost.	  Not	  making	  this	  adjustment	  treats	  each	  data	  point	  as	  non-­‐stochastic	  i.e.	  an	  
actual	  observation	  which	  gives	  the	  impression	  of	  greater	  significance	  than	  the	  main	  results	  indicate.	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Figure	  6-­‐5	  is	  the	  cost-­‐effectiveness	  plot	  for	  the	  ASCOT	  outcome	  across	  the	  whole	  sample.	  The	  
majority	  of	  points	  are	  in	  the	  dominant	  quadrant	  A	  and	  the	  majority	  of	  the	  rest	  are	  also	  to	  the	  left	  of	  
the	  zero-­‐NMB	  line.	  Corresponding	  to	  the	  significance	  results	  above,	  we	  found	  that	  just	  under	  95%	  of	  
points	  were	  in	  the	  cost-­‐effective	  region	  for	  personal	  health	  budgets.	  From	  the	  in-­‐depth	  qualitative	  
interviews,	  it	  was	  clear	  that	  organisational	  representatives	  thought	  that	  personal	  health	  budgets	  
would	  have	  an	  impact	  on	  both	  costs	  and	  well-­‐being:	  
“One	  case	  where	  [participant]	  needed	  a	  communication	  device,	  the	  standard	  communication	  devices	  
provided	  by	  the	  NHS	  weighs	  about	  three	  kilos,	  very	  cumbersome,	  it's	  a	  bit	  like	  an	  old	  fashioned	  
typewriter.	  She's	  lying	  in	  bed,	  she	  wouldn't	  be	  able	  to	  actually	  use	  this	  thing	  'cause	  she	  couldn't	  hold	  
it,	  but	  they	  also	  cost	  between	  five	  and	  seven	  thousand	  a	  time.	  We	  bought	  an	  iPad	  for	  £355,	  with	  that	  
she	  can	  actually	  hold	  it,	  type	  on	  it	  as	  a	  keyboard,	  which	  is	  great	  for	  her	  communication,	  she	  can	  also	  
use	  a	  voice	  synthesiser	  so	  she	  can	  verbalise	  but	  she	  can	  also,	  as	  a	  side	  effect,	  contact	  her	  peers	  via	  
social	  network	  sites	  and	  help	  combat	  that	  feeling	  of	  being	  socially	  isolated”	  (Project	  Lead).	  
Figure	  6-­‐5.	  Cost-­‐effectiveness	  plot	  –	  ASCOT	  outcome,	  whole	  sample	  
	   	  
Regarding	  the	  EQ-­‐5D	  plot	  (Figure	  6-­‐6),	  although	  the	  majority	  of	  points	  are	  in	  the	  cost-­‐effective	  
region,	  a	  significant	  number	  of	  points	  are	  in	  the	  non-­‐cost-­‐effective	  region	  (to	  the	  right	  of	  the	  zero-­‐
NMB	  line).	  Moreover,	  where	  points	  are	  in	  the	  cost-­‐effective	  region	  this	  is	  due	  to	  personal	  health	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Figure	  6-­‐6.	  Cost-­‐effectiveness	  plot	  –	  EQ-­‐5D	  outcome,	  whole	  sample	  
	  
6.5.2 Sub-­‐groups	  
Cost-­‐effectiveness	  can	  be	  assessed	  for	  particular	  sub-­‐groups	  within	  the	  sample	  to	  give	  us	  insight	  into	  
which	  groups	  of	  participants	  did	  well,	  or	  not	  so	  well,	  with	  personal	  health	  budgets.	  We	  assessed	  the	  
differential	  impact	  of	  personal	  health	  budgets	  by:	  participants’	  health	  condition;	  age	  group	  (e.g.	  
people	  aged	  over	  75);	  and	  the	  characteristics	  of	  the	  personal	  health	  budget	  model	  used	  in	  each	  case.	  
In	  addition,	  we	  assessed	  the	  relative	  impact	  of	  personal	  health	  budgets	  by	  other	  socio-­‐economic	  
conditions,	  namely	  sex	  and	  income.	  We	  were	  unable	  to	  robustly	  investigate	  whether	  people	  from	  
different	  ethnic	  groups	  have	  a	  different	  experience	  with	  personal	  health	  budgets	  because	  only	  7.2%	  
of	  the	  active	  sample	  where	  non-­‐white.35	  	  
We	  also	  explored	  whether	  there	  were	  any	  differences	  between	  participants	  in	  the	  randomised	  sub-­‐
sample	  compared	  to	  the	  non-­‐randomised	  sample	  in	  terms	  of	  the	  cost-­‐effectiveness	  of	  personal	  
health	  budgets.	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
35	  Bearing	  in	  mind	  the	  sample	  size	  issue,	  the	  analysis	  did	  not	  show	  a	  significant	  difference	  of	  effect	  by	  ethnic	  group	  (white	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Sub-­‐group	  effects	  were	  estimated	  using	  the	  difference	  between	  NMB-­‐change	  for	  the	  people	  with	  
personal	  health	  budgets	  in	  the	  sub-­‐group	  and	  the	  people	  acting	  as	  controls	  in	  the	  same	  sub-­‐group.	  
This	  approach	  ensured	  that	  like-­‐with-­‐like	  comparisons	  of	  experience	  of	  personal	  health	  budgets	  or	  
the	  usual	  care	  process	  were	  made	  given	  that	  there	  were	  differences	  between	  the	  sub-­‐groups	  at	  
baseline	  which	  needed	  to	  be	  removed.	  For	  example,	  people	  in	  the	  NHS	  Continuing	  Healthcare	  cohort	  
were	  more	  intensive	  service	  users	  at	  baseline	  than	  the	  other	  cohorts.	  We	  therefore	  compared	  
personal	  health	  budget	  holders	  in	  the	  NHS	  Continuing	  Healthcare	  cohort	  with	  controls	  in	  the	  NHS	  
Continuing	  Healthcare	  cohort	  to	  assess	  cost-­‐effectiveness	  for	  this	  sub-­‐sample.	  When	  assessing	  the	  
implications	  of	  particular	  implementation	  models	  for	  personal	  health	  budgets,	  we	  used	  the	  whole	  
control	  group	  sample	  as	  the	  comparator	  because,	  by	  definition,	  they	  could	  not	  be	  differentiated	  by	  
type	  of	  personal	  health	  budget	  (i.e.	  they	  had	  no	  personal	  health	  budget).	  
All	  of	  the	  sub-­‐group	  analyses	  were	  for	  the	  £30,000	  willingness-­‐to-­‐pay	  threshold.	  As	  indicated	  by	  
Figure	  6-­‐4,	  these	  results	  would	  have	  to	  be	  adjusted	  up	  or	  down	  for	  difference	  thresholds.	  
6.5.2.1 Health	  conditions	  
Table	  6-­‐12	  reports	  the	  sample	  mean	  difference	  between	  the	  personal	  health	  budget	  and	  control	  
groups	  in	  changes	  in	  NMB	  for	  the	  six	  health	  conditions	  in	  the	  study.	  The	  analysis	  in	  the	  table	  takes	  
the	  sub-­‐sample	  of	  people	  in	  the	  study	  with	  the	  listed	  health	  condition	  and	  compares	  the	  change	  in	  
NMB	  for	  that	  sub-­‐sample	  with	  a	  personal	  health	  budget	  against	  people	  in	  the	  sub-­‐sample	  with	  
conventional	  service	  delivery.	  Because	  sample	  sizes	  in	  the	  health	  condition	  sub-­‐groups	  are	  much	  
smaller	  than	  for	  the	  whole	  sample,	  confidence	  intervals	  will	  be	  wider	  (or	  significance	  probabilities	  
lower),	  other	  things	  equal.	  Finding	  a	  significant	  result	  in	  a	  given	  health	  condition	  sub-­‐group	  means	  
that	  the	  personal	  health	  budget	  effect	  size	  will	  have	  had	  to	  have	  been	  greater	  in	  that	  case	  than	  the	  
personal	  health	  budget	  effect	  size	  for	  the	  whole	  sample	  at	  the	  same	  significance	  level.	  An	  alternative	  
way	  of	  assessing	  whether	  there	  was	  any	  difference	  in	  the	  personal	  health	  budget	  effect	  size	  by	  sub-­‐
group	  was	  to	  test	  whether	  the	  PHB	  effect	  size	  for	  the	  sub-­‐group	  was	  significantly	  different	  from	  the	  
whole-­‐sample	  PHB	  effect	  size.	  We	  did	  not	  find	  any	  significant	  differences	  from	  this	  latter	  analysis.	  
Table	  6-­‐12	  reports	  the	  corresponding	  probabilities	  that	  this	  difference	  was	  significantly	  different	  
from	  zero.	  For	  example,	  for	  the	  mental	  health	  cohort	  in	  the	  sample,	  average	  net	  benefit	  was	  £4880	  
greater	  for	  people	  in	  the	  personal	  health	  budget	  group	  compared	  to	  people	  in	  the	  control	  group	  
(accounting	  for	  baseline	  differences).	  Figure	  6-­‐7	  shows	  the	  confidence	  intervals	  for	  these	  estimates	  
at	  both	  the	  90%	  and	  95%	  confidence	  levels.	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Table	  6-­‐12.	  NMB	  Diff-­‐in-­‐Diff,	  by	  health	  condition,	  point	  estimate	  and	  significance	  probability	  
	   ASCOT	   	   EQ-­‐5D	   	  
	   Coeff	   prob	   Coeff	   prob	  
CHC	  	   9840	   0.096*	   6550	   0.301	  
Stroke	  	   3160	   0.254	   3320	   0.227	  
Diabetes	  	   510	   0.768	   -­‐670	   0.708	  
Mental	  health	  	   4880	   0.096*	   1810	   0.489	  
COPD	  	   1410	   0.456	   370	   0.847	  
Neurological	  	   -­‐150	   0.931	   -­‐720	   0.696	  
Significance	  levels:	  *	  p<0.10	  **	  p<0.05***	  p<	  0.001	  	  
Using	  the	  ASCOT	  scale,	  the	  results	  indicated	  that	  personal	  health	  budgets	  were	  cost-­‐effective	  for	  
both	  NHS	  Continuing	  Healthcare	  and	  mental	  health	  cohorts	  at	  the	  10%	  significance	  level	  (or	  90%	  
confidence	  level).	  Otherwise	  we	  did	  not	  find	  significant	  differences	  between	  the	  groups.	  The	  final	  
sample	  size	  for	  the	  NHS	  Continuing	  Healthcare	  sub-­‐group	  was	  relatively	  small.36	  Death	  rates	  in	  the	  
NHS	  Continuing	  Healthcare	  cohort	  were	  also	  substantially	  higher	  than	  those	  for	  other	  groups.	  This	  
meant	  that	  the	  NHS	  Continuing	  Healthcare	  results	  were	  subject	  to	  a	  high	  degree	  of	  noise	  which	  
makes	  for	  wide	  confidence	  intervals.	  We	  also	  calculated	  bootstrap	  significance	  levels	  for	  this	  group	  
which,	  given	  the	  small	  sample	  sizes,	  is	  especially	  important.	  The	  results,	  however,	  were	  essentially	  
unchanged:	  bootstrap	  significance	  for	  NHS	  Continuing	  Healthcare	  was	  0.097	  for	  ASCOT	  and	  0.302	  for	  
EQ-­‐5D.	  Figure	  6-­‐8	  and	  Figure	  6-­‐9	  present	  indicative	  cost-­‐effectiveness	  plots	  for	  the	  NHS	  Continuing	  
Healthcare	  cohort.	  
The	  sample	  mean	  NMB	  difference-­‐in-­‐differences	  was	  high	  for	  the	  NHS	  Continuing	  Healthcare	  cohort.	  
Where	  this	  is	  representative	  of	  the	  population	  of	  patients	  receiving	  NHS	  Continuing	  Healthcare,	  we	  
would	  expect	  this	  result	  to	  be	  significant	  at	  higher	  levels	  with	  a	  larger	  sample	  size.	  
The	  mental	  health	  result	  is	  in	  keeping	  with	  the	  findings	  of	  the	  national	  evaluation	  of	  personal	  
budgets	  in	  social	  care.	  This	  group	  appears	  to	  respond	  particularly	  well	  to	  personal	  health	  budgets.	  	  
	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
36	  A	  number	  of	  participants	  within	  the	  NHS	  Continuing	  Healthcare	  cohort	  had	  moved	  into	  residential	  care	  by	  follow-­‐up	  and,	  

























Figure	  6-­‐7.	  NMB	  Diff-­‐in-­‐Diff,	  by	  health	  condition,	  point	  estimates	  and	  confidence	  intervals	  
	   	   	   ASCOT	  	   	   	   	   	   EQ-­‐5D	  
	  
The	  bootstrap	  plots	  below	  show	  the	  different	  impacts	  of	  personal	  health	  budgets	  on	  ASCOT	  and	  EQ-­‐
5D	  outcomes.	  The	  personal	  health	  budget	  group	  in	  the	  sample	  reported	  better	  outcomes	  than	  the	  
control	  group	  (from	  baseline)	  on	  ASCOT,	  but	  there	  was	  no	  significant	  difference	  on	  EQ-­‐5D.	  By	  chance	  
we	  might	  have	  a	  sub-­‐sample	  of	  patients	  receiving	  NHS	  Continuing	  Healthcare	  in	  the	  personal	  health	  
budget	  that	  were	  going	  to	  have	  poor	  EQ-­‐5D	  outcomes	  anyway,	  regardless	  of	  their	  use	  of	  personal	  
health	  budgets.	  We	  cannot	  reject	  this	  possibility	  at	  usual	  confidence	  levels	  for	  the	  EQ-­‐5D	  indicator.	  
EQ-­‐5D	  measures	  personal	  functioning	  and	  impairment	  in	  achieving	  good	  quality	  of	  life	  experiences	  
whereas	  ASCOT	  measures	  achieved	  quality	  of	  life	  experiences,	  regardless	  of	  whether	  this	  
achievement	  was	  via	  personal	  functioning	  or	  the	  support	  of	  services	  or	  others.	  This	  distinction	  is	  
particularly	  sharp	  for	  the	  NHS	  Continuing	  Healthcare	  cohort	  where	  many	  people	  have	  high	  levels	  of	  
personal	  impairment	  and	  accessed	  the	  services	  and	  support	  aimed	  at	  helping	  them	  to	  manage	  the	  
consequences.	  In	  this	  regard	  we	  might	  infer	  that	  personal	  health	  budgets	  help	  people	  manage	  the	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Figure	  6-­‐8.	  Cost-­‐effectiveness	  plot	  –	  ASCOT	  outcome,	  NHS	  Continuing	  Healthcare	  sub-­‐sample	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6.5.2.2 Age	  group	  
Regarding	  people	  aged	  over	  75,	  those	  in	  the	  personal	  health	  budget	  group	  showed	  higher	  ASCOT-­‐
measured	  net	  benefit	  than	  those	  in	  the	  control	  group	  (after	  subtracting	  for	  baseline	  differences).	  This	  
effect	  was	  significant	  at	  the	  90%	  confidence	  level	  (p	  =	  0.055).	  The	  mean	  effect	  size	  was	  £4610	  in	  the	  
sample,	  with	  much	  of	  the	  additional	  net	  benefit	  coming	  from	  the	  cost	  savings	  (which	  were	  £4300	  less	  
for	  the	  personal	  health	  budget	  group	  compared	  to	  the	  controls,	  after	  baseline,	  see	  Table	  6-­‐7)	  rather	  
than	  improved	  quality	  of	  life	  benefits	  relative	  to	  the	  control	  group.	  This	  result	  does	  not	  necessarily	  
mean	  that	  people	  over	  75	  gained	  no	  quality	  of	  life	  benefits	  from	  personal	  health	  budgets.	  Indeed,	  in	  
that	  these	  personal	  health	  budget-­‐holders	  were	  getting	  some	  £4300	  less	  support	  than	  their	  
counterparts	  in	  the	  control	  group,	  which	  on	  its	  own	  could	  produce	  worst	  outcomes,	  we	  could	  argue	  
that	  the	  direct	  benefits	  from	  personal	  health	  budgets	  offset	  these	  resource	  deficits	  –	  see	  Figure	  6-­‐1.	  
We	  are	  able	  to	  explore	  this	  result	  using	  structural	  modelling	  –	  see	  section	  6.6	  below.	  
For	  people	  aged	  under	  50	  there	  was	  no	  significant	  difference	  between	  change	  in	  net	  benefit	  between	  
the	  personal	  health	  budget	  and	  control	  groups	  (on	  the	  ASCOT	  scale).	  There	  were	  no	  significant	  
differences	  between	  the	  groups	  on	  the	  EQ-­‐5D	  scale	  for	  any	  age	  group	  –	  see	  Figure	  6-­‐10	  and	  Table	  
6-­‐13.	  
Table	  6-­‐13.	  NMB	  Diff-­‐in-­‐Diff,	  by	  age	  group,	  point	  estimate	  and	  significance	  probability	  
	   	   Coeff	   Prob	  
ASCOT	   Over	  75	   4610	   0.055*	  
	   Under	  50	   2850	   0.205	  
EQ-­‐5D	   Over	  75	   3870	   0.128	  
	   Under	  50	   980	   0.606	  




Figure	  6-­‐10.	  NMB	  Diff-­‐in-­‐Diff,	  by	  age	  group,	  point	  estimates	  and	  confidence	  intervals	  
	  
These	  results	  suggest	  that	  people	  aged	  over	  75	  have	  a	  greater	  capacity	  to	  benefit	  from	  personal	  
health	  budgets	  than	  other	  age	  groups.	  Part	  of	  the	  reason	  for	  this	  result	  is	  that	  over	  75s	  have	  a	  
greater	  use	  of	  services	  and	  so	  more	  opportunity	  to	  make	  savings	  with	  personal	  health	  budgets.	  
6.5.2.3 Personal	  health	  budget	  process	  
As	  outlined	  in	  Chapters	  4	  and	  5,	  a	  range	  of	  implementation	  methods	  were	  used	  for	  personal	  health	  
budgets,	  varying	  according	  to:	  the	  processes	  for	  determining	  the	  size	  of	  budgets;	  whether	  the	  budget	  
is	  known	  before	  support	  planning;	  what	  flexibility	  there	  is	  in	  terms	  of	  what	  help	  can	  be	  purchased;	  
the	  choice	  of	  deployment	  (including	  DPs);	  and	  so	  on.	  The	  range	  of	  specification	  options	  were	  reduced	  
into	  five	  models	  for	  personal	  health	  budget	  implementation	  –	  see	  Table	  1-­‐3.	  
In	  Chapter	  5	  on	  outcomes	  we	  found	  models	  1,	  4	  and	  5	  to	  have	  significant	  positive	  impacts	  on	  ASCOT	  
for	  personal	  health	  budgets	  compared	  to	  controls.	  As	  to	  EQ-­‐5D,	  only	  model	  3	  showed	  significant	  
results	  and	  these	  suggested	  that	  the	  personal	  health	  budget	  group	  had	  worsened	  with	  respect	  to	  the	  
control	  group	  by	  follow-­‐up.	  In	  this	  chapter	  we	  will	  focus	  on	  model	  1	  which	  can	  be	  regarded	  as	  the	  
most	  ambitious	  form	  of	  personal	  health	  budget	  implementation,	  and	  model	  3	  which	  is	  perhaps	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section.37	  We	  also	  looked	  at	  the	  implications	  of	  the	  size	  of	  budget	  and	  whether	  the	  budget	  is	  a	  direct	  
payment	  for	  cost-­‐effectiveness.	  
Table	  6-­‐14	  shows	  the	  results.	  We	  found	  that	  people	  with	  high-­‐amount	  personal	  health	  budgets	  
(more	  than	  £1000	  per	  year)	  were	  cost-­‐effective	  compared	  to	  controls:	  on	  the	  ASCOT	  scale,	  high-­‐
amount	  budgets	  were	  cost-­‐effective	  at	  the	  95%	  confidence	  level	  and	  on	  the	  EQ-­‐5D	  scale,	  these	  
personal	  health	  budgets	  were	  cost-­‐effective	  at	  the	  90%	  confidence	  level.	  In	  other	  words,	  whereas	  
personal	  health	  budgets	  of	  all	  types	  were	  cost-­‐effective	  with	  90%	  confidence	  levels	  using	  ASCOT,	  
high-­‐amount	  budgets	  were	  cost-­‐effective	  at	  the	  higher	  95%	  confidence	  level.	  This	  result	  is	  
particularly	  apparent	  when	  looking	  at	  the	  cost-­‐effectiveness	  plots	  for	  high-­‐amount	  personal	  health	  
budgets	  –	  see	  Figure	  6-­‐12	  and	  Figure	  6-­‐13	  below.	  
The	  results	  also	  indicated	  that	  personal	  health	  budgets	  were	  cost-­‐effective	  at	  the	  95%	  level	  for	  the	  
ASCOT	  scale	  when	  implemented	  in	  Model	  1	  form.	  By	  contrast,	  personal	  health	  budgets	  in	  Model	  3	  
form	  were	  not	  cost-­‐effective	  compared	  to	  conventional	  practice	  in	  the	  control	  group.	  
Finally,	  personal	  health	  budgets	  were	  cost-­‐effective	  (on	  the	  ASCOT	  scale)	  when	  deployed	  as	  direct	  
payments	  as	  compared	  to	  the	  control	  group	  (at	  the	  90%	  confidence	  level).	  For	  other	  deployments,	  
effect	  sizes	  fell	  short	  of	  significant	  levels.	  	  
Table	  6-­‐14.	  NMB	  Diff-­‐in-­‐Diff,	  by	  personal	  health	  budget	  process,	  point	  estimate	  and	  significance	  
probability	  
	   	   Coeff	   prob	  
ASCOT	   Hi	  Budget	   4340	   0.025**	  
	   PHB	  model	  1	   4830	   0.041**	  
	   PHB	  model	  3	   190	   0.932	  
	   Direct	  payment	   3030	   0.074*	  
EQ5D	   Hi	  Budget	   2850	   0.099*	  
	   PHB	  model	  1	   2580	   0.267	  
	   PHB	  model	  3	   -­‐1570	   0.447	  
	   Direct	  payment	   1520	   0.335	  
Significance	  levels:	  *	  p<0.10	  **	  p<0.05	  ***	  p<	  0.001	  	  
Confidence	  intervals	  for	  these	  three	  comparisons	  can	  be	  seen	  in	  Figure	  6-­‐11.	  As	  before	  the	  
bootstrap,	  significance	  probabilities	  were	  very	  similar	  to	  the	  parametric	  versions.	  For	  high-­‐value	  
personal	  health	  budgets	  compared	  to	  controls,	  significance	  probabilities	  were	  0.024	  for	  ASCOT	  and	  
0.098	  for	  EQ-­‐5D.	  Regarding	  personal	  health	  budget	  model	  1,	  the	  respective	  bootstrap	  significance	  
probabilities	  were	  0.041	  for	  ASCOT	  and	  0.266	  for	  EQ-­‐5D.	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
37	  We	  did	  test	  models	  4	  and	  5	  but	  these	  did	  not	  show	  significantly	  different	  results.	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Figure	  6-­‐12.	  Cost-­‐effectiveness	  plot	  –	  ASCOT	  outcome,	  personal	  health	  budget	  model	  1	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6.5.2.4 Other	  socio-­‐economic	  characteristics	  
Further	  sub-­‐group	  analyses	  were	  conducted	  by:	  gender	  (male);	  whether	  the	  participant	  reported	  
claiming	  income	  benefits;	  and	  by	  reported	  university	  or	  college	  education.	  In	  none	  of	  these	  cases	  did	  
we	  find	  a	  statistically	  significant	  differential	  effect	  of	  personal	  health	  budgets	  on	  net	  benefit.	  We	  
surmise	  that	  the	  cost-­‐effectiveness	  of	  personal	  health	  budgets	  was	  not	  affected	  by	  their	  sex,	  income	  
status	  or	  education	  level.38	  
6.5.3 Controlling	  for	  baseline	  characteristics	  on	  trend	  
The	  difference-­‐in-­‐difference	  design	  of	  the	  study	  accounts	  for	  any	  differences	  between	  the	  personal	  
health	  budget	  and	  control	  groups	  at	  baseline.	  It	  is	  possible,	  nonetheless,	  that	  differences	  between	  
the	  groups	  at	  baseline	  affect	  how	  costs,	  outcomes	  and	  other	  variables	  change	  after	  baseline.	  If	  this	  
pattern	  was	  characteristic	  of	  the	  data,	  we	  would	  expect	  differences	  between	  the	  groups	  at	  follow-­‐up,	  
after	  subtracting	  baseline	  values,	  even	  if	  personal	  health	  budgets	  had	  not	  been	  implemented	  and	  the	  
‘personal	  health	  budget’	  group	  had	  continued	  with	  conventional	  support.	  As	  outlined	  in	  Appendix	  C,	  
we	  can	  limit	  this	  potential	  problem	  by	  explicitly	  accounting	  for	  baseline	  characteristics	  that	  might	  
cause	  differences	  in	  the	  rate	  of	  change	  of	  the	  variables	  of	  interest	  (i.e.	  cost	  and	  outcomes).	  For	  
example,	  differences	  in	  age	  or	  baseline	  activities	  of	  daily	  living	  (ADL)	  disability	  might	  be	  relevant	  
factors.	  
To	  this	  end,	  we	  gauged	  the	  impact	  of	  personal	  health	  budgets	  by	  estimating	  the	  NMB	  difference	  in	  
difference	  between	  the	  personal	  health	  budget	  and	  control	  group	  after	  accounting	  for	  the	  variation	  
in	  the	  change	  of	  NMB	  that	  was	  associated	  with	  a	  range	  of	  baseline	  factors	  (see	  equation	  C-­‐9	  in	  
Appendix	  C).	  The	  factors	  are	  listed	  in	  Table	  6-­‐15	  and	  include	  personal	  characteristics	  (e.g.	  age	  and	  
sex),	  health	  conditions,	  characteristics	  of	  the	  areas	  in	  which	  the	  study	  participant	  lived,	  and	  some	  
factors	  accounting	  for	  timings	  in	  the	  study.	  We	  estimated	  this	  difference-­‐in-­‐difference	  model	  for	  the	  
whole	  sample	  and	  also	  for	  the	  sub-­‐groups	  which	  showed	  significant	  cost-­‐effectiveness	  above.	  
There	  is	  a	  risk	  in	  attempting	  to	  control	  for	  rate-­‐of-­‐change	  variation	  as	  we	  might	  inadvertently	  affect	  
the	  impact	  of	  personal	  health	  budgets	  on	  cost-­‐effectiveness.	  In	  particular,	  the	  control	  factors	  we	  
used	  were	  significantly	  correlated	  with	  baseline	  service	  and	  support	  costs	  (e.g.	  someone	  with	  high	  
ADL	  disability	  is	  more	  likely	  to	  have	  had	  higher	  service	  expenditure	  at	  baseline	  than	  someone	  with	  
low	  need).	  We	  also	  know	  that	  the	  size	  of	  a	  person’s	  personal	  health	  budget	  will	  be	  correlated	  with	  
their	  baseline	  care	  needs	  (i.e.	  people	  with	  high	  service	  expenditure	  at	  baseline	  will	  have	  higher-­‐value	  
budgets,	  other	  things	  equal,	  than	  people	  with	  low	  baseline	  expenditure).	  As	  the	  above	  results	  
suggest	  that	  the	  size	  of	  budget	  matters,	  we	  potentially	  introduce	  this	  bias	  when	  trying	  to	  control	  for	  
extraneous	  change-­‐of-­‐change	  variation.	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
38	  Also,	  with	  the	  caution	  about	  small	  sub-­‐sample	  sizes,	  no	  difference	  of	  effect	  was	  found	  by	  ethnic	  group.	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These	  deliberations	  suggest	  that	  using	  control	  factors	  might	  give	  further	  insight	  but	  that	  some	  
caution	  is	  required	  in	  interpreting	  the	  results.39	  Table	  6-­‐15	  and	  Table	  6-­‐16	  report	  our	  findings	  for	  the	  
ASCOT	  NMB	  change.	  As	  regards	  to	  the	  base	  model	  (whole	  sample),	  the	  estimated	  mean	  increase	  in	  
NMB	  change	  of	  the	  personal	  health	  budget	  group	  compared	  to	  the	  control	  group	  was	  £1878	  rather	  
than	  a	  mean	  difference	  of	  £2300	  without	  additional	  control	  factors	  (see	  results	  in	  Table	  6-­‐9).	  The	  
difference	  in	  these	  two	  results	  is	  well	  within	  the	  confidence	  intervals	  of	  the	  estimates	  and	  the	  
(controlled)	  result	  remained	  significant	  at	  the	  10%	  level.	  	  
We	  also	  tested	  the	  joint	  significance	  of	  the	  additional	  control	  factors	  together	  and	  found	  they	  were	  
not	  significantly	  different	  from	  zero	  (p	  =	  0.298).	  The	  same	  pattern	  of	  results	  occurred	  for	  the	  sub-­‐
group	  models.	  On	  the	  basis	  of	  these	  control	  factors,	  we	  can	  infer	  that	  there	  were	  not	  any	  significant	  
differences	  in	  rate-­‐of-­‐change	  of	  NMB	  over	  and	  above	  the	  effect	  of	  personal	  health	  budgets.	  
We	  estimated	  similar	  models	  for	  EQ-­‐5D.	  In	  all	  cases	  the	  additional	  control	  factors	  were	  (jointly)	  
insignificant	  except	  for	  the	  NHS	  Continuing	  Healthcare	  sub-­‐group,	  which	  was	  significant	  at	  the	  10%	  
level.	  The	  overall	  result	  of	  no	  cost-­‐effective	  improvement	  from	  personal	  health	  budgets	  on	  EQ-­‐5D	  
outcomes	  was	  unaffected.	  
We	  tested	  the	  main	  sub-­‐group	  results	  to	  see	  whether	  control	  factors	  made	  a	  difference.	  In	  all	  cases	  
the	  control	  factors	  were	  jointly	  insignificant	  and	  had	  very	  small	  changes	  to	  the	  average	  effect	  sizes.	  
This	  included	  sub-­‐group	  analyses	  for	  personal	  health	  budget	  process,	  age	  and	  health	  condition.	  The	  
only	  exceptions	  were	  for	  NHS	  Continuing	  Healthcare	  and	  diabetes	  using	  EQ-­‐5D,	  where	  control	  factors	  
were	  jointly	  significant,	  but	  where	  the	  difference	  in	  NMB	  change	  remained	  insignificant	  –	  see	  Table	  
6-­‐12.	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
39	  These	  cautions	  would	  be	  especially	  relevant	  if	  we	  were	  to	  include	  baseline	  expenditure	  in	  the	  model	  as	  a	  control	  factor.	  
We	  did	  try	  these	  estimations:	  baseline	  expenditure	  was	  highly	  significant	  with	  a	  co-­‐efficient	  of	  near	  to	  one	  (as	  expected	  
because	  baseline	  expenditure	  directly	  enters	  the	  difference-­‐in-­‐difference	  dependent	  variable	  on	  the	  left-­‐hand	  side	  of	  the	  
model).	  In	  the	  main	  this	  did	  not	  qualitatively	  affect	  the	  above	  results,	  with	  one	  exception.	  The	  interaction	  model	  with	  high-­‐	  
and	  low-­‐	  budget	  showed	  substantially	  changed	  coefficients.	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Table	  6-­‐15.	  ASCOT	  NMB	  Diff-­‐in-­‐Diff	  models	  with	  control	  factors	  -­‐	  base,	  personal	  health	  budget	  size	  
&	  PHB	  model	  versions	  
	   Base	   PHB	  size	   PHB	  model	  1	  
	   Coeff	   Prob	   Coeff	   Prob	   Coeff	   Prob	  
PHB	  Group	   1877.75	   0.089*	   	   	   	   	  
High-­‐budget	  PHB	   	   	   3665.62	   0.028**	   	   	  
Low-­‐budget	  PHB	   	   	   884.47	   0.482	   	   	  
PHB,	  Model	  1	   	   	   	   	   4184.06	   0.032**	  
PHB,	  other	  model	   	   	   	   	   871.40	   0.428	  
Person	  characteristics	   	   	   	   	   	   	  
Age	   -­‐242.05	   0.306	   -­‐217.33	   0.347	   -­‐237.98	   0.316	  
Age	  (sqrd)	   1.76	   0.411	   1.54	   0.462	   1.75	   0.417	  
Male	   -­‐106.30	   0.927	   -­‐90.61	   0.938	   -­‐27.31	   0.981	  
ADL	  score	   -­‐297.89	   0.372	   -­‐258.56	   0.439	   -­‐306.32	   0.360	  
ADL	  score	  (sqrd)	   5.65	   0.548	   5.52	   0.559	   6.12	   0.515	  
Receives	  benefits	   -­‐2412.06	   0.047**	   -­‐2446.35	   0.042**	   -­‐2305.06	   0.053*	  
Health	  condition	  cohort	   	   	   	   	   	   	  
CHC	   1019.17	   0.716	   638.52	   0.823	   163.71	   0.951	  
Stroke	   2487.71	   0.342	   2793.68	   0.287	   3058.04	   0.262	  
Diabetes	   1921.97	   0.528	   2102.49	   0.498	   2411.94	   0.432	  
Mental	  health	   4560.93	   0.068*	   4676.93	   0.062*	   4497.07	   0.073*	  
COPD	   47.87	   0.987	   267.78	   0.928	   239.02	   0.936	  
Neurological	   -­‐204.67	   0.941	   -­‐87.99	   0.975	   15.26	   0.996	  
Study	  timing	   	   	   	   	   	   	  
Follow-­‐up	  period	   -­‐105.62	   0.322	   -­‐99.65	   0.361	   -­‐95.73	   0.371	  
Follow-­‐up	  period	  (sqrd)	   0.13	   0.318	   0.12	   0.352	   0.11	   0.367	  
Consent	  date	   -­‐0.49	   0.958	   -­‐0.42	   0.964	   -­‐0.58	   0.950	  
Area	  classification	   	   	   	   	   	   	  
ACA	   3721.43	   0.697	   3559.41	   0.708	   5070.13	   0.600	  
Town	  &	  Fringe	  location	   1895.77	   0.385	   1816.24	   0.408	   1542.58	   0.484	  
Rural	  location	  	   -­‐247.20	   0.919	   -­‐166.24	   0.946	   -­‐713.62	   0.775	  
Constant	   	   	   	   	   	   	  
Constant	   35677.58	   0.839	   31618.81	   0.855	   33502.60	   0.847	  
	   	   	   	   	   	   	  
Joint	  sig	  control	  factors	   1.17	   0.289	   1.08	   0.367	   1.08	   0.367	  
RESET	   0.57	   0.572	   0.61	   0.553	   -­‐0.12	   0.905	  




Table	  6-­‐16.	  ASCOT	  NMB	  Diff-­‐in-­‐Diff	  models	  with	  control	  factors	  -­‐	  base,	  personal	  health	  budget	  size	  
&	  PHB	  model	  versions	  
	   Over	  75	   CHC	   Mental	  Health	  
	   Coeff	   Prob	   Coeff	   Prob	   Coeff	   Prob	  
PHB	  Group,	  Over	  75	   4225.20	   0.067*	   	   	   	   	  
PHB	  Group,	  Under	  75	   1360.81	   0.243	   	   	   	   	  
PHB	  Group,	  CHC	   	   	   8958.35	   0.10	   	   	  
PHB	  Group,	  Other	  health	  cohort	   	   	   1107.51	   0.28	   	   	  
PHB	  Group,	  Mental	  health	   	   	   	   	   4152.71	   0.120	  
PHB	  Group,	  Other	  health	  cohort	   	   	   	   	   1352.67	   0.259	  
Person	  characteristics	   	   	   	   	   	   	  
Over	  75	   -­‐1370.57	   0.623	   	   	   	   	  
Age	   -­‐252.61	   0.438	   -­‐224.15	   0.347	   -­‐221.54	   0.339	  
Age	  (sqrd)	   1.84	   0.570	   1.65	   0.444	   1.59	   0.450	  
Male	   -­‐84.60	   0.941	   -­‐81.30	   0.944	   -­‐110.92	   0.923	  
ADL	  score	   -­‐294.93	   0.377	   -­‐312.12	   0.350	   -­‐306.32	   0.358	  
ADL	  score	  (sqrd)	   5.58	   0.553	   6.29	   0.502	   5.77	   0.540	  
Receives	  benefits	   -­‐2376.40	   0.056*	   -­‐2306.64	   0.052*	   -­‐2384.21	   0.051**	  
Health	  condition	  cohort	   	   	   	   	   	   	  
CHC	   1005.84	   0.718	   -­‐3774.48	   0.231	   1016.68	   0.716	  
Stroke	   2480.21	   0.341	   2373.33	   0.361	   2371.10	   0.368	  
Diabetes	   1907.60	   0.529	   1786.54	   0.555	   1772.79	   0.568	  
Mental	  health	   4495.55	   0.070*	   4481.48	   0.071*	   2999.52	   0.348	  
COPD	   104.98	   0.972	   -­‐47.57	   0.987	   -­‐23.31	   0.994	  
Neurological	   -­‐208.29	   0.940	   -­‐322.17	   0.907	   -­‐297.18	   0.915	  
Study	  timing	   	   	   	   	   	   	  
Follow-­‐up	  period	   -­‐106.10	   0.320	   -­‐95.88	   0.379	   -­‐102.37	   0.329	  
Follow-­‐up	  period	  (sqrd)	   0.13	   0.316	   0.11	   0.378	   0.12	   0.325	  
Consent	  date	   -­‐0.75	   0.937	   -­‐0.29	   0.975	   0.35	   0.969	  
Area	  classification	   	   	   	   	   	   	  
ACA	   3960.895	   0.680	   3837.75	   0.688	   3697.75	   0.699	  
Town	  &	  Fringe	  location	   1982.995	   0.366	   1926.29	   0.377	   1846.70	   0.396	  
Rural	  location	  	   -­‐192.693	   0.937	   70.85	   0.976	   -­‐405.20	   0.867	  
Constant	   	   	   	   	   	   	  
Constant	   40841.43	   0.818	   29714.5	   0.863	   19124.79	   0.911	  
	   	   	   	   	   	   	  
Joint	  sig	  control	  factors	   1.14	   0.313	   1.12	   0.334	   0.82	   0.666	  
RESET	   0.61	   0.55	   -­‐0.04	   0.972	   0.46	   0.648	  
Significance	  levels:	  *	  p<0.10	  **	  p<0.05***	  p<	  0.001	  	  
6.5.4 Randomisation	  
The	  randomised	  sub-­‐sample	  of	  the	  study	  involved	  people	  that	  had	  been	  offered	  the	  chance	  to	  
participate	  in	  the	  study	  as	  a	  potential	  recipient	  of	  a	  personal	  health	  budget	  (or	  participating	  in	  the	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control	  group).	  In	  contrast,	  in	  the	  non-­‐randomised	  sub-­‐sample,	  people	  were	  either	  asked	  to	  
participate	  as	  controls	  or	  they	  were	  offered	  a	  personal	  health	  budget.	  As	  a	  consequence,	  we	  might	  
expect	  some	  differences	  between	  the	  controls	  in	  the	  randomised	  and	  non-­‐randomised	  sub-­‐samples	  
as	  people	  in	  the	  former	  group	  were	  predisposed	  to	  the	  idea	  of	  having	  a	  personal	  health	  budget	  
whilst	  those	  in	  the	  latter	  were	  not.	  
On	  this	  basis,	  we	  might	  anticipate	  a	  greater	  difference	  between	  the	  personal	  health	  budget	  and	  
control	  group	  in	  the	  randomised	  sample	  as	  compared	  to	  those	  in	  the	  non-­‐randomised	  sample,	  other	  
things	  equal.	  On	  the	  other	  hand,	  although	  we	  adopted	  a	  difference-­‐in-­‐difference	  design	  to	  mitigate	  
baseline	  selection	  between	  personal	  health	  budget	  and	  control	  groups,	  in	  the	  absence	  of	  an	  (albeit	  
fully	  blind)	  randomisation	  process,	  some	  selection	  effects	  could	  have	  bled	  into	  the	  final	  result.	  The	  
direction	  of	  any	  selection	  bias,	  should	  it	  have	  occurred,	  was	  difficult	  to	  predict	  however.	  The	  above	  
analyses	  using	  the	  additional	  baseline	  control	  factors	  suggested	  that	  baseline	  selection	  bias	  was	  
limited	  in	  the	  study.	  
We	  explored	  the	  hypothesis	  that	  the	  randomised	  sub-­‐sample	  had	  a	  greater	  chance	  of	  showing	  
personal	  health	  budgets	  to	  be	  cost-­‐effective	  relative	  to	  usual	  practice	  in	  the	  control	  group	  by	  
comparing	  the	  size	  and	  significance	  of	  the	  difference	  in	  the	  change	  in	  NMB	  for	  each	  sub-­‐sample.	  We	  
found	  that	  the	  randomised	  sub-­‐sample	  showed	  a	  small	  change	  in	  NMB	  overall	  but	  that	  the	  difference	  
in	  this	  change	  between	  personal	  health	  budget	  and	  controls	  was	  greater	  in	  the	  randomised	  sub-­‐
sample	  (mean	  difference	  in	  difference	  of	  £4140)	  than	  the	  non-­‐randomised	  sub-­‐sample	  (mean	  
difference	  in	  difference	  of	  £1710).	  The	  difference	  between	  these	  two	  estimates	  was	  not	  statistically	  
significantly	  different.	  We	  can	  infer	  from	  these	  results	  that	  randomisation	  did	  not	  play	  a	  statistically	  
significant	  role	  in	  the	  overall	  results.	  
6.6 Exploring	  the	  relationship	  between	  costs	  and	  benefits	  
Figure	  6-­‐1	  shows	  the	  three	  main	  hypothesised	  effect	  ‘routes’	  for	  personal	  health	  budgets.	  It	  also	  
shows	  that	  the	  costs	  and	  benefits	  are	  inter-­‐related.	  In	  using	  the	  NMB	  approach,	  we	  are	  assessing	  the	  
impact	  of	  personal	  health	  budgets	  in	  terms	  of	  the	  combined	  effect	  along	  the	  routes	  in	  the	  figure	  (and	  
indeed	  along	  other	  routes	  not	  included	  in	  the	  figure).	  We	  are,	  in	  other	  words,	  considering	  the	  actual	  
implementation	  of	  personal	  health	  budgets	  in	  the	  study,	  including	  choices	  about	  resourcing	  PHBs.	  In	  
theory	  personal	  health	  budgets	  could	  be	  deployed	  without	  changes	  in	  resource	  levels:	  that	  is,	  where	  
they	  are	  cost-­‐neutral.	  Therefore,	  it	  would	  be	  useful	  to	  have	  estimates	  of	  the	  effect	  size	  for	  each	  of	  
the	  three	  routes	  of	  effect.	  This	  set	  of	  estimates	  would	  allow	  us,	  for	  example,	  to	  get	  a	  better	  sense	  of	  
the	  impact	  of	  personal	  health	  budgets	  without	  changes	  in	  resources.	  
One	  way	  to	  produce	  these	  individual	  effect	  sizes	  is	  to	  estimate	  a	  structural	  model	  using	  multivariate	  
regression.	  Details	  of	  this	  method	  are	  given	  in	  Appendix	  C.	  The	  challenge	  with	  estimating	  a	  structural	  
model	  is	  the	  need	  to	  have	  all	  relevant	  factors	  included,	  which	  is	  very	  demanding	  in	  terms	  of	  data	  
collection.	  In	  this	  study	  we	  had	  only	  sufficient	  data	  for	  a	  partial	  structural	  analysis,	  whereby	  we	  
estimated	  the	  impact	  of	  personal	  health	  budgets	  on	  outcome	  change	  whilst	  removing	  the	  effect	  of	  
service	  change	  and	  some	  condition-­‐severity	  characteristics.	  Nonetheless,	  this	  analysis	  gave	  us	  an	  
estimate	  of	  the	  direct	  choice	  and	  control	  effect	  of	  using	  personal	  health	  budgets	  as	  shown	  by	  effect	  
118	  
	  
route	  (1)	  in	  Figure	  6-­‐1	  above.	  It	  also	  provided	  an	  estimate	  of	  the	  impact	  of	  a	  change	  services	  on	  
quality	  of	  life	  (change).	  
The	  ASCOT	  results	  are	  presented	  in	  Table	  6-­‐17.	  This	  table	  shows	  three	  estimated	  (structural)	  
equations	  for	  change	  in	  ASCOT	  between	  baseline	  and	  follow-­‐up.	  In	  the	  base	  model,	  we	  estimated	  the	  
impact	  of	  using	  a	  personal	  health	  budget	  for	  the	  whole	  PHB	  sample.	  The	  estimated	  effect	  of	  personal	  
health	  budgets	  on	  ASCOT	  change,	  assuming	  no	  change	  in	  total	  expenditure,	  was	  0.049.	  This	  estimate	  
corresponds	  to	  the	  ‘choice	  and	  control’	  and	  ‘changed	  utilisation/better	  tailoring’	  effects	  described	  in	  
Figure	  6-­‐1	  –	  effects	  (1)	  and	  (2).	  As	  a	  shorthand,	  we	  can	  described	  both	  effects	  together	  as	  the	  
control/tailoring	  effect.	  
A	  change	  in	  total	  service	  expenditure	  was	  also	  found	  to	  have	  a	  significant	  positive	  effect	  on	  ASCOT	  
change	  (with	  a	  coefficient	  of	  0.012	  for	  every	  £1000	  difference	  in	  total	  cost).	  In	  other	  words,	  an	  
increase	  in	  support	  from	  services	  produces	  an	  increase	  in	  ASCOT	  quality	  of	  life,	  other	  things	  equal.	  
Similarly,	  improved	  ADL	  functioning	  was	  strongly	  associated	  with	  an	  increase	  in	  ASCOT	  score.	  
The	  effect	  size	  of	  0.049	  can	  be	  compared	  with	  the	  overall	  effect	  size	  of	  0.039	  reported	  in	  Chapter	  5	  
(Table	  5-­‐7).	  This	  figure	  can	  be	  interpreted	  as	  the	  net	  impact	  of	  personal	  health	  budgets	  on	  ASCOT	  
quality	  of	  life	  scores	  if	  personal	  health	  budgets	  have	  zero	  effect	  on	  total	  expenditure.	  In	  this	  case,	  we	  
would	  expect	  this	  control/tailoring	  effect	  to	  be	  greater	  than	  the	  overall	  effect	  because	  the	  use	  of	  
personal	  health	  budget	  was	  associated	  with	  a	  decrease	  in	  total	  expenditure	  (of	  on	  average	  -­‐£1120:	  
see	  Table	  6-­‐3).40	  Moreover,	  we	  found	  no	  significant	  effect	  of	  personal	  health	  budget	  on	  change	  in	  
ADL	  functioning	  or	  on	  use	  of	  informal	  care.	  
If	  we	  take	  the	  direct	  control/tailoring	  effect	  and	  add	  the	  service	  effect	  we	  get:	  
Net	  effect	  size	  =	  0.049	  +	  0.012/1000	  x	  -­‐1120	  =	  0.036.	  
This	  net	  effect	  is	  very	  similar	  to	  the	  0.039	  value	  reported	  in	  Chapter	  5.	  
As	  reported	  above,	  there	  was	  some	  indication	  that	  personal	  health	  budgets	  were	  most	  effective	  for	  
the	  NHS	  Continuing	  Healthcare	  and	  mental	  health	  sub-­‐groups.	  On	  this	  basis,	  we	  estimated	  the	  effect	  
of	  personal	  health	  budgets	  on	  these	  two	  sub-­‐groups,	  again	  assuming	  no	  change	  in	  total	  expenditure	  
(i.e.	  the	  control/tailoring	  effect).	  For	  the	  mental	  health	  sub-­‐group,	  the	  control/tailoring	  effect	  was	  
highly	  significant	  with	  a	  coefficient	  of	  0.112.	  As	  regards	  the	  NHS	  Continuing	  Healthcare	  cohort,	  the	  
control/tailoring	  effect	  was	  estimated	  with	  a	  coefficient	  of	  0.153,	  although	  with	  a	  much	  wider	  
confidence	  interval	  and	  significance	  at	  the	  10%	  level.	  In	  both	  cases,	  these	  control/tailoring	  effects	  are	  
much	  higher	  than	  their	  corresponding	  total	  effect	  as	  reported	  in	  Chapter	  5.	  This	  difference	  occurs	  for	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
40	  A	  Two	  Stage	  Least	  Squares	  model	  was	  used	  to	  estimate	  the	  results.	  In	  the	  first-­‐stage	  equation,	  we	  found	  the	  impact	  of	  
personal	  health	  budgets	  on	  total	  expenditure	  change	  to	  have	  a	  point	  estimate	  effect	  size	  of	  -­‐£1210	  (rather	  than	  -­‐£1120	  
without	  controlling	  for	  other	  factors).	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both	  NHS	  Continuing	  Healthcare	  and	  mental	  health	  cohorts	  because	  the	  personal	  health	  budget	  
group	  had	  much	  lower	  costs	  than	  the	  control	  group	  on	  average.	  
To	  sum	  up,	  the	  results	  suggest	  that	  the	  use	  of	  a	  personal	  health	  budget	  has	  a	  direct	  impact	  on	  quality	  
of	  life	  via	  improved	  choice,	  control	  and	  tailoring	  of	  services	  to	  personal	  needs	  and	  circumstances.	  
Personal	  health	  budgets	  also	  have	  an	  impact	  on	  expenditure/cost,	  both	  from	  a	  change	  in	  service	  
need	  and	  also	  as	  a	  consequence	  of	  changed	  resourcing	  levels.	  A	  change	  in	  expenditure	  (i.e.	  due	  to	  a	  
change	  in	  service	  use)	  also	  has	  an	  impact	  on	  quality	  of	  life,	  other	  things	  equal.	  So	  where	  personal	  
health	  budgets	  lead	  to	  a	  change	  in	  service	  use/expenditure,	  they	  also	  have	  a	  knock-­‐on	  effect	  on	  
quality	  of	  life.	  This	  latter	  effect	  goes	  some	  way	  to	  offsetting	  the	  direct	  ‘control/tailoring’	  effect.	  The	  
EQ-­‐5D	  measure	  is	  not	  especially	  sensitive	  to	  measuring	  the	  benefits	  of	  improved	  control	  and	  
tailoring,	  particularly	  the	  value	  of	  choice	  and	  control.	  It	  is	  perhaps	  not	  surprising,	  therefore,	  that	  the	  
service	  effects	  tend	  to	  dominate	  on	  EQ-­‐5D	  leading	  to	  zero	  overall	  effect.	  ASCOT,	  by	  contrast,	  is	  
designed	  for	  people	  with	  long-­‐term	  conditions	  where	  choice	  and	  control	  in	  managing	  one’s	  condition	  
is	  highly	  valued.	  
We	  might	  conclude	  that	  personal	  health	  budgets	  would	  be	  more	  cost-­‐effective	  if	  they	  were	  provided	  
without	  a	  reduction	  in	  expenditure	  i.e.	  would	  have	  a	  greater	  net	  benefit	  improvement	  over	  the	  
control	  group	  in	  that	  case.	  These	  analyses	  do	  suggest	  that,	  other	  things	  equal,	  giving	  people	  more	  
support	  would	  improve	  their	  quality	  of	  life.	  But	  the	  use	  of	  personal	  health	  budgets	  in	  this	  study	  
produced	  joint	  benefit	  and	  cost	  effects,	  and	  so	  we	  cannot	  assume	  that	  net	  benefits	  would	  be	  the	  size	  
of	  the	  control/tailoring	  effect	  estimated	  above	  if	  the	  personal	  health	  budget	  were	  actually	  provided	  
without	  a	  reduction	  in	  expenditure.	  We	  cannot	  be	  sure,	  for	  example,	  that	  personal	  health	  budgets	  
would	  be	  cost-­‐effective	  for	  high-­‐value	  budgets	  without	  expenditure	  reductions	  when	  measured	  on	  
the	  EQ-­‐5D	  scale.	  Nonetheless,	  these	  results	  do	  suggest	  that	  the	  level	  of	  net	  benefit	  of	  personal	  
health	  budgets	  compared	  to	  conventional	  arrangements	  –	  and	  hence	  whether	  we	  assess	  personal	  
health	  budgets	  to	  be	  cost-­‐effective	  –	  is	  sensitive	  to	  policy	  decisions	  about	  resourcing	  levels	  for	  
budgets.	  We	  might,	  in	  other	  words,	  see	  a	  greater	  likelihood	  of	  personal	  health	  budgets	  being	  cost-­‐
effective	  with	  higher	  levels	  of	  expenditure.	  
The	  analysis	  also	  gives	  us	  an	  indication	  of	  the	  marginal	  benefit	  of	  the	  extra	  spending	  on	  people	  in	  the	  
study.	  For	  example,	  other	  things	  equal,	  the	  analysis	  suggests	  that	  an	  extra	  £1000	  expenditure	  
produces	  additional	  EQ-­‐5D	  benefit	  of	  0.016	  on	  average	  (with	  a	  confidence	  interval	  of	  0.0070	  to	  
0.025).	  The	  point	  estimate	  translates	  to	  a	  marginal	  cost	  per	  (EQ-­‐5D)	  QALY	  of	  £62,500.	  Even	  
accounting	  for	  the	  uncertainty	  of	  the	  estimate	  there	  is	  a	  considerable	  likelihood	  that	  extra	  
expenditure	  at	  this	  level	  is	  outside	  the	  cost-­‐effective	  range.	  We	  might	  interpret	  this	  finding	  as	  a	  
reason	  to	  scale	  back	  expenditure	  on	  this	  group,	  but	  this	  judgement	  is	  hard	  to	  make	  without	  a	  better	  
understanding	  of	  the	  change	  in	  marginal	  benefit	  rates	  that	  result	  from	  lower	  levels	  of	  expenditure	  
and	  also	  about	  alternative	  uses	  of	  this	  resource.	  	  
Table	  6-­‐18	  has	  structural	  estimation	  results	  for	  the	  EQ-­‐5D	  measure.	  The	  overall	  effect	  of	  personal	  
health	  budgets	  on	  the	  change	  in	  EQ-­‐5D	  was	  essentially	  zero	  –	  see	  Table	  5-­‐10.	  Controlling	  for	  change	  
in	  total	  expenditure,	  the	  use	  of	  all	  personal	  health	  budgets	  (whole	  sample)	  showed	  a	  small	  positive,	  
but	  insignificant	  coefficient.	  We	  also	  estimated	  the	  impact	  on	  EQ-­‐5D	  change	  of	  high-­‐value	  personal	  
health	  budgets	  compared	  to	  controls.	  The	  overall	  effect	  from	  the	  uncontrolled	  analysis	  was	  again	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very	  close	  to	  zero	  -­‐.008.	  Controlling	  for	  total	  expenditure	  change,	  however,	  produced	  a	  
control/tailoring	  effect	  of	  0.063,	  which	  is	  significant	  at	  the	  5%	  level.	  The	  high	  budgets	  group	  showed	  
a	  change	  in	  total	  costs	  of	  some	  £3100	  less	  than	  controls,	  which	  accounts	  for	  much	  of	  this	  result.	  On	  
average,	  an	  increase	  in	  total	  expenditure	  of	  £1000	  leads	  to	  a	  0.016	  increase	  in	  EQ-­‐5D	  according	  to	  
our	  results	  (at	  the	  point	  estimates),	  so	  -­‐£3100	  would	  mean	  a	  change	  in	  EQ-­‐5D	  of	  -­‐0.05,	  which	  largely	  
offset	  the	  0.063	  direct	  effect.	  
Interaction	  effects	  for	  NHS	  Continuing	  Healthcare	  and	  mental	  health	  were	  also	  estimated	  for	  the	  EQ-­‐
5D	  change	  equation	  and,	  whilst	  the	  estimated	  control/tailoring	  effect	  sizes	  were	  much	  higher	  than	  




Table	  6-­‐17.	  Differences	  in	  ASCOT	  score	  –	  controlling	  for	  expenditure	  
	   Base	   CHC	   Mental	  health	  
	   Co-­‐eff	   Prob	   Co-­‐eff	   Prob	   Co-­‐eff	   Prob	  
Change	  in	  process	   	   	   	   	   	   	  
PHB	  group	  (all)	  	   0.049	   0.008**	   	   	   	   	  
PHB	  -­‐	  not	  CHC	   	   	   0.039	   0.039**	   	   	  
PHB	  -­‐	  CHC	   	   	   0.153	   0.072*	   	   	  
PHB	  -­‐	  not	  MH	   	   	   	   	   0.033	   0.041**	  
PHB	  -­‐	  MH	   	   	   	   	   0.112	   0.004**	  
Other	  change	  characteristics	   	   	   	   	   	   	  
Total	  cost	  diff	  (predicted)	  (£1000s)	   0.012	   0.004**	   0.012	   0.004**	   0.012	   0.005**	  
Receives	  benefit	  (T1)	   -­‐0.030	   0.223	   -­‐0.028	   0.244	   -­‐0.028	   0.255	  
Receives	  benefit	  (T2)	   -­‐0.003	   0.907	   -­‐0.005	   0.848	   -­‐0.003	   0.897	  
Care	  from	  co-­‐resident	  (T1)	   -­‐0.055	   0.035**	   -­‐0.057	   0.036**	   -­‐0.054	   0.032**	  
Care	  from	  co-­‐resident	  (T2)	   -­‐0.017	   0.662	   -­‐0.015	   0.693	   -­‐0.015	   0.686	  
Change	  in	  Care	  from	  others	   0.034	   0.085*	   0.035	   0.085*	   0.033	   0.089*	  
Change	  in	  ADL	  need	   0.016	   0.000***	   0.016	   0.000***	   0.016	   0.000***	  
Change	  in	  ADL	  need	  -­‐	  CHC	  group	   -­‐2.99E-­‐04	   0.950	   1.05E-­‐03	   0.840	   -­‐8.78E-­‐04	   0.853	  
Invariant	  characteristics	   	   	   	   	   	   	  
Age	   -­‐0.006	   -­‐2.340	   -­‐0.007	   -­‐2.400	   -­‐0.005	   -­‐2.000	  
Age	  squared	   4.47E-­‐05	   1.890	   4.63E-­‐05	   1.930	   3.72E-­‐05	   1.580	  
Age,	  CHC	  cohort	   -­‐2.75E-­‐04	   -­‐0.220	   3.41E-­‐04	   0.310	   -­‐5.80E-­‐04	   -­‐0.470	  
Married	  	   0.055	   2.700	   0.056	   2.740	   0.053	   2.610	  
Male	   0.016	   0.990	   0.017	   1.030	   0.016	   0.980	  
Married	  males	   -­‐0.042	   -­‐1.880	   -­‐0.043	   -­‐1.900	   -­‐0.042	   -­‐1.880	  
CHC	  cohort	   0.177	   1.400	   0.110	   1.010	   0.187	   1.490	  
Stroke	  cohort	   0.160	   1.810	   0.195	   1.930	   0.153	   1.730	  
Diabetes	  cohort	   0.188	   1.970	   0.223	   2.050	   0.181	   1.880	  
Mental	  health	  cohort	   0.144	   1.600	   0.178	   1.760	   0.100	   1.050	  
COPD	  cohort	   0.168	   1.910	   0.203	   1.960	   0.164	   1.860	  
Neurological	  cohort	   0.165	   1.900	   0.198	   1.950	   0.162	   1.860	  
Area	  cost	  adjustment	   0.132	   0.690	   0.122	   0.610	   0.129	   0.680	  
Pilot	  site	  dummies	   Yes	   	   Yes	   	   Yes	   	  
Constant	   -­‐0.114	   0.612	   -­‐0.125	   0.577	   -­‐0.125	   0.578	  
Model	   	   	   	   	   	   	  
F-­‐test	   2.84	   <0.0001***	   2.71	   <0.0001***	   2.87	   <0.0001***	  
Weak	  identification	   	   	   	   	   	   	  
F	   7.28	   0.0014	   6.75	   0.0023	   7.39	   0.0013	  
Over-­‐identification	   	   	   	   	   	   	  
Sargan	  Chi2	   1.406	   0.495	   1.338	   0.512	   1.427	   0.490	  
Endogeneity	   	   	   	   	   	   	  
Hausman	  (t-­‐test)	   -­‐3.21	   0.004	   -­‐3.18	   0.005	   -­‐3.15	   0.005	  
Note	  1:	  CHC	  refers	  to	  NHS	  Continuing	  Healthcare	  
Significance	  levels:	  *	  p<0.10	  **	  p<0.05	  ***	  p<	  0.001	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To	  sum	  up,	  the	  results	  suggest	  that	  the	  use	  of	  a	  personal	  health	  budget	  has	  a	  direct	  impact	  on	  quality	  
of	  life	  via	  improved	  choice,	  control	  and	  tailoring	  of	  services	  to	  personal	  needs	  and	  circumstances.	  
Personal	  health	  budgets	  also	  have	  an	  impact	  on	  expenditure/cost,	  both	  from	  a	  change	  in	  service	  
need	  and	  also	  as	  a	  consequence	  of	  changed	  resourcing	  levels.	  A	  change	  in	  expenditure	  (i.e.	  due	  to	  a	  
change	  in	  service	  use)	  also	  has	  an	  impact	  on	  quality	  of	  life,	  other	  things	  equal.	  So	  where	  personal	  
health	  budgets	  lead	  to	  a	  change	  in	  service	  use/expenditure,	  they	  also	  have	  a	  knock-­‐on	  effect	  on	  
quality	  of	  life.	  This	  latter	  effect	  goes	  some	  way	  to	  offsetting	  the	  direct	  ‘control/tailoring’	  effect.	  The	  
EQ-­‐5D	  measure	  is	  not	  especially	  sensitive	  to	  measuring	  the	  benefits	  of	  improved	  control	  and	  
tailoring,	  particularly	  the	  value	  of	  choice	  and	  control.	  It	  is	  perhaps	  not	  surprising,	  therefore,	  that	  the	  
service	  effects	  tend	  to	  dominate	  on	  EQ-­‐5D	  leading	  to	  zero	  overall	  effect.	  ASCOT,	  by	  contrast,	  is	  
designed	  for	  people	  with	  long-­‐term	  conditions	  where	  choice	  and	  control	  in	  managing	  one’s	  condition	  
is	  highly	  valued.	  
We	  might	  conclude	  that	  personal	  health	  budgets	  would	  be	  more	  cost-­‐effective	  if	  they	  were	  provided	  
without	  a	  reduction	  in	  expenditure	  i.e.	  would	  have	  a	  greater	  net	  benefit	  improvement	  over	  the	  
control	  group	  in	  that	  case.	  These	  analyses	  do	  suggest	  that,	  other	  things	  equal,	  giving	  people	  more	  
support	  would	  improve	  their	  quality	  of	  life.	  But	  the	  use	  of	  personal	  health	  budgets	  in	  this	  study	  
produced	  joint	  benefit	  and	  cost	  effects,	  and	  so	  we	  cannot	  assume	  that	  net	  benefits	  would	  be	  the	  size	  
of	  the	  control/tailoring	  effect	  estimated	  above	  if	  the	  personal	  health	  budget	  were	  actually	  provided	  
without	  a	  reduction	  in	  expenditure.	  We	  cannot	  be	  sure,	  for	  example,	  that	  personal	  health	  budgets	  
would	  be	  cost-­‐effective	  for	  high-­‐value	  budgets	  without	  expenditure	  reductions	  when	  measured	  on	  
the	  EQ-­‐5D	  scale.	  Nonetheless,	  these	  results	  do	  suggest	  that	  the	  level	  of	  net	  benefit	  of	  personal	  
health	  budgets	  compared	  to	  conventional	  arrangements	  –	  and	  hence	  whether	  we	  assess	  personal	  
health	  budgets	  to	  be	  cost-­‐effective	  –	  is	  sensitive	  to	  policy	  decisions	  about	  resourcing	  levels	  for	  
budgets.	  We	  might,	  in	  other	  words,	  see	  a	  greater	  likelihood	  of	  personal	  health	  budgets	  being	  cost-­‐
effective	  with	  higher	  levels	  of	  expenditure.	  
The	  analysis	  also	  gives	  us	  an	  indication	  of	  the	  marginal	  benefit	  of	  the	  extra	  spending	  on	  people	  in	  the	  
study.	  For	  example,	  other	  things	  equal,	  the	  analysis	  suggests	  that	  an	  extra	  £1000	  expenditure	  
produces	  additional	  EQ-­‐5D	  benefit	  of	  0.016	  on	  average	  (with	  a	  confidence	  interval	  of	  0.0070	  to	  
0.025).	  The	  point	  estimate	  translates	  to	  a	  marginal	  cost	  per	  (EQ-­‐5D)	  QALY	  of	  £62,500.	  Even	  
accounting	  for	  the	  uncertainty	  of	  the	  estimate	  there	  is	  a	  considerable	  likelihood	  that	  extra	  
expenditure	  at	  this	  level	  is	  outside	  the	  cost-­‐effective	  range.	  We	  might	  interpret	  this	  finding	  as	  a	  
reason	  to	  scale	  back	  expenditure	  on	  this	  group,	  but	  this	  judgement	  is	  hard	  to	  make	  without	  a	  better	  
understanding	  of	  the	  change	  in	  marginal	  benefit	  rates	  that	  result	  from	  lower	  levels	  of	  expenditure	  
and	  also	  about	  alternative	  uses	  of	  this	  resource.	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Table	  6-­‐18.	  Differences	  in	  EQ-­‐5D	  score	  –	  controlling	  for	  expenditure	  
	   Co-­‐eff	   Prob	   Co-­‐eff	   Prob	  
Change	  in	  process	   	   	   	   	  
PHB,	  hi	  budget	   0.063	   0.038**	   	   	  
PHB	  group,	  all	  budgets	   	   	   0.015	   0.425	  
Other	  change	  characteristics	   	   	   	   	  
Change	  in	  Total	  cost	  (predicted)	  (£1000s)	   0.016	   0.002**	   0.016	   0.002**	  
Change	  in	  Care	  from	  co-­‐resident	   -­‐0.007	   0.811	   -­‐0.008	   0.784	  
Change	  in	  Care	  from	  others	   0.027	   0.132	   0.025	   0.155	  
Change	  in	  ADL	  need	   0.024	   0.000***	   0.024	   0.000***	  
Change	  in	  ADL	  need	  –	  CHC	  cohort	   0.006	   0.133	   0.006	   0.162	  
Invariant	  characteristics	  	   	   	   	   	  
Age,	  log	   -­‐0.004	   0.803	   -­‐0.008	   0.644	  
Uni	  education	   0.015	   0.323	   0.014	   0.348	  
Married	  	   0.012	   0.568	   0.013	   0.538	  
Male	   0.006	   0.796	   0.006	   0.788	  
CHC	  cohort	   0.124	   0.082*	   0.144	   0.061*	  
Stroke	  cohort	   0.164	   0.020**	   0.165	   0.019**	  
Diabetes	  cohort	   0.147	   0.082*	   0.152	   0.070*	  
Mental	  health	  cohort	   0.122	   0.148	   0.128	   0.124	  
COPD	  cohort	   0.132	   0.079*	   0.134	   0.071*	  
Neurological	  cohort	   0.128	   0.064*	   0.131	   0.054*	  
Pilot	  site	  dummies	   Yes	   	   Yes	   	  
Constant	   -­‐0.133	   0.198	   -­‐0.108	   0.254	  
	   	   	   	   	  
Model	   	   	   	   	  
F-­‐test	   4.22	   <0.001***	   4.16	   <0.001***	  
Weak	  identification	   	   	   	   	  
F	   6.17	   0.004**	   6.12	   0.004**	  
Over-­‐identification	   	   	   	   	  
Sargan	  Chi2	   4.13	   0.126	   4.38	   0.112	  
Endogeneity	   	   	   	   	  
Hausman	  (t-­‐test)	   -­‐3.79	   0.003	   -­‐3.80	   0.003	  
Significance	  levels:	  *	  p<0.10	  **	  p<0.05	  ***	  p<	  0.001	  	  
6.7 Sensitivity	  analysis	  
A	  number	  of	  assumptions	  were	  made	  in	  the	  course	  of	  this	  analysis.	  They	  fall	  into	  two	  categories:	  
those	  around	  the	  statistical	  modelling	  of	  missing	  data	  in	  the	  multiple	  imputation	  process;	  and	  others	  
made	  during	  the	  costing	  of	  personal	  health	  budgets	  as	  compared	  to	  the	  control	  group.	  We	  explored	  
the	  sensitivity	  of	  our	  main	  results	  to	  changes	  in	  these	  assumptions	  by	  re-­‐estimating	  net	  benefit	  
differences	  with	  changes	  in	  assumptions	  as	  follows:	  
 Using	  a	  different	  imputation	  dataset	  (created	  by	  added	  further	  imputations);	  
 Using	  a	  different	  imputation	  model;	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 Selecting	  different	  sub-­‐sample	  of	  the	  data	  for	  imputation;	  
 Changing	  assumptions	  about	  which	  personal	  health	  budgets	  substitute	  for,	  rather	  than	  be	  
provided	  in-­‐addition	  to,	  conventional	  services.	  
Details	  of	  the	  results	  are	  in	  the	  Annex	  to	  this	  chapter.	  In	  summary,	  the	  sensitivity	  analysis	  supported	  
the	  main	  findings	  outlined	  above	  for	  all	  but	  the	  most	  extreme	  assumptions.	  In	  many	  cases	  the	  cost-­‐
effectiveness	  results	  were	  stronger,	  with	  personal	  health	  budgets	  showing	  cost-­‐effectiveness	  (on	  the	  
ASCOT	  scale)	  at	  the	  95%	  confidence	  level.	  
6.8 Discussion	  
Personal	  health	  budgets	  were	  hypothesised	  to	  change	  costs	  and	  benefits	  for	  study	  participants	  in	  
three	  ways:	  	  
 Personal	  health	  budgets	  could	  have	  a	  direct	  effect	  on	  quality	  of	  life	  by	  improving	  people’s	  
choice	  and	  control	  over	  their	  own	  lives;	  
 Personal	  health	  budgets	  could	  allow	  people	  to	  change	  their	  utilisation	  of	  services	  and	  
support	  to	  better	  match	  their	  own	  needs	  and	  preferences	  (other	  things	  equal	  this	  would	  also	  
improve	  their	  quality	  of	  life);	  	  
 the	  use	  of	  personal	  health	  budgets	  might	  imply	  different	  overall	  resourcing	  levels	  for	  each	  
recipient,	  compared	  to	  their	  situation	  without	  a	  personal	  health	  budget,	  receiving	  
conventional	  support.	  	  
The	  three	  effects	  would	  change	  the	  amount	  and	  mix	  of	  services	  and	  support	  people	  use	  and	  thus	  
change	  costs	  compared	  to	  the	  control	  group.	  They	  also	  have	  consequences	  for	  care-­‐related	  quality	  of	  
life	  and	  so	  might	  change	  the	  benefits	  people	  gain	  from	  the	  services	  and	  support	  they	  use.	  These	  
considerations	  framed	  our	  analysis	  of	  costs	  and	  benefits.	  
As	  a	  system	  level	  reform,	  the	  use	  of	  personal	  health	  budgets	  can	  affect	  the	  use	  of	  a	  wide	  range	  of	  
services	  and	  support,	  and	  these	  can	  differ	  significantly	  from	  the	  services	  available	  under	  
conventional	  practice.	  Ideally	  we	  would	  aim	  to	  measure	  the	  total	  use	  of	  all	  forms	  of	  service	  and	  
support	  for	  all	  participants	  in	  the	  study,	  regardless	  of	  funding	  source,	  but	  this	  was	  clearly	  infeasible	  in	  
any	  practical	  evaluation.	  Instead,	  we	  collected	  information	  about	  what	  services	  and	  support	  people	  
purchased	  or	  secured	  with	  their	  budgets,	  as	  well	  service	  use	  in	  a	  broad	  range	  of	  conventional	  service	  
categories	  from	  respite	  care	  to	  inpatient	  hospital	  services.	  People	  in	  the	  personal	  health	  budget	  
group	  used	  a	  mix	  of	  both	  conventional	  services	  and	  those	  funded	  from	  their	  budgets.	  Moreover,	  the	  
coverage,	  possible	  use,	  size	  and	  specification	  of	  personal	  health	  budgets	  implementation	  models	  
varied	  significantly	  between	  sites	  and	  by	  health	  condition.	  There	  was	  also	  a	  very	  broad	  mix	  of	  
participants	  in	  the	  pilot	  who	  varied	  significantly	  according	  to	  their	  service	  use.	  
Both	  the	  personal	  health	  budget	  and	  control	  groups	  showed	  increased	  total	  cost	  averages	  between	  
baseline	  and	  follow-­‐up,	  although	  the	  rate	  of	  increase	  was	  slightly	  lower	  for	  the	  personal	  health	  
budget	  group.	  Overall,	  in	  the	  personal	  health	  budget	  group	  the	  average	  cost	  increase	  was	  £800	  per	  
person	  per	  year	  as	  compared	  to	  a	  £1920	  increase	  for	  the	  control	  group,	  a	  difference	  of	  £1120	  less	  for	  
the	  personal	  health	  budget	  group.	  The	  variety	  of	  both	  personal	  health	  budget	  implementations	  and	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study	  participants	  meant	  there	  was	  a	  high	  degree	  of	  variation	  of	  each	  participant’s	  cost	  around	  these	  
sample	  mean	  values	  so	  that	  the	  differences	  were	  not	  statistically	  significant.	  In	  other	  words,	  although	  
we	  found	  in	  this	  sample	  that	  people	  in	  the	  personal	  health	  budget	  group	  had	  lower	  costs	  than	  those	  
in	  the	  control	  group	  overall,	  we	  could	  not	  be	  confident	  (at	  the	  10%	  level	  or	  better)	  that	  the	  true	  cost	  
effect	  of	  personal	  health	  budgets	  is	  actually	  different	  from	  zero.	  	  
Total	  costs	  are	  a	  sum	  of	  the	  cost	  of	  direct	  services	  (those	  which	  can	  be	  purchased	  using	  a	  personal	  
health	  budget)	  and	  indirect	  services	  (those	  which	  cannot	  by	  secured	  using	  a	  personal	  health	  budget	  
e.g.	  hospital	  care).	  Direct	  costs	  showed	  very	  little	  difference	  between	  personal	  health	  budget	  and	  
control	  groups.	  However,	  indirect	  costs	  were	  significantly	  lower	  for	  people	  using	  personal	  health	  
budgets.	  This	  latter	  effect	  was	  not	  strong	  enough	  to	  carry	  through	  to	  produce	  a	  significant	  difference	  
in	  total	  costs,	  as	  noted.	  	  
Overall,	  we	  did	  not	  find	  significant	  differences	  in	  the	  change	  in	  total	  costs	  between	  the	  groups.	  Some	  
differences	  were	  significant,	  however,	  for	  sub-­‐groups.	  In	  the	  mental	  health	  cohort,	  individuals’	  
indirect	  costs	  (mainly	  inpatient	  costs)	  were	  reduced	  by	  a	  significantly	  greater	  amount	  in	  the	  personal	  
health	  budget	  group	  than	  in	  the	  control	  group	  (significant	  at	  1%).	  A	  similar	  result	  occurred	  for	  the	  
NHS	  Continuing	  Healthcare	  sample,	  but	  at	  the	  10%	  significance	  level.	  
People	  gain	  benefit	  from	  using	  services	  and	  support	  as	  arranged	  with	  personal	  health	  budgets	  or	  
through	  conventional	  means.	  Personal	  health	  budgets	  might	  affect	  the	  size	  of	  the	  benefits	  by	  
changing	  what	  sort	  of	  services	  people	  actually	  use	  and	  also	  in	  the	  way	  people	  experience	  this	  
support.	  These	  benefits	  need	  to	  be	  set	  against	  the	  costs	  of	  the	  services	  and	  support	  people	  used.	  
Where	  benefits	  can	  be	  measured	  in	  £-­‐equivalent	  terms,	  net	  (monetary)	  benefit	  can	  be	  calculated	  as	  
the	  value	  of	  benefits	  less	  the	  costs	  incurred.	  The	  cost-­‐effectiveness	  of	  personal	  health	  budgets	  was	  
assessed	  by	  comparing	  whether	  people	  in	  the	  personal	  health	  budget	  experienced	  greater	  net	  
benefit	  than	  those	  people	  in	  the	  control	  group.	  	  
Benefits	  were	  measured	  as	  the	  change	  in	  health	  and	  care-­‐related	  quality	  of	  life	  using	  the	  ASCOT	  and	  
EQ-­‐5D	  scales.	  These	  changes	  were	  converted	  into	  monetary	  values	  using	  pre-­‐determined	  willingness-­‐
to-­‐pay	  thresholds	  for	  a	  unit	  gain	  in	  quality	  of	  life	  over	  a	  year.	  As	  a	  base	  we	  used	  a	  £30,000	  per	  QALY	  
threshold	  for	  both	  ASCOT	  and	  EQ-­‐5D.	  To	  better	  ensure	  we	  attribute	  the	  differences	  in	  net	  benefits	  at	  
follow-­‐up	  between	  the	  personal	  health	  budget	  and	  control	  groups	  to	  the	  use	  of	  personal	  health	  
budgets,	  we	  subtracted	  any	  difference	  in	  net	  benefit	  amount	  that	  existed	  at	  baseline	  (i.e.	  prior	  to	  
personal	  health	  budgets	  use).	  
After	  subtracting	  the	  baseline	  difference,	  the	  personal	  health	  budget	  group	  had	  ASCOT-­‐measured	  
net	  benefits	  of	  £2300	  more	  than	  the	  control	  group	  on	  average	  (at	  the	  £30,000	  threshold)	  –	  
comprising	  £1180	  worth	  of	  additional	  benefit	  and	  £1120	  less	  cost.	  The	  difference	  in	  net	  benefit	  
between	  the	  groups	  was	  statistically	  significantly	  different	  from	  zero	  at	  the	  10%	  significance	  level,	  
suggesting	  with	  90%	  confidence	  that	  personal	  health	  budgets	  actually	  produce	  greater	  net	  benefit	  
than	  conventional	  arrangements.	  Bootstrapping	  confirmed	  that	  in	  over	  90%	  of	  re-­‐samples	  of	  the	  
data,	  the	  corresponding	  net	  benefit	  difference	  was	  in	  the	  cost-­‐effective	  range	  i.e.	  greater	  than	  zero	  
(at	  thresholds	  of	  £30,000	  or	  above).	  The	  corresponding	  difference	  in	  net	  benefit	  using	  a	  £20,000	  
threshold	  (£1910)	  or	  below	  was	  not	  significantly	  different	  from	  zero.	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We	  did	  not	  find	  significant	  differences	  on	  the	  EQ-­‐5D	  scale.	  With	  a	  £30,000	  threshold	  EQ-­‐5D-­‐
measured	  net	  benefit	  averaged	  only	  £810	  greater	  in	  the	  personal	  health	  budget	  group	  than	  in	  the	  
control	  group	  (after	  subtracting	  baseline	  differences).	  Given	  the	  variation	  between	  participants	  in	  the	  
study,	  we	  could	  not	  be	  confident	  (at	  90%	  or	  better)	  that	  this	  was	  a	  real	  difference.	  
Although	  the	  results	  suggested	  personal	  health	  budget	  to	  be	  cost-­‐effective	  at	  borderline	  significance	  
(10%)	  for	  the	  whole	  sample,	  we	  found	  stronger	  and	  more	  significant	  effects	  for	  sub-­‐groups.	  In	  
particular,	  where	  personal	  health	  budgets	  were	  implemented	  as	  model	  1	  (i.e.	  with	  the	  budget	  known	  
before	  support	  planning;	  with	  flexibility	  in	  what	  help	  can	  be	  purchased	  and	  where	  the	  recipient	  has	  a	  
choice	  of	  the	  type	  of	  budget),	  they	  showed	  improvements	  in	  net	  benefits	  of	  a	  sample	  average	  £4830	  
over	  the	  control	  group,	  with	  significance	  at	  the	  5%	  level.	  Furthermore,	  where	  budgets	  exceeded	  
£1000	  a	  year	  in	  value,	  the	  gain	  in	  net	  benefits	  for	  personal	  health	  budgets	  averaged	  £4340	  in	  the	  
sample	  which,	  again,	  is	  significant	  at	  the	  5%	  level.	  For	  all	  types	  of	  personal	  health	  budgets	  we	  found	  
that	  PHBs	  were	  cost-­‐effective	  compared	  to	  controls	  in	  the	  NHS	  Continuing	  Healthcare	  and	  mental	  
health	  sub-­‐sample	  (at	  10%	  significance).	  However,	  the	  change	  in	  net	  benefits	  was	  no	  higher	  in	  the	  
personal	  health	  budget	  group	  than	  in	  controls	  for	  the	  other	  health	  condition	  sub-­‐groups.	  It	  is	  worth	  
noting	  that	  the	  size	  of	  the	  NHS	  Continuing	  Healthcare	  sample	  was	  relatively	  small	  due	  to	  a	  number	  of	  
ineligible	  study	  participants	  and	  higher	  mortality	  rates	  after	  baseline.	  As	  a	  result,	  statistical	  
significance	  was	  low,	  even	  though	  effect	  sizes	  were	  often	  very	  high	  compared	  to	  other	  groups.	  
The	  difference-­‐in-­‐difference	  design	  of	  the	  evaluation	  removed	  the	  effects	  of	  baseline	  differences	  
between	  personal	  health	  budget	  and	  control	  groups.	  To	  guard	  against	  the	  possibility	  of	  systematic	  
differences	  in	  changes	  in	  costs	  and	  benefits	  due	  to	  baseline	  differences,	  we	  also	  used	  range	  of	  
control	  factors	  in	  the	  net	  benefit	  analysis.	  These	  were	  not	  significant	  overall	  and	  did	  not	  affect	  the	  
results.	  
A	  number	  of	  assumptions	  were	  made	  in	  the	  analysis	  –	  in	  particular	  about	  calculating	  costs	  and	  in	  the	  
process	  of	  imputing	  missing	  data.	  ‘Sensitivity	  analysis’	  involves	  changing	  the	  assumptions	  and	  re-­‐
estimating	  the	  results.	  We	  found	  for	  all	  but	  the	  most	  extreme	  assumptions,	  that	  the	  study	  data	  
showed	  personal	  health	  budgets	  to	  be	  cost-­‐effective	  using	  the	  ASCOT	  measure.	  In	  most	  cases	  in	  fact,	  
the	  strength	  of	  the	  result	  increased	  so	  that	  personal	  health	  budgets	  were	  estimated	  to	  be	  cost-­‐
effective	  at	  the	  95%	  confidence	  level.	  
In	  gauging	  cost-­‐effectiveness,	  we	  assessed	  the	  overall	  effect	  of	  personal	  health	  budgets	  in	  the	  pilot.	  
In	  other	  words,	  we	  assessed	  personal	  health	  budgets	  in	  terms	  of	  their	  actual	  implementation	  in	  the	  
study,	  including	  choices	  about	  resourcing	  PHBs.	  It	  is	  possible,	  nonetheless,	  that	  personal	  health	  
budgets	  could	  be	  deployed	  without	  changes	  in	  resource	  levels.	  We	  therefore	  conducted	  further	  
analyses	  to	  estimate	  effect	  size	  as	  if	  the	  level	  of	  expenditure	  on	  services	  and	  support	  was	  the	  same	  
between	  personal	  health	  budget	  and	  control	  groups.	  To	  begin	  with,	  these	  analyses	  suggested	  that	  
the	  use	  of	  a	  personal	  health	  budget	  has	  a	  direct	  impact	  on	  quality	  of	  life	  via	  improved	  choice,	  control	  
and	  tailoring	  of	  services	  to	  person	  need	  and	  circumstances	  –	  the	  ‘control/tailoring’	  effect.	  
The	  analysis	  also	  showed	  that	  personal	  health	  budgets	  have	  an	  impact	  on	  expenditure	  levels,	  both	  as	  
a	  result	  of	  a	  change	  in	  service	  need	  and	  also	  as	  a	  consequence	  of	  changed	  resourcing	  levels.	  In	  turn,	  a	  
change	  in	  expenditure	  (i.e.	  a	  change	  in	  service	  use)	  has	  an	  impact	  on	  quality	  of	  life,	  other	  things	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equal.	  So,	  where	  personal	  health	  budgets	  lead	  to	  a	  change	  in	  service	  use/expenditure,	  they	  also	  have	  
a	  knock-­‐on	  effect	  on	  quality	  of	  life.	  This	  latter	  effect	  goes	  some	  way	  to	  offsetting	  the	  direct	  
‘control/tailoring’	  effect,	  depending	  on	  whether	  we	  use	  the	  ASCOT	  or	  EQ-­‐5D	  measure.	  
The	  EQ-­‐5D	  measure	  is	  not	  especially	  sensitive	  to	  measuring	  the	  benefits	  of	  improved	  control	  and	  
tailoring,	  particularly	  the	  value	  of	  choice	  and	  control.	  It	  is	  perhaps	  not	  surprising,	  therefore,	  that	  the	  
service	  effects	  tended	  to	  dominate	  on	  EQ-­‐5D	  leading	  to	  zero	  overall	  effect.	  ASCOT,	  by	  contrast,	  is	  
designed	  for	  people	  with	  long-­‐term	  conditions,	  where	  choice	  and	  control	  in	  managing	  one’s	  
condition	  is	  highly	  valued.	  In	  this	  case,	  the	  ‘control/tailoring’	  effect	  was	  greater	  than	  the	  ‘service	  
resourcing’	  effect,	  which	  is	  why	  we	  found	  that	  personal	  health	  budgets	  were	  generally	  cost-­‐effective	  
on	  the	  ASCOT	  scale	  but	  not	  with	  EQ-­‐5D.	  
Cost-­‐effectiveness	  was	  assessed	  in	  this	  chapter	  in	  terms	  people’s	  use	  of	  the	  health	  and	  social	  care	  
systems’	  resources.	  In	  practice,	  we	  might	  expect	  wider	  implications	  of	  using	  personal	  health	  budgets.	  
The	  impact	  on	  families	  and	  carers	  of	  personal	  health	  budgets	  is	  considered	  in	  the	  next	  chapter,	  
although	  we	  do	  not	  explicitly	  build	  this	  into	  our	  cost-­‐effectiveness	  analysis.	  Furthermore,	  in	  this	  
chapter	  we	  have	  looked	  at	  cost-­‐effectiveness	  on	  the	  basis	  of	  people	  that	  survived	  to	  follow-­‐up.	  It	  is	  
theoretically	  possible	  to	  include	  people	  that	  died	  during	  the	  analysis	  as	  that	  both	  the	  EQ-­‐5D	  and	  
ASCOT	  scales	  have	  death-­‐equivalent	  quality	  of	  life	  ratings	  (of	  0).	  After	  death,	  service	  utilisation	  is	  also	  
clearly	  zero.	  The	  problem	  is	  that	  we	  do	  not	  know	  the	  profile	  of	  outcomes	  or	  service	  use	  in	  the	  follow-­‐
up	  period	  prior	  to	  death.	  We	  expect	  these	  profiles	  to	  be	  quite	  different	  to	  those	  people	  that	  did	  not	  
die.	  As	  reported	  in	  the	  previous	  chapter,	  we	  found	  no	  significant	  difference	  in	  mortality	  rate	  between	  
groups	  which	  mitigates	  the	  consequences	  of	  this	  omission	  to	  a	  certain	  extent.	  It	  remains	  the	  case,	  
nonetheless,	  that	  we	  cannot	  know	  whether	  there	  were	  any	  systematic	  differences	  in	  service	  use	  or	  
outcome	  between	  the	  groups	  prior	  to	  death.	  
This	  was	  a	  highly	  complex	  evaluation	  that	  involved	  a	  substantial	  data	  collection	  from	  a	  population	  of	  
people	  with	  significant	  long-­‐term	  health	  conditions	  and	  with	  a	  follow-­‐up	  period	  of	  a	  year	  or	  more.	  
Not	  surprisingly	  there	  was	  missing	  data	  and	  loss	  of	  participants	  to	  follow-­‐up.	  It	  was	  therefore	  
especially	  important	  to	  use	  multiple	  imputation	  techniques	  and	  to	  ensure	  that	  those	  techniques	  
were	  well	  specified	  for	  this	  dataset.	  As	  with	  any	  statistical	  method,	  some	  assumptions	  had	  to	  be	  
made	  using	  multiple	  imputation.	  As	  noted	  we	  tested	  the	  sensitivity	  of	  our	  results	  using	  an	  alternative	  
imputed	  dataset,	  alternative	  imputation	  models,	  different	  sub-­‐samples	  reflecting	  missing	  data	  
patterns,	  and	  different	  costing	  assumption.	  We	  found	  very	  similar	  –	  if	  not	  stronger	  –	  results.	  
Sensitivity	  analyses	  of	  this	  kind	  provide	  more	  confidence	  in	  the	  main	  results	  of	  the	  study.	  
6.9 Annex	  to	  chapter	  6:	  Sensitivity	  analysis	  
6.9.1 Imputation	  assumptions	  
Multiple	  imputation	  (MI)	  involves	  using	  the	  full	  set	  of	  data	  in	  the	  sample	  to	  infer	  or	  impute	  missing	  
values	  of	  certain	  variables.	  Statistical	  relationships	  are	  estimated	  for	  this	  purpose	  and	  link	  the	  
variables	  in	  the	  dataset.	  Multiple	  imputation	  uses	  chains	  of	  these	  estimated	  equations	  to	  build	  up	  a	  
full	  imputed	  dataset	  using	  an	  iterative	  feedback	  process.	  The	  basic	  idea	  is	  that	  there	  are	  underlying	  
patterns	  in	  the	  dataset	  that	  can	  be	  exploited	  to	  fill	  in	  missing	  data	  –	  essentially	  the	  whole	  is	  greater	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than	  the	  sum	  of	  the	  parts.	  However,	  because	  these	  are	  statistical	  processes,	  they	  are	  subject	  to	  
statistical	  noise.	  Actual	  values	  estimated	  to	  replace	  missing	  values	  are	  subject	  to	  some	  ‘error’	  and	  
also	  the	  randomness	  in	  the	  process	  that	  resolves	  a	  statistical	  probability	  into	  a	  specific	  value.	  
To	  reflect	  this	  statistical	  noise,	  multiple	  imputation	  produces	  a	  set	  of	  parallel	  samples	  of	  the	  data	  
with	  slightly	  different	  values	  of	  missing	  data.	  Any	  analysis	  of	  the	  data	  is	  made	  on	  each	  dataset	  and,	  
after	  variations	  between	  the	  datasets	  are	  accounted	  for,	  the	  results	  are	  combined.	  A	  practical	  
consideration	  is	  how	  many	  imputations	  of	  the	  dataset	  to	  use.	  Rubin	  (1987),	  the	  originator	  of	  the	  
multiple	  imputation	  technique,	  showed	  that	  five	  imputations	  were	  often	  sufficient	  but	  that	  there	  are	  
no	  hard-­‐and-­‐fast	  rules.	  There	  is	  also	  the	  choice	  of	  the	  starting	  values	  for	  the	  randomness	  process	  (the	  
randomness	  ‘seed’)	  which	  in	  theory	  should	  not	  affect	  the	  imputation	  results	  in	  a	  large	  dataset.	  Finally	  
there	  are	  choices	  to	  be	  made	  about	  the	  imputation	  ‘model’.	  A	  relevant	  consideration	  here	  how	  
‘censored’	  variables	  are	  modelled;	  these	  are	  variable	  which	  cannot	  take	  certain	  values	  –	  for	  example	  
we	  cannot	  have	  negative	  costs.	  Stata	  offers	  two	  approaches	  in	  this	  regard:	  truncated	  regression	  and	  
predictive	  mean	  matching	  (PMM).	  Our	  base	  models	  use	  truncated	  regression	  and	  so	  as	  part	  of	  our	  
sensitivity	  analysis	  we	  instead	  use	  the	  PMM	  approach.	  	  
To	  test	  the	  sensitivity	  of	  the	  main	  results,	  we	  added	  a	  further	  five	  imputations	  to	  our	  main	  dataset	  
with	  a	  different	  randomly	  selected	  seed	  value.	  The	  main	  analyses	  were	  then	  re-­‐produced	  using	  the	  
ten	  imputations	  dataset.	  The	  key	  results	  are	  presented	  in	  Figure	  6-­‐14	  and	  Figure	  6-­‐15	  below,	  
comparing	  results	  from	  the	  base	  five	  imputations	  dataset	  with	  the	  ‘sensitivity’	  results	  where	  an	  
additional	  five	  imputations	  are	  added.	  The	  figures	  show	  difference-­‐in-­‐difference	  results	  for	  NMB	  
using	  ASCOT	  and	  EQ-­‐5D	  scales	  respectively.	  The	  results	  are	  very	  similar	  for	  the	  two	  datasets	  with,	  if	  
anything,	  slightly	  tighter	  confidence	  intervals	  than	  for	  the	  ten	  imputations	  dataset.	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Figure	  6-­‐14.	  ASCOT	  NMB	  Diff-­‐in-­‐Diff,	  comparing	  base	  MI	  and	  sensitivity	  MI	  results,	  point	  estimates	  
and	  confidence	  intervals	  
	  
Figure	  6-­‐15.	  EQ-­‐5D	  NMB	  Diff-­‐in-­‐Diff,	  comparing	  base	  MI	  and	  sensitivity	  MI	  results,	  point	  estimates	  




£4,830	   £5,460	   £4,340	   £4,880	  






























































£810	   £1,670	  
£2,580	   £3,210	   £2,850	   £3,400	  

































































MI	  estimation	  accounts	  for	  a	  proportion	  of	  missing	  data.	  In	  general,	  a	  high	  proportion	  of	  missing	  
values	  will	  generate	  higher	  between	  imputation	  variance	  (more	  noise)	  than	  a	  low	  proportion	  of	  
missing	  values.	  Nonetheless,	  we	  also	  tested	  the	  main	  analyses	  on	  sub-­‐samples	  of	  the	  full	  dataset	  
selected	  according	  to	  the	  availability	  of	  actual	  follow-­‐up	  data.	  The	  results	  are	  shown	  in	  Table	  6-­‐19.	  
Although	  there	  are	  some	  small	  differences	  in	  estimation	  coefficients	  and	  significance	  levels,	  which	  
are	  to	  be	  expected,	  the	  overall	  nature	  of	  the	  results	  is	  largely	  unaffected.	  
Table	  6-­‐19.	  Sensitivity	  of	  results	  to	  data	  sub-­‐samples	  
	   Only	  specific	  outcome	  
data	  at	  follow-­‐up	  
Any	  follow-­‐up	  data	  
	   Coeff	   prob	   Coeff	   prob	  
PHB	  any	   1751	   0.134	   1997	   0.089*	  
High	  Budget	   3687	   0.084*	   3752	   0.034**	  
PHB	  model	  1	   5104	   0.032*	   4396	   0.052*	  
Mental	  health	   5118	   0.066*	   4459	   0.111	  
NHS	  Continuing	  Healthcare	   9551	   0.095*	   9644	   0.124	  
	   	   	   	   	  
Sample	  size	   1615	   	   2077	   	  
Percentage	  of	  full	  sample	   72%	   	   93%	   	  
Significance	  levels:	  *	  p<0.10	  **	  p<0.05***	  p<	  0.001	  	  
Using	  PMM	  estimations	  rather	  than	  truncated	  regression	  in	  the	  imputation	  model	  made	  very	  little	  
difference	  to	  the	  point	  effect	  sizes	  when	  comparing	  net	  benefit	  for	  the	  personal	  health	  budget	  and	  
control	  groups.	  It	  did	  appear,	  however,	  to	  produce	  smaller	  standard	  errors	  and	  therefore	  results	  that	  
were	  significant	  at	  higher	  confidence	  levels	  –	  see	  Figure	  6-­‐16	  (ASCOT)	  and	  Figure	  6-­‐17	  (EQ-­‐5D).	  For	  
example,	  in	  using	  PMM	  in	  the	  imputation,	  we	  estimated	  that	  net	  benefits	  were	  £2310	  higher	  for	  the	  
personal	  health	  budget	  group	  compared	  to	  the	  control	  group,	  after	  baseline	  subtraction	  (rather	  than	  
£2300	  in	  the	  base	  model).	  This	  new	  estimate	  was	  significant	  at	  the	  95%	  confidence	  level	  (rather	  than	  
the	  90%	  level).	  Also,	  the	  high-­‐value	  personal	  health	  budget	  group	  had	  net	  benefits	  of	  £2760	  greater	  
than	  the	  control	  group,	  when	  measured	  using	  the	  EQ-­‐5D	  scale,	  which	  was	  significant	  at	  the	  95%	  
confidence	  level.	  The	  largest	  difference	  in	  the	  sensitivity	  results	  were	  for	  the	  NHS	  Continuing	  
Healthcare	  sub-­‐group,	  reflecting	  the	  relatively	  small	  sub-­‐sample	  size	  and	  the	  high	  volatility	  in	  costs	  
for	  this	  group.	  Effect	  sizes	  in	  this	  case	  were	  reduced,	  but	  so	  were	  the	  standard	  errors	  compared	  to	  
the	  base	  case.	  The	  net	  benefit	  difference	  (after	  baseline)	  remained	  significant	  at	  the	  90%	  confidence	  
level	  for	  ASCOT	  and	  insignificant	  for	  EQ-­‐5D-­‐measured	  net	  benefit.	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Figure	  6-­‐16.	  ASCOT	  NMB	  Diff-­‐in-­‐Diff,	  comparing	  MI	  models	  (truncated	  regression	  is	  base	  against	  
PMM),	  point	  estimates	  and	  confidence	  intervals	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Figure	  6-­‐17.	  EQ-­‐5D	  NMB	  Diff-­‐in-­‐Diff,	  comparing	  MI	  models	  (truncated	  regression	  is	  base	  against	  
PMM),	  point	  estimates	  and	  confidence	  intervals	  
	  
	  
6.9.2 Cost	  assumptions	  
The	  main	  cost	  assumption	  concerns	  the	  threshold	  at	  which	  personal	  health	  budgets	  are	  regarded	  as	  
funded	  by	  substitution	  rather	  than	  by	  additional	  resources.	  In	  the	  main	  analysis	  we	  assumed	  a	  
threshold	  of	  £1000	  per	  annum:	  that	  is,	  personal	  health	  budgets	  of	  £1000	  or	  less	  in	  each	  service	  
category	  were	  provided	  in	  addition	  to	  convention	  services	  in	  that	  category.	  Budgets	  over	  £1000	  for	  
each	  category	  of	  service	  were	  provided	  as	  a	  substitute	  for	  conventional	  service	  in	  that	  category.	  
To	  test	  the	  sensitivity	  of	  this	  assumption	  we	  re-­‐estimated	  the	  models	  with	  a	  £500	  limit	  instead.	  We	  
also	  re-­‐estimated	  with	  no	  limit,	  meaning	  that	  the	  personal	  health	  budget	  substituted	  for	  all	  service	  
categories.	  This	  latter	  option	  is	  very	  unlikely	  to	  be	  valid	  in	  practice	  and	  is	  provided	  only	  for	  
comparison.	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Figure	  6-­‐18.	  ASCOT	  NMB	  Diff-­‐in-­‐Diff,	  comparing	  base	  cost	  assumption	  (£1000	  limit)	  with	  the	  
alternative	  assumption	  (£500	  limit),	  point	  estimates	  and	  confidence	  intervals	  
	  
Figure	  6-­‐19.	  EQ-­‐5D	  NMB	  Diff-­‐in-­‐Diff,	  comparing	  base	  cost	  assumption	  (£1000	  limit)	  with	  the	  
alternative	  assumption	  (£500	  limit),	  point	  estimates	  and	  confidence	  intervals	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Figure	  6-­‐20.	  ASCOT	  NMB	  Diff-­‐in-­‐Diff,	  comparing	  base	  cost	  assumption	  (£1000	  limit)	  with	  the	  
alternative	  assumption	  (£0	  limit),	  point	  estimates	  and	  confidence	  intervals	  
	  
Figure	  6-­‐21.	  EQ-­‐5D	  NMB	  Diff-­‐in-­‐Diff,	  comparing	  base	  cost	  assumption	  (£1000	  limit)	  with	  the	  
alternative	  assumption	  (£0	  limit),	  point	  estimates	  and	  confidence	  intervals	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7 The	  impact	  of	  receiving	  personal	  health	  budgets	  on	  carers	  
7.1 Summary	  
	  
An	  important	  element	  of	  the	  evaluation	  was	  to	  explore	  whether	  personal	  health	  budgets	  had	  an	  impact	  
on	  informal	  care	  and	  on	  the	  caring	  role,	  compared	  to	  conventional	  service	  delivery.	  There	  were	  three	  
aims:	  
 To	  explore	  whether	  personal	  health	  budgets	  had	  an	  impact	  on	  participants’	  receipt	  of	  informal	  
care.	  	  
 To	  explore	  the	  perceptions	  held	  by	  informal	  carers	  who	  provided	  help	  to	  participants	  in	  both	  the	  
personal	  health	  budget	  and	  the	  control	  group.	  	  
 To	  explore	  whether	  personal	  health	  budgets	  had	  an	  impact	  on	  carers’	  quality	  of	  life	  and	  the	  
caring	  role,	  compared	  with	  conventional	  service	  delivery.	  
In	  total,	  147	  questionnaires	  were	  received	  from	  the	  sample	  of	  282	  carers	  (52%).	  Of	  these,	  88	  were	  caring	  
for	  a	  participant	  in	  the	  personal	  health	  budget	  group	  and	  59	  for	  a	  participant	  in	  the	  control	  group.	  
From	  the	  difference-­‐in-­‐difference	  multivariate	  analysis,	  a	  number	  of	  key	  results	  were	  found:	  	  
 In	  the	  whole	  sample	  analysis	  we	  did	  not	  find	  a	  significant	  difference	  in	  the	  reported	  use	  of	  
informal	  care	  between	  personal	  health	  budget	  and	  control	  groups.	  	  
 Personal	  health	  budgets	  using	  implementation	  model	  3	  were	  associated	  with	  an	  increase	  in	  
informal	  care	  receipt	  inside	  the	  household	  relative	  to	  controls.	  	  
 Personal	  health	  budgets	  of	  model	  1	  type	  were	  associated	  with	  a	  decrease	  in	  informal	  care	  receipt	  
from	  outside	  the	  household	  relative	  to	  controls.	  	  
 We	  also	  found	  that	  personal	  health	  budgets	  of	  model	  2	  type	  were	  associated	  with	  an	  increase	  in	  
informal	  care	  receipt	  inside	  the	  household	  relative	  to	  controls.	  	  
This	  pattern	  of	  results	  does	  not	  entirely	  accord	  with	  our	  prior	  expectation	  that	  personal	  health	  budgets	  
would	  reduce	  the	  need	  for	  people	  to	  rely	  on	  informal	  care.	  	  
Analysis	  involving	  the	  data	  from	  the	  carer	  outcome	  questionnaire	  revealed:	  	  
 Carers	  providing	  assistance	  to	  an	  individual	  in	  the	  personal	  health	  budget	  group	  were	  more	  likely	  
to	  report	  better	  quality	  of	  life	  and	  perceived	  health	  compared	  to	  carers	  assisting	  an	  individual	  in	  
the	  control	  group.	  	  
 Carers	  in	  the	  personal	  health	  budget	  group	  generally	  reported	  lower	  instances	  of	  having	  their	  
health	  affected	  by	  their	  caring	  role.	  
 Carers	  seemed	  to	  be	  satisfied	  with	  the	  personal	  health	  budget	  process	  in	  terms	  of	  support	  
planning,	  the	  amount	  of	  the	  budget	  and	  the	  amount	  of	  help	  that	  was	  offered	  when	  deciding	  
what	  services	  or	  support	  to	  purchase	  from	  the	  personal	  health	  budget.	  




An	  important	  element	  of	  the	  evaluation	  was	  to	  explore	  whether	  personal	  health	  budgets	  had	  an	  
impact	  on	  informal	  care	  and	  on	  the	  caring	  role,	  compared	  to	  conventional	  service	  delivery.	  Three	  
questions	  will	  be	  addressed	  in	  this	  chapter:	  
 Is	  there	  evidence	  to	  suggest	  that	  personal	  health	  budgets	  have	  a	  significant	  impact	  on	  
informal	  care	  receipt	  at	  follow-­‐up	  compared	  to	  conventional	  service	  delivery?	  
 What	  factors	  are	  associated	  with	  a	  change	  in	  informal	  care	  receipt?	  
 Is	  there	  evidence	  to	  suggest	  that	  personal	  health	  budgets	  had	  an	  impact	  on	  carers’	  quality	  of	  
life	  and	  the	  caring	  role,	  compared	  with	  conventional	  service	  delivery?	  
This	  chapter	  is	  structured	  as	  follows.	  In	  the	  next	  section	  we	  briefly	  review	  the	  methods	  that	  we	  used	  
to	  explore	  the	  effects	  of	  using	  a	  personal	  health	  budget	  on	  carers.	  Section	  7.4	  reports	  the	  results	  of	  
the	  analysis	  of	  receipt	  of	  informal	  care.	  Section	  7.5	  presents	  the	  results	  of	  the	  analysis	  of	  carer	  
impact	  and	  we	  end	  with	  a	  discussion	  of	  those	  results	  in	  Section	  7.6.	  
7.3 Method	  
One	  of	  the	  aims	  of	  the	  overall	  study	  was	  to	  explore	  whether	  personal	  health	  budgets	  had	  an	  impact	  
on	  participants’	  receipt	  of	  informal	  care.	  The	  baseline	  and	  main	  follow-­‐up	  outcome	  questionnaires	  
asked	  whether	  participants	  received	  practical	  help	  on	  a	  regular	  basis	  from	  any	  friends,	  neighbours,	  
partner	  or	  family	  member	  who	  lived	  in	  or	  outside	  the	  service	  user’s	  household.	  The	  questionnaire	  
also	  asked	  about	  the	  number	  of	  different	  people	  who	  provided	  support,	  and	  the	  relationship	  the	  
participant	  had	  with	  people	  who	  provided	  support.	  
An	  additional	  aim	  of	  the	  study	  was	  to	  explore	  the	  perceptions	  held	  by	  informal	  carers	  who	  provided	  
help	  to	  participants	  in	  both	  the	  personal	  health	  budget	  and	  the	  control	  group.	  The	  data	  collection	  
included	  sending	  a	  postal	  questionnaire	  to	  carers	  of	  participants	  recruited	  to	  the	  main	  study	  12	  
months	  after	  the	  date	  of	  consent.	  At	  the	  time	  of	  recruitment	  the	  participant	  was	  asked	  whether	  they	  
would	  give	  permission	  for	  their	  carer	  to	  be	  contacted.	  The	  questionnaire	  included	  a	  number	  of	  
outcome	  measures	  to	  explore	  whether	  personal	  health	  budgets	  had	  an	  impact	  on	  carers’	  quality	  of	  
life	  and	  the	  caring	  role.	  Appendix	  A	  describes	  the	  measures	  used	  in	  more	  detail,	  and	  here	  we	  briefly	  
summarise	  them.	  
 Health-­‐related	  quality	  of	  life:	  The	  EQ-­‐5D	  utility	  scale	  aims	  to	  measure	  a	  person’s	  quality	  of	  
life	  in	  domains	  likely	  to	  be	  related	  to	  their	  underlying	  health	  status.	  It	  measures	  personal	  
functioning	  (as	  potentially	  constrained	  by	  poor	  health).	  We	  use	  the	  three-­‐level	  version	  in	  this	  
study.	  
 Care-­‐related	  quality	  of	  life:	  The	  scale	  was	  based	  on	  the	  first	  national	  survey	  of	  adult	  carers’	  
experiences,	  views	  and	  outcomes	  conducted	  in	  England	  by	  councils	  with	  social	  services	  




 Perceived	  quality	  of	  life:	  The	  seven-­‐point	  scale	  with	  categories	  ranging	  from	  ‘So	  good,	  it	  
could	  not	  be	  better’	  to	  ‘So	  bad,	  it	  could	  not	  be	  worse’.	  
	  
 Perceived	  health:	  The	  five-­‐point	  scale	  asks	  respondents	  to	  rate	  their	  health	  in	  general	  
according	  to	  five	  categories	  ranging	  from	  ‘Very	  good’	  to	  ‘Very	  bad’.	  
	  
The	  outcome	  questionnaire	  also	  contained	  a	  number	  of	  socio-­‐demographic	  and	  socio-­‐economic	  
questions	  which	  will	  be	  controlled	  for	  in	  the	  multivariate	  analysis.	  
The	  quantitative	  arm	  of	  the	  study	  was	  supplemented	  with	  qualitative	  data	  derived	  from	  semi-­‐
structured	  interviews	  with	  a	  sub-­‐sample	  of	  carers.	  These	  interviews	  were	  conducted	  three	  and	  nine	  
months	  after	  the	  offer	  of	  a	  personal	  health	  budget	  was	  made	  to	  the	  cared-­‐for	  person.	  Semi-­‐
structured	  interviews	  were	  conducted	  only	  with	  carers	  of	  someone	  in	  receipt	  of	  a	  personal	  health	  
budget.	  
7.3.1 Response	  rates	  
The	  initial	  analysis	  was	  run	  on	  the	  main	  imputed	  dataset	  to	  explore	  variation	  in	  informal	  care	  receipt	  
between	  baseline	  and	  follow-­‐up	  (See	  Appendix	  C,	  section	  C-­‐7	  for	  details).	  
The	  dataset	  containing	  responses	  from	  carers	  was	  used	  to	  explore	  whether	  personal	  health	  budgets	  
had	  an	  impact	  on	  their	  quality	  of	  life	  and	  the	  caring	  role.	  This	  analysis	  was	  followed	  by	  running	  
analysis	  on	  the	  dataset	  containing	  responses	  from	  carers.	  At	  the	  time	  of	  recruitment	  to	  the	  main	  
study,	  282	  participants	  agreed	  that	  their	  carer	  could	  be	  contacted	  by	  the	  research	  team.	  The	  
following	  processes	  were	  followed	  with	  the	  aim	  of	  obtaining	  the	  best	  possible	  sample	  of	  carers	  for	  
this	  aspect	  of	  the	  study.	  
1. A	  postal	  questionnaire	  was	  sent	  to	  carers	  12	  months	  after	  the	  cared-­‐for	  person	  had	  
consented	  to	  participate	  in	  the	  study;	  
2. A	  reminder	  questionnaire	  was	  sent	  to	  non-­‐respondents	  five	  weeks	  after	  the	  initial	  
questionnaire	  was	  sent	  to	  carers;	  
3. Where	  a	  participant’s	  consultee	  was	  a	  carer,	  an	  invitation	  letter	  and	  questionnaire	  were	  sent	  
to	  ask	  whether	  they	  would	  be	  willing	  to	  participate	  in	  the	  study.	  41	  
	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
41	  To	  reduce	  burden	  on	  carers	  and	  increase	  response	  rates,	  not	  all	  questions	  were	  included	  in	  reminder	  questionnaires	  and	  
questionnaires	  to	  consultees.	  This	  is	  reflected	  in	  the	  responses	  to	  some	  questions.	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7.3.2 Analyses	  of	  responses	  
The	  difference-­‐in-­‐difference	  approach	  was	  followed	  to	  allow	  us	  to	  explore	  whether	  personal	  health	  
budgets	  had	  an	  impact	  on	  receipt	  of	  informal	  care	  compared	  to	  conventional	  service	  delivery.	  The	  
analysis	  explored	  whether	  the	  average	  change	  in	  informal	  care	  receipt	  in	  the	  personal	  health	  budget	  
group	  was	  higher	  than	  the	  average	  change	  in	  the	  control	  group.	  A	  number	  of	  confounding	  factors	  
were	  used	  in	  the	  analysis	  to	  control	  for	  any	  differences	  in	  the	  characteristics	  of	  individuals	  within	  the	  
personal	  health	  budget	  and	  control	  groups.	  Furthermore,	  the	  impact	  that	  personal	  health	  budget	  
implementation	  models	  had	  on	  explaining	  changes	  to	  informal	  care	  receipt	  was	  explored	  in	  the	  
multivariate	  difference-­‐in-­‐difference	  analysis.	  
This	  analysis	  will	  be	  followed	  by	  exploring	  whether	  personal	  health	  budgets	  had	  an	  impact	  on	  carers’	  
perceptions	  of	  quality	  of	  life,	  health	  and	  their	  caring	  role.	  However,	  the	  extent	  to	  which	  we	  can	  
explore	  sub-­‐groups	  is	  limited	  due	  to	  the	  sample	  size	  of	  carers	  participating	  in	  the	  study.	  
7.4 Variation	  in	  informal	  care	  receipt	  between	  baseline	  and	  follow-­‐up	  
The	  initial	  analysis	  explored	  the	  variation	  in	  informal	  care	  receipt	  between	  baseline	  and	  follow-­‐up.	  
Table	  7-­‐1	  shows	  there	  was	  an	  increase	  in	  receiving	  informal	  care	  at	  follow-­‐up	  in	  both	  groups,	  
although	  the	  change	  was	  lower	  among	  individuals	  in	  the	  personal	  health	  budget	  group.	  However,	  
potentially	  baseline	  differences	  could	  account	  for	  some	  of	  the	  difference	  in	  change,	  rather	  than	  
receiving	  the	  personal	  health	  budget.	  For	  this	  reason	  we	  also	  estimated	  the	  difference	  in	  the	  change	  
over	  time	  when	  controlling	  for	  a	  range	  of	  baseline	  characteristics.	  	  
	  
Table	  7-­‐1	  Informal	  care	  receipt–	  sample	  means	  and	  differences,	  baseline	  and	  follow-­‐up	  
	   	   PHB	  Group	   Control	  Group	  
	   	   Mean	   SD	   Mean	   SD	  
Informal	  care	  within	  
household	  
Baseline	   .565	   .496	   .474	   .499	  
Follow-­‐up	   .572	   .495	   .520	   .499	  
Change	   .006	   .469	   .043	   .485	  
Informal	  care	  
outside	  household	  
Baseline	   .412	   .492	   .364	   .481	  
Follow-­‐up	   .663	   .473	   .699	   .459	  
Change	   .249	   .756	   .335	   .733	  
No	  informal	  care	   Baseline	   .197	   .397	   .268	   .443	  
Follow-­‐up	   .139	   .345	   .144	   .351	  
Change	   -­‐.052	   .536	   -­‐.115	   -­‐.115	  
	  
Table	  7-­‐2	  shows	  that	  the	  difference	  in	  receiving	  informal	  care	  between	  baseline	  and	  follow-­‐up	  was	  
associated	  with	  baseline	  dependency	  levels	  and	  health	  conditions.	  The	  non-­‐significant	  interaction	  
effects	  with	  the	  group	  variable	  (personal	  health	  budget	  or	  control	  group)	  indicate	  that	  receiving	  a	  
personal	  health	  budget	  did	  not	  have	  a	  significant	  impact	  on	  informal	  care	  receipt.	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Table	  7-­‐2	  Direction	  of	  change	  in	  receipt	  of	  informal	  care,	  with	  control	  factors	  
	   Informal	  care	  receipt	  
inside	  the	  household	  
Informal	  care	  receipt	  
outside	  the	  household	  
No	  informal	  care	  receipt	  
	   Coeff	   Prob	   Coeff	   Prob	   Coeff	   Prob	  
PHB	  group	   .019	   .807	   -­‐.068	   .256	   .024	   .690	  
Age	   .003	   .457	   -­‐.001	   .707	   -­‐.000	   .871	  
Male	   -­‐.079	   .244	   .142	   .007**	   -­‐.063	   .261	  
ADL	  score	   -­‐.022	   .198	   -­‐.031	   .025
**	   .052	   .002**	  
ADL	  score	  (sqrd)	   .001	   .033**	   .002	   .000***	   -­‐.003	   .000***	  
Health	  condition	   	   	   	   	   	   	  
NHS	  Continuing	  
Healthcare	  
-­‐.495	   .025**	   .073	   .875	   .309	   .455	  
Stroke	   -­‐.348	   .220	   .072	   .887	   .370	   .422	  
Diabetes	   .009	   .974	   .175	   .714	   -­‐.063	   .883	  
Mental	  health	   -­‐.531	   .045**	   -­‐.013	   .979	   .318	   .464	  
COPD	   -­‐.370	   .144	   -­‐.015	   .975	   .316	   .465	  
Neurological	   -­‐.496	   .048**	   .129	   .790	   .349	   .413	  
	   	   	   	   	   	   	  
Follow-­‐up	  period	   -­‐.001	   .315	   .000	   .749	   .000	   .783	  
Consent	  date	   .000	   .569	   .000	   .344	   -­‐.000	   .641	  
Area	  cost	  adjust	   -­‐.028	   .968	   .356	   .370	   -­‐.321	   .411	  
Constant	   3.73	   .713	   5.93	   .376	   -­‐4.94	   .559	  
N	   2235	   	   2235	   	   2235	   	  
Model	  F	   4.16	   .000***	   3.97	   .000***	   9.87	   .000***	  
Significance	  levels:	  *	  p<0.10	  **	  p<0.05***	  p<	  0.001	  	  
As	  reported	  earlier,	  five	  implementation	  models	  were	  developed	  based	  on	  the	  findings	  from	  the	  in-­‐
depth	  qualitative	  interviews	  with	  organisational	  representatives	  (see	  Table	  1-­‐2).	  The	  models	  were	  
classified	  in	  terms	  of	  whether	  pilot	  sites	  informed	  budget	  holders	  of	  the	  amount	  in	  the	  personal	  
health	  budget	  before	  support	  planning	  began;	  the	  degree	  of	  flexibility	  in	  what	  services/help	  could	  be	  
purchased	  through	  the	  budget;	  and	  the	  degree	  to	  which	  different	  deployment	  options	  were	  offered	  
when	  the	  decision	  on	  how	  to	  manage	  the	  budget	  was	  made.	  The	  analysis	  highlights	  a	  significant	  
impact	  on	  informal	  care	  receipt	  after	  controlling	  for	  confounding	  variables.	  Personal	  health	  budgets	  
of	  model	  3	  type	  were	  associated	  with	  an	  increase	  in	  informal	  care	  receipt	  inside	  the	  household	  
relative	  to	  controls.	  Personal	  health	  budgets	  of	  model	  1	  type	  were	  associated	  with	  a	  decrease	  in	  
informal	  care	  receipt	  from	  outside	  the	  household	  relative	  to	  controls.	  We	  also	  found	  that	  personal	  
health	  budgets	  of	  model	  2	  type	  were	  associated	  with	  an	  increase	  in	  informal	  care	  receipt	  inside	  the	  
household	  relative	  to	  controls.	  This	  pattern	  of	  results	  does	  not	  entirely	  accord	  with	  our	  prior	  
expectation	  that	  personal	  health	  budgets	  would	  reduce	  the	  need	  for	  people	  to	  rely	  on	  informal	  care.	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Table	  7-­‐3	  Direction	  of	  change	  in	  receipt	  of	  informal	  care,	  with	  implementation	  models	  
	   Informal	  care	  receipt	  
inside	  the	  household	  
Informal	  care	  receipt	  
outside	  the	  household	  
No	  informal	  care	  receipt	  
	   Coeff	   Prob	   Coeff	   Prob	   Coeff	   Prob	  
Model	  1	   -­‐.150	   .124	   -­‐.191	   .011
**	   .073	   .362	  
Model	  2	   .030	   .023**	   -­‐.084	   .367	   .035	   .693	  
Model	  3	   .236	   .076*	   -­‐.035	   .750	   -­‐.152	   .166	  
Model	  4	   -­‐.100	   .333	   .009	   .932	   .103	   .325	  
Model	  5	   .032	   .727	   -­‐.144	   .024
**	   .056	   .398	  
Significance	  levels:	  *	  p<0.10	  **	  p<0.05***	  p<	  0.001	  	  
The	  next	  section	  will	  explore	  whether	  there	  was	  an	  impact	  on	  carers’	  quality	  of	  life	  and	  caring	  role.	  
7.5 The	  impact	  of	  personal	  health	  budgets	  on	  carers	  
In	  total,	  147	  questionnaires	  were	  received	  from	  the	  sample	  of	  282	  carers	  (52%).	  Of	  these,	  88	  were	  
caring	  for	  a	  participant	  in	  the	  personal	  health	  budget	  group	  and	  59	  for	  a	  participant	  in	  the	  control	  
group.	  The	  majority	  of	  carers	  were	  aged	  60	  years	  or	  over	  (58%,	  n=83)	  followed	  by	  carers	  aged	  45-­‐59	  
(32%,	  n=46).	  The	  remaining	  carers	  in	  the	  sample	  were	  aged	  16-­‐24	  (1%,	  n=2),	  25-­‐34	  (4%,	  n=5)	  and	  35-­‐
44	  (6%,	  n=8).	  Three	  people	  declined	  to	  answer.	  
Table	  7-­‐4	  shows	  the	  spread	  of	  health	  conditions	  in	  terms	  of	  the	  carers’	  looked-­‐after	  participants.	  
Notably,	  there	  are	  no	  carers	  for	  any	  participants	  with	  diabetes	  as	  their	  primary	  health	  condition.	  
Other	  than	  diabetes,	  carers	  for	  participants	  with	  COPD	  were	  the	  least	  represented	  in	  both	  the	  
personal	  health	  budget	  and	  control	  groups.	  The	  research	  team	  relied	  on	  participants	  in	  the	  main	  
study	  to	  consent	  for	  their	  carer	  to	  be	  contacted.	  
Table	  7-­‐4	  Health	  condition	  of	  the	  cared	  for	  participant	  




Stroke	   15%	  (13)	   26%	  (15)	  
Mental	  health	  	   20%	  (17)	   10%	  (6)	  
COPD	   5%	  (4)	   9%	  (5)	  
Neurological	  condition	   38%	  (33)	   34%	  (20)	  
Continuing	  healthcare	   22%	  (19)	   21%	  (12)	  
Total	   100%	  (86)	   100%	  (58)	  
	  
A	  number	  of	  semi-­‐structured	  interviews	  were	  also	  conducted	  with	  carers	  of	  personal	  health	  budget	  
holders,	  and	  evidence	  gathered	  from	  these	  will	  be	  drawn	  on	  throughout	  this	  chapter.	  Chapter	  3	  
provides	  a	  full	  description	  of	  the	  carers	  that	  participated	  in	  the	  in-­‐depth	  qualitative	  interviews.	  
Within	  the	  sample	  of	  carers,	  71%	  (n=45)	  were	  caring	  for	  a	  budget	  holder	  who	  was	  receiving	  
support/services	  paid	  for	  by	  the	  personal	  health	  budget.	  Of	  these,	  49%	  (n=22)	  had	  been	  receiving	  
their	  personal	  health	  budget	  for	  more	  than	  six	  months.	  Almost	  three	  quarters	  had	  been	  receiving	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their	  budget	  for	  at	  least	  three	  months.	  Some	  participants	  either	  had	  nothing	  in	  place	  at	  all,	  did	  not	  
have	  all	  of	  their	  budget	  in	  place,	  or	  had	  had	  their	  budget	  in	  place	  for	  a	  month	  or	  less	  (8%,	  n=4).	  
	  
Despite	  the	  delays	  within	  the	  implementation	  process,	  overall	  the	  personal	  health	  budget	  process	  
did	  appear	  to	  have	  an	  impact	  on	  carers’	  aspirations.	  Table	  7-­‐5	  explores	  the	  response	  among	  carers	  
when	  asked	  whether	  or	  not	  they	  thought	  the	  personal	  health	  budget	  had	  changed	  their	  view	  of	  what	  
could	  be	  achieved	  by	  the	  person	  they	  cared	  for.	  It	  shows	  that	  42%	  (n=31)	  of	  carers	  stated	  that	  their	  
view	  had	  changed	  ‘a	  lot’,	  39%	  (n=29)	  stated	  that	  their	  view	  had	  changed	  ‘a	  little’,	  while	  19%	  (n=14)	  
stated	  that	  their	  view	  had	  not	  changed	  at	  all.	  
Table	  7-­‐5	  Changed	  view	  of	  what	  cared	  for	  person	  can	  achieve	  
	   %	  (N)	  
Has	  the	  personal	  health	  budget	  changed	  your	  view	  
of	  what	  cared	  for	  person	  can	  achieve?	  
	  
A	  lot	  	   42%	  (31)	  
A	  little	   39%	  (29)	  
Not	  at	  all	  	   19%	  (14)	  
	  
Table	  7-­‐6	  shows	  the	  trend	  in	  satisfaction	  levels	  expressed	  by	  carers.	  This	  table	  indicates	  that	  carers	  
were	  generally	  satisfied	  with	  the	  amount	  of	  the	  budget	  that	  the	  person	  they	  cared	  for	  received	  (76%,	  
n=31)	  and	  that	  the	  majority	  of	  carers	  were	  also	  satisfied	  with	  the	  knowledge	  of	  the	  support	  planner	  
(74%,	  n=32).	  When	  asked	  whether	  they	  thought	  the	  cared-­‐for	  person	  had	  enough	  help	  with	  deciding	  
what	  to	  spend	  their	  personal	  health	  budget	  on,	  86%	  of	  carers	  agreed	  (n=30).	  A	  majority	  of	  carers	  
(78%;	  n=66)	  expressed	  a	  degree	  of	  satisfaction	  with	  the	  support	  planning	  process,	  and	  more	  carers	  in	  
the	  personal	  health	  budget	  group	  (29%,	  n=22)	  reported	  that	  it	  was	  ‘very	  easy’	  to	  get	  the	  support	  or	  
services	  they	  needed	  in	  place	  compared	  to	  carers	  in	  the	  control	  group	  (13%,	  n=6).	  All	  results	  in	  the	  
table	  did	  not	  reach	  statistical	  significance	  due	  to	  the	  small	  sample	  sizes.	  Percentages	  may	  not	  equal	  
100	  due	  to	  rounding.	  	  
Table	  7-­‐6	  Satisfaction	  and	  support	  planning	  process	  (personal	  health	  budget	  group)	  
	   Satisfaction	  with	  
amount	  of	  budget	  
Satisfaction	  with	  




Extremely	  satisfied	   24%	  (10)	   19%	  (8)	   14%	  (12)	  
Very	  satisfied	   29%	  (12)	   26%	  (11)	   25%	  (21)	  
Quite	  satisfied	   22%	  (9)	   30%	  (13)	   39%	  (33)	  
Neither	  satisfied	  nor	  dissatisfied	   12%	  (5)	   7%	  (3)	   6%	  (5)	  
Quite	  dissatisfied	   2%	  (1)	   9%	  (4)	   6%	  (5)	  
Very	  dissatisfied	   5%	  (2)	   2%	  (1)	   2%	  (2)	  
Extremely	  dissatisfied	   5%	  (2)	   7%	  (3)	   7%	  (6)	  




The	  13	  carers	  that	  took	  part	  in	  the	  in-­‐depth	  interviews	  had	  mixed	  experiences	  of	  implementation	  and	  
support	  planning.	  One	  carer	  reported	  clear	  benefits	  from	  her	  lead	  role	  in	  planning	  how	  her	  son’s	  
budget	  would	  be	  used:	  	  
“It	  did	  me	  good	  because	  I	  actually	  sat	  down	  over	  a	  few	  days	  and	  wrote	  out	  a	  list	  of	  
things.	  ...	  When	  you’re	  a	  carer	  you’re	  so	  wrapped	  up	  in	  just	  trying	  to	  get	  through	  the	  day	  
and	  the	  next	  day,	  you	  don’t	  really	  think	  outside	  the	  box.	  It	  kind	  of	  threw	  a	  spanner	  in	  the	  
works	  for	  me	  really	  ...	  but	  it	  was	  good	  for	  me	  to	  think	  outside	  the	  box	  and	  it’s	  made	  me	  
think	  outside	  the	  box	  in	  other	  ways”	  (carer).	  
One	  or	  two	  carers	  reported	  receiving	  a	  great	  deal	  of	  help	  with	  the	  recruitment	  and	  on-­‐going	  
employment	  of	  paid	  carers	  to	  be	  funded	  by	  the	  personal	  health	  budget	  where	  this	  was	  required.	  In	  
addition,	  carers	  of	  people	  with	  a	  long-­‐term	  neurological	  condition,	  and	  in	  particular	  those	  eligible	  for	  
NHS	  Continuing	  Healthcare,	  described	  how	  their	  own	  needs	  were	  also	  addressed	  as	  part	  of	  the	  care	  
planning	  process:	  
“It	  takes	  the	  pressure	  off	  of	  me.	  I’ll	  get	  a	  break	  which’ll	  mean	  that	  I’m	  not	  tired	  all	  the	  
time...	  and	  I	  think	  that’s	  better	  for	  [son]	  as	  well	  that	  I’m	  not	  stressed	  out	  all	  the	  time”	  
(carer).	  
Around	  half	  of	  the	  carers	  interviewed	  for	  the	  in-­‐depth	  arm	  of	  the	  study	  had	  experienced	  difficulties	  
or	  delays	  in	  decision-­‐making	  about	  the	  size	  of	  their	  relative’s	  budget,	  agreeing	  care/support	  plans,	  or	  
setting	  up	  efficient	  payment	  arrangements.	  Indeed,	  three	  of	  the	  13	  carers	  still	  did	  not	  have	  a	  budget	  
in	  place	  at	  the	  time	  of	  their	  nine-­‐month	  interview.	  The	  problems	  mainly	  affected	  carers	  supporting	  
people	  with	  long-­‐term	  neurological	  conditions	  or	  who	  were	  eligible	  for	  NHS	  Continuing	  Healthcare.	  
Some	  problems	  appeared	  to	  reflect	  difficulties	  in	  agreeing	  the	  respective	  responsibilities	  of	  local	  NHS	  
and	  social	  care	  agencies,	  where	  both	  were	  involved	  in	  funding	  high-­‐level	  support	  packages	  for	  people	  
with	  very	  complex	  needs,	  or	  where	  funding	  responsibilities	  transferred	  from	  social	  services	  to	  NHS	  
Continuing	  Healthcare.	  For	  example,	  one	  carer	  wanted	  to	  use	  an	  underspend	  in	  her	  social	  care	  
personal	  budget	  for	  a	  ‘special	  offer’	  on	  gym	  membership	  for	  her	  son,	  but:	  
“They	  said	  ‘No,	  health’s	  got	  to	  pay	  for	  that.’	  I	  said	  ‘I’m	  a	  bit	  confused	  now,	  is	  that	  self-­‐
directed?’	  and	  they	  said	  ‘Yes,	  but	  that’s	  a	  health	  [thing]’”	  (carer).	  
Other	  carers	  reported	  difficulties	  when	  arrangements	  for	  managing	  the	  personal	  health	  budget	  were	  
inconsistent	  with	  those	  already	  in	  place	  to	  manage	  a	  social	  care	  personal	  budget;	  occasionally	  new	  
arrangements	  for	  employing	  and	  paying	  personal	  assistants	  were	  required	  which	  worked	  less	  well	  
than	  those	  they	  had	  been	  using	  for	  many	  years	  for	  social	  care-­‐funded	  support.	  It	  is	  worth	  noting	  that	  
carers	  recruited	  to	  the	  study	  were	  among	  the	  first	  people	  to	  be	  engaged	  in	  using	  a	  personal	  health	  
budget	  and	  therefore	  some	  of	  these	  difficulties	  are	  likely	  to	  reflect	  the	  challenges	  of	  setting	  up	  a	  new	  
pilot	  programme.	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7.5.1 Impact	  of	  personal	  health	  budgets	  on	  the	  health	  and	  quality	  of	  life	  of	  carers	  
One	  of	  the	  main	  aims	  of	  this	  analysis	  was	  to	  explore	  whether	  personal	  health	  budgets	  had	  an	  impact	  
on	  the	  quality	  of	  life	  and	  the	  caring	  role	  of	  carers	  compared	  to	  carers	  providing	  help	  to	  someone	  in	  
the	  control	  group.	  
Carers	  were	  asked	  whether	  specific	  aspects	  of	  their	  health	  had	  been	  affected	  by	  their	  caring	  role	  in	  
the	  last	  12	  months.	  Table	  7-­‐7	  details	  their	  responses.	  Carers	  in	  the	  personal	  health	  budget	  group	  
generally	  reported	  lower	  instances	  of	  having	  their	  health	  affected	  by	  their	  caring	  role.	  While	  the	  
findings	  are	  not	  statistically	  significant	  this	  is	  nonetheless	  an	  interesting	  observation,	  particularly	  
given	  that	  participants	  in	  the	  personal	  health	  budget	  group	  had	  higher	  levels	  of	  need	  and	  
dependency	  than	  participants	  in	  the	  control	  group	  (see	  Chapter	  3).	  However,	  carers	  in	  the	  personal	  
health	  budget	  group	  reported	  marginally	  greater	  problems	  with	  sleep,	  general	  feeling	  of	  stress	  and	  
irritableness.	  	  
Table	  7-­‐7	  Caring	  role	  and	  carers’	  health	  in	  the	  last	  12	  months	  
In	  the	  last	  12	  months	  has	  your	  health	  been	  






Feeling	  tired	   77%	  (36)	   81%	  (29)	  
Feeling	  depressed	   43%	  (20)	   50%	  (18)	  
Loss	  of	  appetite	   6%	  (3)	   14%	  (5)	  
Disturbed	  sleep	   66%	  (31)	   61%	  (22)	  
General	  feeling	  of	  stress	   62%	  (29)	   58%	  (21)	  
Physical	  strain	   43%	  (20)	   50%	  (18)	  
Short	  tempered/irritable	   43%	  (20)	   42%	  (15)	  
Had	  to	  see	  my	  own	  GP	   30%	  (14)	   28%	  (10)	  
Developed	  health	  condition	   11%	  (5)	   25%	  (9)	  
Made	  existing	  condition	  worse	   17%	  (8)	   25%	  (9)	  
Other	   4%	  (2)	   6%	  (2)	  
None	  of	  these	   11%	  (5)	   11%	  (4)	  
	  
7.5.2 Outcomes	  of	  personal	  health	  budgets	  for	  carers	  
Overall,	  carers	  providing	  assistance	  to	  an	  individual	  in	  the	  personal	  health	  budget	  group	  were	  more	  
likely	  to	  report	  better	  quality	  of	  life	  and	  perceived	  health	  than	  carers	  providing	  assistance	  to	  an	  
individual	  in	  the	  control	  group.	  Carers’	  perceived	  quality	  of	  life	  (a	  seven-­‐point	  scale);	  perceived	  
health	  (a	  five-­‐point	  scale);	  health-­‐related	  quality	  of	  life	  (EQ-­‐5D)	  and	  perceived	  health	  compared	  to	  12	  
months	  ago	  are	  shown	  in	  Table	  7-­‐8.	  EQ-­‐5D	  scores	  are	  marginally	  higher	  (indicating	  better	  health)	  for	  
carers	  in	  the	  personal	  health	  budget	  group	  than	  the	  control	  group,	  although	  the	  difference	  is	  not	  
statistically	  significant.	  Looking	  at	  health	  compared	  to	  12	  months	  ago,	  we	  can	  see	  that	  17%	  (n=14)	  of	  
carers	  in	  the	  personal	  health	  budget	  group	  stated	  that	  they	  felt	  ‘better’	  compared	  with	  5%	  (n=3)	  of	  
carers	  in	  the	  control	  group.	  It	  is	  also	  the	  case	  that	  more	  carers	  in	  the	  control	  group	  (30%,	  n=17)	  said	  
that	  they	  felt	  ‘worse’	  compared	  to	  carers	  in	  the	  personal	  health	  budget	  group	  (24%,	  n=20).	  Quality	  of	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life	  and	  self-­‐perceived	  health	  both	  indicate	  that	  those	  in	  the	  personal	  health	  budget	  group	  have	  a	  
more	  positive	  view.	  
Table	  7-­‐8	  Quality	  of	  life	  and	  well-­‐being	  for	  carers	  




Quality	  of	  life	   	   	  
So	  good,	  it	  could	  not	  be	  better	   1%	  (1)	   2%	  (1)	  
Very	  good	   13%	  (11)	   9%	  (5)	  
Good	   30%	  (26)	   27%	  (16)	  
Alright	   45%	  (39)	   39%	  (23)	  
Bad	   10%	  (9)	   17%	  (10)	  
Very	  bad	   1%	  (1)	   5%	  (1)	  
So	  bad,	  it	  could	  not	  be	  worse	   0%	  (0)	   2%	  (1)	  
EQ-­‐5D	   	   	  
Mean	  score	  (n)	  (sd)	   0.75	  (83)	  (0.17)	   0.72	  (59)	  (0.19)	  
Self-­‐perceived	  health	   	   	  
Very	  good	   17%	  (8)	   14%	  (5)	  
Good	   43%	  (20)	   36%	  (13)	  
Fair	   34%	  (16)	   36%	  (13)	  
Bad	   4%	  (2)	   14%	  (5)	  
Very	  bad	   2%	  (1)	   0%	  (0)	  
Health	  compared	  to	  12	  months	  ago	   	   	  
Better	   17%	  (14)	   5%	  (3)	  
Much	  the	  same	   60%	  (51)	   65%	  (37)	  
Worse	   24%	  (20)	   30%	  (17)	  
	  
When	  asked	  whether	  the	  personal	  health	  budget	  had	  an	  impact	  on	  their	  quality	  of	  life	  and	  health,	  
over	  40%	  of	  carers	  reported	  it	  had	  a	  positive	  impact:	  41%	  thought	  the	  personal	  health	  budget	  had	  an	  
impact	  on	  their	  own	  health,	  whilst	  56%	  (n=42)	  thought	  that	  the	  budget	  had	  an	  impact	  on	  their	  well-­‐
being.	  It	  would	  also	  seem	  that	  the	  deployment	  option	  had	  an	  effect	  on	  carers’	  well-­‐being.	  Over	  two-­‐
thirds	  of	  carers	  (68%;	  n=15)	  caring	  for	  patients	  receiving	  their	  personal	  health	  budget	  via	  the	  direct	  
payment	  deployment	  option	  said	  that	  the	  personal	  health	  budget	  had	  had	  a	  positive	  impact	  on	  their	  
well-­‐being	  compared	  to	  36%	  (n=10)	  of	  carers	  with	  participants	  using	  an	  alternative	  deployment	  
option.	  
A	  number	  of	  carers	  that	  took	  part	  in	  the	  in-­‐depth	  interviews	  reported	  benefits	  to	  their	  own	  well-­‐
being	  when	  they	  could	  see	  improvement	  in	  the	  quality	  of	  life	  for	  the	  person	  they	  supported,	  derived	  
from	  the	  latter’s	  personal	  health	  budget:	  
“Anything	  that’s	  positive	  in	  [son’s]	  life	  is	  a	  positive	  to	  me….	  It’s	  definitely	  had	  an	  impact	  on	  my	  
life	  as	  well	  because	  he’s	  just	  happier	  in	  himself,	  emotionally….	  He’s	  not	  so	  emotionally	  needy,	  
which	  has	  made	  my	  life	  a	  lot	  easier”	  (carer).	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Further	  to	  this,	  carers	  thought	  that	  one	  main	  direct	  benefit	  was	  an	  increase	  in	  the	  amount	  of	  support	  
provided	  by	  paid	  care	  workers,	  which	  relieved	  some	  of	  the	  carers’	  own	  responsibilities	  for	  providing	  
hands-­‐on	  care.	  Greater	  flexibility	  over	  respite	  care	  arrangements,	  including	  new	  opportunities	  to	  
‘save’	  some	  funding	  in	  case	  additional	  emergency	  respite	  was	  needed,	  was	  another	  direct	  benefit.	  
For	  example,	  a	  man	  caring	  full-­‐time	  for	  his	  wife	  had	  started	  to	  have	  an	  evening	  out	  each	  week	  
because	  of	  the	  respite	  funded	  from	  his	  wife’s	  personal	  health	  budget:	  
“Now	  I’ve	  got	  used	  to	  it	  I	  quite	  look	  forward	  to	  it	  ….	  It	  really	  does	  make	  a	  fantastic	  difference	  
because	  I’m	  actually	  free….[The	  break]	  blows	  all	  the	  cobwebs	  away	  and	  I	  enjoy	  myself	  for	  
four	  hours	  and	  then	  I	  come	  back	  and	  we	  start	  all	  over	  again”	  (carer).	  
“It’s	  changed	  my	  life	  actually	  because	  now	  I’ve	  got	  the	  flexibility	  of	  when	  I	  want	  respite…	  I	  
can	  save	  up	  the	  hours	  for	  when	  it’s	  a	  nice	  day	  and	  I	  can	  ask	  [paid	  care	  worker]	  to	  take	  [son]	  
out”	  (carer).	  
Personal	  health	  budgets	  allow	  people	  to	  use	  a	  wide	  range	  of	  support	  and	  services	  to	  best	  meet	  their	  
own	  needs.	  As	  shown	  in	  the	  previous	  chapter	  this	  did	  not	  increase	  costs	  in	  the	  personal	  health	  
budget	  group	  (and	  in	  some	  cases	  resulted	  in	  a	  decrease	  in	  costs),	  therefore	  it	  is	  possible	  that	  
outcomes	  such	  as	  those	  outlined	  above	  were	  achieved	  by	  people	  restructuring	  or	  changing	  the	  way	  
they	  utilise	  services	  as	  opposed	  to	  adding	  services	  to	  their	  original	  care	  package.	  	  
Indirect	  benefits	  enjoyed	  by	  carers	  included	  new	  opportunities	  for	  an	  adult	  child	  to	  start	  going	  out	  
and	  engaging	  in	  social	  activities	  with	  a	  paid	  carer,	  rather	  than	  a	  parent.	  Carers	  saw	  this	  as	  an	  
important	  first	  step	  towards	  establishing	  alternative	  care	  arrangements	  when	  they	  were	  no	  longer	  
able	  to	  provide	  care	  themselves:	  
“I	  like	  the	  fact	  that	  someone	  young	  is	  coming	  in	  and	  spending	  a	  bit	  of	  time	  with	  [son]	  so	  
that’s	  already	  a	  positive”	  (carer).	  
In	  contrast	  to	  some	  of	  the	  findings	  above,	  two	  of	  the	  13	  carers	  that	  were	  supporting	  relatives	  with	  
stroke	  or	  COPD	  reported	  no	  benefits	  whatsoever	  for	  themselves,	  as	  their	  respective	  partners’	  
personal	  health	  budgets	  were	  restricted	  to	  items	  directly	  linked	  to	  their	  healthcare	  -­‐	  for	  example,	  to	  
fund	  standard	  post-­‐stroke	  rehabilitation	  services.	  
Table	  7-­‐9	  that	  shows	  there	  was	  a	  positive	  trend	  in	  almost	  all	  domains	  within	  ASCOT	  quality	  of	  life	  for	  
carers	  (apart	  from	  ‘time	  to	  look	  after	  self’	  and	  ‘occupation	  and	  employment’).	  Similarly,	  a	  higher	  
proportion	  of	  carers	  in	  the	  control	  group	  reported	  having	  ‘high	  needs’	  in	  all	  domains	  barring	  safety	  
(which	  is	  equal	  (zero)	  for	  both	  groups).	  Again,	  this	  is	  potentially	  of	  interest	  given	  that	  the	  cared-­‐for	  
participants	  in	  the	  personal	  health	  budget	  group	  reported	  higher	  levels	  of	  need	  at	  baseline.	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Table	  7-­‐9	  ASCOT	  outcome	  domains	  and	  carers	  




Encouragement	  /	  support	  in	  caring	  role	   	   	  
No	  needs	   46%	  (40)	   40%	  (23)	  
Low	  needs	   44%	  (38)	   40%	  (23)	  
High	  needs	   10%	  (9)	   19%	  (13)	  
Social	  participation	  and	  involvement	   	   	  
No	  needs	   31%	  (27)	   26%	  (15)	  
Low	  needs	   56%	  (49)	   53%	  (30)	  
High	  needs	   13%	  (11)	   21%	  (12)	  
Control	  over	  daily	  life	   	   	  
No	  needs	   23%	  (20)	   17%	  (10)	  
Low	  needs	   63%	  (55)	   67%	  (39)	  
High	  needs	   14%	  (12)	   16%	  (9)	  
Space	  and	  time	  for	  self	   	   	  
No	  needs	   20%	  (17)	   17%	  (10)	  
Low	  needs	   64%	  (56)	   61%	  (36)	  
High	  needs	   16%	  (14)	   22%	  (13)	  
Safety	   	   	  
No	  needs	   92%	  (80)	   91%	  (53)	  
Low	  needs	   8%	  (7)	   9%	  (5)	  
High	  needs	   0%	  (0)	   0%	  (0)	  
Time	  to	  look	  after	  yourself	  (sleeping	  /eating)	   	   	  
No	  needs	   52%	  (45)	   59%	  (34)	  
Low	  needs	   31%	  (27)	   22%	  (13)	  
High	  needs	   17%	  (15)	   19%	  (11)	  
Occupation	  and	  employment	   	   	  
No	  needs	   12%	  (10)	   16%	  (9)	  
Low	  needs	   79%	  (68)	   71%	  (41)	  
High	  needs	   9%	  (8)	   14%	  (8)	  
Skills	  needed	  for	  caring	  	   	   	  
No	  needs	   92%	  (79)	   91%	  (50)	  
Low	  needs	   7%	  (6)	   7%	  (4)	  
High	  needs	   1%	  (1)	   2%	  (1)	  
	  
7.6 Discussion	  
The	  main	  findings	  suggest	  personal	  health	  budgets	  did	  not	  have	  an	  impact	  on	  the	  change	  of	  informal	  
care	  receipt	  at	  follow-­‐up	  compared	  to	  conventional	  service	  delivery	  once	  the	  confounding	  variables	  
were	  accounted	  for	  in	  the	  difference-­‐in-­‐difference	  multivariate	  analysis.	  	  
In	  the	  whole	  sample	  analysis	  we	  did	  not	  find	  a	  significant	  difference	  in	  the	  reported	  use	  of	  informal	  
care	  between	  the	  personal	  health	  budget	  and	  control	  group.	  There	  were	  some	  significant	  results	  in	  
the	  sub-­‐sample	  analysis	  in	  this	  regard.	  Personal	  health	  budgets	  of	  model	  3	  type	  were	  associated	  with	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an	  increase	  in	  informal	  care	  receipt	  inside	  the	  household	  relative	  to	  controls.	  Personal	  health	  
budgets	  of	  model	  1	  type	  were	  associated	  with	  a	  decrease	  in	  informal	  care	  receipt	  from	  outside	  the	  
household	  relative	  to	  controls.	  We	  also	  found	  that	  personal	  health	  budgets	  of	  model	  2	  type	  were	  
associated	  with	  an	  increase	  in	  informal	  care	  receipt	  inside	  the	  household	  relative	  to	  controls.	  This	  
pattern	  of	  results	  does	  not	  entirely	  accord	  with	  our	  prior	  expectation	  that	  personal	  health	  budgets	  
would	  reduce	  the	  need	  for	  people	  to	  rely	  on	  informal	  care.	  
Carers	  providing	  assistance	  to	  an	  individual	  in	  the	  personal	  health	  budget	  group	  were	  more	  likely	  to	  
report	  better	  quality	  of	  life	  and	  perceived	  health	  compared	  to	  carers	  assisting	  an	  individual	  in	  the	  
control	  group.	  Carers	  also	  seemed	  to	  be	  satisfied	  with	  the	  personal	  health	  budget	  process	  in	  terms	  of	  
support	  planning,	  the	  amount	  of	  the	  budget	  and	  the	  amount	  of	  help	  that	  was	  offered	  when	  deciding	  
what	  services	  or	  support	  to	  purchase	  from	  the	  personal	  health	  budget.	  However,	  we	  need	  to	  
exercise	  caution	  here	  due	  to	  the	  small	  sample	  sizes	  for	  the	  sub-­‐group	  analysis.	  
Findings	  from	  the	  semi-­‐structured	  interviews	  (Davidson	  et	  al.,	  2012)	  suggested	  that	  carers	  derived	  
little	  direct	  benefit	  from	  budgets	  that	  were	  tightly	  targeted	  at	  the	  symptoms	  and	  healthcare	  of	  the	  
person	  they	  supported.	  The	  potential	  for	  benefit	  appeared	  to	  be	  considerable	  among	  those	  carers	  
providing	  substantial	  amounts	  of	  support	  to	  a	  relative	  with	  a	  progressive	  long-­‐term	  neurological	  
condition	  or	  someone	  eligible	  for	  NHS	  Continuing	  Healthcare.	  As	  with	  the	  study	  of	  the	  impact	  of	  
social	  care	  individual	  budgets	  on	  carers	  (Glendinning	  et	  al.,	  2009),	  these	  benefits	  could	  be	  realised	  if	  
carers’	  needs	  for	  regular	  breaks,	  or	  for	  flexibility	  over	  the	  provision	  of	  respite	  care,	  were	  taken	  into	  
account	  in	  the	  care/support	  plan.	  Carers	  may	  also	  experience	  indirect	  benefits	  if	  they	  see	  
improvements	  in	  the	  health,	  well-­‐being,	  or	  quality	  of	  life	  of	  the	  person	  they	  support.	  However,	  
difficulties	  in	  agreeing	  complex	  funding	  responsibilities	  or	  alterations	  to	  established	  arrangements	  
for	  employing	  paid	  carers	  could	  potentially	  jeopardise	  and	  undermine	  these	  benefits.	  
Overall	  the	  findings	  suggest	  that	  personal	  health	  budgets	  have	  the	  potential	  to	  have	  a	  positive	  
impact	  on	  the	  lives	  of	  carers.	  However,	  the	  findings	  should	  be	  treated	  with	  caution	  due	  to	  the	  small	  
sample	  of	  carers,	  and	  a	  larger	  research	  study	  would	  be	  required	  before	  firm	  conclusions	  could	  be	  
made.	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8 Personal	  health	  budgets	  –	  successes	  and	  challenges	  
8.1 Summary	  
	  
This	  chapter	  draws	  together	  the	  main	  evidence	  to	  discuss	  the	  operation,	  benefits	  and	  costs	  of	  personal	  
health	  budgets.	  We	  then	  outline	  the	  limitations	  of	  this	  highly	  complex	  evaluation	  that	  should	  serve	  as	  
cautions	  when	  interpreting	  the	  results.	  	  
Overall	  the	  chapter	  outlines	  how	  the	  findings	  point	  to	  the	  conclusion	  that	  personal	  health	  budgets	  have	  
benefits	  in	  terms	  of	  higher-­‐order	  aspects	  of	  quality	  of	  life	  that	  are	  valued	  by	  people	  beyond	  
improvements	  in	  health	  status	  per	  se.	  	  
The	  value	  society	  places	  on	  the	  improvement	  of	  quality	  of	  life,	  particularly	  through	  improvements	  in	  
control	  and	  autonomy,	  will	  be	  critical	  in	  the	  overall	  conclusion	  about	  the	  cost-­‐effectiveness	  of	  personal	  
health	  budgets.	  In	  the	  main	  analysis	  we	  found	  personal	  health	  budgets	  to	  be	  cost	  effective	  when	  the	  
willingness	  to	  pay	  for	  a	  unit	  improvement	  of	  ASCOT	  quality	  of	  life	  over	  a	  year	  is	  more	  than	  £30,000.	  
The	  research	  limitations	  are	  broadly	  divided	  into	  three	  categories:	  	  
Evaluation	  design	  
 Rather	  than	  a	  single	  intervention	  there	  was	  a	  whole	  range	  of	  implementations	  of	  personal	  
health	  budgets	  with	  different	  models	  operating	  in	  the	  20	  in-­‐depth	  pilot	  sites	  over	  six	  patient	  
groups.	  Personal	  health	  budgets	  were	  entirely	  new	  and	  a	  radical	  departure	  in	  some	  areas,	  so	  
the	  operation	  of	  PHBs	  was	  developing	  and	  changing	  during	  the	  course	  of	  the	  evaluation.	  
 The	  pragmatic	  controlled	  design	  we	  used	  involved	  both	  randomised	  and	  non-­‐randomised	  sub-­‐
samples.	  In	  choosing	  the	  study	  design,	  the	  potential	  for	  selection	  bias	  in	  the	  absence	  of	  
randomisation	  was	  balanced	  against	  the	  potential	  for	  contamination	  bias,	  that	  is,	  the	  control	  
group	  being	  affected	  by	  the	  operation	  of	  the	  pilot	  programme.	  In	  the	  study,	  we	  had	  some	  
significant	  differences	  between	  the	  groups	  at	  baseline.	  The	  control	  group	  was	  significantly	  older	  
but	  also	  healthier	  than	  the	  personal	  health	  budget	  group.	  We	  have	  accounted	  for	  any	  
potentially	  biasing	  consequences	  by	  using	  a	  difference-­‐in-­‐difference	  design	  and	  also	  using	  
baseline	  control	  factors	  in	  the	  analysis	  where	  required.	  
Loss	  to	  follow-­‐up	  
 We	  expected	  drop-­‐out	  rates	  to	  be	  higher	  for	  this	  study	  population	  as	  a	  result	  of	  much	  lower	  
than	  population-­‐average	  health	  status	  and	  well-­‐being	  scores.	  We	  have	  suggested	  that	  the	  
reasons	  for	  drop-­‐out	  are	  due	  to	  baseline	  factors	  to	  a	  significant	  extent	  and	  therefore	  not	  a	  
source	  of	  bias	  in	  the	  evaluation	  of	  the	  personal	  health	  budget	  pilot	  programme.	  	  
Data	  quality	  
 A	  number	  of	  assumptions	  had	  to	  be	  made	  to	  produce	  like-­‐with-­‐like	  cost	  estimates	  between	  




Personal	  health	  budgets	  represent	  a	  significant	  departure	  from	  the	  conventional	  operation	  of	  the	  
health	  service.	  There	  has	  been	  considerable	  debate	  about	  the	  potential	  advantages	  and	  
disadvantages	  of	  personal	  health	  budgets.	  This	  evaluation	  has	  aimed	  to	  shed	  some	  light	  on	  these	  
questions.	  In	  this	  chapter	  we	  gather	  our	  analysis	  results	  and	  evidence	  together	  to	  discuss	  the	  
operation,	  benefits	  and	  costs	  of	  personal	  health	  budgets.	  In	  the	  next	  chapter	  we	  build	  on	  our	  findings	  
to	  discuss	  the	  implications	  for	  rolling	  out	  personal	  health	  budgets	  nationally.	  
We	  begin	  by	  assessing,	  overall,	  the	  effectiveness	  of	  personal	  health	  budgets,	  their	  costs	  and	  their	  
cost-­‐effectiveness.	  We	  then	  turn	  to	  a	  discussion	  of	  the	  robustness	  of	  the	  findings	  in	  terms	  of	  the	  
strengths	  and	  limitations	  of	  the	  evaluation.	  
8.3 Costs	  and	  benefits	  
We	  used	  a	  range	  of	  measures	  of	  outcome	  or	  effectiveness	  in	  the	  evaluation	  to	  build	  up	  a	  
comprehensive	  picture	  of	  the	  potential	  impact	  of	  personal	  health	  budgets.	  Broadly	  speaking,	  we	  can	  
distinguish	  our	  more	  objective	  clinical	  measures,	  such	  as	  the	  HbA1c	  blood	  glucose	  test,	  lung-­‐function	  
and	  mortality	  rates,	  from	  the	  more	  subjective	  measures	  that	  involve	  self-­‐report	  about	  health	  and	  
social	  care	  related	  quality	  of	  life	  (EQ-­‐5D	  and	  ASCOT),	  psychological	  well-­‐being	  (GHQ-­‐12)	  and	  
subjective	  global	  well-­‐being.	  Of	  the	  latter,	  there	  is	  also	  the	  distinction	  between	  measures	  focused	  on	  
personal	  health-­‐related	  functioning,	  such	  as	  EQ-­‐5D,	  and	  those	  which	  emphasise	  the	  achievement	  or	  
otherwise,	  through	  all	  means,	  of	  activities	  and	  experiences	  that	  are	  important	  to	  care-­‐related	  quality	  
of	  life,	  such	  as	  ASCOT.	  Finally,	  subjective	  (global)	  well-­‐being	  measures	  seek	  people’s	  overall	  rating	  of	  
life	  satisfaction,	  worry,	  happiness	  and	  satisfaction	  with	  health.	  
Key	  results	  with	  respect	  to	  the	  outcomes	  measures	  were	  as	  follows.	  
 The	  results	  of	  the	  analysis	  indicate	  that	  personal	  health	  budgets	  overall	  have	  a	  (statistically	  
significant)	  positive	  impact	  on	  care-­‐related	  quality	  of	  life	  (ASCOT)	  and	  psychological	  well-­‐
being	  (GHQ-­‐12).	  	  
 We	  found	  that	  the	  size	  and	  significance	  of	  the	  effect	  of	  personal	  health	  budgets	  on	  these	  
measures	  differed	  significantly	  for	  different	  configuration	  models	  of	  personal	  health	  budgets.	  
Personal	  health	  budgets	  models	  with	  high	  degrees	  of	  flexibility	  and	  choice	  showed	  especially	  
strong	  effects.	  The	  data	  also	  suggested	  that	  budgets	  of	  more	  than	  £1,000	  per	  year	  (40%	  of	  all	  
personal	  health	  budgets)	  were	  more	  effective	  than	  those	  with	  less	  than	  £1,000	  in	  the	  
budget.	  This	  latter	  result	  is	  likely	  to	  reflect	  the	  more	  limited	  scope	  of	  personal	  health	  budgets	  
with	  small	  budgets	  to	  make	  a	  meaningful	  difference.	  It	  might	  also	  be	  due	  to	  people	  with	  
higher	  levels	  of	  need	  –	  and	  hence	  larger	  budgets,	  other	  things	  equal	  –	  having	  a	  greater	  
capacity	  to	  benefit	  from	  personal	  health	  budgets	  than	  people	  with	  lower	  needs.	  
 The	  difference	  in	  effectiveness	  of	  personal	  health	  budgets	  for	  different	  health	  conditions	  was	  
less	  marked	  than	  we	  anticipated.	  With	  the	  exception	  of	  COPD,	  we	  found	  no	  significant	  
differences	  in	  this	  regard.	  COPD	  patients	  showed	  significant	  improvements	  on	  ASCOT,	  GHQ-­‐
12	  and	  subjective	  well-­‐being.	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 Personal	  health	  budgets	  appeared	  to	  have	  no	  impact	  on	  health	  status	  per	  se.	  We	  found	  no	  
significant	  effects	  with	  regard	  to	  the	  two	  clinical	  measures,	  HbA1c	  blood	  glucose	  test	  and	  
lung-­‐function,	  as	  used	  for	  the	  diabetes	  and	  COPD	  sub-­‐groups.	  Furthermore	  we	  found	  no	  
significant	  difference	  in	  mortality	  rates	  between	  the	  groups.	  
 Consistent	  with	  the	  previous	  result,	  the	  study	  did	  not	  find	  that	  personal	  health	  budgets	  had	  a	  
significant	  effect	  on	  EQ-­‐5D	  compared	  to	  the	  control	  group.	  	  
The	  cost	  analysis	  included	  a	  wide	  range	  of	  service	  and	  support	  expenditures,	  including	  those	  
classified	  as	  social	  care42,	  nursing,	  therapy	  and	  well-­‐being	  services	  that	  can	  be	  secured	  (directly)	  using	  
a	  personal	  health	  budget;	  and	  primary	  and	  secondary	  health	  care	  services	  that	  might	  be	  affected	  
indirectly.	  As	  regard	  the	  cost	  of	  services	  and	  support,	  personal	  health	  budgets	  can	  be	  provided	  in-­‐
addition	  to	  conventional	  services	  or	  as	  substitutes	  for	  conventional	  services.	  The	  main	  findings	  with	  
regard	  to	  costs	  were	  as	  follows.	  
 Personal	  health	  budgets	  were	  largely	  cost	  neutral	  (although	  there	  was	  substantial	  variation	  
in	  the	  level	  and	  types	  of	  costs	  between	  participants).	  For	  certain	  categories	  of	  expenditure,	  
the	  personal	  health	  budget	  group	  had	  slightly	  lower	  costs	  than	  the	  control	  group	  after	  
correcting	  for	  baseline	  differences.	  In	  particular,	  indirect	  costs	  (primary	  and	  secondary	  care	  
costs)	  were	  lower	  for	  the	  personal	  health	  budget	  group	  after	  subtracting	  baseline	  cost	  
differences.	  	  
 This	  neutral	  result	  was	  found	  where	  we	  used	  the	  relatively	  conservative	  assumption	  that	  
many	  personal	  health	  budgets	  (60%+)	  were	  provided	  in-­‐addition	  to	  conventional	  services.	  
For	  high-­‐budget	  personal	  health	  budgets	  (more	  than	  £1000	  a	  year)	  where	  the	  PHB	  was	  more	  
likely	  to	  be	  provided	  as	  a	  substitute	  for	  conventional	  service	  delivery,	  costs	  were	  lower	  after	  
baseline	  for	  the	  personal	  health	  budget	  group	  compared	  to	  controls	  at	  the	  10%	  significance	  
level.	  
The	  analysis	  focused	  on	  recurrent	  costs	  and	  did	  not	  include	  one-­‐off	  costs	  such	  as	  set-­‐up	  costs.	  We	  did	  
not	  attempt	  a	  comparison	  of	  the	  transaction	  costs	  of	  personal	  health	  budgets	  compared	  to	  
conventional	  service	  delivery	  arrangements	  due	  to	  the	  variation	  with	  implementing	  the	  initiative	  
within	  the	  pilot	  sites.	  
The	  quantitative	  analysis	  also	  considered	  the	  impact	  of	  personal	  health	  budgets	  on	  the	  utilisation	  of	  
carers.	  We	  did	  not,	  however,	  find	  an	  increase	  in	  the	  proportion	  of	  budget	  holders	  claiming	  to	  have	  
either	  co-­‐resident	  or	  other	  carers,	  as	  compared	  to	  the	  control	  group.	  
The	  cost-­‐effectiveness	  analysis	  assessed	  differences	  in	  net	  monetary	  benefit	  between	  the	  personal	  
health	  budget	  and	  control	  groups.	  Net	  monetary	  benefit	  (NMB)	  is	  the	  £-­‐equivalent	  value	  of	  gains	  in	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  




EQ-­‐5D	  or	  ASCOT	  (initially	  assumed	  to	  be	  £30,000	  per	  unit	  gain	  in	  EQ-­‐5D	  or	  ASCOT	  for	  one	  year)	  less	  
the	  cost	  of	  services	  and	  support.	  
 For	  all	  types	  of	  personal	  health	  budgets,	  the	  results	  suggested	  that	  personal	  health	  budgets	  
were	  cost-­‐effective	  with	  regard	  to	  ASCOT	  outcomes:	  people	  in	  the	  personal	  health	  budget	  
group	  reported	  higher	  net	  (monetary)	  benefit	  than	  for	  people	  in	  the	  control	  group	  after	  
subtracting	  any	  baseline	  difference	  in	  net	  benefit	  between	  the	  groups.	  This	  result	  was	  
significant	  overall	  at	  the	  10%	  significance	  level.	  
 We	  did	  not,	  however,	  find	  a	  statistically	  significant	  difference	  in	  net	  benefit	  between	  the	  
groups	  when	  benefits	  were	  measured	  on	  the	  EQ-­‐5D	  scale.	  
 When	  we	  compared	  specific	  types	  of	  personal	  health	  budget	  to	  conventional	  service	  delivery	  
we	  found	  cost-­‐effectiveness	  at	  a	  higher	  level	  of	  significance.	  People	  using	  personal	  health	  
budgets	  implemented	  as	  model	  1	  reported	  a	  greater	  positive	  change	  in	  ASCOT	  compared	  to	  
those	  in	  the	  control	  group,	  significant	  at	  the	  5%	  level.	  The	  same	  result	  also	  occurred	  for	  
people	  using	  personal	  health	  budgets	  with	  a	  budget	  of	  more	  than	  £1000	  a	  year,	  also	  with	  
significance	  at	  5%.	  
 We	  found	  little	  difference	  in	  the	  effect	  size	  of	  personal	  health	  budgets	  for	  the	  different	  
health	  condition	  sub-­‐groups	  compared	  to	  the	  whole-­‐sample	  effect.	  We	  did	  find	  personal	  
health	  budgets	  to	  be	  significantly	  cost-­‐effective	  (at	  10%)	  when	  just	  comparing	  personal	  
health	  budget	  and	  control	  groups	  in	  the	  sub-­‐samples	  for	  patients	  within	  the	  NHS	  Continuing	  
Healthcare	  and	  mental	  health	  cohorts.	  These	  results	  suggest,	  somewhat	  tentatively,	  that	  the	  
net	  benefits	  of	  a	  personal	  health	  budget	  are	  greater	  for	  NHS	  Continuing	  Healthcare	  and	  
patients	  with	  mental	  health	  problems	  than	  for	  other	  patient	  groups.	  
 Further	  investigation	  of	  the	  main	  effect	  routes	  estimated	  that	  people	  with	  personal	  health	  
budgets	  would	  have	  significantly	  better	  ASCOT	  outcomes	  than	  controls	  after	  removing	  any	  
differences	  in	  total	  expenditure	  on	  services.	  The	  same	  result	  was	  also	  found	  for	  EQ-­‐5D	  when	  
only	  £1,000+	  personal	  health	  budgets	  were	  considered.	  These	  findings	  support	  our	  
conjecture	  that	  the	  extra	  choice	  and	  control,	  and	  its	  consequences,	  are	  the	  main	  reasons	  
why	  personal	  health	  budgets	  produce	  greater	  net	  benefits	  than	  conventional	  service	  delivery	  
(rather	  than	  just	  differences	  in	  resourcing	  levels	  for	  personal	  health	  budgets).	  Choice	  and	  
control	  can	  be	  valued	  for	  its	  own	  sake	  and	  as	  a	  means	  for	  people	  to	  secure	  services	  and	  
support	  that	  better	  fits	  with	  their	  own	  needs	  and	  preferences.	  
The	  findings	  point	  to	  the	  conclusion	  that	  personal	  health	  budgets	  have	  benefits	  in	  terms	  of	  higher-­‐
order	  aspects	  of	  quality	  of	  life	  that	  are	  valued	  by	  people	  beyond	  improvements	  in	  health	  status	  per	  
se.	  There	  is	  a	  substantial	  literature	  on	  defining,	  identifying	  and	  measuring	  the	  consequences	  that	  
people	  experience	  as	  a	  result	  of	  using	  health,	  social	  care	  and	  other	  related	  public	  services.	  Much	  of	  
this	  literature	  recognises	  that	  these	  consequences	  are	  more	  far-­‐reaching	  than	  improvements	  in	  
health	  alone,	  at	  least	  where	  ‘health’	  is	  understood	  in	  the	  sense	  of	  people	  being	  free	  of	  impairing	  
conditions,	  be	  they	  physical	  or	  mental	  (Sen,	  1982;	  Sen,	  1993;	  Grewal	  et	  al.,	  2006;	  Higgs	  et	  al.,	  2003;	  
Schalock,	  2004).	  
Two	  inter-­‐related	  ideas	  are	  particularly	  relevant:	  first,	  a	  distinction	  between	  more	  basic	  human	  needs	  
and	  higher-­‐order	  needs	  (Maslow,	  1968;	  Nussbaum,	  1995;	  Nussbaum	  and	  Sen,	  1993);	  and	  second,	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that	  it	  is	  the	  meeting	  of	  needs	  which	  is	  important,	  rather	  than	  how	  they	  are	  met.	  These	  ideas	  imply	  
that	  having	  good	  health	  and	  also	  having	  control	  or	  autonomy	  (economic,	  political,	  or	  otherwise)	  are	  
capabilities	  with	  which	  to	  achieve	  happiness,	  well-­‐being	  and	  good	  quality	  of	  life.	  Arguably,	  the	  results	  
suggest	  that	  personal	  health	  budgets	  serve	  to	  improve	  capability	  in	  the	  latter	  sense.	  
The	  value	  society	  places	  on	  the	  improvement	  of	  quality	  of	  life,	  particularly	  through	  improvements	  in	  
control	  and	  autonomy,	  will	  be	  critical	  in	  the	  overall	  conclusion	  about	  the	  cost-­‐effectiveness	  of	  
personal	  health	  budgets.	  In	  the	  main	  analysis	  we	  found	  personal	  health	  budgets	  to	  be	  cost-­‐effective	  
when	  the	  willingness	  to	  pay	  for	  a	  unit	  improvement	  of	  ASCOT	  quality	  of	  life	  over	  a	  year	  is	  more	  than	  
£30,000.43	  	  
These	  benefits	  are	  expressed	  in	  monetary	  terms	  when	  a	  willingness	  to	  pay	  threshold	  is	  applied	  to	  the	  
underlying	  scale.	  Measures	  like	  ASCOT	  or	  EQ-­‐5D	  are	  amenable	  scales	  for	  this	  purpose	  because	  they	  
are	  designed	  to	  produce	  quantitative	  ratings	  of	  experiences	  that	  people	  have	  which	  are	  relevant	  to	  
their	  quality	  of	  life	  –	  for	  example,	  being	  in	  pain,	  being	  able	  to	  conduct	  usual	  activities,	  feeling	  in	  
control	  of	  their	  lives	  etc.	  People’s	  valuation	  of	  difference	  in	  quality	  of	  life	  are	  made	  with	  reference	  to	  
the	  trade-­‐offs	  they	  are	  willing	  to	  make	  in	  terms	  of	  living	  with	  better	  quality	  of	  life	  but	  dying	  earlier.	  
They	  are	  therefore	  ‘anchored’	  in	  a	  meaningful	  way.	  	  
8.4 Limitations	  
The	  evaluation	  of	  the	  personal	  health	  budget	  pilot	  programme	  was	  highly	  complex.	  As	  such	  there	  
were	  a	  number	  of	  limitations	  that	  should	  serve	  as	  cautions	  when	  interpreting	  the	  results.	  
8.4.1 Evaluation	  design	  
Rather	  than	  a	  single	  intervention	  there	  was	  a	  whole	  range	  of	  implementations	  of	  personal	  health	  
budgets	  with	  different	  models	  operating	  in	  the	  20	  in-­‐depth	  pilot	  sites	  over	  six	  patient	  groups.	  
Personal	  health	  budgets	  were	  entirely	  new	  and	  a	  radical	  departure	  in	  some	  areas,	  so	  that	  the	  
operation	  of	  personal	  health	  budgets	  was	  developing	  and	  changing	  during	  the	  course	  of	  the	  
evaluation.	  Other	  sites	  were	  further	  ahead	  and	  made	  more	  progress	  than	  others.	  This	  did	  however	  
mean	  that	  the	  establishment	  of	  detailed	  and	  consistent	  evaluation	  protocols	  and	  designing	  study	  
selection	  criteria	  in	  advance	  was	  not	  always	  possible.	  A	  particular	  difficulty	  was	  in	  establishing	  what	  
the	  personal	  health	  budget	  was	  for	  and	  which	  services	  could	  be	  purchased	  or	  secured	  with	  it	  before	  
the	  evaluation	  started.	  	  
As	  a	  ‘process/system’	  intervention	  there	  was	  no	  way	  to	  make	  the	  evaluation	  ‘blind’	  in	  the	  sense	  that	  
participants	  and	  others	  would	  not	  know	  whether	  they	  were	  in	  the	  personal	  health	  budget	  or	  control	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
43	  Whilst	  there	  is	  no	  well-­‐established	  willingness-­‐to-­‐pay	  threshold	  for	  ASCOT,	  because	  its	  scaling	  is	  comparable	  to	  the	  EQ-­‐5D	  
scale	  (and	  anchored	  in	  the	  same	  way),	  we	  can	  follow	  NICE	  guidelines	  in	  using	  a	  willingness-­‐to-­‐pay	  threshold	  of	  £30,000	  for	  
ASCOT	  as	  it	  is	  used	  for	  EQ-­‐5D.	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groups.	  It	  was	  possible	  in	  some	  cases	  to	  randomly	  assign	  people	  to	  the	  personal	  health	  budget	  and	  
control	  groups	  but	  only	  where	  sites	  were	  set	  up	  so	  that	  personal	  health	  budgets	  and	  conventional	  
service	  delivery	  options	  were	  available	  to	  the	  same	  health	  practitioner.	  The	  majority	  of	  sites,	  by	  
contrast,	  set	  up	  personal	  health	  budgets	  in	  particular	  areas,	  a	  configuration	  that	  created	  difficulties	  
in	  drawing	  control	  group	  participants	  from	  the	  same	  area.	  For	  these	  reasons	  a	  standard	  RCT	  design	  
was	  both	  not	  feasible	  and	  inappropriate.	  
The	  pragmatic	  controlled	  design	  we	  used	  involved	  both	  randomised	  (26%	  of	  participants)	  and	  non-­‐
randomised	  sub-­‐samples	  (74%).	  In	  the	  latter,	  the	  control	  group	  participants	  were	  drawn	  from	  
different	  localities	  than	  participants	  in	  the	  personal	  health	  budget	  group.	  In	  choosing	  the	  study	  
design,	  the	  potential	  for	  selection	  bias	  in	  the	  absence	  of	  randomisation	  was	  balanced	  against	  the	  
potential	  for	  contamination	  bias44	  when	  randomisation	  is	  used	  at	  an	  individual	  level.	  In	  the	  study,	  we	  
had	  some	  significant	  differences	  between	  the	  groups	  at	  baseline.	  The	  control	  group	  was	  significantly	  
older	  but	  also	  healthier	  than	  the	  personal	  health	  budget	  group.	  We	  have	  accounted	  for	  any	  
potentially	  biasing	  consequences	  by	  using	  a	  difference-­‐in-­‐difference	  design	  and	  also	  using	  baseline	  
control	  factors	  in	  the	  analysis	  where	  required.	  
8.4.2 Loss	  to	  follow-­‐up	  
Another	  tension	  in	  the	  design	  of	  the	  evaluation	  was	  between	  allowing	  sufficient	  elapsed	  time	  after	  
baseline	  for	  the	  effects	  of	  personal	  health	  budgets	  to	  be	  felt	  on	  the	  one	  hand,	  and	  minimising	  loss	  to	  
follow-­‐up	  on	  the	  other.	  The	  experience	  from	  the	  evaluation	  of	  the	  individual	  budgets	  pilots	  
(Glendinning	  et	  al.,	  2008)	  was	  that	  a	  six-­‐month	  follow-­‐up	  period	  was	  unlikely	  to	  be	  sufficient	  and	  so	  
we	  opted	  for	  a	  main	  follow-­‐up	  period	  of	  one	  year.	  As	  a	  consequence,	  although	  final	  recruitment	  
rates	  were	  good,	  drop-­‐out	  rates	  were	  an	  issue.	  Some	  2,393	  people	  entered	  the	  study	  at	  baseline.45	  
Of	  these,	  158	  people	  died	  before	  follow-­‐up,	  leaving	  2,235	  cases	  as	  the	  active	  sample.	  We	  had	  
returned	  main	  follow-­‐up	  instruments	  from	  1,524	  cases	  or	  68%	  of	  the	  active	  sample.	  Regarding	  any	  
outcomes	  instrument	  data,	  we	  had	  at	  least	  some	  follow-­‐up	  data	  in	  1,656	  cases	  (74.1%	  of	  the	  active	  
sample)	  -­‐	  see	  Appendix	  C	  for	  more	  details.	  
The	  study	  population	  was	  also	  in	  the	  most	  part	  very	  frail	  with	  much	  lower	  than	  population-­‐average	  
health	  status	  and	  well-­‐being	  scores.	  We	  expect	  drop-­‐out	  rates	  to	  be	  higher	  for	  this	  study	  population	  
as	  a	  result,	  but	  can	  argue	  that	  the	  reasons	  for	  drop-­‐out	  are	  due	  to	  baseline	  factors	  to	  a	  significant	  
extent	  and	  therefore	  not	  a	  source	  of	  bias	  in	  the	  evaluation	  of	  personal	  health	  budgets.	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
44	  that	  is,	  the	  control	  group	  being	  affected	  by	  the	  operation	  of	  the	  PHB	  pilot.	  
45	  Consent	  forms	  for	  the	  study	  were	  gained	  from	  2,700	  people	  but	  302	  people	  were	  excluded	  from	  the	  study:	  because	  they	  
had	  neither	  taken	  part	  in	  the	  baseline	  or	  follow-­‐up	  interviews	  and	  had	  in	  effect	  withdrawn	  consent	  before	  baseline;	  
because	  they	  were	  in	  residential	  care	  at	  baseline;	  because	  they	  were	  under	  18;	  or	  because	  they	  had	  died	  before	  baseline.	  
154	  
	  
Multiple-­‐imputation	  is	  a	  now-­‐established	  method	  to	  deal	  with	  drop-­‐out	  and	  missing	  data.	  The	  study	  
used	  (a)	  a	  wide	  range	  of	  predictors	  in	  the	  statistical	  models	  to	  estimate	  values	  for	  missing	  data,	  and	  
(b)	  used	  different	  specifications	  of	  the	  imputation	  model	  to	  assess	  the	  sensitivity	  of	  the	  results	  to	  the	  
implicit	  assumptions	  of	  those	  models.	  
8.4.3 Data	  quality	  
The	  quality	  of	  the	  outcomes	  data	  was	  good,	  especially	  the	  main	  subjective	  instruments.	  Because	  we	  
had	  to	  rely	  on	  local	  site	  tracking	  and	  records	  regarding	  mortality	  data,	  we	  were	  less	  able	  to	  rate	  the	  
quality	  of	  this	  data.	  Service	  data	  was	  drawn	  from	  a	  number	  of	  sources.	  Where	  possible	  we	  did	  not	  
rely	  on	  self-­‐reported	  use,	  instead	  interrogating	  care	  plans,	  using	  medical	  records	  and	  hospital	  
episode	  statistics.	  Some	  data	  had	  to	  be	  collected	  by	  self-­‐report	  however.	  Another	  issue	  was	  the	  
sheer	  range	  of	  services	  and	  support	  people	  in	  the	  study	  could	  have	  used.	  As	  outlined	  in	  Chapters	  2	  
and	  6,	  a	  number	  of	  assumptions	  had	  to	  be	  made	  to	  produce	  like-­‐with-­‐like	  cost	  estimates	  between	  
personal	  health	  budget	  and	  control	  groups.	  
8.4.4 Sensitivity	  
A	  number	  of	  assumptions	  had	  to	  be	  made	  in	  the	  analysis.	  We	  tested	  the	  sensitivity	  of	  three	  types	  of	  
assumption:	  
 Statistical	  assumptions.	  For	  key	  analyses	  such	  as	  the	  cost-­‐effectiveness	  estimates	  we	  used	  
both	  parametric	  and	  non-­‐parametric	  (bootstrapping)	  methods.	  We	  found	  very	  little	  
difference	  in	  the	  results.	  
 Costing	  assumption.	  A	  key	  assumption	  in	  this	  regard	  was	  the	  identification	  of	  personal	  health	  
budgets	  provided	  in-­‐addition	  or	  as	  a	  substitute	  for	  conventional	  services.	  In	  the	  main	  analysis	  
we	  adopted	  conservative	  assumptions	  (i.e.	  in	  favour	  of	  conventional	  service	  delivery)	  in	  this	  
regard.	  On	  testing	  the	  sensitivity	  of	  the	  main	  results	  to	  this	  assumption,	  we	  did	  not	  find	  any	  
qualitative	  impact	  on	  the	  results	  until	  quite	  unrealistic	  assumptions	  were	  tried.	  
 Multiple	  imputation.	  To	  test	  the	  sensitivity	  of	  the	  main	  results	  we,	  first,	  added	  a	  further	  five	  
imputations	  to	  our	  main	  dataset	  with	  a	  different	  randomly	  selected	  seed	  value,	  and	  second,	  
used	  a	  variant	  imputation	  model.	  The	  main	  results	  in	  both	  alternative	  cases	  were	  very	  similar	  
to	  the	  original	  estimates,	  with,	  if	  anything,	  slightly	  better	  statistical	  significance.	  In	  particular,	  
with	  both	  the	  alternative	  dataset	  and	  the	  alternative	  imputation	  model	  the	  results	  for	  the	  
whole	  sample	  analysis	  indicated	  that	  personal	  health	  budgets	  were	  cost-­‐effective	  on	  the	  
ASCOT	  scale	  at	  the	  5%	  significance	  level	  rather	  than	  at	  10%.	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The	  evaluation	  aimed:	  first,	  to	  investigate	  the	  operation,	  effectiveness	  and	  cost-­‐effectiveness	  of	  
personal	  health	  budgets;	  and,	  second,	  to	  inform	  the	  national	  roll-­‐out	  of	  personal	  health	  budgets	  by	  
providing	  information	  about	  how	  the	  initiative	  should	  be	  implemented.	  Clearly,	  these	  are	  
interrelated	  aims:	  the	  implications	  for	  the	  roll-­‐out	  involve	  identifying	  which	  kinds	  of	  personal	  health	  
budget,	  in	  what	  circumstances	  and	  for	  whom,	  have	  the	  greatest	  effect.	  We	  would	  recommend	  roll-­‐
out	  to	  be	  arranged	  on	  this	  basis.	  
During	  the	  evaluation	  period	  there	  was	  a	  growing	  emphasis	  on	  informing	  the	  roll-­‐out	  of	  personal	  
health	  budgets	  although	  accepting	  that	  decisions	  would	  be	  subject	  to	  the	  research	  findings	  regarding	  
the	  costs	  and	  benefits	  of	  personal	  health	  budgets.	  On	  25	  September	  2012,	  the	  Government	  
announced	  that	  £1.5	  million	  will	  become	  available	  to	  support	  the	  roll-­‐out	  of	  the	  initiative	  beyond	  the	  
This	  chapter	  draws	  together	  the	  evidence	  and	  provides	  a	  series	  of	  policy	  recommendations:	  
 The	  optimal	  use	  and	  design	  of	  personal	  health	  budgets.	  
o This	  section	  will	  draw	  mainly	  on	  results	  of	  the	  comparative	  evaluation	  and	  focus	  on	  
which	  options	  were	  most	  cost-­‐effective.	  	  	  
 The	  configuration	  of	  personal	  health	  budgets	  and	  supporting	  processes	  from	  the	  individuals’	  
perspective.	  	  
o The	  qualitative	  analysis	  results	  mostly	  inform	  the	  recommendations	  made	  in	  this	  
section.	  
 The	  initial	  set	  up	  and	  configuration	  of	  personal	  health	  budgets	  from	  an	  organisational	  
perspective.	  
 The	  wider	  impact	  of	  personal	  health	  budgets,	  assessing	  implications	  of	  personal	  health	  
budget	  use	  for	  health	  and	  social	  care	  integration,	  commissioning	  and	  diversification	  of	  
supply	  in	  the	  health	  and	  care	  economy.	  
The	  key	  recommendations	  are:	  	  
 Personal	  health	  budgets	  are	  best	  offered	  to	  people	  with	  greater	  need,	  to	  act	  as	  a	  substitute	  
for	  conventional	  service	  delivery.	  
 Personal	  health	  budgets	  are	  cost-­‐effective	  for	  people	  with	  mental	  health	  problems	  and	  
those	  receiving	  NHS	  Continuing	  Healthcare	  but	  are	  inconclusive	  for	  other	  health	  conditions.	  
Focusing	  initial	  roll-­‐out	  on	  these	  two	  groups	  is	  suggested,	  but	  the	  study	  cannot	  recommend	  
specific	  direction	  for	  the	  other	  health	  condition	  cohorts.	  
 Policy	  makers	  should	  anticipate	  that	  the	  use	  of	  personal	  health	  budgets	  is	  likely	  to	  result	  in	  a	  
higher	  level	  of	  expenditure	  going	  to	  ‘non-­‐conventional’	  (i.e.	  non-­‐NHS)	  providers.	  Further	  
research	  is	  required	  to	  better	  understand	  the	  scale	  of	  these	  changes.	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pilot	  programme.	  On	  4	  October	  2011,	  the	  Secretary	  of	  State	  for	  Health	  announced	  that,	  subject	  to	  
the	  evaluation,	  by	  April	  2014	  everyone	  in	  receipt	  of	  NHS	  Continuing	  Healthcare	  (NHS	  CHC)	  will	  have	  
the	  right	  to	  ask	  for	  a	  personal	  health	  budget,	  including	  a	  direct	  payment.	  Furthermore,	  it	  is	  planned	  
that	  the	  new	  Clinical	  Commissioning	  Group	  (CCGs)	  will	  be	  able	  to	  offer	  personal	  health	  budgets	  on	  a	  
voluntary	  basis	  more	  widely.	  
This	  chapter	  aims	  to	  present	  our	  findings	  and	  evidence	  to	  inform	  the	  question	  of	  how	  best	  to	  direct	  a	  
roll-­‐out.	  The	  implications	  of	  the	  study	  will	  be	  organised	  into	  the	  following	  four	  sections:	  	  
1. The	  optimal	  use	  and	  design	  of	  personal	  health	  budgets.	  
o This	  section	  will	  draw	  mainly	  on	  results	  of	  the	  comparative	  evaluation	  and	  focus	  on	  
which	  options	  were	  most	  cost-­‐effective.	  	  
2. The	  configuration	  of	  personal	  health	  budgets	  and	  supporting	  processes	  from	  the	  individual’s	  
perspective.	  	  
o The	  qualitative	  analysis	  results	  mostly	  inform	  the	  recommendations	  made	  in	  this	  
section.	  
3. The	  initial	  set	  up	  and	  configuration	  of	  personal	  health	  budgets	  from	  an	  organisational	  
perspective.	  
4. The	  wider	  impact	  of	  personal	  health	  budgets,	  assessing	  implications	  of	  personal	  health	  
budget	  use	  for	  health	  and	  social	  care	  integration,	  commissioning	  and	  diversification	  of	  supply	  
in	  the	  health	  and	  care	  economy.	  	  
Our	  analysis	  in	  the	  section	  will	  consider	  cross-­‐cutting	  themes	  of	  how	  to	  set	  up	  and	  facilitate	  the	  
implementation	  of	  personal	  health	  budgets,	  and	  which	  models	  appear	  to	  work	  best	  and	  for	  which	  
groups,	  including	  design	  choices	  about	  a	  personal	  health	  budget	  system,	  such	  as	  care	  planning,	  
deployment	  options	  and	  resource	  allocation	  systems.	  
9.3 Optimal	  use	  and	  design	  of	  personal	  health	  budgets	  	  
9.3.1 Should	  personal	  health	  budgets	  be	  deployed?	  
This	  evaluation	  took	  a	  sample	  of	  people	  with	  chronic	  obstructive	  pulmonary	  disease,	  diabetes	  and	  
long-­‐term	  neurological	  conditions,	  mental	  health,	  stroke,	  or	  those	  using	  NHS	  Continuing	  Healthcare	  
in	  20	  localities	  to	  assess	  whether	  personal	  health	  budgets	  are	  cost-­‐effective.	  The	  study	  suggested	  
that	  personal	  health	  budgets	  are	  cost-­‐effective,	  producing	  valued	  well-­‐being	  benefits	  with	  a	  largely	  
neutral	  impact	  on	  (recurrent)	  costs	  and	  on	  health/clinical	  outcomes.	  
This	  conclusion	  applies	  to	  the	  population	  of	  patients	  from	  which	  this	  sample	  was	  drawn,	  in	  terms	  of	  
an	  average	  effect.	  Clearly,	  the	  net	  benefits	  of	  personal	  health	  budgets	  vary	  between	  individuals,	  and	  
therefore	  we	  would	  expect	  to	  see	  variation	  between	  health	  condition	  sub-­‐groups	  and	  between	  
localities.	  But	  this	  ‘whole-­‐sample’	  conclusion	  does	  not	  rest	  on	  these	  distinctions.	  We	  had	  the	  benefit,	  
in	  this	  case,	  of	  a	  larger	  sample	  size	  –	  and	  therefore	  more	  precision	  for	  the	  result	  –	  but	  with	  a	  loss	  of	  




The	  overall	  implication	  is	  that	  personal	  health	  budgets	  are	  cost-­‐effective	  for	  the	  study	  population,	  
given	  the	  assumptions	  we	  have	  made,	  and	  should	  be	  rolled	  out	  for	  this	  population	  if	  these	  
assumptions	  are	  acceptable.	  The	  main	  assumptions	  concern:	  the	  monetary	  value	  placed	  on	  care-­‐
related	  quality	  of	  life	  (as	  measured	  by	  ASCOT);46	  assessing	  cost	  implications	  in	  terms	  of	  recurrent	  
health	  and	  social	  care	  service	  use;47	  and	  the	  level	  of	  statistical	  significance.48	  In	  as	  far	  as	  the	  localities	  
in	  the	  sample	  are	  representative	  of	  the	  whole	  country,	  on	  average,	  the	  results	  support	  a	  national	  
roll-­‐out	  where	  people	  are	  offered	  a	  personal	  health	  budget.	  
Recommendation:	  Overall,	  the	  study	  found	  that	  personal	  health	  budgets	  were	  cost-­‐effective,	  given	  
the	  assumptions	  that	  were	  made	  (e.g.	  regarding	  the	  value	  of	  ASCOT	  quality	  of	  life),	  and	  should	  be	  
rolled	  out	  for	  the	  study	  population	  (if	  these	  assumptions	  are	  acceptable).	  
In	  practice,	  personal	  health	  budgets	  will	  be	  more	  cost-­‐effective	  for	  some	  sub-­‐groups	  and	  less	  cost-­‐
effective	  for	  others.	  We	  were	  able	  to	  explore	  some	  of	  these	  differences	  in	  the	  sub-­‐group	  analysis,	  the	  
results	  of	  which	  we	  turn	  to	  next.	  Nonetheless,	  if	  a	  more	  inclusive	  roll-­‐out	  programme	  is	  adopted,	  
then	  ideally	  there	  would	  be	  an	  opportunity	  to	  review	  the	  cost-­‐effectiveness	  of	  personal	  health	  
budgets	  and	  on	  that	  basis	  refine	  how	  the	  offered	  use	  personal	  health	  budgets	  is	  targeted	  for	  
different	  health	  condition	  groups.	  
In	  contrast	  to	  the	  cost-­‐effectiveness	  results	  using	  ASCOT-­‐measured	  quality	  of	  life,	  the	  analysis	  did	  not	  
find	  that	  personal	  health	  budgets	  had	  a	  different	  effect	  on	  the	  size	  of	  participants’	  net	  benefit	  
(compared	  to	  the	  control	  group)	  when	  those	  benefits	  were	  measured	  using	  the	  EQ-­‐5D	  health-­‐related	  
quality	  of	  life	  scale	  or	  using	  clinical	  markers.	  We	  might	  therefore	  ask	  how	  relevant	  therefore	  is	  the	  
ASCOT-­‐measured	  quality	  of	  life	  result?	  People	  value	  care-­‐related	  quality	  of	  life	  as	  measured	  using	  the	  
ASCOT	  scale	  in	  that	  they	  are	  willing	  to	  exchange	  shorter	  life	  expectancy	  (with	  full	  ASCOT-­‐measured	  
quality	  of	  life)	  to	  avoid	  a	  longer	  life	  expectancy	  with	  poorer	  ASCOT-­‐measured	  quality	  of	  life.	  We	  also	  
sought	  to	  understand	  whether	  the	  sensitivity	  of	  the	  ASCOT	  measure	  was	  concentrated	  among	  those	  
people	  using	  social	  care.	  We	  found	  that	  whether	  or	  not	  the	  participant	  was	  a	  social	  care	  service	  user	  
at	  baseline	  made	  no	  difference	  to	  the	  size	  of	  the	  improvement	  in	  ASCOT-­‐measured	  quality	  of	  life	  
associated	  with	  personal	  health	  budget	  use	  (relative	  to	  the	  controls).49	  If	  ASCOT	  was	  only	  sensitive	  to	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
46	  i.e.	  £30,000	  or	  more	  per	  ASCOT	  QALY.	  
47	  i.e.	  putting	  aside	  any	  extra	  transaction	  costs	  that	  might	  accrue	  in	  using	  personal	  health	  budgets	  .	  
48	  In	  this	  case	  a	  90%	  confidence	  level	  (although	  the	  sensitivity	  analysis	  suggests	  this	  is	  a	  conservative	  assumption).	  	  
49	  This	  assessment	  was	  made	  by	  estimating	  whether	  the	  impact	  of	  personal	  health	  budgets	  on	  ASCOT-­‐measured	  quality	  of	  
life	  at	  follow-­‐up	  (relative	  to	  the	  control	  group	  and	  controlling	  for	  baseline	  differences)	  was	  different	  in	  size	  comparing	  social	  




improvements	  in	  quality	  of	  life	  stemming	  from	  social	  care	  use	  only,	  we	  would	  have	  expected	  a	  
significant	  difference	  in	  this	  effect	  size.50	  	  
9.3.2 Refining	  the	  implications	  for	  targeting	  of	  personal	  health	  budgets	  
The	  study	  sample	  was	  drawn	  from	  a	  range	  of	  people	  with	  long-­‐term	  conditions	  and	  this	  allowed	  us	  to	  
conduct	  some	  sub-­‐sample	  analyses	  to	  assess	  the	  costs	  and	  benefits	  of	  personal	  health	  budgets	  for	  
different	  sub-­‐groups.	  The	  sample	  could	  have	  been	  divided	  up	  in	  a	  number	  of	  ways,	  but	  we	  focused	  
on	  sub-­‐samples	  where	  (a)	  we	  expected	  that	  personal	  health	  budgets	  might	  have	  differential	  effects	  
and	  (b)	  where	  there	  was	  sufficient	  sample	  size	  in	  the	  respective	  sub-­‐group.	  
The	  relevance	  of	  these	  sub-­‐sample	  analyses	  for	  policy	  about	  the	  national	  roll-­‐out	  of	  personal	  health	  
budgets	  is	  that	  they	  provide	  some	  insight	  into	  which	  groups	  of	  patients	  show	  better	  than	  average,	  
and	  which	  worse	  than	  average,	  improvements	  in	  net	  benefits	  from	  the	  use	  of	  personal	  health	  
budgets	  relative	  to	  conventional	  methods.	  Similarly,	  we	  can	  assess	  whether	  certain	  types	  of	  personal	  
health	  budget	  process	  show	  better	  or	  worse	  than	  average	  effects.	  This	  information	  can	  help	  in	  
targeting	  personal	  health	  budgets	  to	  their	  most	  cost-­‐effective	  use.	  	  
We	  assessed	  these	  effects	  for	  the	  following	  sub-­‐groups:	  
o Personal	  health	  budget	  process	  models;	  
o Size	  of	  personal	  health	  budget;	  
o Socio-­‐demographic	  factors;	  
o Health	  conditions.	  
9.3.2.1 Personal	  health	  budget	  process	  models	  
As	  outlined	  in	  Chapter	  1,	  a	  range	  of	  implementation	  models	  were	  used	  to	  implement	  personal	  health	  
budgets,	  varying	  according	  to:	  whether	  the	  budget	  level	  was	  known	  before	  the	  care	  and	  support	  
planning	  process	  began;	  what	  flexibility	  there	  was	  in	  terms	  of	  services/support	  that	  could	  be	  
purchased	  with	  the	  budget;	  and	  the	  choice	  of	  deployment	  options	  (including	  DPs).	  Chapters	  5	  and	  6	  
reported	  analyses	  suggesting	  these	  models	  had	  quite	  different	  impacts	  on	  improvements	  in	  outcome	  
measures	  or	  effectiveness,	  and	  on	  the	  cost-­‐effectiveness	  of	  personal	  health	  budgets.	  
Implementation	  models	  4	  and	  5	  had	  a	  positive	  impact	  in	  terms	  of	  well-­‐being	  outcomes,	  but	  model	  3	  
generally	  had	  a	  negative	  impact.	  Model	  5	  offered	  pre-­‐determined	  budget	  levels,	  flexibility	  and	  
deployment	  choice.	  Model	  4	  offered	  only	  the	  flexibility	  and	  choice	  component.	  Pilot	  sites	  
implementing	  personal	  health	  budgets	  following	  model	  3	  limited	  the	  degree	  of	  flexibility	  and	  choice	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
50	  This	  result	  is	  not	  definitive	  in	  this	  respect	  because	  other	  factors	  change	  after	  baseline	  –	  but	  it	  does	  support	  our	  
expectation	  that	  ASCOT	  is	  not	  just	  sensitive	  to	  the	  impact	  of	  social	  care	  services	  but	  also	  other	  forms	  of	  support	  for	  people	  
with	  long-­‐term	  conditions.	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around	  services	  and	  deployment.	  Together,	  the	  findings	  suggest	  that	  while	  knowing	  the	  budget	  is	  a	  
fundamental	  part	  of	  the	  personal	  health	  budget	  initiative,	  flexibility	  and	  choice	  given	  to	  individuals	  
and	  families	  are	  perhaps	  of	  greater	  importance.	  
In	  the	  whole-­‐sample	  analysis	  we	  did	  not	  find	  a	  significant	  difference	  in	  the	  reported	  use	  of	  informal	  
care	  between	  personal	  health	  budget	  and	  control	  groups.	  There	  were	  some	  significant	  results	  in	  the	  
sub-­‐sample	  analysis	  in	  this	  regard.	  Personal	  health	  budgets	  of	  model	  3	  type	  were	  associated	  with	  an	  
increase	  in	  informal	  care	  receipt	  inside	  the	  household	  relative	  to	  controls.	  Personal	  health	  budgets	  of	  
model	  1	  type	  were	  associated	  with	  a	  decrease	  in	  informal	  care	  receipt	  from	  outside	  the	  household	  
relative	  to	  controls.	  We	  also	  found	  that	  personal	  health	  budgets	  of	  model	  2	  type	  were	  associated	  
with	  an	  increase	  in	  informal	  care	  receipt	  inside	  the	  household	  relative	  to	  controls.	  This	  pattern	  of	  
results	  does	  not	  entirely	  accord	  with	  our	  prior	  expectation	  that	  personal	  health	  budgets	  would	  
reduce	  the	  need	  for	  people	  to	  rely	  on	  informal	  care.	  	  
Personal	  health	  budgets	  produced	  the	  most	  significant	  improvements	  in	  net	  benefit	  compared	  to	  
controls	  (significant	  at	  the	  5%	  level	  for	  the	  ASCOT	  scale)	  when	  implemented	  in	  model	  1	  form.	  By	  
contrast,	  personal	  health	  budgets	  in	  model	  3	  form	  were	  not	  cost-­‐effective	  compared	  to	  conventional	  
practice	  in	  the	  control	  group.	  
Although	  somewhat	  intuitive,	  the	  implication	  for	  the	  roll-­‐out	  is:	  
Recommendation:	  That	  personal	  health	  budgets	  should	  be	  configured	  to	  give	  recipients	  choice	  and	  
flexibility	  over	  how	  the	  budget	  can	  be	  used.	  
In	  this	  respect,	  new	  personal	  health	  budget	  sites	  should	  resist	  the	  inclination	  to	  put	  in	  place	  limits	  in	  
this	  regard.	  
9.3.2.2 Size	  of	  the	  budget	  
The	  monetary	  size	  of	  personal	  health	  budgets	  in	  the	  study	  varied	  enormously.	  Those	  of	  modest	  scale	  
were	  generally	  being	  provided	  on	  top	  of	  conventional	  service	  delivery,	  not	  as	  substitutes.	  Our	  prior	  
expectation	  was	  that	  if	  personal	  health	  budgets	  were	  going	  to	  offer	  improved	  net	  benefits	  then	  this	  
improvement	  would	  be	  proportional	  to	  the	  size	  of	  the	  budget.	  Compared	  to	  modest	  size	  budgets,	  
those	  of	  larger	  (monetary)	  size	  might	  not	  only	  indicate	  that	  the	  recipient	  had	  higher	  levels	  of	  service	  
need	  –	  and	  therefor	  a	  greater	  capacity	  to	  benefit	  from	  services	  –	  but	  also	  that	  a	  greater	  proportion	  of	  
their	  service	  and	  support	  needs	  are	  being	  met	  from	  the	  budget	  rather	  than	  via	  conventional	  service	  
delivery.	  	  
We	  assumed	  in	  the	  analysis	  that	  high	  monetary	  amounts	  indicate	  that	  the	  personal	  health	  budget	  
was	  funded	  by	  substituting	  for	  existing	  services,	  while	  the	  smaller	  budgets	  were	  in	  addition	  to	  what	  
the	  individual	  would	  have	  received	  conventionally.	  	  
The	  results	  showed	  that	  larger	  monetary	  value	  budgets	  had	  a	  significantly	  different	  impact	  on	  both	  
costs	  and	  cost-­‐effectiveness	  than	  smaller	  personal	  health	  budgets.	  Overall,	  the	  use	  of	  a	  high-­‐value	  
personal	  health	  budget	  (i.e.	  greater	  than	  £1000	  per	  year)	  was	  associated	  with	  significantly	  lower	  
service	  costs	  at	  follow-­‐up	  compared	  to	  the	  control	  group	  (accounting	  for	  baseline	  differences).	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Furthermore,	  people	  in	  the	  high-­‐value	  personal	  health	  budget	  group	  had	  significantly	  higher	  net	  
benefits	  than	  those	  people	  in	  the	  control	  group	  (accounting	  for	  baseline	  differences)	  –	  at	  the	  95%	  
confidence	  level	  for	  ASCOT-­‐measured	  benefits	  and	  the	  90%	  confidence	  level	  for	  EQ-­‐5D-­‐measured	  
benefits.	  By	  contrast,	  lower	  value	  budgets	  did	  not	  show	  significant	  differences	  in	  net	  benefits	  
accrued	  compared	  to	  controls.	  
The	  monetary	  size	  of	  personal	  health	  budgets	  in	  the	  sample	  varied	  significantly	  between	  different	  
health	  conditions	  and	  other	  factors,	  clouding	  our	  interpretation	  of	  these	  results.	  Nonetheless,	  the	  
findings	  would	  support	  a	  policy	  of	  offering	  personal	  health	  budgets	  to	  people	  with	  greater	  need	  to	  
substitute	  for	  conventional	  services.	  	  
Recommendation:	  Personal	  health	  budgets	  are	  best	  offered	  to	  people	  with	  greater	  need,	  to	  act	  as	  
a	  substitute	  for	  conventional	  service	  delivery.	  
This	  does	  not	  rule	  out	  offering	  more	  modest	  size	  personal	  health	  budgets	  in	  other	  circumstances,	  but	  
only	  with	  the	  expectation	  that	  the	  net	  benefit	  of	  recipients	  is	  not	  likely	  to	  be	  greater	  than	  the	  net	  
benefits	  they	  get	  from	  conventional	  service	  delivery.	  
9.3.2.3 Health	  conditions	  
The	  study	  sample	  drew	  participants	  from	  a	  population	  of	  people	  with	  different	  primary	  health	  
conditions	  (and,	  indeed,	  multiple	  conditions).	  This	  provided	  the	  opportunity	  to	  explore	  whether	  
personal	  health	  budgets	  are	  more	  beneficial	  for	  some	  groups	  rather	  than	  others.	  The	  study	  found	  
that	  personal	  health	  budgets	  were	  cost	  effective	  (i.e.	  averaged	  higher	  net	  benefit)	  compared	  to	  the	  
control	  groups	  for	  both	  the	  mental	  health	  and	  NHS	  Continuing	  Healthcare	  groups,	  at	  the	  90%	  
confidence	  level.51	  We	  did	  not	  find	  significant	  differences	  for	  the	  other	  health	  condition	  groups.	  	  
The	  small	  sample	  sizes	  for	  the	  sub-­‐group	  analyses	  mean	  the	  results	  for	  the	  other	  health	  conditions	  
are	  generally	  non-­‐conclusive	  on	  their	  own.	  We	  cannot	  be	  confident	  that	  a	  non-­‐significant	  result	  
implies	  that	  there	  was	  no	  personal	  health	  budget	  effect	  for	  the	  health	  condition	  group	  in	  question;	  
rather,	  it	  might	  be	  that	  we	  did	  not	  have	  the	  statistical	  power	  to	  be	  able	  to	  confidently	  reject	  the	  
possibility	  that	  no	  effect	  exists.	  Limits	  on	  the	  scale	  of	  the	  study	  meant	  that	  we	  could	  only	  realistically	  
expect	  to	  detect	  strong	  personal	  health	  budget	  effects	  for	  individual	  sub-­‐samples.	  	  
In	  terms	  of	  the	  implications	  for	  roll-­‐out,	  the	  results	  do	  suggest	  –	  accepting	  the	  usual	  assumptions	  –	  
that	  efforts	  should	  initially	  be	  focused	  on	  offering	  personal	  health	  budgets	  to	  people	  receiving	  NHS	  
Continuing	  Healthcare	  and	  to	  those	  with	  mental	  health	  problems	  as	  their	  primary	  health	  condition.	  
The	  latter	  result	  is	  in	  line	  with	  the	  findings	  from	  the	  evaluation	  of	  individual	  budgets	  in	  social	  care.	  
We	  cannot	  make	  specific	  recommendations	  for	  the	  other	  health	  condition	  groups	  for	  the	  reasons	  
outlined,	  and	  need	  to	  defer	  to	  our	  overall	  findings	  in	  this	  case.	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
51	  Again,	  on	  the	  basis	  of	  ASCOT-­‐measured	  net	  benefit.	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Recommendation:	  The	  results	  indicate	  that	  personal	  health	  budgets	  are	  cost-­‐effective	  for	  people	  
with	  mental	  health	  problems	  and	  those	  receiving	  NHS	  Continuing	  healthcare	  but	  are	  inconclusive	  
for	  other	  health	  conditions.	  Focusing	  initial	  roll-­‐out	  on	  these	  two	  groups	  is	  suggested,	  but	  the	  
study	  cannot	  make	  specific	  recommendations	  for	  the	  other	  health	  condition	  cohorts.	  
9.3.2.4 Socio-­‐demographic	  factors	  
Many	  particular	  socio-­‐economic	  characteristics	  of	  individuals	  could	  make	  them	  more	  or	  less	  
predisposed	  to	  benefiting	  from	  personal	  health	  budgets.	  This	  study	  focused	  on	  three:	  age,	  gender	  
and	  income	  levels.	  As	  regards	  the	  former,	  older	  age	  is	  generally	  associated	  with	  higher	  levels	  of	  need	  
and	  support	  and	  therefore	  a	  greater	  opportunity	  for	  personal	  health	  budgets	  to	  result	  in	  changes	  in	  
services.	  The	  individual	  budgets	  evaluation,	  however,	  suggested	  that	  older	  people	  were	  less	  likely	  to	  
benefit	  from	  social	  care	  personal	  budgets.	  In	  this	  study	  we	  distinguished	  between	  people	  aged	  75	  
and	  over	  and	  those	  younger	  than	  75.	  
The	  analysis	  found	  that	  younger	  people	  with	  personal	  health	  budgets	  had	  higher	  ASCOT	  outcome	  
scores	  at	  follow-­‐up	  than	  younger	  people	  in	  the	  control	  group	  (after	  accounting	  for	  baseline	  
differences	  in	  ASCOT	  scores	  between	  the	  two	  groups).	  There	  was	  no	  significant	  difference	  in	  
outcome	  scores	  for	  people	  over	  75	  between	  the	  groups.	  We	  did	  not	  find	  significant	  differences	  by	  
age	  using	  EQ-­‐5D-­‐measured	  outcomes.	  
By	  contrast,	  when	  we	  investigated	  the	  impact	  of	  personal	  health	  budgets	  on	  net	  benefit	  for	  different	  
age	  groups,	  we	  found	  that	  personal	  health	  budgets	  were	  cost-­‐effective	  for	  people	  over	  75	  at	  the	  90%	  
confidence	  level,	  but	  that	  there	  was	  no	  significant	  differences	  between	  net	  benefit	  levels	  for	  people	  
aged	  younger	  than	  75	  with	  personal	  health	  budgets	  compared	  to	  people	  aged	  younger	  than	  75	  in	  the	  
control	  group.52	  This	  apparent	  inconsistency	  was	  due	  to	  the	  greater	  cost	  savings	  that	  were	  indicated	  
for	  over	  75s	  using	  personal	  health	  budgets	  compared	  to	  younger	  people.	  This	  result	  is	  consistent	  
with	  our	  contention	  that	  people	  over	  75	  used	  a	  higher	  level	  of	  services	  and	  so	  there	  was	  more	  
opportunity	  to	  make	  savings	  with	  personal	  health	  budgets.	  	  
The	  complex	  nature	  of	  this	  analysis	  with	  regard	  to	  age	  makes	  it	  difficult	  to	  draw	  out	  clear	  
implications.	  We	  need	  to	  be	  particularly	  aware	  of	  the	  relatively	  large	  variation	  in	  the	  cost	  data	  and	  
note	  that	  the	  sensitivity	  analysis	  suggested	  some	  volatility	  of	  these	  findings	  based	  on	  the	  
assumptions	  made.	  Even	  putting	  aside	  issues	  around	  the	  legality	  of	  targeting	  policies	  on	  the	  basis	  of	  
age,	  these	  results	  are	  certainly	  not	  unambiguous	  in	  this	  respect	  anyway.	  
The	  analysis	  did	  not	  find	  any	  differential	  impact	  of	  personal	  budgets	  in	  terms	  of	  ethnicity,	  gender	  or	  
income	  (using	  uptake	  of	  income	  benefits	  as	  a	  proxy	  for	  income	  levels).	  Note	  that	  sample	  sizes	  were	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
52	  A	  significant	  difference	  was	  found	  for	  under	  75s	  in	  the	  sensitivity	  analysis	  (PMM	  results).	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small	  for	  the	  ethnicity	  sub-­‐group	  analyses;	  a	  non-­‐significant	  result	  might	  arise	  from	  an	  under-­‐
powered	  sample	  size.	  
Recommendation:	  the	  results	  do	  not	  suggest	  that	  the	  impact	  of	  personal	  health	  budgets	  is	  
differentiated	  by	  ethnicity,	  gender	  or	  income	  of	  recipients	  –	  no	  particular	  targeting	  in	  this	  respect	  
need	  therefore	  be	  considered.	  
9.4 Configuring	  personal	  health	  budgets	  from	  the	  individuals’	  perspective	  
The	  in-­‐depth	  interviews	  with	  budget	  holders	  and	  carers	  highlighted	  a	  number	  of	  issues	  that	  could	  
provide	  further	  guidance	  for	  the	  future	  roll-­‐out	  of	  personal	  health	  budgets.	  It	  should	  be	  kept	  in	  mind	  
that	  the	  sub-­‐samples	  of	  budget	  holders	  and	  carers	  who	  took	  part	  in	  the	  in-­‐depth	  interviews	  were	  
among	  the	  earliest	  to	  be	  offered	  a	  budget	  within	  the	  pilot	  programme.	  Moreover,	  few	  had	  begun	  to	  
receive	  services,	  care	  or	  equipment	  funded	  through	  the	  personal	  health	  budget	  by	  the	  time	  of	  the	  
three-­‐month	  interviews,	  and	  several	  still	  did	  not	  have	  a	  budget	  in	  place	  when	  re-­‐interviewed	  at	  nine	  
months.	  Consequently,	  they,	  and	  some	  of	  their	  experiences,	  may	  not	  have	  been	  typical	  of	  the	  pilots	  
once	  these	  were	  fully	  operational.	  Nevertheless,	  their	  views	  provide	  valuable	  learning	  about	  the	  
factors	  that	  contributed	  to	  more	  or	  less	  positive	  experiences	  of	  implementation.	  
9.4.1 Initial	  impressions	  and	  understanding	  
Despite	  the	  fact	  that	  the	  participants	  had	  been	  specifically	  recruited	  to	  the	  pilot	  programme,	  initial	  
understandings	  of	  personal	  health	  budgets	  were	  mixed.	  While	  some	  understood	  the	  principle	  of	  a	  
personal	  allocation	  of	  resources,	  others	  thought	  they	  were	  drawing	  on	  a	  general	  fund	  rather	  like	  a	  
grant-­‐making	  scheme,	  so	  that	  if	  they	  did	  not	  use	  the	  budget	  it	  could	  be	  allocated	  to	  someone	  else.	  
Moreover,	  around	  half	  the	  sub-­‐sample	  reported	  initial	  anxiety	  about	  trying	  a	  budget,	  including	  
whether	  other	  healthcare	  treatments	  would	  be	  affected;	  the	  size	  of	  the	  budget;	  how	  they	  would	  
decide	  on	  its	  use;	  whether	  a	  desired	  use	  would	  be	  approved;	  and	  the	  ‘hassle’	  involved.	  
These	  concerns	  highlight	  the	  importance	  of	  giving	  clear,	  detailed	  information	  about	  personal	  health	  
budgets	  from	  the	  earliest	  contacts	  with	  potential	  budget	  holders,	  and	  ample	  subsequent	  
opportunities	  for	  discussions	  with	  healthcare	  staff	  as	  new	  questions	  arise.	  Participants	  confirmed	  
that	  written	  leaflets	  could	  be	  useful	  in	  providing	  a	  general	  overview,	  but	  these	  could	  be	  difficult	  to	  
relate	  to	  individual	  circumstances.	  Subsequent	  face-­‐to-­‐face	  discussions	  with	  health	  professionals	  
were	  particularly	  valued,	  especially	  if	  patients	  had	  been	  very	  unwell	  and	  unable	  to	  retain	  detailed	  
information	  when	  first	  told	  about	  the	  budget.	  
Recommendation:	  Clear,	  detailed	  information	  about	  personal	  health	  budgets	  should	  be	  given	  to	  
potential	  budget	  holders	  from	  the	  earliest	  contact.	  	  
9.4.2 The	  level	  of	  the	  personal	  health	  budget	  
Three	  months	  after	  the	  offer	  of	  a	  personal	  health	  budget,	  only	  a	  minority	  of	  the	  sub-­‐sample	  knew	  
how	  much	  their	  budget	  would	  be;	  even	  at	  nine	  months	  a	  few	  participants	  still	  did	  not	  know	  the	  level	  
of	  their	  budget.	  Sometimes	  this	  was	  because	  they	  still	  thought	  the	  budget	  was	  a	  centralised	  ‘pot’	  of	  
money	  rather	  than	  an	  individual	  allocation;	  others	  thought	  the	  equipment	  or	  service	  that	  had	  been	  
163	  
	  
funded	  through	  the	  budget	  was	  a	  one-­‐off	  grant,	  in	  response	  to	  a	  specific	  expressed	  need,	  rather	  than	  
part	  of	  a	  personal	  health	  budget.	  This	  meant	  that	  most	  participants	  started	  –	  and	  sometimes	  
completed	  –	  planning	  the	  use	  of	  their	  budget	  without	  knowing	  how	  much	  it	  was.	  They	  were	  also	  
therefore	  unable	  to	  assess	  the	  adequacy	  of	  the	  budget	  for	  their	  needs,	  or	  how	  much	  of	  the	  budget	  
remained	  unspent:	  
“I	  think	  it	  is	  [enough];	  the	  problem	  is	  we	  don’t	  know	  how	  much	  we’ve	  spent”	  (budget	  
holder).	  
“I’m	  worried	  that	  there’s	  not	  going	  to	  be	  enough,	  come	  the	  end	  of	  the	  year”	  (budget	  
holder).	  
As	  reported	  in	  Chapter	  5,	  around	  a	  quarter	  of	  participants	  thought	  they	  knew	  how	  their	  budget	  had	  
been	  calculated,	  but	  the	  basis	  for	  these	  calculations	  varied	  widely.	  Some	  thought	  it	  was	  a	  standard	  
amount	  for	  their	  particular	  health	  condition;	  others	  thought	  it	  reflected	  the	  cost	  of	  the	  items	  they	  
planned	  to	  use	  the	  budget	  for;	  a	  third	  group	  thought	  it	  was	  related	  to	  the	  costs	  of	  the	  NHS	  services	  
they	  used.	  Most,	  however,	  would	  have	  been	  interested	  in	  knowing.	  
Some	  interviewees	  had	  used	  their	  own	  money	  to	  pay	  for	  health	  or	  related	  services	  for	  various	  
reasons:	  because	  they	  were	  unclear	  about	  what	  the	  budget	  was	  for	  or	  how	  it	  could	  be	  used;	  because	  
their	  plans	  for	  using	  the	  budget	  had	  been	  refused;	  or	  because	  the	  budget	  was	  insufficient	  to	  
purchase	  all	  the	  services	  or	  items	  they	  wanted:	  
“They	  said	  ‘Well	  no,	  we’re	  not	  going	  to	  give	  you	  the	  full	  amount,	  we	  can	  give	  you	  a	  basic	  rate	  
and	  then	  ...	  you’re	  going	  to	  have	  to	  pay	  a	  top	  up	  for	  that”	  (budget	  holder).	  
It	  was	  clear	  from	  the	  interviews	  that	  there	  was	  considerable	  scope	  for	  improving	  the	  information	  
given	  to	  potential	  budget	  holders	  about	  the	  indicative	  level	  of	  the	  budget,	  especially	  before	  starting	  
care/support	  planning.	  
Recommendation:	  Potential	  budget	  holders	  should	  be	  given	  better	  information	  about	  the	  
indicative	  level	  of	  the	  budget,	  especially	  before	  starting	  care/support	  planning.	  
9.4.3 Support	  and	  care	  planning	  
Participants	  emphasised	  the	  wish	  to	  use	  their	  budget	  ‘wisely’,	  and	  ‘in	  the	  right	  way’.	  Most	  had	  some	  
ideas	  for	  how	  they	  might	  use	  their	  budget	  at	  the	  point	  of	  accepting	  the	  offer	  of	  a	  personal	  health	  
budget.	  However,	  not	  all	  were	  able	  to	  realise	  these	  plans;	  indeed,	  even	  at	  nine	  months,	  there	  was	  
considerable	  uncertainty	  among	  participants	  about	  what	  personal	  health	  budgets	  could	  and	  could	  
not	  legitimately	  be	  used	  for.	  Participants	  found	  it	  helpful	  to	  be	  given	  a	  list	  of	  suggestions;	  information	  
about	  how	  other	  people	  with	  similar	  conditions	  had	  used	  their	  budget	  to	  improve	  their	  health	  and	  
quality	  of	  life	  was	  particularly	  useful,	  as	  this	  helped	  them	  to	  ‘think	  outside	  the	  box’.	  However,	  it	  was	  
important	  that	  such	  lists	  were	  treated	  as	  suggestions	  only,	  rather	  than	  constituting	  a	  definitive	  menu,	  
otherwise	  participants	  felt	  uncomfortable	  about	  or	  inhibited	  from	  requesting	  items	  they	  thought	  
would	  benefit	  them	  but	  that	  were	  not	  on	  the	  list.	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It	  was	  important	  for	  information	  about	  possible	  uses	  of	  the	  budget	  to	  be	  freely	  available;	  some	  
participants	  felt	  uncomfortable	  asking	  if	  they	  could	  use	  their	  budget	  for	  a	  particular	  item	  or	  service	  
and	  consequently	  used	  very	  little	  of	  the	  budget.	  A	  few	  felt	  they	  had	  been	  pressured	  by	  pilot	  site	  staff	  
into	  agreeing	  a	  particular	  use	  for	  their	  budget,	  although	  it	  was	  not	  high	  on	  their	  own	  list	  of	  priorities.	  
Occasionally,	  participants	  discovered	  the	  budget	  was	  being	  used	  for	  items	  they	  did	  not	  recall	  
agreeing	  to.	  
Budget	  holders	  and	  carers	  who	  had	  deteriorating	  long-­‐term	  neurological	  conditions	  or	  were	  eligible	  
for	  NHS	  Continuing	  Healthcare	  usually	  had	  little	  difficulty	  deciding	  how	  to	  use	  their	  budget;	  in	  many	  
instances	  the	  budget	  would	  enable	  them	  to	  maintain	  or	  increase	  the	  support	  they	  received	  from	  paid	  
carers	  or	  personal	  assistants.	  However,	  one	  group	  of	  participants	  who	  had	  great	  difficulty	  with	  
care/support	  planning	  were	  those	  offered	  a	  budget	  shortly	  after	  suffering	  a	  stroke,	  sometimes	  even	  
before	  their	  discharge	  from	  hospital:	  
“When	  you’re	  not	  well	  -­‐	  and	  I	  was	  still	  quite	  confused	  early	  on	  -­‐	  it’s	  hard	  to	  really	  know	  what	  
you’re	  going	  to	  need	  and	  what	  you	  want”	  (budget	  holder).	  
Experiences	  of	  getting	  support/care	  plans	  approved	  varied	  from	  quick	  and	  smooth	  to	  complex	  and	  
lengthy;	  in	  the	  latter	  cases,	  frustration	  was	  compounded	  by	  participants’	  lack	  of	  clarity	  over	  who	  
exactly	  made	  approval	  decisions.	  Common	  reasons	  for	  delays	  included	  the	  need	  to	  obtain	  risk	  
assessments	  from	  GPs	  or	  hospital	  consultants;	  and	  care	  plans	  that	  included	  items	  not	  on	  a	  standard	  
list	  that	  had	  also	  so	  far	  not	  been	  approved	  for	  anyone	  else	  in	  the	  local	  pilot.	  Delays	  in	  obtaining	  
approval	  led	  to	  participants	  feeling	  ‘saddened’,	  ‘upset’,	  ‘uncertain’	  and	  ‘destabilised’,	  particularly	  if	  
they	  were	  keen	  to	  start	  a	  particular	  treatment	  or	  exercise.	  A	  further	  cause	  of	  major	  distress	  was	  
when	  items	  within	  a	  support/care	  plan	  were	  turned	  down.	  Participants	  expressed	  anger	  at	  being	  
unable	  to	  use	  ‘their’	  budget	  for	  things	  they	  thought	  important.	  Having	  support/care	  plans	  turned	  
down	  also	  compounded	  uncertainties	  about	  what	  were	  and	  were	  not	  legitimate	  uses	  for	  personal	  
health	  budgets;	  one	  or	  two	  participants	  had	  accessed	  websites	  about	  the	  pilots	  and	  knew	  that	  such	  
items	  had	  been	  allowed	  for	  other	  budget	  holders.	  
Recommendation:	  Greater	  clarity	  is	  needed	  regarding	  what	  types	  of	  services	  and	  support	  people	  
can	  secure	  with	  their	  personal	  health	  budget.	  	  
9.4.4 Getting	  approved	  services	  in	  place	  
The	  internet,	  shops,	  friends	  and	  relatives	  were	  all	  consulted	  to	  find	  suitable	  services	  or	  items.	  
Participants	  who	  were	  helped	  by	  health	  professionals	  to	  source	  items	  or	  services	  said	  they	  
appreciated	  being	  able	  to	  avoid	  the	  ‘legwork’	  of	  investigating	  providers.	  
Participants	  who	  used	  their	  budget	  to	  pay	  for	  services	  or	  items	  from	  a	  local	  list	  or	  ‘menu’	  usually	  
experienced	  few	  delays	  with	  procurement	  or	  supply.	  However,	  others	  experienced	  significant	  delays,	  
especially	  when	  the	  pilot	  sites	  took	  responsibility	  for	  finding	  and	  procuring	  non-­‐standard	  items	  or	  
services.	  Participants’	  frustration	  was	  compounded	  by	  poor	  communication	  and	  difficulties	  in	  getting	  
updates	  on	  progress;	  other	  participants	  were	  reluctant	  to	  ‘pester’	  staff	  for	  information.	  Equally	  
frustrating	  were	  situations	  where	  participants	  knew	  exactly	  what	  they	  wanted	  (for	  example,	  a	  mobile	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phone	  or	  home	  exercise	  equipment)	  and	  could	  have	  purchased	  it	  cheaply	  themselves	  but	  had	  to	  wait	  
for	  the	  pilot	  site	  to	  source	  it	  elsewhere.	  Such	  delays	  led	  to	  some	  participants	  purchasing	  items	  with	  
their	  own	  money	  or	  taking	  undue	  risks.	  Delays	  also	  impacted	  on	  other	  family	  members:	  for	  example,	  
where	  budgets	  were	  being	  used	  to	  fund	  (additional)	  paid	  care	  or	  respite	  care.	  As	  personal	  health	  
budgets	  move	  from	  pilot	  to	  mainstream,	  it	  will	  be	  important	  for	  procurement	  processes	  to	  be	  
streamlined,	  for	  one-­‐off	  as	  well	  as	  standard	  items.	  
Recommendation:	  Procurement	  processes	  for	  personal	  health	  budgets	  should	  be	  streamlined,	  for	  
one-­‐off	  as	  well	  as	  standard	  items.	  
9.4.5 Personal	  health	  budgets	  and	  social	  care	  support	  
Around	  one	  in	  eight	  budget	  holders	  and	  a	  majority	  of	  the	  carers	  in	  the	  sub-­‐sample	  also	  had	  social	  
care	  funding	  as	  well	  as	  their	  personal	  health	  budget.	  Only	  a	  minority	  were	  able	  to	  manage	  both	  their	  
social	  care	  personal	  budget	  and	  their	  personal	  health	  budget	  through	  a	  single	  bank	  account.	  Others	  
had	  to	  keep	  the	  two	  budgets	  entirely	  separate.	  Moreover,	  there	  were	  instances	  of	  considerable	  
confusion,	  particularly	  among	  carers	  supporting	  people	  with	  progressive	  or	  very	  complex	  conditions,	  
about	  what	  could	  be	  funded	  from	  each	  budget.	  For	  example,	  one	  carer	  reported	  disputes	  between	  
the	  local	  authority	  and	  PCT	  over	  the	  funding	  of	  a	  new	  wheelchair	  for	  her	  severely	  disabled	  daughter:	  
“It’s	  sold	  as	  if	  you’ve	  got	  much	  more	  control...	  but	  when	  it	  comes	  down	  to	  it,	  we’ve	  had	  
all	  this	  trouble	  in	  getting	  it	  approved	  to	  buy	  an	  electric	  wheelchair	  which	  [daughter]	  has	  
been	  assessed	  as	  needing”	  (carer	  of	  budget	  holder).	  
Other	  participants	  experienced	  problems	  when	  arrangements	  for	  managing	  personal	  health	  budgets	  
received	  as	  direct	  payments	  were	  incompatible	  with	  well-­‐established	  arrangements	  for	  managing	  
their	  social	  care	  direct	  payment.	  Instances	  were	  reported	  of	  pilot	  sites	  requiring	  new	  references	  and	  
criminal	  records	  bureau	  checks	  (CRB)	  for	  paid	  carers	  who	  had	  been	  employed	  for	  many	  years,	  or	  
insisting	  on	  different	  accounting	  and	  payroll	  systems	  from	  those	  used	  for	  social	  care	  direct	  payments:	  
“I	  think	  it’s	  going	  to	  be	  more	  time-­‐consuming	  [than	  social	  care	  direct	  payments],	  
definitely....	  They	  want	  receipts	  and	  they	  want	  proof	  every	  six	  months	  –	  I	  will	  have	  to	  
send	  in	  bank	  statements,	  slips	  of	  the	  money	  being	  used”	  (budget	  holder).	  
For	  those	  more	  severely	  disabled	  budget	  holders	  and	  carers	  receiving	  both	  personal	  health	  budgets	  
and	  social	  care	  personal	  budgets,	  arrangements	  appeared	  to	  work	  best	  when	  the	  former	  could	  be	  
integrated	  with	  their	  established	  bank	  accounts,	  accounting	  and	  payroll	  arrangements.	  
Recommendation:	  Accounting	  procedures	  for	  personal	  health	  budgets	  should	  be	  better	  co-­‐
ordinated	  with	  those	  of	  social	  care	  personal	  budgets,	  where	  relevant.	  
9.4.6 Budget	  holders’	  and	  carers’	  experiences	  of	  deployment	  options	  
When	  interviewed	  three	  months	  after	  the	  offer	  of	  a	  personal	  health	  budget,	  only	  a	  minority	  of	  
participants	  recalled	  being	  offered	  a	  choice	  of	  how	  their	  budget	  would	  be	  managed.	  Others	  recalled	  
being	  told	  that	  their	  budget	  would	  be	  managed	  by	  the	  PCT	  or	  a	  third-­‐party	  organisation;	  being	  told	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that	  a	  direct	  payment	  was	  not	  possible	  for	  them;	  or	  that	  it	  had	  been	  ‘assumed’	  they	  would	  want	  a	  
direct	  payment,	  particularly	  if	  the	  personal	  health	  budget	  was	  for	  NHS	  Continuing	  Healthcare.	  
Those	  who	  did	  recall	  being	  offered	  a	  choice	  of	  deployment	  options	  generally	  felt	  well	  supported,	  
with	  adequate	  information	  about	  the	  different	  options.	  The	  most	  common	  information	  gaps	  
concerned	  setting	  up	  special	  bank	  accounts	  and	  paying	  staff;	  one	  interviewee	  questioned	  how	  ‘Mr	  or	  
Mrs	  Average’	  was	  supposed	  to	  cope	  with	  these	  responsibilities.	  
The	  nine-­‐month	  interviews	  explored	  budget	  holders’	  and	  carers’	  actual	  experiences	  of	  different	  
deployment	  options.	  PCT	  or	  third-­‐party	  management	  was	  valued	  because	  it	  removed	  any	  risk	  of	  the	  
budget	  being	  used	  inappropriately;	  avoided	  additional	  responsibility	  and	  stress;	  and	  offered	  better	  
opportunities	  for	  securing	  good	  deals	  and	  bargains.	  On	  the	  other	  hand,	  some	  participants	  whose	  
budget	  was	  managed	  by	  the	  PCT	  without	  having	  had	  a	  choice	  of	  deployment	  option	  felt	  they	  were	  
not	  trusted:	  ‘They	  don’t	  think	  you	  can	  look	  after	  it	  yourself	  ...	  so	  ...	  we’ll	  look	  after	  it.’	  PCT	  or	  third-­‐
party	  management	  also	  involved	  greater	  risk	  of	  delays	  in	  the	  procurement	  of	  goods	  or	  paying	  for	  
services:	  for	  example,	  one	  budget	  holder	  was	  deeply	  embarrassed	  when	  she	  was	  told	  at	  the	  gym	  that	  
her	  fees	  had	  not	  been	  paid	  by	  the	  PCT.	  In	  retrospect,	  some	  participants	  said	  they	  would	  have	  
preferred	  a	  direct	  payment	  so	  they	  could	  obtain	  items	  more	  quickly	  themselves.	  
In	  contrast,	  those	  who	  had	  direct	  payments	  generally	  felt	  this	  had	  been	  the	  right	  choice	  for	  them,	  
despite	  relatively	  common	  initial	  difficulties	  in	  setting	  up	  bank	  accounts,	  and	  delays	  with	  the	  PCT	  
paying	  money	  into	  designated	  accounts.	  Most	  participants	  using	  direct	  payments	  were	  employing	  
their	  own	  carers	  or	  personal	  assistants.	  Some	  had	  not	  needed	  any	  help	  with	  recruitment	  as	  they	  had	  
previous	  social	  care-­‐funded	  carers	  in	  place,	  while	  others	  employed	  friends	  or	  relatives.	  For	  those	  
recruiting	  carers	  for	  the	  first	  time,	  help	  from	  PCT	  staff	  or	  support	  workers	  with	  advertising	  and	  
interviewing	  applicants,	  obtaining	  CRB	  clearance	  and	  drawing	  up	  employment	  contracts	  was	  greatly	  
appreciated,	  ‘taking	  a	  weight	  off	  my	  shoulders’.	  Even	  so,	  some	  recruitment	  problems	  were	  reported	  
in	  finding	  suitable	  people	  who	  were	  willing	  to	  work	  on	  a	  payroll	  basis	  and	  not	  ‘cash	  in	  hand’.	  On-­‐
going	  back-­‐up	  support	  with	  employing	  carers	  was	  also	  highly	  valued,	  in	  case	  new	  employment	  
arrangements	  broke	  down.	  
Recommendation:	  Procurement	  and	  recruitment	  support	  for	  personal	  health	  budget	  holders	  
(especially	  direct	  payment	  options)	  are	  valued	  by	  recipients.	  
9.5 Personal	  health	  budget	  initial	  set	  up	  and	  configuration	  
As	  with	  any	  major	  system	  organisation	  reform,	  the	  introduction	  of	  personal	  health	  budgets	  in	  the	  
pilot	  sites	  presented	  a	  range	  of	  challenges	  in	  getting	  the	  new	  systems	  in	  place	  and	  also	  securing	  
sufficient	  ‘cultural’	  acceptance	  of	  a	  substantially	  new	  way	  of	  working.	  To	  some	  extent	  the	  initial	  
implementation	  of	  personal	  health	  budgets	  was	  hampered	  by	  a	  number	  of	  external	  factors,	  not	  least	  
of	  which	  was	  the	  wholesale	  restructuring	  of	  the	  health	  system	  during	  the	  study	  period.	  Although	  
these	  external	  factors	  would	  not	  necessarily	  apply	  to	  a	  future	  roll-­‐out	  of	  personal	  health	  budgets,	  




During	  the	  study	  period,	  a	  number	  of	  implementation	  issues	  were	  raised	  as	  contributing	  to	  the	  
delays	  within	  the	  pilot	  process.	  In	  addition	  to	  the	  restructuring	  that	  organisational	  representatives	  
faced,	  it	  was	  questioned	  whether	  the	  degree	  of	  cultural	  change	  had	  been	  under-­‐estimated	  at	  the	  
beginning	  of	  the	  pilot	  process.	  
Organisational	  representatives	  who	  were	  interviewed	  at	  an	  early	  stage	  of	  implementation	  suggested	  
a	  number	  of	  factors	  that	  would	  facilitate	  future	  implementation,	  including:	  
o Acknowledging	  the	  importance	  of	  engaging	  with	  all	  representatives	  during	  the	  early	  
implementation	  phase,	  including	  stakeholders,	  patients,	  clinicians,	  middle	  managers	  and	  
chief	  executives;	  
o Developing	  adequate	  internal	  systems	  and	  processes	  to	  support	  personal	  health	  budgets;	  
o Acknowledging	  and	  managing	  the	  cultural	  change	  in	  terms	  of:	  
§ The	  immediate	  impact	  on	  the	  workplace:	  for	  example,	  the	  capacity	  to	  implement	  a	  
new	  initiative;	  
§ Training	  needs	  for	  frontline	  staff;	  
§ Identifying	  the	  concerns	  of	  the	  middle	  managers	  as	  it	  was	  feared	  that	  their	  views	  
could	  be	  communicated	  to	  other	  representatives	  in	  the	  local	  area;	  
§ Identifying	  and	  addressing	  concerns	  among	  frontline	  staff	  that	  could	  have	  the	  
potential	  to	  delay	  the	  implementation	  process	  and	  also	  have	  an	  impact	  on	  the	  
experiences	  of	  budget	  holders	  and	  their	  families.	  
Representatives	  also	  expressed	  a	  view	  that	  setting	  up	  personal	  health	  budget	  systems	  would	  benefit	  
from	  Department	  of	  Health	  guidance,	  especially	  regarding:	  
o How	  to	  set	  budgets;	  
o Which	  services	  could	  be	  included	  in	  the	  personal	  health	  budget;	  
o How	  to	  facilitate	  choice,	  including	  the	  importance	  of	  market	  development	  to	  be	  able	  to	  offer	  
real	  choice	  to	  budget	  holders.	  
We	  were	  unable	  to	  test	  these	  specific	  suggestions	  in	  the	  main	  quantitative	  analysis,	  although	  they	  
appear	  generally	  consistent	  with	  the	  findings	  regarding	  the	  personal	  health	  budget	  process	  –	  see	  
section	  9.3.2.1.	  	  
Recommendation:	  Regarding	  initial	  set-­‐up	  of	  personal	  health	  budget	  systems,	  organisational	  
representatives	  indicated	  the	  benefits	  of:	  tackling	  cultural	  change	  issues	  among	  staff	  with	  good	  
communication;	  engaging	  with	  all	  representatives;	  and	  developing	  adequate	  internal	  systems.	  
Recommendation:	  that	  the	  Department	  of	  Health	  provides	  further	  guidance	  as	  to	  budget	  setting,	  
coverage	  and	  the	  facilitation	  of	  choice.	  
9.6 The	  wider	  impact	  of	  personal	  health	  budgets	  
The	  main	  analysis	  has	  concentrated	  on	  the	  impact	  of	  personal	  health	  budgets	  on	  the	  individual	  
recipient	  and	  their	  family	  (carers).	  The	  third	  interim	  report	  (Jones	  et	  al.,	  2011)	  assessed	  the	  costs	  of	  
implementing	  and	  operating	  the	  personal	  health	  budget	  pilot.	  There	  are	  also	  wider	  impacts	  to	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consider,	  including	  the	  consequences	  of	  moving	  beyond	  the	  pilot	  stage	  for	  local	  health	  and	  care	  
economies.	  The	  main	  study	  was	  not	  designed	  to	  address	  these	  broader	  issues,	  but	  we	  can	  draw	  out	  
some	  implications	  in	  terms	  of	  the	  changing	  balance	  of	  services	  that	  might	  result	  and	  which	  types	  of	  
providers	  might	  be	  commissioned	  by	  budget	  holders.	  
9.6.1 Impacts	  beyond	  the	  individual/family	  
9.6.1.1 Impact	  on	  commissioning	  staff	  	  
Although	  the	  study	  was	  not	  designed	  to	  estimate	  comparable	  transaction	  costs	  for	  the	  personal	  
health	  budget	  group	  and	  the	  control	  group,	  we	  did	  ask	  about	  the	  staffing	  of	  project	  teams	  in	  the	  PCT	  
(as	  was)	  in	  interviews	  with	  project	  leads.	  New	  appointments,	  rather	  than	  changed	  staff	  roles	  or	  
secondments,	  might	  indicate	  an	  increase	  in	  the	  costs	  of	  running	  personal	  health	  budget	  systems.	  It	  is	  
nonetheless	  difficult	  to	  distinguish	  one-­‐off	  set	  up	  costs	  from	  recurrent	  transaction	  costs	  in	  this	  
respect.	  Furthermore,	  for	  a	  pilot	  there	  may	  be	  double	  running	  costs	  as	  both	  conventional	  and	  
personal	  health	  budget	  systems	  are	  maintained.	  The	  third	  interim	  report	  (Jones	  et	  al.,	  2011)	  outlined	  
that	  an	  overall	  average	  cost	  of	  £93,280	  (median	  £81,680)	  within	  the	  first	  year	  would	  be	  required	  to	  
implement	  the	  initiative.	  This	  cost	  would	  be	  in	  addition	  to	  what	  would	  have	  been	  incurred	  without	  
personal	  health	  budgets	  within	  the	  health	  authority.	  	  
9.6.1.2 Change	  in	  services	  accessed	  	  
Budget	  holders	  did	  change	  the	  mix	  of	  services	  they	  secured	  with	  their	  budget.	  We	  found	  significant	  
increases	  in	  the	  use	  of	  well-­‐being	  services	  and	  other	  health	  services,	  such	  as	  specialised	  continuing	  
healthcare.	  We	  also	  saw	  a	  reduction	  in	  the	  use	  of	  hospital	  care	  by	  the	  personal	  health	  budget	  groups	  
compared	  to	  the	  control	  group.	  The	  study	  did	  not,	  however,	  show	  a	  change	  in	  the	  use	  of	  social	  care-­‐
type	  services	  between	  personal	  health	  budget	  and	  control	  groups.	  These	  results	  suggest,	  overall,	  that	  
the	  use	  of	  personal	  health	  budgets	  was	  associated	  with	  a	  change	  in	  the	  balance	  between	  secondary	  
and	  primary	  health	  on	  the	  one	  hand,	  and	  either	  community	  health	  or	  social	  care	  on	  the	  other.	  	  
The	  changes	  involved	  were	  relatively	  modest,	  but	  they	  do	  suggest	  that	  personal	  health	  budget	  
holders	  had	  slightly	  different	  priorities	  than	  commissioners	  working	  on	  behalf	  of	  people	  in	  the	  
control	  group.	  While	  the	  exact	  causes	  are	  difficult	  to	  tease	  out,	  the	  results	  imply	  that	  service	  use	  
across	  different	  service	  categories	  was	  inter-­‐related.	  There	  are	  tentative	  implications	  for	  policy	  
around	  integration;	  the	  results	  could	  be	  interpreted	  as	  implying	  that	  greater	  integration	  would	  lead	  
to	  a	  change	  in	  the	  balance	  of	  services	  used,	  and	  also	  that	  personal	  health	  budgets	  might	  be	  a	  vehicle	  
to	  promote	  better	  integration.	  
Recommendation:	  Personal	  health	  budgets	  should	  be	  considered	  as	  a	  vehicle	  to	  promote	  greater	  
service	  integration	  (especially	  where	  social	  care	  personal	  budgets	  and	  personal	  health	  budgets	  
could	  be	  integrated	  around	  established	  bank	  accounts,	  accounting	  and	  payroll	  arrangements).	  
We	  did	  not	  find	  a	  significant	  effect	  of	  personal	  health	  budgets	  on	  the	  demand	  for	  informal	  care	  
support.	  In	  this	  respect,	  costs	  to	  the	  family	  would	  not	  appear	  to	  be	  greatly	  affected	  in	  the	  longer	  run.	  
This	  result	  is	  somewhat	  at	  odds	  with	  our	  initial	  expectations.	  It	  is	  worth	  cautioning	  that	  our	  main	  
results	  regarding	  carers	  were	  in	  relation	  to	  the	  amounts	  of	  informal	  care	  used	  by	  personal	  health	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budget	  holders.	  The	  data	  we	  had	  about	  the	  impact	  on	  carers	  of	  cared-­‐for	  people	  using	  personal	  
health	  budgets	  was	  much	  more	  limited.	  
9.6.1.3 Change	  in	  provider	  type	  
The	  use	  of	  personal	  health	  budgets	  might	  also	  be	  expected	  to	  impact	  on	  which	  organisations	  are	  
commissioned	  by	  the	  budget-­‐holder	  to	  deliver	  services.	  In	  as	  far	  as	  the	  use	  of	  personal	  health	  
budgets	  leads	  to	  a	  change	  in	  what	  sorts	  of	  services	  people	  might	  want	  to	  commission,	  we	  would	  also	  
see	  a	  change	  in	  where	  these	  services	  and	  support	  are	  sourced.	  In	  particular,	  some	  types	  of	  services	  
are	  not	  provided	  by	  NHS	  organisations	  and	  would	  have	  to	  be	  sourced	  externally.	  As	  regards	  social	  
care	  in	  general,	  a	  very	  high	  proportion	  –	  around	  90%	  -­‐	  of	  mainstream	  publicly-­‐funded	  services	  are	  
commissioned	  from	  private	  and	  voluntary	  sector	  providers.53	  We	  would	  expect	  that	  social	  care-­‐
related	  services	  commissioned	  using	  personal	  health	  budgets	  aimed	  at	  meeting	  both	  health	  and	  
social	  care	  needs	  will	  continue	  to	  be	  secured	  from	  the	  independent	  sector.	  	  
Primary	  and	  secondary	  health	  care	  services	  (classed	  as	  indirect	  expenditure	  in	  the	  main	  analysis	  -­‐	  see	  
chapter	  6)	  are	  not	  funded	  from	  personal	  health	  budgets,	  so	  we	  would	  not	  see	  any	  change	  in	  the	  
providers	  of	  these	  services.	  Other	  types	  of	  services	  –	  well-­‐being	  services,	  community	  health	  services,	  
therapy	  services	  and	  so	  on	  –	  could	  be	  sourced	  from	  non-­‐public	  sector	  providers.	  We	  did	  not	  
specifically	  gather	  information	  about	  the	  organisation	  providing	  the	  service.	  We	  did	  collect	  data	  on	  
the	  proportion	  of	  personal	  health	  budget-­‐funded	  expenditure	  that	  was	  made	  as	  a	  direct	  payment,	  
and	  this	  might	  be	  indicative	  of	  the	  amount	  of	  expenditure	  that	  went	  to	  non-­‐public	  providers	  in	  the	  
study.54	  	  
As	  outlined	  in	  chapter	  6,	  this	  assumption	  about	  the	  spending	  of	  direct	  payment	  budgets	  underpinned	  
an	  estimation	  of	  the	  change	  in	  the	  amount	  of	  service	  secured	  outside	  the	  NHS	  (and	  in-­‐house	  social	  
care	  providers)	  as	  a	  result	  of	  the	  introduction	  of	  personal	  health	  budgets.	  Two	  other	  key	  assumptions	  
were	  made	  in	  this	  analysis.	  First,	  that	  irrespective	  of	  the	  use	  of	  personal	  health	  budgets,	  around	  90%	  
of	  social	  care	  was	  purchased	  from	  independent	  sector	  providers	  anyway.	  Second,	  that	  all	  well-­‐being	  
services	  were	  sourced	  outside	  of	  the	  NHS.	  With	  these	  assumptions,	  we	  found	  that	  the	  amount	  of	  
expenditure	  going	  outside	  the	  NHS	  averaged	  £2180	  per	  year	  greater	  for	  the	  personal	  health	  budgets	  
group	  as	  compared	  to	  the	  control	  group.	  This	  figure	  corresponds	  to	  around	  12%	  of	  the	  average	  level	  
of	  direct	  expenditure	  in	  the	  personal	  health	  budget	  group	  (£18000	  per	  year).	  If	  we	  assume	  that	  only	  
half	  of	  well-­‐being	  services	  were	  sourced	  outside	  of	  the	  NHS,	  this	  figure	  reduces	  to	  £1900	  per	  year.	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
53	  See	  Allan,	  S.	  and	  J.	  Forder	  (2012).	  Care	  Markets	  in	  England	  –	  lessons	  from	  research.	  PSSRU,	  University	  of	  Kent,	  PSSRU	  
Discussion	  paper:	  DP2815	  (http://www.pssru.ac.uk/archive/pdf/dp2815.pdf).	  
54	  In	  theory	  the	  commissioning	  of	  publicly-­‐delivered	  services	  would	  not	  require	  a	  monetary	  payment	  and	  so	  it	  is	  not	  
unreasonable	  to	  expect	  that	  most	  direct	  payment	  budgets	  are	  used	  to	  purchase	  non-­‐publicly-­‐delivered	  services.	  
Nonetheless,	  it	  might	  be	  possible	  that	  local	  arrangements	  are	  made	  to	  accommodate	  these	  sorts	  of	  transactions	  e.g.	  
netting	  off	  the	  cost	  of	  public	  services	  from	  the	  direct	  payment.	  These	  arrangements	  ought	  to	  be	  classed	  as	  mixed	  notional	  
and	  DP	  deployment	  in	  the	  data,	  but	  interpretation	  can	  differ	  between	  sites.	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These	  figures	  give	  us	  a	  sense	  of	  the	  wider	  impact	  of	  personal	  health	  budgets.	  They	  are	  made	  on	  the	  
basis	  of	  assumptions	  that	  might	  reasonably	  be	  challenged,	  and	  that	  would	  affect	  the	  results.	  A	  
systematic	  re-­‐analysis	  of	  care	  plans	  and	  follow-­‐up	  with	  participants	  would	  be	  needed	  to	  derive	  a	  
more	  robust	  figure.	  There	  appears,	  nonetheless,	  some	  grounds	  to	  expect	  that	  the	  use	  of	  personal	  
health	  budgets	  is	  likely	  to	  result	  in	  a	  change	  in	  the	  supply	  of	  services.	  On	  this	  basis	  we	  make	  the	  
following	  recommendation.	  
Recommendation:	  Policy	  makers	  should	  anticipate	  that	  the	  use	  of	  personal	  health	  budgets	  is	  likely	  
to	  result	  in	  a	  higher	  level	  of	  expenditure	  going	  to	  ‘non-­‐conventional’	  providers	  (for	  example,	  a	  
greater	  use	  of	  non-­‐NHS	  providers).	  Further	  research	  is	  required	  to	  better	  understand	  the	  scale	  of	  
these	  changes.	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 Methodological	  Framework	  Appendix	  A
A.1 Research	  design	  
The	  evaluation	  within	  the	  in-­‐depth	  sites	  used	  a	  controlled	  trial	  with	  a	  pragmatic	  design	  
(depending	  on	  pilot	  site	  arrangements)	  to	  compare	  the	  experiences	  of	  people	  selected	  to	  
receive	  personal	  health	  budgets	  with	  the	  experiences	  of	  people	  continuing	  under	  the	  current	  
support	  arrangements	  for	  their	  condition.	  Two	  arrangements	  were	  used	  for	  sample	  allocation	  
between	  intervention	  and	  control	  group:	  
 Randomisation.	  Where	  the	  pilot	  was	  set	  up	  so	  that	  personal	  health	  budgets	  were	  
potentially	  offered	  by	  any	  health	  professional	  in	  the	  site,	  people	  who	  were	  judged	  as	  
potentially	  eligible	  for	  a	  personal	  health	  budget	  were	  then	  randomised	  into	  either	  the	  
personal	  health	  budget	  group	  or	  a	  control	  group.	  	  
 Stratification	  between	  different	  groups	  of	  health	  professions.	  In	  the	  main,	  personal	  
health	  budget	  patients	  were	  drawn	  from	  practices	  in	  one	  patch	  within	  the	  PCT	  and	  the	  
control	  patients	  from	  practices	  in	  a	  different	  patch	  (chosen	  to	  be	  as	  similar	  as	  
possible).	  Where	  this	  was	  not	  possible,	  for	  example	  because	  local	  GPs	  refused	  to	  offer	  
personal	  health	  budgets	  or	  where	  equivalent	  patches	  could	  not	  be	  easily	  found,	  
control	  patients	  were	  drawn	  from	  practices	  selected	  on	  a	  more	  opportunistic	  basis.	  
The	  two	  arrangements	  have	  different	  implications	  for	  potential	  selection	  bias	  and	  





Table	  A-­‐1.	  Comparison	  of	  selection	  methods	  
Issues	   Individual	  level	  
randomisation	  method	  
Comparison	  method	  
Selection	  bias	   Potential	  for	  selected	  sample	  as	  
eligible	  for	  PHB.	  Therefore	  possible	  
selected	  PHB	  and	  control	  
participants,	  which	  do	  not	  reflect	  
everyday	  practice	  and	  where	  the	  
generalising	  of	  conclusions	  will	  be	  
more	  limited.	  
No	  selection	  of	  patients	  into	  PHB	  or	  
control	  groups.	  Baseline	  
characteristics	  of	  sample	  should	  not	  
be	  different	  between	  PHB	  and	  
control	  groups.	  
	  
Potential	  for	  selected	  sample	  as	  
eligible	  for	  PHB.	  But	  control	  group	  
not	  chosen	  using	  PHB	  criteria;	  hence	  
PHBs	  compared	  to	  existing	  practice	  
and	  patients	  rather	  than	  a	  selected	  
group	  of	  control	  patients.	  
PHB	  and	  control	  groups	  likely	  to	  
have	  different	  characteristics	  for	  
operational	  reasons.	  
PHB	  and	  controls	  can	  be	  deliberately	  
selected	  into	  the	  PHB	  or	  control	  
group	  to	  influence	  evaluation	  
outcomes.	  	  
Difference-­‐in-­‐difference	  methods	  
can	  mitigate	  these	  problems.	  
Extra-­‐patient	  
contamination	  
PHBs	  are	  a	  systemic	  process	  centred	  
on	  the	  individual.	  Within	  any	  site	  
practitioners	  work	  with	  both	  PHB	  
and	  control	  group	  patients.	  
Implementation	  of	  PHB	  systems	  
might	  affect	  (‘contaminate’)	  the	  
operation	  of	  ‘usual	  treatment’	  
alterative,	  undermining	  the	  validity	  
of	  the	  control	  group	  experience	  as	  a	  
counterfactual.	  
Contamination	  less	  likely	  as	  PHB	  and	  
control	  group	  are	  drawn	  from	  
different	  groups	  of	  practitioners.	  
Loss-­‐to-­‐follow	  
up	  
External	  factors	  that	  cause	  data	  to	  
be	  missing	  completely	  at	  random	  
(MCAR)	  less	  likely	  to	  be	  
differentiated	  between	  PHB	  and	  
control	  groups.	  
Missing	  at	  random	  (MAR)	  data	  more	  
problematic	  but	  can	  be	  imputed.	  
MCAR	  missing	  data	  are	  less	  
problematic	  and	  can	  be	  imputed.	  
Missing	  at	  random	  (MAR)	  data	  more	  
problematic	  but	  can	  be	  imputed.	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A.2 Data	  collection	  sources	  
Table	  A-­‐2.	  Data	  collection	  sources	  
	   Data	  collection	  source	   Timeline	  
Outcome	  data	   Participant	  self-­‐report	   Baseline	  	  
12	  months	  after	  consent	  (main	  follow-­‐up)	  
6	  months	  after	  consent	  
24	  months	  after	  consent	  
Health	  condition	  information	  	   Medical	  records	   Baseline	  
12	  months	  after	  consent	  
Primary	  care	  service	  use	   Medical	  records	   Baseline	  
12	  month	  after	  consent	  	  
Secondary	  care	  service	  use	   Hospital	  Episodes	  Statistics	   2009/2011	  
2010/2011	  
	   Participant	  self-­‐report	  
	  
Medical	  records	  
Baseline	  outcome	  questionnaire	  
Follow-­‐up	  outcome	  questionnaire	  
Baseline	  and	  follow-­‐up	  
	  
Social	  care-­‐related	  services-­‐	  unit	  
costs	  
Participant	  self-­‐report	   Baseline	  outcome	  questionnaire	  
Follow-­‐up	  outcome	  questionnaire	  
A.3 Outcome	  questionnaires	  	  
The	  questionnaires	  contained	  a	  number	  of	  outcome	  indicators	  and	  measures.	  	  
A.3.1 Psychological	  well-­‐being	  
The	  psychological	  well-­‐being	  of	  service	  users	  was	  measured	  by	  the	  12-­‐item	  version	  of	  the	  
General	  Health	  Questionnaire	  (Goldberg,	  1992)	  that	  explores	  whether	  respondents	  have	  
experienced	  a	  particular	  symptom	  or	  behaviour	  over	  the	  past	  few	  weeks.	  Each	  item	  is	  rated	  on	  
a	  four-­‐point	  scale	  (less	  than	  usual,	  no	  more	  than	  usual,	  rather	  more	  than	  usual,	  or	  much	  more	  
than	  usual).	  There	  are	  two	  scoring	  methods;	  the	  bi-­‐modal	  (0	  to	  1)	  scoring	  style	  that	  indicates	  
the	  likely	  presence	  of	  psychological	  distress	  according	  to	  a	  designated	  cut-­‐off	  score	  of	  4	  or	  
more;	  and	  the	  Likert	  scoring	  scale	  (0	  to	  3)	  which	  generates	  a	  total	  score	  ranging	  from	  0	  to	  36,	  
with	  higher	  scores	  indicating	  worse	  conditions.	  The	  GHQ-­‐12	  has	  been	  extensively	  used	  in	  
national	  studies	  including	  British	  Household	  Panel	  Survey	  and	  the	  Health	  Survey	  for	  England	  
providing	  the	  scope	  for	  comparative	  analysis	  in	  the	  future.	  	  
A.3.2 Self-­‐Perceived	  Health	  
A	  person’s	  perception	  of	  his/her	  own	  health	  has	  been	  found	  to	  be	  a	  reliable	  predictor	  of	  
functional	  decline	  (Ferraro,	  1980),	  chronic	  disease	  (Shadbolt,	  2007)	  and	  even	  mortality	  (Idler	  
and	  Benyamini,	  1997).	  The	  perceived	  health	  question	  was	  based	  on	  the	  five	  point	  scale	  
suggested	  by	  Robine	  et	  al.,	  (2003)	  as	  part	  of	  a	  European	  project	  on	  health	  indicators.	  This	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question	  asks	  respondents	  to	  rate	  their	  health	  in	  general	  according	  to	  five	  categories	  ranging	  
from	  ‘Very	  good’	  to	  ‘Very	  bad’.	  	  
A.3.3 Perceived	  Quality	  of	  Life	  
The	  quality	  of	  life	  item	  was	  developed	  as	  part	  of	  a	  project	  funded	  under	  the	  ESRC	  Growing	  
Older	  Research	  Programme	  (Bowling	  et	  al.,	  2002).	  This	  item	  was	  measured	  using	  a	  seven	  point	  
scale,	  with	  categories	  ranging	  from	  ‘So	  good,	  it	  could	  not	  be	  better’	  to	  ‘So	  bad,	  it	  could	  not	  be	  
worse’	  (Bowling,	  1995).	  	  
A.3.4 Subjective	  well-­‐being	  
We	  used	  a	  subjective	  global	  measure	  based	  on	  the	  measure	  used	  by	  ONS	  in	  the	  Integrated	  
Household	  Survey	  (IHS).	  This	  measure	  used	  in	  this	  study	  seeks	  to	  capture	  general	  life	  
happiness	  and	  satisfaction.	  We	  used	  a	  scale	  that	  considers	  satisfaction	  with	  life,	  happiness	  and	  
satisfaction/worry	  about	  the	  person’s	  health	  (Dolan	  et	  al.,	  2010).	  This	  measure	  consists	  of	  five	  
questions	  using	  an	  eleven-­‐point	  scale	  (ranging	  from	  0-­‐10).	  The	  questions	  are	  below:	  
 Overall,	  how	  satisfied	  are	  you	  with	  your	  life?	  	  
 Overall,	  how	  happy	  did	  you	  feel	  yesterday?	  	  
 Overall,	  how	  worried	  did	  you	  feel	  yesterday?	  	  
 Overall,	  how	  satisfied	  are	  you	  with	  your	  health?	  
 Overall,	  how	  worried	  are	  you	  about	  your	  health?	  	  
A.3.5 Health-­‐related	  quality	  of	  life	  (EQ-­‐5D)	  
The	  three-­‐level	  Euro-­‐QoL	  (EQ-­‐5D)	  measure	  was	  used	  to	  explore	  the	  impact	  of	  the	  projects	  on	  
users’	  reported	  changes	  in	  health	  related	  quality	  of	  life.	  There	  are	  three	  parts	  to	  this	  measure.	  	  
	  
Part	  1:	  Participants	  are	  asked	  to	  indicate	  what	  level	  of	  difficulty	  they	  have	  in	  carrying	  out	  five	  
tasks;	  Mobility,	  Self-­‐Care,	  Usual	  Activities,	  Pain/Discomfort	  and	  Anxiety/Depression.	  The	  levels	  
of	  difficulty	  are,	  ‘no	  problems’,	  ‘some	  problems’	  and	  ‘extreme	  problems/unable’.	  	  
	  
Part	  2:	  Participants	  are	  asked	  to	  say	  how	  they	  feel	  their	  ‘general	  level’	  of	  health	  has	  changed	  
compared	  to	  the	  previous	  12	  months,	  whether	  it	  has	  got	  better,	  is	  much	  the	  same,	  or	  worse.	  	  
	  
Part	  3:	  Participants	  are	  asked	  to	  indicate	  how	  good	  or	  bad	  their	  heath	  state	  is	  on	  a	  
‘thermometer’	  that	  runs	  from	  0	  (worst	  imaginable	  health	  state)	  to	  100	  (best	  imaginable	  health	  
state).	  	  
A.3.6 Service	  satisfaction	  and	  quality	  of	  services	  
Measures	  of	  service	  satisfaction	  were	  based	  on	  quality	  indicators	  derived	  from	  the	  extensions	  
to	  national	  user	  experience	  surveys	  for	  older	  home	  care	  service	  users	  and	  younger	  adults	  
(Jones	  et	  al.,	  2007;	  Malley	  et	  al.,	  2006).	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A.3.7 Care	  outcome-­‐related	  quality	  of	  life	  (ASCOT)	  
The	  Adult	  Social	  Care	  Outcomes	  Toolkit	  (ASCOT)	  was	  used	  to	  capture	  care-­‐related	  quality	  of	  
life	  measure	  that	  measure	  people’s	  achievement	  of	  everyday	  activities,	  including	  basic	  
capabilities	  such	  as	  dressing	  and	  feeding,	  as	  well	  as	  more	  complex	  capabilities	  such	  as	  feeling	  
safe,	  being	  occupied	  and	  having	  a	  sense	  of	  control.	  ASCOT	  recognises	  that	  achievement	  of	  
these	  activities	  may	  come	  from	  the	  support	  of	  services	  and	  interventions,	  as	  well	  as	  personal	  
functioning.	  Whilst	  it	  was	  developed	  for	  people	  using	  long-­‐term	  social	  care,	  many	  of	  the	  
indicators	  are	  highly	  relevant	  for	  people	  with	  long-­‐term	  conditions	  in	  general.	  For	  example,	  it	  
would	  be	  expected	  that	  having	  a	  sense	  of	  control	  over	  daily	  living	  would	  be	  equally	  important	  
for	  patients	  with	  a	  long-­‐term	  health	  condition	  as	  well	  as	  for	  service	  users	  with	  social	  care	  
needs.	  	  
The	  questions	  ask	  respondents	  to	  choose	  from	  a	  series	  of	  three	  deteriorating	  situations.	  
Table	  A-­‐3	  below	  shows	  the	  responses	  actually	  used	  in	  the	  interview.	  Rather	  than	  assuming	  that	  
each	  domain	  and	  level	  is	  of	  equivalent	  importance	  the	  measure	  is	  weighted	  using	  population	  




Table	  A-­‐3.	  Options	  provided	  for	  each	  domain	  to	  reflect	  each	  need	  level	  
Domain	   Need	  
level	  
Description	  
Control	   No	  	  
Low	  	  
High	  	  
I	  have	  as	  much	  control	  over	  my	  daily	  life	  as	  I	  want	  
Sometimes	  I	  don’t	  feel	  I	  have	  as	  much	  control	  over	  my	  daily	  
I	  have	  no	  control	  over	  my	  daily	  life	  	  
Personal	  care	   No	  	  
Low	  	  
High	  
I	  feel	  clean	  and	  wear	  what	  I	  want	  
I	  sometimes	  feel	  less	  clean	  than	  I	  want	  or	  sometimes	  can’t	  wear	  what	  I	  want	  






I	  eat	  the	  meals	  I	  like	  when	  I	  want	  
I	  don’t	  always	  eat	  the	  right	  meals	  I	  want,	  but	  I	  don’t	  think	  there	  is	  a	  risk	  to	  my	  health	  
I	  don’t	  always	  eat	  the	  right	  meals	  I	  want,	  and	  I	  think	  there	  is	  a	  risk	  to	  my	  health	  
Safety	   No	  	  
Low	  	  
High	  	  
I	  feel	  as	  safe	  as	  I	  want	  
Sometimes	  I	  do	  not	  feel	  as	  safe	  as	  I	  want	  






My	  social	  situation	  and	  relationships	  are	  as	  good	  as	  I	  want	  
Sometimes	  I	  feel	  my	  social	  situation	  and	  relationships	  are	  not	  as	  good	  as	  I	  want	  






I	  do	  the	  activities	  I	  want	  to	  do	  
I	  do	  some	  of	  the	  activities	  I	  want	  to	  do	  
I	  don’t	  do	  any	  of	  the	  activities	  I	  want	  to	  do	  
Accommodation	   No	  
Low	  
High	  
My	  home	  is	  as	  clean	  and	  comfortable	  as	  I	  want	  
My	  home	  is	  less	  clean	  and	  comfortable	  than	  I	  want	  
My	  home	  is	  not	  at	  all	  as	  clean	  or	  comfortable	  as	  I	  want	  





I	  feel	  free	  from	  worry	  and	  concerns	  on	  a	  day-­‐to-­‐day	  basis	  
I	  sometimes	  feel	  worried	  and	  concerned	  






I	  am	  treated	  by	  other	  people	  with	  the	  dignity	  and	  respect	  that	  I	  want	  
Sometimes	  I	  am	  not	  treated	  by	  other	  people	  with	  the	  dignity	  and	  respect	  that	  I	  want	  
I	  am	  never	  treated	  with	  the	  dignity	  and	  respect	  that	  I	  want	  
	  
Table	  A-­‐4	  gives	  the	  weights	  that	  we	  applied	  to	  each	  of	  the	  attributes.	  For	  example,	  if	  a	  person	  
reported	  that	  their	  personal	  cleanliness	  was	  at	  a	  desired	  level	  then	  this	  would	  be	  scored	  at	  
4.541.	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
1	  Further	  information	  concerning	  the	  development	  and	  preference	  weights	  for	  the	  ASCOT	  quality	  of	  life	  measure	  
can	  be	  found	  at	  the	  following	  website	  -­‐	  http://www.hta.ac.uk/fullmono/mon1616.pdf	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Table	  A-­‐4.	  Preference	  weights	  for	  attributes	  and	  levels	  
 Desired Adequate Poor 
Control	  over	  daily	  life	   5.18	   1.5	   0	  
Personal	  cleanliness	   4.54	   1.87	   1.09	  
Meals	  and	  nutrition	   4.16	   2.59	   1.96	  
Safety	   4.71	   1.71	   1.14	  
Social	  participation	   4.67	   2.36	   0.76	  
Activities/occupation	   4.50	   3.95	   1.69	  
Home	  cleanliness	  and	  comfort	   4.38	   2.47	   1.76	  
Anxiety	   4.69	   1.88	   1.24	  
Dignity	  and	  respect	   4.25	   1.63	   1.18	  
A.4 Cost	  estimates	  
Table	  A-­‐5	  shows	  the	  social	  care	  unit	  data	  that	  was	  taken	  from	  the	  PSS	  EX1.	  	  
Table	  A-­‐5.	  Summary	  of	  the	  social	  care	  cost	  estimates	  




Day	  care	  -­‐	  older	  person	   £30	   £34	  
Day	  care-­‐	  younger	  person	  (average	  cost	  between	  mental	  
health,	  learning	  disability	  and	  physical	  disability)	  
£67	   £73	  
Home	  care	  per	  hour	  (local	  authority)	   £38	   £42	  
Home	  care	  per	  hour	  (delivered	  by	  others)	   £15	   £15	  
Meals	  on	  wheels	   £8	   £4	  
Residential	  care2	   £580	   £633	  
Local	  authority	  social	  worker3	   £55	   £53	  
A.5 Primary	  care	  service	  use	  
The	  outcome	  questionnaire	  and	  the	  medical	  record	  template	  collected	  information	  about	  
participant’s	  primary	  care	  service	  use	  at	  two	  time	  points:	  baseline	  and	  at	  12	  months	  after	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
2	  Average	  gross	  weekly	  expenditure	  per	  person	  on	  supporting	  adults	  and	  older	  people	  in	  residential	  and	  nursing	  
care	  (including	  full	  cost	  paying	  and	  preserved	  rights	  residents)	  and	  providing	  intensive	  home	  care	  
3	  Based	  on	  an	  hour	  of	  face	  to	  face	  contact.	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consent	  date.	  Table	  A-­‐6	  shows	  the	  national	  unit	  costs	  that	  were	  used	  for	  these	  services	  (Curtis,	  
2011;	  Curtis,	  2010).	  	  
Table	  A-­‐6.	  Summary	  of	  primary	  care	  service	  use	  and	  unit	  costs	  




District	  nurse,	  health	  visitor	  or	  other	  kind	  of	  nurse	  4	   	   	  
Home	  and	  clinic	  
	  
£385	   £41	  
Occupation	  therapist,	  physiotherapist,	  speech	  
therapist	  or	  any	  other	  kind	  of	  therapist6	  
	   	  
Home	  and	  clinic	  
	  
£30	   £31	  
General	  Practitioner	   	   	  
Surgery	  	   £327	   £44	  
Home	  	   £1068	   £99	  
A.6 Secondary	  care	  service	  use	  
Information	  concerning	  secondary	  care	  service	  use	  was	  extracted	  at	  two	  time-­‐points	  from	  the	  
Hospital	  Episodes	  Statistics	  database	  (NHS	  Information	  Centre).	  We	  collected	  admitted	  patient,	  
outpatient	  and	  A&E	  activity	  data	  for	  each	  study	  participant	  using	  their	  NHS	  number.	  Due	  to	  the	  
time	  lag	  in	  the	  availability	  of	  HES	  data,	  some	  activity	  was	  truncated	  for	  those	  participants	  
joining	  the	  study	  at	  the	  end	  of	  the	  recruitment	  period.	  Data	  from	  medical	  records	  was	  used	  for	  
any	  missing	  period	  rather	  than	  HES	  –	  see	  section	  C.6.1.1	  below	  for	  details	  of	  this	  calculation.	  
Inpatient	  data	  were	  costed	  by	  applying	  the	  2008/9	  admitted	  patient	  tariff.	  We	  calculated	  the	  
cost	  of	  individual	  spells	  for	  participants	  using	  either	  the	  elective	  or	  non-­‐elective	  tariff	  for	  the	  
corresponding	  HRG	  of	  the	  spell.	  Using	  data	  on	  bed-­‐days	  for	  the	  spend,	  we	  adjusted	  for	  elective	  
and	  non-­‐elective	  long-­‐stays	  applying	  the	  long-­‐stay	  tariff	  after	  the	  relevant	  trim-­‐point	  for	  that	  
HRG	  and	  admission	  type.	  Short-­‐stay	  reductions	  were	  also	  applied.	  The	  total	  annual	  cost	  of	  
inpatient	  care	  per	  study	  participant	  was	  then	  calculated	  by	  summing	  up	  the	  cost	  of	  individual	  
spells.	  Total	  costs	  for	  different	  years	  were	  inflated	  using	  the	  weighted	  mean	  costs	  for	  the	  
corresponding	  year.	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
4	  Based	  on	  an	  average	  unit	  cost	  per	  hour	  in	  clinic	  of	  between	  a	  community	  nurse	  (including	  a	  district	  nursing	  sister	  
and	  district	  nurse)	  and	  health	  visitor.	  
5	  Based	  on	  an	  hour	  of	  client	  contact.	  
6	  Based	  on	  an	  average	  unit	  cost	  per	  hour	  in	  clinic	  between	  a	  hospital	  physiotherapist,	  community	  physiotherapist,	  
community	  occupational	  therapist	  and	  a	  community	  speech	  and	  language	  therapist	  
7	  Based	  a	  clinic	  consultation	  lasting	  11.7	  minutes	  including	  direct	  care	  staff	  costs.	  
8	  Based	  on	  a	  home	  visit	  lasting	  11.7	  minutes	  including	  12	  minutes	  for	  travel	  and	  direct	  care	  staff	  costs.	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Outpatient	  attendances	  were	  collected	  for	  study	  participants,	  by	  type	  of	  attendance.	  An	  
average	  cost	  per	  attendance	  was	  applied	  at	  £136	  for	  2009/10	  and	  £147	  for	  2010/11	  (taken	  
from	  the	  Unit	  Costs	  report,	  Curtis	  2011	  and	  2012).	  Total	  annual	  costs	  per	  person	  were	  
calculated	  by	  summing	  attendances.	  	  
Accident	  and	  Emergency	  attendances	  were	  also	  collected	  for	  study	  participants,	  by	  type	  of	  
A&E	  attendance	  as	  categorised	  using	  the	  10	  A&E	  tariff	  codes	  (2010/11	  tariff).	  The	  
corresponding	  A&E	  tariff	  rate	  was	  applied	  and	  the	  totals	  deflated	  for	  the	  relevant	  year.	  We	  
also	  added	  in	  ambulance	  transport	  using	  HES	  data	  on	  arrival	  mode	  per	  patient.	  Total	  yearly	  
cost	  per	  study	  participant	  was	  calculated	  by	  summing	  attendances	  and	  transport	  costs.	  
Table	  A-­‐7	  provides	  a	  summary	  of	  the	  unit	  costs	  used	  in	  these	  calculations.	  
Table	  A-­‐7.	  Summary	  of	  secondary	  care	  service	  use	  and	  unit	  costs	  






£136	   £147	  
Inpatient	  hospital	  stay	  
	  
Inflated	  2008/09	  Admitted	  Patient	  Care	  
Mandatory	  Tariff	  	  
Accident	  and	  emergency	  attendance	   	   	  
Consultant-­‐led	   £131	   £147	  
Other	  type	  of	  A&E/minor	  injury	  activity	   £51	   £49	  
NHS	  walk-­‐in	  centres	  
	  
£37	   £49	  
Ambulance	  transport	  to	  Accident	  and	  
Emergency	  
	  
£223	   £253	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 Research	  methods	  and	  sample:	  in-­‐depth	  examination	  of	  Appendix	  B
personal	  health	  budgets	  from	  users’	  and	  carers’	  perspectives	  
This	  appendix	  gives	  details	  of	  the	  recruitment	  and	  interviewing	  of	  personal	  health	  budget	  
holders	  and	  carers.	  
The	  in-­‐depth	  strand	  as	  a	  whole	  had	  two	  main	  elements:	  
 Interviews	  with	  budget	  holders	  at	  approximately	  three	  months	  and	  nine	  months	  after	  
taking	  up	  the	  personal	  health	  budget;	  
 Interviews	  with	  carers	  of	  budget	  holders	  at	  approximately	  three	  months	  and	  nine	  months	  
after	  taking	  up	  the	  personal	  health	  budget.	  
B.1 Ethical	  considerations	  
The	  wider	  evaluation	  received	  ethical	  approval	  from	  an	  NHS	  Research	  Ethics	  Committee;	  no	  
additional	  approvals	  were	  required	  for	  the	  in-­‐depth	  strand.	  However,	  in	  accordance	  with	  good	  
practice,	  separate	  information	  sheets	  and	  consent	  forms	  specific	  to	  the	  in-­‐depth	  research	  
strand	  were	  prepared	  for	  participants.	  A	  number	  of	  preparatory	  measures	  (detailed	  below)	  
were	  also	  carried	  out,	  in	  order	  to	  ensure	  appropriate	  and	  sensitive	  conduct	  of	  the	  in-­‐depth	  
interview	  research.	  
B.2 Constructing	  the	  samples	  	  
The	  sampling	  frame	  was	  provided	  by	  the	  wider	  personal	  health	  budget	  evaluation.	  The	  
research	  team	  at	  the	  University	  of	  Kent	  supplied	  the	  SPRU	  research	  team	  with	  a	  database	  of	  all	  
individuals	  recruited	  to	  the	  personal	  health	  budget	  evaluation.	  Transfer	  of	  the	  database	  was	  
done	  electronically	  via	  a	  secure	  virtual	  private	  network.	  This	  database	  was	  updated	  
periodically,	  allowing	  the	  SPRU	  team	  to	  construct	  a	  sample	  iteratively,	  according	  to	  the	  
recruitment	  targets	  for	  each	  sub	  sample	  and	  health	  condition	  and	  also	  balanced	  for	  other	  
characteristics	  including	  age	  and	  gender.	  The	  primary	  sampling	  criterion	  for	  the	  budget	  holders	  
was	  the	  individual’s	  health	  condition;	  secondary	  criteria	  were	  a	  spread	  of	  ages	  and	  an	  
approximately	  even	  gender	  balance.	  The	  intention	  was	  also	  to	  include	  a	  range	  of	  ethnic	  groups	  
within	  the	  in-­‐depth	  sub-­‐samples.	  However,	  this	  was	  dependent	  on	  the	  wider	  sample	  and,	  
given	  the	  small	  numbers	  of	  non-­‐White	  British	  budget	  holders	  in	  the	  evaluation	  at	  the	  time	  that	  
people	  were	  being	  approached	  for	  the	  interviews,	  the	  potential	  number	  of	  minority	  ethnic	  
interviewees	  in	  the	  in-­‐depth	  sample	  was	  similarly	  limited.  
The	  researchers	  aimed	  to	  include	  participants	  from	  at	  least	  half	  of	  the	  20	  in-­‐depth	  evaluation	  
sites	  in	  order	  to	  obtain	  a	  variety	  of	  local	  experiences.	  The	  range	  of	  health	  conditions	  being	  
covered	  in	  the	  different	  pilot	  sites	  also	  guided	  sampling	  decisions.	  Most	  sites	  were	  offering	  
personal	  health	  budgets	  to	  only	  two	  or	  three	  condition	  groups	  and	  their	  overall	  recruitment	  
targets	  also	  varied,	  meaning	  that	  some	  sites	  offered	  more	  potential	  for	  in-­‐depth	  sample	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selection	  than	  others.	  Only	  one	  of	  the	  sites	  offered	  personal	  health	  budgets	  for	  maternity	  
services.	  	  
Regarding	  deployment	  options	  for	  personal	  health	  budgets,	  the	  intention	  was	  to	  include	  some	  
budget	  holders	  who	  were	  receiving	  direct	  payments.	  However,	  this	  was	  again	  dictated	  by	  the	  
number	  of	  pilot	  sites	  offering	  direct	  payments	  at	  the	  time	  of	  fieldwork	  and	  the	  numbers	  of	  
budget	  holders	  taking	  up	  this	  deployment	  option.	  
B.3 Preparing	  for	  recruitment	  and	  interviewing	  	  
Prior	  to	  beginning	  fieldwork,	  the	  two	  researchers	  conducting	  the	  in-­‐depth	  interviews	  held	  an	  
informal	  meeting	  with	  a	  small	  group	  of	  colleagues	  in	  SPRU	  who	  had	  substantial	  collective	  
experience	  of	  interviewing	  people	  with	  long-­‐term	  and	  severe	  health	  conditions.	  This	  meeting	  
highlighted	  a	  number	  of	  practical	  and	  ethical	  considerations	  to	  take	  into	  account	  when	  
arranging	  and	  conducting	  the	  interviews.	  These	  included,	  for	  example,	  the	  most	  appropriate	  
times	  of	  day	  to	  interview	  people	  with	  fluctuating	  conditions	  or	  complex	  medication	  regimes;	  
the	  importance	  of	  pacing	  and	  breaks	  for	  participants	  who	  could	  tire	  easily;	  how	  to	  respond	  if	  a	  
participant	  became	  unwell	  or	  distressed;	  and	  appropriate	  ways	  to	  involve	  other	  parties	  who	  
might	  wish	  to	  be	  present	  during	  interviews.	  
A	  key	  source	  of	  background	  information	  in	  preparing	  for	  the	  semi-­‐structured	  interviews	  was	  
the	  personal	  health	  budget	  lead	  in	  each	  of	  the	  20	  in-­‐depth	  pilot	  sites.	  When	  details	  of	  budget	  
holders	  and	  carers	  were	  provided	  to	  the	  SPRU	  team	  by	  the	  University	  of	  Kent,	  the	  SPRU	  
researchers	  contacted	  the	  personal	  health	  budget	  lead	  in	  each	  site	  to	  gather	  up-­‐to-­‐date	  
information	  on	  the	  personal,	  health	  and	  wider	  circumstances	  of	  each	  budget	  holder	  or	  carer	  
who	  was	  being	  considered	  for	  recruitment	  to	  the	  in-­‐depth	  interview	  sub-­‐sample.	  The	  purpose	  
of	  these	  preliminary	  enquiries	  was	  to	  avoid	  making	  approaches	  to	  budget	  holders	  or	  carers	  if	  
their	  current	  circumstances	  suggested	  this	  would	  be	  inconvenient	  or	  inappropriate	  and	  to	  
ensure	  that	  the	  researchers	  were	  aware	  of	  any	  potential	  risks	  to	  their	  own	  wellbeing	  posed	  by	  
that	  budget	  holder’s	  circumstances.	  	  
The	  researchers	  first	  sent	  an	  introductory	  email	  to	  personal	  health	  budget	  leads	  explaining	  the	  
reason	  for	  their	  contact,	  and	  then	  made	  a	  telephone	  call	  to	  gather	  key	  information	  including:	  
 The	  main	  health	  condition	  for	  which	  the	  person	  was	  receiving	  a	  personal	  health	  budget.	  	  
 Any	  recent	  changes	  in	  health	  or	  personal	  circumstances	  that	  should	  be	  taken	  into	  account	  
before	  making	  contact	  or	  making	  a	  home	  visit.	  
 Any	  language	  or	  communication	  needs	  that	  should	  be	  taken	  into	  account	  when	  making	  
initial	  contact	  and	  carrying	  out	  a	  research	  interview.	  
	  
Personal	  health	  budget	  leads	  and	  care	  navigators	  were	  invariably	  very	  helpful	  in	  responding	  to	  
these	  requests	  for	  information.	  Sometimes	  personal	  health	  budget	  leads	  identified	  some	  
budget	  holders	  as	  particularly	  ‘good’	  people	  to	  approach.	  However,	  the	  researchers	  attempted	  
to	  set	  aside	  this	  type	  of	  information	  so	  as	  not	  to	  construct	  a	  sample	  biased	  towards	  the	  most	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articulate,	  positive	  or	  amenable	  respondents.	  Personal	  health	  budget	  leads	  and	  care	  
navigators	  also	  commented	  on	  the	  likelihood	  of	  the	  budget	  holder	  being	  capable	  of	  engaging	  
in	  an	  in-­‐depth	  interview	  of	  the	  type	  intended	  for	  this	  strand	  of	  the	  evaluation.	  On	  the	  basis	  of	  
the	  above	  range	  of	  information,	  the	  researchers	  made	  decisions	  about	  who	  to	  approach	  with	  
an	  invitation	  to	  take	  part	  in	  an	  in-­‐depth	  interview.	  	  
B.4 Recruitment	  and	  consent	  	  
Having	  identified	  potential	  participants,	  recruitment	  proceeded	  with	  an	  initial	  invitation	  letter	  
and	  information	  sheet	  sent	  to	  selected	  budget	  holders	  or	  carers.	  All	  budget	  holders	  and	  carers	  
had	  been	  informed	  when	  recruited	  to	  the	  wider	  evaluation	  that	  they	  may	  be	  contacted	  about	  
taking	  part	  in	  some	  more	  in-­‐depth	  research.	  However,	  being	  aware	  that	  not	  all	  participants	  
would	  recall	  this	  clearly,	  the	  invitation	  letter	  reiterated	  why	  participants	  were	  being	  contacted	  
and	  the	  information	  sheet	  set	  out	  comprehensive	  details	  of	  what	  participation	  in	  the	  in-­‐depth	  
strand	  of	  the	  study	  would	  involve.	  
Invitation	  letters	  were	  sent	  out	  in	  several	  successive	  waves,	  in	  part	  to	  pace	  the	  fieldwork	  but	  
also	  because	  of	  the	  initially	  slow	  recruitment	  of	  participants	  to	  the	  wider	  evaluation.	  These	  
waves	  were	  timed	  to	  correspond	  to	  three	  months	  after	  being	  offered	  a	  personal	  health	  budget	  
for	  budget	  holders	  and	  carers,	  and	  three	  months	  after	  the	  birth	  of	  their	  baby	  for	  maternity	  
personal	  health	  budget	  holders.	  Experience	  of	  the	  Individual	  Budgets	  Pilot	  evaluation	  also	  
suggested	  that	  it	  would	  be	  worth	  undertaking	  some	  interviews	  for	  later	  on	  in	  the	  pilots,	  when	  
personal	  health	  budgets	  pilot	  sites’	  recruitment	  and	  care/support	  planning	  processes	  had	  
‘bedded	  in’.	  	  
In	  the	  first	  wave	  of	  invitation	  letters	  for	  budget	  holders,	  the	  researchers	  offered	  a	  two-­‐week	  
opt-­‐out	  period,	  during	  which	  budget	  holders	  could	  state	  (by	  pre-­‐paid	  postal	  reply	  slip,	  
telephone	  or	  email)	  if	  they	  did	  not	  wish	  for	  further	  contact	  from	  the	  researchers.	  The	  first	  six	  
invitation	  letters	  sent	  out	  included	  this	  option,	  but	  no	  opt-­‐outs	  were	  received	  during	  the	  two-­‐
week	  period.	  Following	  the	  two-­‐week	  opt-­‐out	  period,	  the	  researchers	  contacted	  budget	  
holders	  by	  telephone	  to	  ask	  if	  they	  had	  any	  further	  questions	  and	  to	  see	  if	  they	  would	  be	  
willing	  to	  participate	  in	  a	  research	  interview.	  Of	  these	  initial	  six	  approaches,	  four	  participants	  
agreed	  to	  interview,	  one	  opted	  out	  at	  the	  point	  of	  telephone	  contact	  and	  one	  was	  not	  able	  to	  
be	  contacted	  by	  telephone.	  Of	  those	  who	  agreed	  to	  be	  interviewed,	  most	  did	  not	  have	  a	  clear	  
recall	  of	  the	  invitation	  letter	  by	  the	  time	  of	  the	  researcher’s	  telephone	  call,	  though	  they	  still	  
expressed	  willingness	  to	  take	  part	  in	  an	  in-­‐depth	  interview.	  Based	  on	  this	  experience,	  the	  
research	  team	  decided	  that	  a	  two-­‐week	  opt-­‐out	  period	  was	  unnecessary	  for	  future	  invitations	  
and	  invitation	  letters	  were	  amended	  to	  say	  that	  a	  researcher	  would	  be	  in	  touch	  by	  telephone	  
to	  talk	  about	  possible	  participation.	  	  
Budget	  holders	  and	  carers	  who	  chose	  not	  to	  take	  part	  in	  an	  in-­‐depth	  interview	  did	  so	  because	  
of	  severe	  ill	  health,	  current	  personal	  circumstances	  (for	  example,	  moving	  house),	  too	  many	  
other	  time	  commitments,	  or	  simply	  feeling	  that	  it	  would	  be	  too	  demanding.	  In	  a	  number	  of	  
cases	  where	  the	  budget	  holder	  was	  very	  unwell,	  frail	  or	  had	  communication	  difficulties,	  the	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initial	  telephone	  conversation	  took	  place	  with	  a	  third	  party	  (typically	  a	  partner)	  and,	  in	  such	  
cases,	  it	  was	  usually	  established	  that	  it	  would	  be	  inappropriate	  to	  conduct	  an	  in-­‐depth	  
interview	  with	  the	  budget	  holder.	  Wherever	  possible,	  however,	  the	  researchers	  endeavoured	  
to	  speak	  to	  the	  budget	  holder	  themselves	  before	  deciding	  not	  to	  pursue	  an	  interview.	  
The	  following	  three	  sections	  give	  specific	  details	  on	  the	  samples	  and	  interviews	  with	  personal	  
health	  budget	  holders,	  budget	  holders	  for	  maternity	  services	  and	  carers,	  respectively.	  
B.5 Personal	  health	  budget	  holders	  
B.5.1 Sample	  of	  budget	  holders	  
The	  study	  aimed	  to	  interview	  a	  sample	  of	  55	  personal	  health	  budget	  holders.	  The	  timing	  of	  the	  
three	  month	  interview	  was	  intended	  to	  allow	  for	  reflection	  on	  the	  decision-­‐making	  and	  
care/support	  planning	  process	  at	  a	  point	  in	  time	  when	  participant	  recall	  remained	  relatively	  
good	  but	  sufficient	  time	  had	  elapsed	  for	  some	  care/support	  planning	  to	  have	  taken	  place.9	  	  
Six	  health	  conditions	  would	  be	  covered	  by	  the	  budget	  holder	  sample:	  diabetes,	  chronic	  
obstructive	  pulmonary	  disease	  (COPD),	  stroke,	  long-­‐term	  neurological	  conditions	  (for	  example,	  
multiple	  sclerosis,	  Parkinson’s),	  mental	  health	  conditions	  and	  people	  receiving	  NHS	  Continuing	  
Healthcare.	  Target	  recruitment	  numbers	  were	  agreed	  in	  advance.	  Table	  B-­‐1	  gives	  the	  target	  









	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
9	  Previous	  experience	  of	  the	  individual	  budgets	  pilot	  evaluation	  suggested	  that	  scheduling	  interviews	  any	  earlier	  
than	  three	  months	  may	  mean	  that	  little	  planning	  had	  taken	  place	  with	  the	  budget	  holder.	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Table	  B-­‐1.	  Recruitment	  targets	  and	  sample:	  personal	  health	  budget	  holders	  





COPD	   5	   7	   6	  
Diabetes	   5	   6	   5	  
Stroke	   10	   8	   8	  
Mental	  health	   10	   9	   8	  
NHS	  continuing	  healthcare	   10	   15	   15	  
LTNC	   15	   13	   10	  
TOTAL	   55	   58	   52	  
	  
Table	  B-­‐2	  shows	  the	  characteristics	  of	  the	  58	  budget	  holders	  recruited	  and	  interviewed	  at	  
three	  months.	  	  
 
Table	  B-­‐2.	  Characteristics	  of	  sample:	  personal	  health	  budget	  holders	  
Characteristic	   3	  month	  interviews	  
Age*	  range	  	   	  
	   Teens	   1	  
	   20s	   8	  
	   30s	   11	  
	   40s	   7	  
	   50s	   10	  
	   60s	   13	  
	   70s	   4	  
	   80s	   3	  
Gender	   	  
	   Female	  	   31	  
	   Male	  	   27	  
*	  1	  person’s	  age	  unknown.  
B.5.2 Interviews	  with	  budget	  holders	  
The	  majority	  of	  interviews	  were	  conducted	  face-­‐to-­‐face	  in	  the	  budget	  holder’s	  home,	  using	  a	  
semi-­‐structured	  topic	  guide.	  A	  small	  number	  of	  interviews	  were	  conducted	  by	  telephone.	  
Three	  month	  interviews	  typically	  lasted	  80-­‐90	  minutes;	  nine	  month	  interviews	  lasted	  about	  60-­‐
90	  minutes.	  Several	  at	  both	  three	  and	  nine	  months	  approached	  two	  hours.	  Sometimes	  people	  
190	  
	  
chose	  to	  take	  a	  brief	  break	  but	  in	  most	  cases	  interviews	  continued	  uninterrupted	  for	  their	  
duration.	  
The	  main	  topics	  covered	  in	  the	  three	  month	  interviews	  were:	  
 Health	  condition	  and	  satisfaction	  with	  services	  prior	  to	  taking	  up	  a	  personal	  health	  
budget.	  
 Finding	  out	  about	  personal	  health	  budgets.	  
 Making	  the	  decision	  to	  try	  a	  personal	  health	  budget.	  
 The	  amount	  of	  the	  personal	  health	  budget	  and	  feelings	  about	  this.	  
 Deciding	  how	  to	  use	  the	  personal	  health	  budget.	  
 How	  the	  personal	  health	  budget	  is	  managed.	  
 Experiences	  so	  far	  of	  having	  a	  personal	  health	  budget.	  
	  
The	  main	  topics	  covered	  in	  the	  nine	  month	  interviews	  were:	  
 The	  impacts	  of	  the	  personal	  health	  budget	  on	  the	  health,	  well-­‐being	  and	  quality	  of	  life	  of	  
the	  budget	  holder	  (and	  other	  family	  members).	  
 How	  the	  personal	  health	  budget	  had	  been	  used	  and	  budget	  holders’	  reflections	  on	  the	  
choices	  they	  had	  made.	  	  
 Budget	  holders’	  satisfaction	  with	  the	  level	  of	  their	  personal	  health	  budget.	  	  
 Reflections	  on	  the	  chosen	  management	  options	  for	  the	  personal	  health	  budget.	  
 Experiences	  of	  the	  implementation	  of	  personal	  health	  budgets.	  	  
	  
The	  researchers	  used	  the	  topic	  guides	  flexibly.	  While	  key	  themes	  were	  covered	  with	  all	  
participants,	  certain	  questions	  or	  probes	  were	  omitted	  where	  not	  applicable	  to	  that	  person’s	  
circumstances	  or	  experience.	  	  
Although	  the	  researchers	  tried	  to	  avoid	  conducting	  interviews	  with	  ‘proxy’	  respondents	  on	  
behalf	  of	  a	  personal	  health	  budget	  holder,	  in	  a	  number	  of	  cases	  a	  third	  party	  was	  present	  
during	  the	  interview	  and	  often	  contributed	  a	  substantial	  amount	  to	  the	  conversation.	  	  
Three	  and	  nine	  month	  interviews	  were	  digitally	  recorded	  with	  the	  participant’s	  consent.	  Some	  
participants	  showed	  printed	  papers	  to	  the	  researcher	  during	  the	  interview,	  for	  example,	  
assessment	  forms,	  care/support	  plans,	  financial	  information	  or	  correspondence	  from	  the	  
personal	  health	  budget	  lead	  or	  care	  navigator.	  These	  documents	  were	  discussed	  during	  the	  
interviews	  as	  relevant	  but	  detailed	  information	  from	  such	  paperwork	  was	  not	  recorded	  and	  
copies	  were	  not	  taken	  away	  by	  the	  researcher.	  
B.6 Carers	  of	  personal	  health	  budget	  holders	  
The	  evaluation	  aimed	  to	  conduct	  semi-­‐structured	  interviews	  with	  20	  carers	  of	  personal	  budget	  
holders,	  at	  three	  and	  nine	  months	  after	  the	  offer	  of	  a	  personal	  health	  budget.	  Although	  a	  
number	  of	  carers	  had	  consented	  to	  participate	  in	  the	  main	  evaluation	  as	  proxy	  respondents	  for	  
budget	  holders,	  they	  were	  not	  considered	  appropriate	  to	  interview,	  as	  they	  had	  not	  consented	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to	  participate	  as	  carers	  in	  their	  own	  right.	  Recruitment	  of	  carers	  (as	  respondents	  in	  their	  own	  
right)	  to	  the	  main	  evaluation	  was	  delayed.	  Therefore,	  in	  order	  to	  be	  able	  to	  conduct	  both	  the	  
three-­‐	  and	  nine-­‐	  month	  interviews	  within	  the	  overall	  timeframe	  of	  the	  evaluation,	  it	  was	  
necessary	  to	  select	  the	  sample	  from	  a	  limited	  number	  of	  the	  earliest	  carer	  recruits.	  
Consequently,	  it	  was	  not	  possible	  to	  recruit	  carers	  supporting	  personal	  budget	  holders	  with	  
the	  full	  range	  of	  conditions	  covered	  by	  the	  pilot	  sites,	  nor	  carers	  from	  all	  the	  sites	  involved	  in	  
the	  evaluation.	  Nineteen	  carers	  were	  recruited	  for	  the	  in-­‐depth	  interviews,	  a	  majority	  of	  whom	  
were	  supporting	  personal	  budget	  holders	  with	  long-­‐term	  neurological	  conditions	  (LTNC)	  or	  
eligible	  for	  NHS	  Continuing	  Healthcare.	  	  
Subsequently	  there	  was	  some	  attrition	  from	  the	  sample:	  five	  carers	  withdrew	  from	  the	  
personal	  health	  budget	  pilot	  and/or	  the	  evaluation	  before	  the	  nine-­‐month	  interview	  and	  one	  
who	  was	  interviewed	  at	  three	  months	  could	  not	  be	  contacted	  again	  at	  nine	  months.	  Table	  B-­‐3	  
summarises	  the	  sample.	  
Table	  B-­‐3.	  Sample:	  carers	  of	  personal	  health	  budget	  holders	  
Carers	  who	  were	  supporting	  relatives	  with:	  	   3	  month	  interview	   9	  month	  interview	  
Stroke	  1	   3	   1	  
COPD	  2	   2	   1	  
LTNC	  3	   7	   4	  
NHS	  Continuing	  Healthcare	  	   7	   7	  
Total	   19	   13	  
1. One	  of	  these	  had	  a	  long-­‐term	  neurological	  condition	  as	  well	  as	  stroke.	  
2. One	  of	  these	  had	  multiple	  health	  problems,	  including	  arthritis,	  as	  well	  as	  COPD.	  
3. Two	  of	  these	  had	  additional	  health	  problems,	  including	  diabetes	  and	  Aspergers	  Syndrome.	  
	  
Fourteen	  carers	  were	  female	  and	  five	  were	  male.	  Their	  ages	  varied.	  At	  the	  time	  of	  recruitment	  
eight	  people	  were	  in	  their	  forties;	  three	  in	  their	  fifties;	  five	  in	  their	  sixties	  and	  the	  remaining	  
three	  were	  in	  their	  seventies.	  	  
To	  focus	  specifically	  on	  the	  impacts	  and	  outcomes	  of	  personal	  health	  budgets,	  the	  analysis	  
concentrated	  only	  on	  the	  13	  carers	  who	  took	  part	  in	  both	  interviews.	  Even	  so,	  at	  nine	  months	  
one	  of	  these	  carers	  had	  recently	  withdrawn	  from	  the	  personal	  health	  budget	  pilot;	  one	  was	  
caring	  for	  someone	  still	  waiting	  to	  receive	  a	  personal	  health	  budget;	  and	  one	  was	  not	  sure	  
whether	  a	  personal	  health	  budget	  had	  been	  awarded	  or	  not.	  	  
B.7 Interviews	  with	  carers	  	  
As	  with	  the	  main	  sample	  of	  budget	  holders,	  carers	  were	  interviewed	  using	  a	  semi-­‐structured	  
topic	  guide.	  The	  three-­‐month	  interviews	  focused	  on:	  
 carers’	  early	  knowledge	  of	  personal	  health	  budgets;	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 their	  role	  in	  the	  decision	  to	  try	  a	  personal	  health	  budget	  and	  	  
 their	  role	  in	  planning,	  so	  far,	  how	  it	  would	  be	  used	  and	  managed.	  	  
	  
The	  nine-­‐month	  interviews	  explored:	  
 carers’	  experiences	  with	  the	  overall	  implementation	  of	  the	  personal	  health	  budget;	  	  
 their	  satisfaction	  with	  the	  roles	  they	  had	  been	  able	  to	  play	  in	  planning	  how	  the	  budget	  
was	  to	  be	  used;	  and	  	  
 the	  direct	  and	  indirect	  impacts	  of	  the	  budget	  on	  their	  carer	  role.	  	  
	  
The	  researchers	  used	  the	  topic	  guides	  flexibly.	  While	  key	  themes	  were	  covered	  with	  all	  
participants,	  certain	  questions	  or	  probes	  were	  omitted	  where	  not	  applicable	  to	  that	  person’s	  
circumstances	  or	  experience.	  Both	  rounds	  of	  interviews	  were	  conducted	  face-­‐to-­‐face	  or	  by	  
telephone	  and	  were	  digitally	  recorded.	  
B.8 Data	  analysis	  
The	  completed	  interviews	  for	  personal	  health	  budget	  holders,	  maternity	  services	  budget	  
holders	  and	  carers	  of	  budget	  holders	  were	  transcribed	  in	  full.	  Data	  (summaries	  and	  quotations)	  
was	  extracted	  from	  each	  transcript	  and	  placed	  in	  a	  template	  organised	  by	  themes.	  The	  themes	  
included	  in	  the	  template	  followed	  closely	  the	  structure	  of	  the	  topic	  guide.	  The	  thematic	  
analysis	  was	  supported	  using	  MaxQDA	  and	  used	  the	  Framework	  (Ritchie	  and	  Spencer,	  1994)	  
approach.	  The	  themes	  were	  written	  up	  for	  the	  sample	  as	  a	  whole,	  with	  each	  researcher	  taking	  
lead	  responsibility	  for	  writing	  up	  a	  number	  of	  these.	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 Statistical	  Analysis	  Appendix	  C
C.1 Confounding	  variables	  included	  in	  the	  difference-­‐in-­‐difference	  multivariate	  
analysis	  
Table	  C-­‐1.	  Confounding	  variables	  include	  in	  the	  difference-­‐in-­‐difference	  multivariate	  models	  
Demographic	  information	   Socio-­‐economic	  information	  
Age	   Highest	  education	  level	  	  
Ethnicity	   Benefit	  receipt	  
Accommodation	   	  
Gender	  (excluding	  trans-­‐gender)	   Current	  circumstances	  
Household	  composition	  	   Activities	  of	  daily	  living	  
Employment	  status	   Receipt	  of	  informal	  care	  support	  
Marital	  status	   	  
	   Personal	  health	  budget	  process	  
Health	  conditions	  –	  dummy	  codes	   Personal	  health	  budget	  /Control	  Group	  
NHS	  Continuing	  Healthcare	   Implementation	  models	  1	  to	  5	  
Diabetes	   Time	  in	  receipt	  of	  services	  paid	  for	  by	  the	  
personal	  health	  budget	  
Mental	  health	   Personal	  health	  budget	  value	  
COPD	   Deployment	  of	  the	  personal	  health	  budget	  
Stroke	   	  
Long-­‐term	  neurological	   Interaction	  effects	  with	  each	  main	  effect	  
	   Group	  (personal	  health	  budget	  or	  Control	  
Group)	  
Other	  factors	   Gender	  
Time	  period	  between	  consent	  and	  12-­‐
month	  outcome	  interview	  
Individual	  health	  conditions	  
Area	  cost	  adjustment10	   Marital	  status	  
Area	  classification	  –	  rural/urban	   	  
Deprivation	  scores	   	  
Help	  with	  the	  outcome	  interview	   	  
Pilot	  site	  dummy	  codes	   	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
10	  The	  area	  cost	  adjustment	  reflects	  the	  varying	  costs	  of	  service	  delivery	  around	  the	  country.	  
194	  
	  
C.2 Evaluating	  impact	  (patient-­‐level)	  
We	  started	  with	  a	  basic	  theoretical	  model,	  whereby	  a	  person’s	  care-­‐related	  quality	  of	  life	  is	  
assumed	  to	  be	  determined	  by	  their	  needs-­‐related	  characteristics	  (e.g.	  severity	  of	  their	  
condition,	  levels	  of	  disability	  or	  impairment,	  age,	  sex	  and	  so	  on)	  and	  also	  the	  support	  and	  
services	  they	  receive.	  Personal	  health	  budgets	  change	  the	  process	  by	  which	  care	  services	  are	  
commissioned	  and	  used,	  and	  this	  should	  also	  have	  an	  impact	  on	  quality	  of	  life.	  A	  simple	  linear	  
model	  can	  be	  expressed	  as:	  
	   𝑦𝑦 = 𝜃𝜃 + 𝜃𝜃𝐵𝐵 + 𝜃𝜃𝑥𝑥 + 𝜃𝜃𝑚𝑚 + 𝜃𝜃𝑤𝑤 	   (C-­‐1)	  
where	  𝑦𝑦	  is	  an	  outcome	  indicator	  such	  as	  an	  ASCOT	  or	  EQ-­‐5D	  quality	  of	  life	  score.	  Also  𝐵𝐵	  is	  
the	  care	  process	  i.e.	  whether	  a	  person	  has	  a	  personal	  health	  budget	  or	  not,	  𝑥𝑥	  is	  expenditure	  
on	  health	  and	  social	  care	  services,	  𝑚𝑚	  is	  a	  vector	  of	  needs-­‐related	  characteristics	  that	  affect	  
people’s	  underlying	  health	  condition	  and	  functioning,	  and	  𝑤𝑤are	  time-­‐invariant	  needs-­‐related	  
characteristics	  (NRCs).	  The	  subscript	  j	  denotes	  each	  patient	  and	  t	  is	  time.	  
Services	  are	  deployed	  according	  to	  need,	  care	  process	  and	  other	  factors	  (denoted	  𝑥𝑥
 )	  
	   𝑥𝑥 = 𝛼𝛼 + 𝛼𝛼𝐵𝐵 + 𝛼𝛼𝑚𝑚 + 𝛼𝛼𝑥𝑥
 	   (C-­‐2)	  
Similarly,	  NRCs	  are	  functions	  of	  care	  services	  and	  care	  processes,	  and	  other	  factors	  (denoted	  
𝑚𝑚
 ):	  
	   𝑚𝑚 = 𝛿𝛿 + 𝛿𝛿𝐵𝐵 + 𝛿𝛿𝑥𝑥 + 𝛿𝛿𝑚𝑚
 	   (C-­‐3)	  
We	  solved	  these	  two	  equations	  for	  their	  partial	  reduced-­‐forms:	  
	   𝑥𝑥 = 𝜇𝜇 + 𝜇𝜇𝐵𝐵 + 𝜇𝜇𝑥𝑥
 + 𝜇𝜇𝑚𝑚
 	   (C-­‐4)	  
Similarly,	  NRCs	  are	  functions	  of	  care	  services	  and	  care	  processes,	  and	  other	  factors	  (denoted	  
𝑚𝑚
 ):	  
	   𝑚𝑚 = 𝜆𝜆 + 𝜆𝜆𝐵𝐵 + 𝜆𝜆𝑥𝑥
 + 𝜆𝜆𝑚𝑚
 	   (C-­‐5)	  
In	  turn,	  these	  functions	  could	  be	  substituted	  into	  (C-­‐1):	  	  
	   𝑦𝑦 = 𝜃𝜃 + 𝜃𝜃𝜇𝜇 + 𝜃𝜃𝛿𝛿 + 𝜃𝜃 + 𝜃𝜃𝜇𝜇 + 𝜃𝜃𝛿𝛿 𝐵𝐵 + 𝜃𝜃𝜇𝜇 + 𝜃𝜃𝛿𝛿 𝑥𝑥

+ 𝜃𝜃𝜇𝜇 + 𝜃𝜃𝛿𝛿 𝑚𝑚
 + 𝜃𝜃𝑤𝑤 	  
(C-­‐6)	  
To	  remove	  the	  time	  invariant	  factors,	  we	  took	  differences:	  
	   𝑦𝑦 − 𝑦𝑦 = 𝜃𝜃 + 𝜃𝜃𝜇𝜇 + 𝜃𝜃𝛿𝛿 𝐵𝐵 − 𝐵𝐵 + 𝜃𝜃𝜇𝜇 + 𝜃𝜃𝛿𝛿 𝑥𝑥
 − 𝑥𝑥





We	  estimated	  this	  difference	  model	  in	  reduced-­‐form	  as:	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   𝑦𝑦 − 𝑦𝑦 = 𝑏𝑏 + 𝑏𝑏 𝐵𝐵 − 𝐵𝐵 + 𝜀𝜀	   (C-­‐8)	  
where	  𝑏𝑏 = 𝜃𝜃 + 𝜃𝜃𝜇𝜇 + 𝜃𝜃𝛿𝛿.	  The	  constant,	  𝑏𝑏,	  will	  capture	  any	  person-­‐invariant	  part	  of	  the	  
last	  two	  terms	  of	  (C-­‐7),	  with	  the	  remaining	  components	  going	  into	  the	  error	  i.e.	  




 .	  Potentially	  an	  OLS	  estimation	  of	  (C-­‐8)	  would	  produce	  a	  
biased	  estimate	  of	  𝑏𝑏	  due	  to	  these	  omitted	  variables	  in	  that	  the	  selection	  of	  participation	  into	  
the	  personal	  health	  budget	  or	  control	  groups	  was	  not	  completely	  blind	  and	  at	  random.	  
However,	  estimating	  this	  model	  in	  differences	  limits	  this	  problem	  in	  practice	  because	  the	  
choice	  of	  𝐵𝐵	  is	  made	  at	  time	  𝑡𝑡	  (baseline)	  not	  𝑡𝑡 + 1.	  Whilst	  it	  might	  be	  possible	  that	  personal	  
health	  budget	  group	  choice	  is	  influenced	  by	  𝑥𝑥
 	  or	  𝑚𝑚




 	  and	  Δ𝑚𝑚
 = 𝑚𝑚
 −𝑚𝑚
 	  were	  correlated	  with	  𝑥𝑥
 	  or	  
𝑚𝑚




 	  and	  Δ𝑚𝑚
 = 𝑚𝑚
 −𝑚𝑚
 	  are	  small	  (approaching	  time-­‐
invariance)	  over	  the	  period	  of	  the	  study.	  In	  this	  case,	  (C-­‐7)	  reduces	  to	  𝑦𝑦 − 𝑦𝑦 = 𝜃𝜃 +
𝜃𝜃𝜇𝜇 + 𝜃𝜃𝛿𝛿 𝐵𝐵 − 𝐵𝐵 	  and	  an	  OLS	  estimation	  will	  be	  unbiased.	  	  
As	  a	  final	  safeguard,	  we	  also	  estimated	  a	  ‘controlled’	  model:	  
	   𝑦𝑦 − 𝑦𝑦 = 𝑏𝑏 + 𝑏𝑏 𝐵𝐵 − 𝐵𝐵 + 𝑏𝑏𝑥𝑥
 + 𝑏𝑏𝑚𝑚
 + 𝜀𝜀	   (C-­‐9)	  
using	  baseline	  characteristics	  as	  proxies,	  𝑥𝑥
 	  and	  𝑚𝑚







 .	  	  
The	  coefficient	  𝑏𝑏	  on	  the	  change	  in	  care	  process	  (use	  of	  PHBs)	  is	  a	  function	  of	  the	  direct	  effect	  
on	  outcome	  (difference),	  𝜃𝜃,	  and	  the	  indirect	  effects	  of	  PHB-­‐use	  on	  services	  (𝜃𝜃𝜇𝜇)	  and	  
dependency	  (𝜃𝜃𝛿𝛿).	  Our	  assessment	  of	  personal	  health	  budgets	  would	  also	  benefit	  from	  an	  
estimate	  of	  the	  direct	  effect	  only,	  mainly	  because	  the	  adoption	  of	  a	  personal	  health	  budget	  
model	  need	  not	  mean	  a	  change	  in	  resources.	  The	  size	  of	  𝛼𝛼	  is	  a	  policy	  choice.	  If	  sites	  used	  a	  
pure	  substitution	  approach,	  for	  example,	  then	  this	  parameter	  would	  be	  zero.	  The	  complicating	  
factor,	  however,	  is	  that	  𝜇𝜇	  need	  not	  be	  zero	  even	  if	  𝛼𝛼 = 0	  because	  the	  use	  of	  personal	  health	  
budgets	  could	  reduce	  need,	  𝑚𝑚,	  which	  in	  turn	  reduces	  the	  demand	  for	  services.	  One	  way	  we	  
chose	  to	  proceed	  was	  to	  estimate	  the	  full	  structural	  model	  (C-­‐1),	  which	  was	  done	  more	  easily	  
in	  difference	  form	  i.e.:	  
	   𝑦𝑦 − 𝑦𝑦 = 𝑏𝑏
 + 𝑏𝑏
 𝐵𝐵 − 𝐵𝐵 + 𝑏𝑏
 𝑥𝑥 − 𝑥𝑥 + 𝑏𝑏 𝑚𝑚
 −𝑚𝑚
 + 𝜀𝜀	   (C-­‐10)	  
where	  the	  S	  superscript	  denotes	  coefficients	  from	  the	  structural	  model.	  In	  estimating	  this	  
model	  in	  practice,	  we	  are	  never	  likely	  to	  have	  a	  complete	  set	  of	  NRC	  factors	  available.	  In	  this	  
study,	  we	  used	  a	  subset	  of	  factors	  𝑚𝑚
 ⊂ 𝑚𝑚,	  specifically:	  ADL	  need,	  informal	  care	  rates	  and	  
income	  proxies.	  Unlike	  the	  choice	  of	  𝐵𝐵	  which	  is	  made	  at	  baseline,	  𝑥𝑥	  is	  determined	  after	  
baseline	  (at	  time	  𝑡𝑡 + 1)	  and	  it	  is	  a	  function	  of	  𝑚𝑚
 .	  As	  such	  the	  difference	   𝑥𝑥 − 𝑥𝑥 	  is	  
likely	  to	  be	  correlated	  with	  omitted	  NRC	  change	  factors	  that	  appear	  in	  the	  error	  term,	  
producing	  endogeneity	  bias.	  In	  other	  words,	  the	  coefficient	  𝑏𝑏
	  in	  an	  OLS	  estimation	  would	  be	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picking	  up	  some	  of	  the	  effects	  of	  changes	  in	  NRC.	  For	  example,	  other	  things	  equal,	  an	  increase	  
in	  services	  would	  be	  expected	  to	  improve	  outcomes.	  But	  the	  demand	  for	  services	  is	  also	  
dependent	  on	  the	  person’s	  health	  state.	  Other	  things	  equal,	  if	  people’s	  health	  deteriorates	  (for	  
external	  reasons),	  their	  quality-­‐of-­‐life	  score	  would	  decrease,	  and	  at	  the	  same	  time,	  service	  use	  
would	  increase.	  Where	  this	  effect	  is	  strong,	  omitting	  proxies	  for	  health	  state	  could	  lead	  to	  a	  
negative	  correlation	  between	  change	  in	  outcomes	  and	  change	  in	  service	  use.	  
C.3 Instrumental	  variables	  estimation	  
We	  accounted	  for	  this	  problem	  by	  including	  as	  many	  changes	  in	  NRCs	  factors	  as	  possible	  and	  
also	  by	  using	  instrumental	  variables	  estimation	  of	  (C-­‐10).	  We	  estimated	  these	  models	  using	  
both	  ASCOT	  and	  EQ-­‐5D	  as	  outcome	  indicators.	  In	  both	  cases,	  the	  strategy	  for	  selecting	  
instruments	  was	  to	  use	  baseline	  health	  state	  and	  care	  need	  indicators	  that	  were	  correlated	  
with	  the	  change	  in	  total	  service	  expenditure	  but	  not	  with	  a	  change	  in	  outcomes.	  By	  including	  
the	  change	  in	  these	  instruments	  directly	  in	  the	  model	  as	  explanatory	  factors	  the	  intention	  was	  
to	  remove	  any	  correlation	  between	  their	  baseline	  value	  and	  the	  outcome	  change	  dependent	  
variable	  (without	  removing	  the	  correlation	  between	  their	  baseline	  value	  and	  change	  in	  
services).	  Baseline	  ADL	  score	  indicators	  were	  found	  to	  work	  well	  for	  ASCOT.	  For	  EQ-­‐5D,	  
because	  this	  measure	  is	  usually	  highly	  correlated	  with	  ADL	  levels,	  using	  ADL	  score	  indicators	  
led	  to	  an	  over-­‐identified	  model.	  Instead	  we	  opted	  to	  use	  time	  1	  psychological	  wellbeing	  (GHQ-­‐
12)	  as	  an	  instrument	  in	  that	  the	  EQ-­‐5D	  measure	  concentrates	  more	  on	  physical	  health.	  In	  
addition,	  for	  EQ-­‐5D	  we	  used	  our	  baseline	  income	  proxy	  –	  whether	  the	  person	  is	  in	  receipt	  of	  
income	  benefits.	  Service	  utilisation,	  especially	  social	  care,	  tends	  to	  be	  influenced	  by	  income,	  
but	  short-­‐term	  changes	  in	  income	  are	  less	  likely	  to	  affect	  health	  directly	  (other	  than	  through	  
service	  use).	  Over-­‐identification	  was	  not	  indicated	  when	  benefits	  receipt	  at	  follow-­‐up	  was	  also	  
included	  in	  the	  model.	  
In	  working	  on	  the	  imputed	  dataset,	  we	  manually	  instrumented	  for	  Δ𝑥𝑥	  using	  a	  first-­‐stage	  
multiple	  imputation	  (MI)	  OLS	  (ordinary	  least	  squares)	  estimation	  of	  the	  change	  in	  total	  
expenditure	  on	  the	  included	  and	  excluded	  instruments.	  The	  predicted	  values	  for	  each	  
imputation	  were	  used	  in	  an	  MI	  OLS	  model	  as	  follows:	  





 ,Δ𝐵𝐵)   + 𝑏𝑏Δ𝑚𝑚
 + 𝜀𝜀	   (C-­‐11)	  
Instrument	  weakness	  was	  tested	  by	  an	  MI	  test	  of	  joint	  significance	  (of	  the	  instruments	  in	  the	  
first-­‐stage	  MI	  OLS	  model).	  Over-­‐identification	  was	  tested	  using	  a	  Sargan	  style	  test	  with	  the	  
mean	  R-­‐squared	  values	  from	  an	  MI	  OLS	  estimation	  of	  the	  residuals	  𝜀𝜀.	  Finally,	  endogeneity	  
was	  tested	  using	  a	  Hausman	  test	  by	  including	  the	  residual	  of	  the	  first-­‐stage	  equation	  in	  an	  MI	  
OLS	  estimation	  of	  the	  main	  model	  using	  the	  Δ𝑥𝑥	  rather	  than	  its	  predicted	  value.	  We	  were	  not	  
able	  to	  correct	  the	  standard	  errors	  on	  the	  coefficient	  estimates	  in	  the	  main-­‐stage	  MI	  model	  for	  




The	  model	  results	  are	  given	  in	  the	  main	  text.	  Overall,	  the	  estimation	  performed	  reasonably	  
well	  although	  we	  were	  hampered	  by	  the	  usual	  problem	  of	  weak	  instruments.	  The	  instruments	  
were	  jointly	  significant	  but	  the	  test	  statistic	  was	  a	  little	  lower	  than	  the	  usual	  benchmarks.	  On	  
the	  other	  hand,	  the	  over-­‐identification	  and	  endogeneity	  tests	  showed	  no	  further	  issues	  and	  
supported	  our	  rejection	  of	  the	  exogeneity	  hypothesis.	  
We	  discuss	  the	  results	  in	  the	  main	  text.	  
C.4 Difference-­‐in-­‐difference	  approach	  
On	  the	  basis	  of	  the	  theoretical	  model	  and	  empirical	  strategy	  outlined	  above	  in	  C.1,	  we	  used	  a	  
difference-­‐in-­‐difference	  (DiD)	  approach	  for	  the	  main	  analyses.	  In	  other	  words	  we	  calculated	  
the	  difference	  between	  personal	  health	  budget	  and	  control	  groups	  in	  the	  change	  through	  time	  
of	  the	  relevant	  indicator	  e.g.	  outcome	  scores	  such	  as	  EQ-­‐5D,	  ASCOT,	  GHQ-­‐12	  and	  also	  costs	  
and	  net	  effects	  (see	  below).	  
The	  difference-­‐in-­‐difference	  (DiD)	  estimator	  is	  calculated	  as:	  
	   Δ𝑦𝑦 = 𝑦𝑦 − 𝑦𝑦 − (𝑦𝑦 − 𝑦𝑦)	   (C-­‐12)	  
where	  𝑦𝑦	  is	  the	  sample	  mean	  value	  of	  the	  intervention	  group	  i	  subgroup	  at	  time	  t.	  Taking	  the	  
whole	  sample,	  the	  DiD	  estimator	  is	  identical	  to	  the	  coefficient	  𝑏𝑏	  in	  the	  estimation	  of	  
difference	  model	  (C-­‐8).	  
This	  approach	  is	  also	  equivalent	  to	  fitting	  a	  pooled	  OLS	  model	  as	  follows:	  
	   𝑦𝑦 = 𝛽𝛽 + 𝛽𝛽𝐵𝐵 + 𝛽𝛽𝑇𝑇 + 𝛽𝛽𝐵𝐵𝑇𝑇 + 𝑒𝑒	   (C-­‐13)	  
where	  𝐵𝐵 = 0,1	  is	  a	  ‘treatment	  dummy’	  variable	  for	  the	  j’th	  person	  i.e.	  having	  a	  personal	  
health	  budget	  or	  using	  the	  convention	  process.	  A	  time	  dummy	  variable	  is	  𝑇𝑇 = 0,1.	  The	  
coefficient	  on	  the	  interaction	  term	  𝑋𝑋𝑇𝑇	  is	  the	  DiD	  estimate:	  Δ𝑦𝑦 = 𝛽𝛽 = 𝑏𝑏.	  
As	  an	  alternative	  we	  can	  estimate	  a	  fixed	  effects	  (FE)	  model	  using	  a	  time	  variant	  indicator	  of	  
personal	  health	  budget	  use,	  𝐵𝐵:	  
	   𝑦𝑦 = 𝜇𝜇 + 𝜇𝜇𝑇𝑇 + 𝜇𝜇𝐵𝐵 + 𝑐𝑐 + 𝑒𝑒	   (C-­‐14)	  
The	  standard	  errors	  between	  the	  OLS	  and	  FE	  models	  will	  differ	  slightly	  (see	  Wooldridge,	  2002).	  
We	  can	  use	  these	  approaches	  to	  estimate	  the	  impact	  on	  effectiveness,	  costs	  and	  also	  NMB	  
(net	  monetary	  benefit).	  Consider	  the	  latter.	  At	  any	  given	  time	  t,	  the	  NMB	  for	  each	  person	  j	  is:	  	  
	   𝑁𝑁𝑁𝑁𝑁𝑁 = 𝜆𝜆𝐸𝐸 − 𝐶𝐶	   (C-­‐15)	  
and	  the	  difference	  over	  time	  in	  NMB	  is:	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   Δ𝑁𝑁𝑁𝑁𝑁𝑁 = 𝜆𝜆 𝐸𝐸 − 𝐸𝐸 − 𝐶𝐶 − 𝐶𝐶 	   (C-­‐16)	  
We	  can	  estimate	  NMB	  using	  a	  fixed-­‐effects	  model	  as	  above	  (substituting	  𝑦𝑦 = 𝑁𝑁𝑁𝑁𝑁𝑁	  in	  
(C-­‐14)).	  	  
C.5 Mortality	  and	  confounding	  factors	  on	  outcome	  indicator	  changes	  
A	  difference-­‐in-­‐difference	  approach	  controls	  for	  baseline	  differences	  in	  the	  level	  of	  the	  
outcome	  indicator.	  There	  remains	  a	  possibility	  that	  baseline	  differences	  in	  characteristics	  
between	  the	  groups	  might	  cause	  differences	  in	  the	  rate	  of	  change	  of	  the	  indicator,	  beyond	  any	  
true	  effect	  of	  personal	  health	  budgets.	  We	  can	  control	  for	  this	  by	  estimating	  DiD	  models	  
incorporating	  baseline	  characteristics:	  
	   Δ𝑦𝑦 = 𝛽𝛽 + 𝛽𝛽𝑚𝑚 + 𝛽𝛽𝐵𝐵 + 𝑒𝑒	   (C-­‐17)	  
where	  𝑚𝑚	  are	  baseline	  NR	  characteristics.	  	  
We	  might	  argue	  that	  outcome	  indicators	  such	  as	  wellbeing	  scores	  are	  less	  inherently	  
susceptible	  to	  baseline	  differences	  causing	  spurious	  change	  effects	  12	  months	  later	  because	  
the	  most	  important	  determinants	  at	  any	  given	  time	  are	  those	  more-­‐immediate	  and	  everyday	  
factors,	  including	  use	  of	  a	  personal	  health	  budget.	  This	  argument	  is	  much	  more	  difficult	  to	  
sustain	  for	  mortality	  rates,	  especially	  because	  a	  lack	  of	  difference	  in	  mortality	  at	  baseline	  can	  
hide	  substantial	  differences	  in	  the	  propensity	  to	  die	  immediately	  after	  baseline	  (where,	  clearly,	  
dead	  people	  cannot	  be	  recruited	  into	  the	  study).	  It	  is	  therefore	  most	  important	  to	  control	  for	  
baseline	  factors	  that	  affect	  change,	  as	  in	  (C-­‐17).	  	  
It	  is	  also	  for	  this	  reason	  that	  we	  should	  note	  the	  limitations	  of	  baseline	  control	  estimations	  and	  
consequently	  that	  the	  design	  of	  this	  study	  was	  not	  the	  ideal	  one	  for	  considering	  the	  mortality	  
question.	  There	  is	  always	  the	  possibility	  that	  some	  significant	  factor	  is	  omitted	  so	  that,	  on	  
average,	  people	  in	  one	  group	  had	  a	  higher	  propensity	  for	  mortality	  than	  those	  in	  the	  other	  
group	  at	  baseline,	  regardless	  of	  the	  effects	  of	  personal	  health	  budgets.	  Ideally,	  an	  RCT	  would	  
have	  been	  used	  to	  avoid	  this	  possibility.	  	  
C.6 Costs	  
People	  receiving	  PHBs	  used	  services	  and	  support	  funded	  from	  the	  personal	  health	  budget	  and	  
also	  from	  conventional	  budgets.	  There	  is	  a	  wide	  range	  of	  forms	  of	  support	  or	  services	  that	  
people	  can	  use,	  which	  we	  classify	  as,	  firstly,	  indirect	  services,	  namely:	  primary	  healthcare;	  
secondary	  inpatient	  healthcare,	  outpatient	  and	  A&E	  services;	  and	  secondly,	  direct	  services:	  
nursing	  (mainstream)	  and	  therapy	  services;	  specialist	  nursing	  and	  other	  health	  services;	  social	  
care,	  equipment	  and	  respite	  support;	  and	  well-­‐being	  and	  leisure	  support.	  Personal	  health	  
budgets	  can	  be	  used	  to	  secure	  all	  these	  services	  except	  the	  first	  three,	  the	  indirect	  services,	  
but	  we	  measure	  the	  use	  of	  indirect	  services	  because	  the	  use	  of	  a	  PHB	  may	  change	  people’s	  
demand	  for	  these	  services.	  In	  theory,	  the	  use	  of	  a	  personal	  health	  budget	  might	  also	  affect	  
199	  
	  
demand	  for	  other	  (non-­‐PHB)	  services	  such	  as	  prescription	  drugs,	  but	  measuring	  this	  wider	  
impact	  was	  deemed	  to	  be	  beyond	  the	  scope	  of	  this	  study.	  
As	  a	  consequence	  of	  study	  participants	  potentially	  receiving	  support	  via	  their	  budgets	  and	  via	  
conventional	  routes	  we	  needed	  to	  measure	  service	  use	  distinguishing	  these	  funding	  sources.	  
Due	  to	  the	  difficulties	  of	  making	  this	  distinction	  in	  the	  data	  collection	  our	  approach	  was	  to	  
measure,	  as	  far	  as	  possible,	  total	  use	  of	  services	  and	  support	  and	  also	  activity	  funded	  by	  the	  
personal	  health	  budget	  as	  specified	  in	  the	  care	  and	  support	  plan.	  To	  this	  end,	  the	  study	  
involved	  four	  methods	  to	  capture	  the	  use	  of	  this	  range	  of	  services:	  secondary	  care	  was	  
captured	  using	  HES	  data;	  medical	  records	  were	  used	  to	  measure	  primary	  and	  AHP	  care;	  the	  
service	  user	  interview	  was	  the	  vehicle	  to	  capture	  the	  use	  of	  nursing	  and	  social	  care	  services	  
and	  the	  care	  and	  support	  plan	  was	  used	  to	  measure	  all	  services	  funded	  by	  the	  personal	  health	  
budget.	  	  
The	  variety	  of	  implementation	  forms	  for	  personal	  health	  budgets	  in	  the	  study	  complicated	  the	  
calculation	  of	  total	  costs	  of	  all	  services	  and	  support	  used	  by	  participants	  in	  the	  PHB	  and	  control	  
groups.	  Our	  costing	  methodology	  is	  outlined	  in	  what	  follows.	  
We	  began	  by	  distinguishing	  five	  categories	  of	  service	  or	  support	  activity.	  These	  categories	  
combined	  one	  or	  more	  specific	  activity,	  𝑥𝑥
 ,	  of	  the	  𝑘𝑘 = 1  𝑡𝑡𝑡𝑡  11	  services	  listed	  above	  (and	  in	  
table	  2-­‐1	  in	  chapter	  2),	  for	  each	  participant	  𝑗𝑗	  at	  time	  𝑡𝑡 = 1,2	  (baseline	  and	  follow-­‐up).	  Cost	  is	  
calculated	  by	  multiplying	  the	  activity	  level	  by	  the	  corresponding	  unit	  cost,	  𝑐𝑐
:	  




 .	  	  	  



















where	  𝑚𝑚 = 𝑁𝑁,𝐵𝐵	  for	  conventionally-­‐funded	  and	  PHB-­‐funded	  services	  respectively.	  	  
Total	  costs	  for	  study	  participants	  in	  group	  j	  (𝑗𝑗 = 1	  for	  PHB	  and	  𝑗𝑗 = 0	  for	  control)	  at	  time	  t	  
(𝑡𝑡 = 1	  for	  baseline	  and	  𝑡𝑡 = 2	  for	  follow-­‐up)	  were	  defined	  as:	  
	   𝐶𝐶 = 𝐼𝐼







 	   (C-­‐18)	  
Our	  definition	  of	  well-­‐being	  support	  and	  services	  was	  chosen	  to	  rule	  out	  any	  services	  that	  
might	  be	  conventionally	  provided.	  We	  therefore	  defined	  𝑤𝑤
 = 0	  for	  all	  j	  and	  t.	  
For	  the	  personal	  health	  budget	  group	  at	  time	  2,	  total	  cost,	  𝐶𝐶	  was	  calculated	  as:	  
	   𝐶𝐶 = 𝐼𝐼







 	   (C-­‐19)	  





 	  with	  𝐵𝐵
 	  being	  any	  underspent	  
part	  of	  the	  budget.	  The	  components	  of	  this	  equation	  were	  measured	  as	  follows.	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Indirect	  service	  use	  cannot	  be	  funded	  using	  a	  personal	  health	  budget	  and	  therefore	  our	  
measurement	  of	  total	  primary	  and	  secondary	  care	  expenditure	  gives	  us	  the	  value	  𝐼𝐼
 .	  We	  
measured	  this	  expenditure	  for	  both	  personal	  health	  budget	  and	  control	  groups	  because	  we	  





≠ 0.	  	  
As	  regards	  direct	  services,	  we	  also	  assumed	  that	  expenditure	  on	  the	  personal	  health	  budget	  
substitutes	  in	  part	  for	  spending	  via	  conventional	  budgets.	  In	  particular	  we	  supposed	  that	  
	   𝐶𝐶
 = 𝐶𝐶
 − 𝑓𝑓 𝐶𝐶
 	   (C-­‐20)	  
for	  each	  direct	  service	  𝐶𝐶 = 𝑞𝑞, 𝑠𝑠, ℎ,𝑤𝑤	  and	  where	  𝐶𝐶
 	  is	  the	  service	  expenditure	  without	  a	  
personal	  health	  budget.	  For	  example,	  social	  care	  expenditure	  may	  be	  shifted	  from	  
conventional	  budgets	  to	  the	  personal	  health	  budget:	  𝑠𝑠
 = 𝑠𝑠
 − 𝑓𝑓 𝑠𝑠
 .	  In	  general	  a	  £1-­‐for-­‐
£1	  substitution	  would	  be:	  𝐶𝐶
 = 𝐶𝐶
 − 𝐶𝐶
   (or	  	  𝑠𝑠
 = 𝑠𝑠
 − 𝑠𝑠
 	  in	  the	  social	  care	  case)	  so	  that	  a	  
full	  transfer	  would	  result	  in:	  𝐶𝐶
 = 0	  and	  𝐶𝐶
 = 𝐶𝐶
 .	  	  




 	  for	  𝐶𝐶 = 𝑞𝑞, 𝑠𝑠, ℎ,𝑤𝑤.	  Ideally,	  in	  the	  study	  we	  aimed	  to	  collect	  data	  on	  the	  total	  
use	  of	  all	  forms	  of	  service	  and	  support	  and	  also	  the	  amount	  funded	  out	  of	  the	  personal	  health	  
budget	  i.e.	  to	  measure	  𝐶𝐶
 	  and	  𝐶𝐶
 .	  In	  practice,	  the	  care	  plan	  gave	  us	  the	  breakdown	  of	  
expenditure	  made	  from	  the	  personal	  health	  budget	  but	  there	  was	  no	  equivalent	  way	  of	  
measuring	  the	  amount	  of	  each	  form	  of	  service	  or	  support	  that	  was	  funded	  conventionally.	  As	  
outlined	  we	  could	  instead	  measure	  the	  total	  use	  of	  those	  services,	  where	  in	  theory	  the	  
personal	  health	  budget	  could	  be	  used	  to	  fund	  part	  of	  this	  total	  alongside	  conventional	  
budgets.	  There	  is	  a	  difficulty	  with	  this	  approach	  however.	  Respondents	  might	  not	  include	  all	  
PHB-­‐funded	  service/support	  category	  because	  they	  did	  not	  use	  their	  personal	  health	  budget	  
according	  to	  conventional	  service	  definitions.	  For	  example,	  suppose	  we	  are	  measuring	  social	  
care	  expenditure.	  A	  personal	  health	  budget	  holder	  who	  was	  receiving	  conventional	  home	  care	  
services	  at	  baseline,	  at	  a	  value	  of	  £250	  per	  week,	  instead	  uses	  their	  budget	  at	  follow-­‐up	  to	  pay	  
for	  a	  personal	  assistant.	  Their	  PA	  might	  cost	  the	  same	  per	  week	  (£250),	  but	  could	  we	  be	  sure	  
that	  the	  study	  participant	  would	  record	  total	  home	  care	  use	  at	  follow-­‐up	  at	  £250	  per	  week?	  
The	  cost	  of	  PA	  support	  could	  be	  confirmed	  in	  the	  support	  plan	  however.	  	  




 	  where	  𝐶𝐶
 	  is	  the	  observed	  total	  such	  that	  the	  PHB	  contribution	  may	  be	  












 	   (C-­‐21)	  
Clearly	  if	  all	  PHB-­‐funded	  care	  was	  counted	  i.e.	  𝑔𝑔 = 1	  then	  𝐶𝐶
 = 𝐶𝐶
 .	  	  
We	  therefore	  needed	  an	  estimate	  of	  𝑔𝑔 .	  For	  this	  purpose,	  we	  distinguished	  between	  two	  
types	  of	  personal	  health	  budgets	  process.	  First	  there	  were	  sites	  that	  offered	  relatively	  small	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budgets	  (of	  less	  than	  £1000)	  which	  were	  provided	  on	  top	  of	  conventional	  services,	  with	  
funding	  from	  new	  sources.	  The	  second	  group	  of	  personal	  health	  budgets	  were	  those	  funded	  by	  
a	  reduction	  of	  budgets	  for	  conventional	  services.	  These	  were	  generally	  more	  substantial.	  On	  
this	  basis	  we	  assumed	  that	  personal	  health	  budgets	  with	  budgets	  of	  greater	  than	  £1000	  in	  
each	  service	  component	  are	  fully	  substituting,	  as	  outlined	  above	  i.e.	  𝐶𝐶
 = 0	  with	  𝑓𝑓 = 1.	  
Those	  with	  budgets	  of	  less	  than	  £1000	  were	  assumed	  to	  have	  personal	  health	  budgets	  funded	  
in	  addition	  to	  usual	  services	  i.e.	  𝐶𝐶
 > 0	  with	  𝑓𝑓 = 0.	  	  




 − 𝑓𝑓 𝐶𝐶
 .	  With	  full	  substitution	  i.e.	  
𝐶𝐶
 = 0	  then	  𝐶𝐶
 = 𝑔𝑔𝐶𝐶
 	  and	  (C-­‐21)	  reduces	  to	  	  
	   𝐶𝐶
 = 𝐶𝐶
 	   (C-­‐22)	  
and	  under-­‐counting	  is	  not	  a	  problem.	  But	  where	  there	  is	  partial	  substitution,	  under-­‐counting	  
might	  occur.	  In	  that	  case,	  actual	  expenditure	  is	  given	  by	  (C-­‐21)	  and	  we	  need	  to	  make	  an	  
assumption	  about	  the	  size	  of	  𝑔𝑔 ≤ 1	  since	  𝐶𝐶
 = 𝐶𝐶
 − 𝑓𝑓 𝐶𝐶
 > 0.	  One	  way	  of	  doing	  this	  
was	  to	  estimate	  a	  value	  of	  𝑔𝑔 	  from	  the	  relationship	  𝐶𝐶
 = 𝑔𝑔𝐶𝐶
 .	  
We	  took	  a	  sub-­‐sample	  of	  cases	  where	  budgets	  are	  greater	  than	  £1000,	  for	  which	  we	  assumed	  
that	  𝐶𝐶
 = 𝑔𝑔𝐶𝐶
 ,	  and	  where	  both	  expenditure	  amounts	  were	  measured.	  Using	  simple	  
regression	  we	  estimated	  the	  coefficient	  𝑔𝑔 .	  For	  social	  care	  services	  we	  estimated	  𝑔𝑔 = 0.47	  
and	  for	  nursing	  and	  therapy	  services,	  𝑔𝑔 = 0.16.	  These	  values	  were	  assumed	  to	  apply	  to	  
budgets	  of	  less	  than	  £1000	  where	  𝐶𝐶
 > 0	  and	  actual	  total	  expenditure	  is	  given	  by	  (C-­‐21).	  With	  
the	  observed	  total	  expenditure	  𝐶𝐶
 	  from	  the	  interviews	  at	  follow-­‐up	  and	  𝐶𝐶
 	  from	  support	  
plans,	  and	  using	  these	  estimates	  we	  calculated	  total	  social	  care	  and	  nursing	  and	  therapy	  
services.	  In	  the	  social	  care	  case	  we	  have:	  
 For	  𝑠𝑠 > £1000	  we	  have:	  𝑠𝑠 + 𝑠𝑠 = 𝑠𝑠 	  
 For	  𝑠𝑠 ≤ £1000	  we	  have:	  𝑠𝑠 + 𝑠𝑠 = 𝑠𝑠 − 0.47𝑠𝑠 + 𝑠𝑠 	  
Similarly	  for	  nursing	  and	  therapy	  services	  we	  have:	  
 For	  𝑞𝑞 > £1000	  we	  have:	  𝑞𝑞 + 𝑞𝑞 = 𝑞𝑞 	  
 For	  𝑠𝑠 ≤ £1000	  we	  have:	  𝑞𝑞 + 𝑞𝑞 = 𝑞𝑞 − 0.16𝑞𝑞 + 𝑞𝑞 	  
These	  amounts	  were	  substituted	  into	  (C-­‐19).	  	  
We	  also	  assumed	  that	  the	  social	  care	  of	  any	  personal	  health	  budget	  might	  include	  elements	  
from	  any	  existing	  social	  care	  personal	  budget	  (PB).	  Specifically	  we	  expected	  that	  the	  social	  care	  
component	  in	  the	  PHB	  would	  be	  a	  function	  of	  the	  existence	  of	  time	  1	  social	  care	  PBs,	  including	  
direct	  payments:	  𝑠𝑠
 = 𝑠𝑠
 𝐵𝐵, 𝑏𝑏 ,	  where	  𝑏𝑏	  is	  the	  existence	  of	  a	  social	  care	  personal	  budget	  
at	  time	  1.	  	  
Regarding	  well-­‐being	  support	  and	  services	  in	  (C-­‐19),	  as	  noted	  above,	  we	  defined	  𝑤𝑤
 = 0.	  
Well-­‐being	  support	  and	  services	  listed	  in	  the	  personal	  health	  budget	  support	  plan	  were	  used	  to	  
cost	  𝑤𝑤
 	  in	  (C-­‐19).	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The	  specialist	  nursing	  and	  other	  health	  services	  are	  somewhat	  of	  a	  catch-­‐all	  category	  for	  health	  
care	  services	  not	  captured	  in	  the	  other	  categories.	  As	  such	  we	  were	  not	  able	  to	  collect	  
information	  about	  total	  activity	  in	  this	  category	  except	  for	  that	  listed	  in	  the	  personal	  health	  
budget	  support	  plan.	  In	  other	  words,	  we	  assumed	  that	  ℎ
 = 011.	  We	  made	  the	  same	  
assumption	  for	  the	  control	  group	  so	  as	  to	  not	  bias	  the	  cost	  comparison.	  	  
For	  the	  personal	  health	  budget	  group	  at	  time	  1:	  




 𝑏𝑏 + 𝑤𝑤
 𝑏𝑏 + ℎ
 	   (C-­‐23)	  
Indirect	  services	  are	  measured	  in	  the	  same	  way	  as	  time	  2.	  In	  the	  absence	  of	  personal	  health	  
budgets,	  conventionally-­‐funded	  nursing	  and	  therapy	  support	  equals	  the	  total	  observed	  level:	  
𝑞𝑞
 = 𝑞𝑞
 .	  	  
As	  regards	  social	  care,	  and	  despite	  personal	  health	  budgets	  not	  being	  available,	  participants	  
might	  have	  been	  receiving	  social	  care	  personal	  budgets	  (PB)	  at	  time	  1.	  Interview	  data	  at	  
baseline	  indicated	  whether	  a	  person	  had	  a	  social	  care	  PB,	  but	  we	  did	  not	  have	  access	  to	  PB	  
care	  plans	  at	  time	  1.	  	  
In	  theory	  the	  same	  social	  care	  services	  can	  be	  funded	  in	  a	  social	  care	  personal	  budget	  as	  those	  
in	  a	  personal	  health	  budget	  (where	  they	  are	  often	  combined).	  We	  therefore	  estimated	  the	  cost	  
of	  time	  1	  social	  care	  personal	  budgets	  using	  the	  cost	  of	  social	  care	  in	  the	  time	  2	  personal	  
health	  budget	  and	  controlling	  for	  any	  changes	  in	  study	  participant	  characteristics,	  such	  as	  ADL	  
dependency,	  and	  also	  baseline	  characteristics.	  Hence	  we	  use:	  𝑠𝑠
 = 𝑠𝑠
 𝛿𝛿 	  from	  the	  time	  2	  
regression:	  𝑠𝑠
 = 𝑠𝑠
 𝛿𝛿 + 𝜀𝜀
.	  To	  avoid	  double-­‐counting,	  we	  calculate	  𝑠𝑠
 + 𝑠𝑠
 𝑏𝑏 = 𝑠𝑠
 +
1 − 0.47 𝑠𝑠
 𝑏𝑏	  in	  all	  cases.	  
We	  can	  also	  make	  the	  similar	  argument	  that	  people	  with	  social	  care	  personal	  budgets	  might	  
have	  been	  using	  that	  budget	  to	  secure	  wellbeing	  services.	  As	  with	  social	  care,	  we	  used	  the	  
wellbeing	  component	  of	  the	  time	  2	  personal	  health	  budget	  as	  an	  indicator,	  controlling	  for	  any	  
changes	  in	  characteristics:	  𝑤𝑤
 = 𝑤𝑤
 𝛿𝛿 .	  As	  noted	  above,	  with	  personal	  health	  budgets	  of	  
less	  than	  £1000,	  we	  assumed	  that	  the	  personal	  health	  budget	  was	  provided	  on	  top	  of	  existing	  
services	  and	  support	  and	  this	  could	  include	  existing	  time-­‐1	  social	  care	  personal	  budgets.	  In	  this	  
case	  the	  actual	  value	  of	  the	  social	  care	  personal	  budget	  would	  be	  less	  than	  implied	  by	  the	  
time-­‐2	  personal	  health	  budget.	  In	  this	  case,	  the	  social	  care	  personal	  budget	  would	  be	  less	  by	  
£1000	  or	  the	  value	  of	  the	  personal	  health	  budget,	  whichever	  is	  greater	  (so	  that	  any	  time-­‐1	  
personal	  budget	  is	  greater	  or	  equal	  to	  zero).	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
11	  Given	  the	  complexities	  of	  measuring	  the	  use	  of	  routine	  equipment	  and	  costing	  this	  use,	  particularly	  in	  terms	  of	  
the	  opportunity	  cost	  where	  equipment	  is	  borrowed	  from	  an	  existing	  (slowly	  depreciating)	  stock	  (i.e.	  treated	  as	  
capital),	  we	  assumed	  that	  this	  cost	  was	  also	  zero	  when	  funded	  from	  conventional	  budgets.	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Although	  we	  did	  not	  collect	  data	  on	  specialist	  and	  other	  health	  care	  that	  is	  conventionally-­‐
funded,	  it	  is	  important	  not	  to	  count	  the	  amount	  in	  the	  personal	  health	  budget	  at	  follow-­‐up	  as	  
purely	  additional	  costs.	  Where	  personal	  health	  budgets	  were	  substituting	  for	  conventionally	  
funded	  services,	  any	  expenditure	  on	  these	  services	  in	  the	  personal	  health	  budgets	  at	  time	  2	  
will	  have	  been	  in	  part	  transferred	  from	  a	  conventional	  budget	  at	  time	  1.	  We	  could	  have	  
proceeded	  by	  removing	  these	  costs	  from	  the	  total	  i.e.	  setting	  ℎ
 = 0	  but	  this	  would	  have	  
under-­‐costed	  the	  personal	  health	  budget	  group	  because	  some	  sites	  made	  additional	  budget	  
available	  and	  this	  was	  used	  to	  purchase	  specialist	  nursing	  and	  other	  health	  services.	  Instead,	  
we	  opted	  to	  infer	  the	  value	  of	  these	  services	  when	  they	  were	  provided	  at	  time	  1	  in	  a	  
conventional	  budget.	  This	  was	  done	  in	  the	  same	  way	  as	  inferring	  the	  time	  1	  social	  care	  
personal	  budget	  i.e.	  ℎ
 = ℎ
 𝛿𝛿 .	  
In	  either	  case,	  we	  have:	  
	   𝑠𝑠
 𝑏𝑏 +   𝑤𝑤
 𝑏𝑏 +   ℎ

= 𝑠𝑠
 +   𝑤𝑤
 𝑏𝑏 + ℎ









where	  Δ 	  signifies	  the	  extra	  money	  available	  in	  the	  personal	  health	  budget	  compared	  to	  time	  
1	  that	  comes	  on	  top	  of	  conventional	  funding.	  It	  is	  also	  possible	  that	  people	  transfer	  
expenditure	  at	  time	  2	  from	  their	  budget	  between	  the	  different	  service	  components	  (compared	  
to	  the	  distribution	  in	  their	  time	  1	  personal	  budget).	  This	  transfer	  could	  be	  positive	  or	  negative	  




 = 0.	  As	  noted	  the	  extra	  amount	  Δ 	  is	  assumed	  to	  be	  zero	  for	  
personal	  health	  budgets	  over	  £1000,	  but	  will	  be	  up	  to	  the	  value	  of	  the	  PHB	  for	  budgets	  of	  less	  
than	  £1000.	  In	  other	  words,	  when	  substituting	  (C-­‐24)	  into	  (C-­‐23)	  we	  use	  𝑠𝑠




 +   𝑤𝑤
 𝑏𝑏 + ℎ
   − 𝐵𝐵	  or	  𝑠𝑠
 𝑏𝑏 +   𝑤𝑤
 𝑏𝑏 +   ℎ
 = 0	  whichever	  is	  greater.	  
For	  the	  control	  group,	  overall	  cost	  per	  individual	  is:	  










 1 − 0.47 + 𝑤𝑤
 𝑏𝑏	  
(C-­‐25)	  
that	  is,	  we	  use	  the	  observed	  totals	  for	  each	  service	  component	  in	  the	  same	  way	  as	  for	  the	  
personal	  health	  budget	  group.	  We	  also	  include	  the	  costs	  of	  social	  care	  personal	  budgets	  in	  the	  
control	  group	  (again	  accounting	  for	  possible	  double	  counting)	  using	  the	  same	  predicted	  values	  
as	  for	  the	  personal	  health	  budget	  group	  but	  with	  control	  group	  characteristics.	  Costs	  are	  
calculated	  in	  the	  same	  way	  for	  time	  1	  and	  time	  2.	  
C.6.1.1 Secondary	  care	  use	  
We	  have	  both	  administrative	  data	  (from	  the	  Hospital	  Episode	  Statistics	  or	  HES)	  and	  self-­‐report	  
data.	  In	  the	  main	  we	  aim	  to	  use	  HES	  data	  over	  self-­‐report	  because	  the	  latter	  can	  embody	  recall	  
bias.	  The	  Payment	  by	  Results	  tariff	  reimburses	  inpatient	  activity	  with	  an	  admission	  payment	  
and	  a	  long-­‐stay	  adjuster	  and	  therefore	  average	  unit	  cost	  (per	  bed	  day)	  is	  not	  constant.	  We	  use	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 < 0.	  	  
Due	  to	  the	  timing	  of	  the	  study	  the	  latest	  available	  HES	  data	  were	  for	  the	  year	  ending	  31	  March	  
2012.	  As	  a	  result	  of	  the	  late	  up-­‐surge	  in	  study	  recruitment	  around	  half	  the	  people	  in	  the	  
sample	  have	  a	  follow-­‐up	  date	  after	  31	  March	  2012,	  with	  the	  last	  follow-­‐up	  interviews	  done	  at	  
the	  end	  of	  July	  2012.	  We	  therefore	  lack	  HES	  data	  for	  between	  one	  to	  four	  months	  at	  the	  end	  of	  
the	  follow-­‐up	  period	  for	  these	  cases.	  We	  can,	  however,	  use	  self-­‐reported	  data	  where	  HES	  data	  
is	  missing.	  Suppose	  monthly	  HES	  costs	  were	  𝑐𝑐
 𝑥𝑥
 𝑥𝑥
 ,	  where	  the	  subscript	  m	  denotes	  31	  
March	  in	  the	  month	  after	  baseline.	  Then	  the	  sum	  of	  these	  costs	  over	  the	  period	  (in	  months)	  of	  
month	  m	  to	  month	  M	  is	  𝐶𝐶











We	  estimated	  inpatient	  costs	  for	  missing	  months	  as	  follows.	  First,	  we	  estimated	  4	  models,	  for	  





,𝐺𝐺 , 𝛿𝛿 ,      𝑚𝑚 = 9,10,11, 12	   (C-­‐27)	  
where	  	  
V	  is	  self-­‐reported	  visits	  over	  the	  year	  
G	  is	  personal	  health	  budget	  or	  control	  group	  
𝛿𝛿	  is	  person	  characteristics	  
The	  sample	  in	  each	  case	  was	  all	  participants	  excluding	  those	  with	  month	  𝑚𝑚	  missing.	  For	  the	  
missing	  cases,	  the	  predicted	  values	  were	  used	  for	  hospital	  costs	  in	  the	  corresponding	  missing	  
month.	  A	  zero-­‐inflated	  negative	  binomial	  model	  was	  used	  for	  the	  estimations.	  
C.6.1.2 Primary	  care	  use	  
We	  have	  two	  sources	  of	  data	  on	  primary	  care	  use:	  the	  medical	  record	  extracts	  and	  the	  main	  
interviews,	  both	  at	  baseline	  and	  at	  12-­‐month	  follow-­‐up.	  We	  collect	  information	  on	  surgery	  and	  
home	  GP	  visits	  and	  on	  practice/community	  nurse	  visits	  using	  both	  these	  sources.	  To	  minimise	  
recall	  bias	  we	  ask	  interviewees	  about	  service	  use	  in	  the	  last	  one	  month.	  From	  medical	  records	  
we	  extracted	  the	  last	  year’s	  worth	  of	  service	  use.	  In	  terms	  of	  priority	  we	  used	  the	  medical	  
records	  information	  as	  the	  primary	  source	  and	  turned	  to	  the	  self-­‐report	  data	  where	  the	  former	  
was	  missing.	  In	  order	  to	  reconcile	  the	  different	  time	  periods	  in	  these	  collections	  we	  first	  
estimated	  annual	  primary	  care	  use	  from	  baseline	  medical	  records	  using	  self-­‐report	  data	  as	  a	  
predictor.	  Given	  the	  significant	  proportion	  of	  zero-­‐use	  across	  the	  sample	  in	  this	  count	  data,	  we	  




 = 𝑝𝑝 𝑦𝑦
 𝑦𝑦
 𝑦𝑦
 + 𝜖𝜖 	   (C-­‐28)	  
where	  
𝑦𝑦
	  is	  annual	  primary	  care	  use	  from	  medical	  records	  (person	  j	  at	  time	  t	  =	  0)	  
𝑦𝑦
 	  is	  the	  previous	  month’s	  primary	  care	  use	  from	  the	  interview	  	  
𝑝𝑝	  is	  the	  probability	  of	  zero	  annual	  use	  
𝑦𝑦
	  is	  the	  level	  of	  annual	  use	  conditional	  on	  a	  person	  having	  at	  least	  one	  visit	  
We	  then	  used	  the	  time	  0	  (baseline)	  estimation	  results	  to	  convert	  self-­‐reported	  service	  use	  in	  
the	  last	  month	  (at	  time	  t)	  to	  annual	  use	  where	  the	  latter	  was	  missing	  at	  either	  baseline	  (time	  t	  
=	  0)	  or	  at	  following	  up	  (time	  t	  =	  1):	  
	   𝑦𝑦
 = 1 − 𝑝𝑝 𝑦𝑦
 ;𝛽𝛽
    exp 𝑦𝑦
 𝑦𝑦
 ;𝛽𝛽
 	   (C-­‐29)	  
We	  set	  𝑦𝑦
 = 𝑦𝑦
 	  for	  each	  𝑗𝑗 = 𝑘𝑘	  missing	  values.	  
C.7 Carers	  
A	  sub-­‐sample	  of	  main	  study	  participants	  consented	  for	  the	  research	  team	  to	  contact	  their	  
carer	  at	  time	  1.	  We	  collected	  information	  on	  carer	  outcomes,	  including	  EQ-­‐5D,	  ASCOT	  and	  
GHQ-­‐12,	  which	  we	  denote,	  respectively,	  𝑦𝑦
 .	  We	  also	  collected	  some	  information	  on	  their	  
time-­‐invariant	  characteristics,	  such	  as	  sex,	  as	  well	  as	  factors	  that	  we	  assume	  are	  age-­‐invariant	  
or	  predictable,	  such	  as	  housing	  tenure,	  living	  arrangements	  and	  age	  group.	  These	  are	  denoted	  
𝑧𝑧 	  below.	  Caring-­‐related	  outcomes	  that	  are	  potentially	  affected	  by	  personal	  health	  budgets	  
are	  also	  likely	  to	  be	  influenced	  by	  the	  characteristics	  of	  the	  cared-­‐for	  person.	  To	  this	  end,	  we	  
included	  relevant	  baseline	  (T0)	  needs-­‐related	  characteristics	  and	  also	  the	  baseline	  quality	  of	  
life	  indicators	  for	  the	  cared-­‐for	  person,	  denoted	  respectively,	  𝑧𝑧
 	  and	  𝑦𝑦
 .	  









𝑋𝑋 + 𝑒𝑒	   (C-­‐30)	  
An	  OLS	  (ordinary	  least	  squares)	  estimator	  was	  used.	  As	  with	  the	  mortality	  analysis,	  omitted	  
variable	  problems,	  especially	  relating	  to	  the	  (unobserved)	  baseline	  quality	  of	  life	  characteristics	  
of	  carers,	  could	  apply.	  Given	  this	  issue	  and	  the	  relatively	  small	  sample,	  we	  need	  to	  be	  
somewhat	  cautious	  when	  interpreting	  the	  results.	  	  
C.8 Missing	  values	  and	  multiple	  imputation	  
Multiple	  imputation	  (MI)	  was	  used	  to	  deal	  with	  missing	  data	  according	  to	  Rubin’s	  method	  
(Rubin,	  1987).	  MI	  requires	  that	  the	  missing	  values	  in	  the	  data	  are	  missing	  at	  random	  (MAR)	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(StataCorp,	  2011).	  Missing	  data	  are	  missing	  at	  random	  (MAR)	  if	  the	  probability	  that	  the	  data	  
are	  missing	  does	  not	  depend	  on	  unobserved	  data,	  but	  may	  depend	  on	  observed	  data	  
(StataCorp,	  2011).	  Under	  MAR,	  the	  missing-­‐data	  values	  do	  not	  contain	  any	  additional	  
information	  given	  observed	  data	  about	  the	  missing-­‐data	  mechanism.	  We	  can	  distinguish	  MAR	  
from	  two	  other	  types	  of	  missing	  data	  patterns.	  Missing	  completely	  at	  random	  (MCAR)	  is	  where	  
the	  probability	  that	  data	  are	  missing	  does	  not	  depend	  on	  observed	  or	  unobserved	  data.	  
Missing	  not	  at	  random	  (MNAR)	  is	  where	  part	  of	  the	  reason	  that	  the	  data	  are	  missing	  is	  
explained	  by	  variables	  that	  have	  missing	  values.	  	  
We	  can	  use	  MI	  for	  MAR	  (and	  MCAR)	  but	  not	  with	  MNAR.	  Essentially,	  MI	  requires	  that	  the	  
reasons/mechanism	  for	  the	  data	  being	  missing	  must	  be	  accounted	  for	  in	  the	  model	  (i.e.	  by	  
factors	  that	  do	  not	  have	  missing	  values).	  The	  alternative	  strategy	  of	  dropping	  cases	  with	  
missing	  data	  is	  generally	  only	  valid	  for	  MCAR	  data,	  and	  could	  lead	  to	  bias	  for	  MAR	  and	  MNAR	  
data.	  The	  options	  available	  for	  MNAR	  are	  limited	  to	  (a)	  assuming	  a	  priori,	  a	  mechanism	  for	  
predicting	  missing	  data	  and	  configuring	  the	  imputation	  process	  on	  that	  basis,	  or	  (b)	  finding	  
additional	  (non-­‐missing)	  data	  that	  can	  be	  reasonably	  argued	  to	  reflect	  the	  reasons	  why	  these	  
data	  were	  missing.	  In	  both	  cases,	  some	  form	  of	  sensitivity	  analysis	  –	  where	  the	  data	  are	  
imputed	  on	  different	  configurations	  –	  is	  recommended.	  
What	  are	  the	  implications	  for	  the	  evaluation	  of	  personal	  health	  budgets?	  We	  categorised	  the	  
following	  types	  of	  missing	  data	  in	  the	  study:	  
	  
 People	  overlooking	  or	  discarding	  individual	  questions.	  These	  data	  are	  either	  MCAR	  
(missing	  completely	  at	  random)	  or	  it	  could	  be	  MAR	  (missing	  at	  random).	  In	  this	  MAR	  
case,	  people’s	  baseline	  characteristics	  such	  as	  their	  level	  of	  frailty,	  which	  are	  
measured,	  can	  explain	  non-­‐response.	  
	  
 Withdrawal	  of	  consent	  for	  external	  reasons.	  One	  example	  would	  be	  a	  change	  of	  
family	  circumstances	  outside	  the	  study	  such	  as	  the	  person	  moving	  away	  as	  the	  cause	  
of	  missing	  data.	  These	  are	  MCAR	  (missing	  completely	  at	  random)	  missing	  values	  and	  
could	  be	  either	  dropped	  or	  imputed.	  
	  
 Loss	  to	  follow-­‐up	  due	  to	  severe	  frailty,	  ill	  health	  or	  poor	  quality	  of	  life	  of	  the	  study	  
participant	  i.e.	  no	  follow-­‐up	  interview	  data.	  There	  were	  two	  relevant	  considerations.	  
Where	  we	  could	  argue	  that	  the	  cause	  of	  severe	  ill	  health	  was	  unrelated	  to	  the	  study	  
directly,	  i.e.	  that	  having	  a	  personal	  health	  budget	  does	  not	  affect	  severe	  morbidity,	  
then	  this	  missing	  data	  is	  MCAR	  (missing	  completely	  at	  random).	  However,	  if	  the	  
treatment	  choice	  potentially	  does	  have	  an	  impact	  on	  morbidity	  as	  we	  expect,	  then	  the	  
issue	  is:	  (a)	  whether	  the	  missing	  data	  were	  direct	  causes	  of	  the	  drop-­‐out	  –	  and	  so	  
MNAR	  (missing	  not	  at	  random),	  or	  (b)	  whether	  the	  missing	  data	  are	  consequences	  of	  
the	  intervention	  and	  other	  non-­‐missing	  characteristics,	  which	  are	  observed,	  and	  so	  
MAR	  (missing	  at	  random).	  We	  maintain	  that	  the	  latter	  case	  seems	  a	  more	  reasonable	  




Study	  consent	  was	  initially	  gained	  from	  2,700	  people.	  Some	  302	  people	  were	  excluded	  from	  
the	  study	  because	  they	  had	  neither	  taken	  part	  in	  the	  baseline	  or	  follow-­‐up	  interviews	  (and	  had	  
in	  effect	  withdrawn	  consent	  before	  baseline),	  because	  they	  were	  in	  residential	  care	  at	  
baseline,	  or	  because	  they	  had	  died	  before	  baseline.	  The	  remaining	  2,398	  cases	  were	  suitable	  
for	  multiple	  imputation.	  Of	  these,	  158	  people	  died	  before	  follow-­‐up.	  A	  further	  5	  cases	  were	  
dropped	  because	  they	  were	  aged	  less	  than	  18	  (these	  cases	  were	  dropped	  after	  the	  imputation	  
because	  some	  ages	  were	  missing	  in	  the	  MI	  sample	  of	  2398).	  For	  the	  main	  analysis	  we	  dropped	  
the	  158	  people	  that	  had	  died	  because	  we	  expected	  them	  to	  have	  a	  relatively	  different	  profile	  
of	  costs	  and	  benefits	  than	  people	  that	  were	  still	  alive	  at	  follow-­‐up.	  Although	  these	  data	  are	  
potentially	  missing	  not	  at	  random	  (MNAR),	  they	  were	  a	  small	  number	  of	  cases.	  We	  also	  found	  
no	  significant	  differences	  in	  mortality	  rates	  between	  the	  personal	  health	  budget	  and	  control	  
groups	  and	  so	  were	  content	  to	  drop	  these	  cases.	  This	  left	  an	  active	  sample	  for	  the	  analysis	  of	  
2235	  cases.	  
	  
The	  pattern	  of	  missing	  data	  in	  the	  sample	  was	  as	  follows.	  Regarding	  outcomes	  data	  from	  the	  
EQ-­‐5D,	  ASCOT,	  and	  GHQ-­‐12	  scores,	  we	  had	  at	  least	  some	  follow-­‐up	  outcomes	  data	  in	  1,656	  
cases	  (74.1%	  of	  the	  active	  sample	  of	  2,235	  cases).	  For	  services	  we	  had	  2,104	  cases	  (94.1%)	  with	  
at	  least	  some	  service	  data	  at	  follow-­‐up.	  We	  had	  either	  some	  follow-­‐up	  outcomes	  data	  or	  some	  
service	  data	  for	  2,133	  cases	  (95.4%),	  leaving	  4.6%	  of	  cases	  with	  just	  baseline	  data	  (35	  control	  
and	  67	  personal	  health	  budget).	  For	  information	  on	  receipt	  of	  informal	  care	  by	  respondents	  we	  
obtained	  data	  from	  1,340	  participants	  (60.0%).	  	  
	  
Reflecting	  the	  arbitrary	  (non-­‐monotonic)	  pattern	  of	  missing	  data,	  multiple	  imputations	  of	  the	  
dataset	  were	  constructed	  using	  the	  chained	  equation	  method	  (ICE).	  The	  imputation	  model	  was	  
constructed	  with	  equation	  estimators	  in	  the	  following	  categories.	  We	  used:	  
 First,	  regression	  models	  without	  constraints	  for	  continuous	  and	  non-­‐censored	  
variables	  such	  as	  age,	  dependency	  score	  (a	  36	  point	  scale)	  and	  some	  outcome	  scores	  
such	  as	  GHQ-­‐12;	  
 Second,	  censored	  regression,	  conditional	  on	  health	  condition,	  for	  clinical	  outcomes;	  
 Third,	  censored	  regression	  with	  an	  upper	  limit	  of	  1	  for	  EQ-­‐5D	  and	  ASCOT;	  	  
 Fourth,	  logit	  models	  for	  binary	  dummy	  variables	  such	  as	  sex,	  marital	  status,	  use	  of	  
benefits	  and	  so	  on	  (these	  logit	  models	  were	  estimated	  with	  augmentation);	  
 Fifth,	  logit	  models	  for	  whether	  or	  not	  people	  used	  particular	  services	  (estimated	  
without	  augmentation);	  
 Sixth,	  censored	  regression	  models	  (with	  a	  zero	  lower	  limit)	  for	  service	  cost	  as	  
conditional	  on	  binary	  service	  use	  (service	  costs	  were	  transformed	  using	  Box-­‐Cox	  with	  a	  
power	  of	  0.67).	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The	  imputation	  model	  therefore	  incorporated	  two-­‐part	  models	  for	  service	  use	  with	  Box-­‐Cox	  
transforms	  in	  order	  to	  better	  estimate	  missing	  service	  costs.	  A	  variety	  of	  final	  model	  
specifications	  were	  used	  and	  in	  some	  cases	  specific	  variables	  were	  omitted	  to	  ensure	  
convergence	  of	  the	  imputation	  run.	  Following	  Rubin	  (1987)	  the	  base	  model	  used	  5	  imputations	  
(10	  iterations).	  12	  In	  total	  152	  variables	  were	  imputed	  in	  the	  dataset.	  	  
We	  conducted	  sensitivity	  analysis	  regarding	  the	  imputed	  dataset	  by	  generating	  a	  further	  5	  
more	  imputations	  using	  a	  different	  random	  seed	  and	  adding	  these	  to	  the	  original	  5	  
imputations.	  As	  outlined	  in	  chapter	  6,	  re-­‐performing	  the	  analyses	  using	  this	  alternative	  dataset	  
did	  not	  change	  the	  nature	  of	  the	  results.	  	  
C.9 Uncertainty	  
The	  estimates	  (including	  the	  difference-­‐in-­‐difference)	  are	  subject	  to	  statistical	  error.	  We	  used	  
two	  methods	  to	  estimate	  the	  standard	  errors	  associated	  with	  the	  parameters,	  as	  follows.	  
C.9.1 Non-­‐parametric	  
Standard	  errors	  were	  estimated	  using	  bootstrapping	  (1000	  reps)	  for	  each	  of	  the	  5	  imputations	  
of	  the	  data.	  We	  used	  the	  bootstrap	  (BS)	  mean	  and	  the	  bootstrap	  standard	  error	  for	  the	  5	  
imputations	  to	  calculate	  overall	  mean,	  and	  BS	  standard	  error	  for	  the	  sample	  using	  Rubin’s	  
rules	  (Rubin,	  1987;	  Schafer,	  1997)	  (see	  Box	  C-­‐1).	  	  
In	  this	  way	  we	  calculated	  BS	  CIs	  for	  the	  difference	  (over	  time)	  in	  effect	  Δ𝐸𝐸,	  the	  difference	  in	  
cost	  Δ𝐶𝐶 	  and	  the	  difference	  in	  NMB	  Δ
𝐵𝐵.	  We	  calculated	  each	  of	  these	  differences	  for	  both	  the	  
intervention	  and	  control	  groups,	  bootstrapping	  each	  group	  separately.	  The	  DiD	  estimate	  was	  
found	  by	  subtracting	  the	  control	  group	  difference	  from	  the	  personal	  health	  budget	  group	  
difference.	  For	  example,	  the	  NMB	  difference	  for	  group	  i	  is:	  
	   Δ𝑁𝑁𝑁𝑁𝑁𝑁 = 𝜆𝜆 𝐸𝐸 − 𝐸𝐸 − 𝐶𝐶 − 𝐶𝐶 	   (C-­‐31)	  
where	  𝐸𝐸 	  is	  the	  sub-­‐sample	  mean	  value	  of	  effectiveness	  for	  intervention	  group	  i	  and	  time	  t.	  
Similarly,	  𝐶𝐶 	  is	  the	  cost.	  The	  DiD	  estimate	  is	  therefore:	  	  
	   ΔΔ𝑁𝑁𝑁𝑁𝑁𝑁 = Δ𝑁𝑁𝑁𝑁𝑁𝑁 − Δ
𝑁𝑁𝑁𝑁𝑁𝑁	   (C-­‐32)	  
The	  personal	  health	  budget	  and	  control	  groups	  as	  independent	  samples	  (each	  with	  clustering	  
by	  site)	  for	  the	  purpose	  of	  finding	  BS	  standard	  errors.	  As	  such,	  the	  standard	  error	  of	  the	  DiD	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
12	  Five	  imputations	  may	  be	  regarded	  as	  at	  the	  lower	  limit,	  but	  was	  chosen	  in	  part	  for	  pragmatic	  reason	  in	  that	  the	  
imputation	  procedure	  required	  over	  7,500	  model	  estimations	  to	  produce	  a	  dataset,	  the	  bulk	  of	  which	  were	  
maximum	  likelihood	  models.	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estimate	  ΔΔ𝑦𝑦	  for	  𝑦𝑦 = 𝑁𝑁𝑁𝑁𝑁𝑁,𝐸𝐸,𝐶𝐶	  is	  the	  sum	  of	  the	  BS	  standard	  errors	  for	  the	  estimates	  for	  
each	  group	  i.e.	  𝜎𝜎(ΔΔ𝑦𝑦) = 𝜎𝜎 Δ
𝑦𝑦 + 𝜎𝜎 Δ
𝑦𝑦 	  where	  𝜎𝜎(. )	  is	  the	  total	  bootstrap	  standard	  
error	  from	  the	  5	  imputations.	  	  
We	  can	  calculate	  the	  probability	  that	  ΔΔ𝑁𝑁𝑁𝑁𝑁𝑁 𝜆𝜆 > 0	  for	  each	  𝜆𝜆.	  This	  can	  be	  done	  non-­‐
parametrically	  by	  finding	  the	  proportion	  of	  the	  1000M	  repetitions	  where	  ΔΔ𝑁𝑁𝑁𝑁𝑁𝑁 𝜆𝜆 > 0	  for	  
a	  range	  of	  threshold	  values	  𝜆𝜆.	  
	  
C.9.2 Parametric	  approach	  
Estimating	  a	  fixed-­‐effects	  model	  as	  in	  (C-­‐14)	  or	  (C-­‐8)	  using	  NMB	  as	  the	  dependent	  variable	  i.e.	  	  
	   Δ𝑁𝑁𝑁𝑁𝑁𝑁 = 𝑏𝑏 + 𝑏𝑏Δ
𝐵𝐵 + 𝑒𝑒 	   (C-­‐33)	  
gives	  the	  difference-­‐in-­‐difference	  estimator	  as:	  ΔΔ𝐵𝐵 = 𝜇𝜇.	  We	  can	  estimate	  this	  model	  over	  
5	  imputations	  of	  the	  data	  and	  combine	  estimates	  on	  each,	  including	  𝜇𝜇,	  using	  Rubin’s	  rules.	  
Standard	  errors	  for	  each	  coefficient	  are	  estimated	  in	  the	  model	  on	  the	  usual	  assumption	  of	  a	  t-­‐
distribution.	  The	  system	  can	  be	  re-­‐estimated	  for	  a	  range	  of	  𝜆𝜆	  threshold	  values.	  For	  each	  𝜆𝜆	  we	  
Box	  C-­‐1.	  Rubin’s	  Rules	  
Following the notation used in the text, the overall estimate is the average of the estimates from the 




























Total	  variance	  is:	  
𝜎𝜎
 = 𝜎𝜎





and	  so	  total	  standard	  error	  𝜎𝜎 = 𝜎𝜎
.	  This	  is	  distributed	  as	  a	  t-­‐distribution	  with	  degrees	  of	  










can	  calculate	  the	  probability	  𝛼𝛼	  required	  such	  that	  𝜇𝜇 ≡ Δ
Δ𝐵𝐵 > 0	  i.e.	  that	  𝜇𝜇 𝜆𝜆 − 𝑡𝑡𝜎𝜎 𝜆𝜆 >
0.	  
 Examples	  of	  quotes	  from	  organisational	  representatives	  Appendix	  D
following	  PHB	  implementation	  models	  




Project	  Lead	   Well	  firstly	  because	  of	  direct	  payments	  we’ve	  got	  a	  very	  good	  working	  relationship	  
with	  [the	  local	  council],	  we’re	  really	  building	  on	  the	  integrated	  working,	  so	  we’ve	  used	  
[the	  local	  councils]	  finance	  systems	  to	  deliver	  the	  direct	  payments,	  and	  we’ve	  used	  all	  




The	  reason	  people	  want	  to	  go	  on	  to	  a	  personal	  health	  budget	  is	  that	  while	  agencies	  
are	  very	  good	  at	  providing	  care,	  they	  do	  not	  provide	  consistency.	  For	  example,	  
someone	  might	  be	  having	  four	  visits	  a	  day,	  and	  within	  those	  four	  visits	  they	  have	  four	  
different	  people,	  and	  those	  four	  different	  people	  may	  be	  different	  on	  the	  next	  day,	  so	  
there’s	  no	  consistency.	  
Project	  Lead	   It’s	  just	  taking	  way	  too	  long.	  I	  mean,	  there	  are	  people	  who	  were	  recruited	  to	  this	  pilot	  
way	  back	  with	  our	  predecessor,	  so	  possibly	  on	  the	  pilot	  a	  year,	  and	  they	  still	  do	  not	  a	  
budget.	  We	  do	  have	  some	  people	  who	  do	  not	  have	  an	  indicative	  budget	  because	  it’s	  
taking	  such	  a	  long	  time	  to	  get	  the	  costs	  revealed.	  
Health	  Professional	  	   It’s	  been	  successful	  where	  you’ve	  got	  somebody	  with	  charisma,	  drive	  passion,	  with	  a	  
real	  heart	  for	  it,	  and	  that	  personality	  has	  made	  it	  happen	  here.	  And	  I	  think	  we	  are	  very	  
fortunate,	  we’ve	  got	  [project	  lead’s	  name]	  who	  is	  just	  absolutely	  super,	  a	  real	  role	  
model	  I	  think	  for	  leading	  it.	  I	  think	  other	  areas,	  who	  haven’t	  got	  the	  same	  personality	  
driving	  it	  haven’t	  been	  quite	  as	  successful.	  	  
Third	  party	  provider	  
/	  budget	  holder	  
They	  [PHBs]	  give	  people	  choice.	  As	  an	  individual,	  you	  do	  sometimes	  feel	  you	  are	  being	  
wheeled	  along	  a	  path	  whether	  you	  like	  it	  or	  not.	  So	  I	  am	  all	  for	  giving	  people	  the	  
opportunity	  to	  make	  decisions	  for	  themselves,	  but	  also	  people	  must	  take	  
responsibility	  for	  their	  decisions,	  if	  you	  make	  a	  wrong	  one	  you	  have	  to	  live	  with	  it.	  
Whoever	  makes	  the	  decision	  needs	  to	  take	  the	  responsibility.	  There	  is	  no	  point	  giving	  
people	  the	  chance	  of	  making	  decisions	  if	  they	  are	  not	  going	  to	  have	  some	  form	  of	  
responsibility	  for	  that	  decision.	  You	  can’t	  blame	  someone	  else	  once	  you	  have	  decided	  
you	  want	  to	  do	  something.	  
Service	  Provider	   It	  was	  okay	  to	  be	  able	  to	  explain	  what	  a	  personal	  health	  budget	  was,	  but	  nobody	  could	  
give	  any	  practical	  examples	  that	  were	  meaningful	  for	  our	  services	  and	  our	  clinicians	  to	  








Project	  Lead	   We’ve	  had	  some	  really	  good	  stories	  and	  we’ve	  had	  some	  really	  positive	  results	  
of	  it,	  but	  equally	  there	  are	  some	  people	  who	  it’s	  not	  really	  worked	  for	  and	  we’ve	  
probably	  been	  giving	  people	  more	  things	  that	  we	  would	  do	  normally.	  
Third	  party	  provider	  
/	  holder	  
The	  main	  thing	  I’ve	  seen,	  concerns	  about	  health	  and	  safety.	  Obviously	  you	  have	  
to	  take	  into	  account	  their	  health	  and	  safety	  and	  even	  giving	  somebody	  the	  
knowledge	  of	  what	  risk	  factors	  there	  are	  in	  their	  choice……you’re	  still	  not	  able	  to	  
go	  with	  certain	  things,	  even	  if	  they	  feel	  that	  they	  can	  take	  that	  risk.	  
Health	  Professional	   I	  think	  nurses	  have	  a	  bit	  of	  a	  problem,	  more	  so	  than	  other	  professionals	  perhaps	  
in	  this-­‐-­‐,	  in	  the	  notion	  of,	  needs	  as	  compared	  to	  wants…Nurses	  sometimes,	  just	  
look	  around	  nursing	  tasks	  instead	  of	  perhaps	  thinking	  of	  the	  broader	  health	  
aspects.	  Perhaps	  an	  air-­‐conditioning	  unit	  or	  something	  could	  improve	  health	  or	  
make	  life	  a	  bit	  more	  comfortable	  for	  a	  person.	  
Project	  Lead	   We’ll	  be	  able	  to	  give	  those	  [personal	  health	  budget]	  patients	  a	  booklet	  about	  
direct	  payment	  support	  services	  and	  it’ll	  list	  all	  the	  providers	  that	  we’ve	  checked	  
and	  have	  met	  certain	  criteria	  and	  will	  hopefully	  do	  them	  a	  good	  job.	  	  
Project	  Lead	   Clinician	  views	  and	  opinions,	  that’s	  been	  a	  massive	  block	  really	  because	  we’ve	  
got	  a	  few	  clinicians	  who	  really	  don’t	  like	  the	  idea	  and	  they	  sort	  of	  scupper	  all	  the	  
plans	  that	  you	  try	  and	  put	  in	  place.	  So	  when	  other	  clinicians	  are	  talking	  about	  
patients	  they	  think	  might	  benefit	  from	  a	  personal	  health	  budget,	  there’s	  always	  
a	  reason	  why	  it’s	  not	  possible.	  	  
Third	  party	  provider	  
/	  holder	  
I	  think	  there	  is	  an	  extensive	  list	  and	  I	  think	  that	  the	  more	  that	  they’re	  done,	  the	  
more	  personal	  budgets	  are	  available	  to	  people,	  the	  larger	  the	  list	  will	  become	  
and	  the	  more	  knowledge	  that	  the	  brokers	  have…But	  I	  do	  think	  it’s	  always	  an	  
open	  document	  that	  can	  be	  added	  to.	  
Project	  Lead	   The	  disadvantages…	  it	  takes	  a	  long	  time	  to	  set	  up	  those	  things	  for	  the	  patients.	  
So	  where	  a	  patient’s	  only	  got	  one-­‐off	  budget	  of	  say	  300	  pounds,	  there’s	  no	  point	  
in	  them	  receiving	  that	  as	  a	  direct	  payment.	  So	  we’ve	  had	  to	  organise	  them	  as	  a	  
notional	  budget	  and	  we’ve	  had	  to	  organise	  the	  services	  on	  the	  patient’s	  behalf,	  








Project	  Lead	   On	  an	  individual	  level,	  personal	  health	  budget	  have	  been	  a	  great	  success.	  The	  
individuals	  have	  benefitted	  greatly	  and	  I	  think	  more	  than	  anticipated	  for	  such	  a	  
relatively	  small	  amount	  of	  money	  compared	  to	  some	  of	  their	  packages	  that	  they	  
were	  receiving.	  We’ve	  started	  to	  see	  the	  personal	  health	  budgets	  have	  actually	  
given	  people	  more	  choice	  about	  how	  they	  would	  spend	  some	  money	  in	  a	  
different	  way	  from	  what	  traditional	  models	  would	  suggest.	  
Commissioning	  
Manager	  
What	  we’ve	  discovered	  is	  that	  outside	  of	  primary	  care	  systems,	  not	  much	  money	  
gets	  spent	  on	  those	  people.	  So	  there	  isn’t	  much	  money	  to	  divert	  into	  personal	  
health	  budgets	  and	  we’ve	  just	  been	  double	  spending.	  The	  general	  perception	  I	  
think	  of	  senior	  staff,	  and	  particularly	  of	  GPs,	  is	  that	  it’s	  not	  worth	  the	  time	  and	  
effort.	  So,	  they	  will	  always	  fall	  back	  on	  clinical	  risk	  as	  an	  issue.	  	  
Commissioning	  
Manager	  
I	  think	  it’s	  been	  successful	  in	  getting	  people	  to	  be	  more	  engaged	  in	  their	  own	  
health.	  I	  think	  people	  enjoy	  the	  experience	  by	  and	  large,	  they	  take	  a	  bit	  of	  
persuading	  to	  get	  involved,	  quite	  a	  lot	  of	  them.	  They’re	  sort	  of	  suspicious	  to	  start	  
with,	  but	  then	  I	  think	  they	  enjoy	  it.	  I	  think	  they	  enjoy	  making	  choices,	  I	  think	  it	  
does	  make	  them	  think	  more	  about	  their	  own	  health,	  so	  I	  thinks	  it’s	  generally	  
very	  positive.	  
Operational	  Staff	   To	  be	  honest	  when	  I’ve	  spoken	  to	  other	  people	  within	  the	  health	  service	  about	  
someone	  on	  the	  PHB	  and	  have	  received	  a	  generally	  negative	  attitude	  towards	  it.	  
The	  people	  who	  are	  negative	  towards	  it	  have	  come	  from	  a	  lot	  of	  different	  
camps.	  I	  would	  say	  that	  there	  isn’t	  one	  particular	  group	  that	  has	  more	  of	  a	  
dislike	  for	  it	  than	  any	  other.	  
Health	  Professional	   We	  work	  in	  an	  area	  of	  very	  high	  deprivation,	  with	  high	  mental	  health	  needs	  and	  
so	  on.	  So	  I	  think	  people	  being	  able	  to	  access	  the	  alternative	  therapy	  type	  
complimentary	  services	  has	  been	  very	  beneficial	  because	  they’ve	  been	  able	  to	  
access	  things	  that	  traditionally	  other	  people	  would	  pay	  privately	  for.	  And	  I	  think	  








Project	  Lead	   When	  people	  have	  come	  to	  us	  around	  thinking	  about	  personal	  health	  budgets,	  
they	  generally	  have	  an	  idea	  about	  what	  it	  is	  that's	  going	  to	  make	  a	  difference,	  
and	  so	  they've	  got	  quite	  a	  clear	  idea	  around	  outcome.	  Sometimes	  they	  know	  
exactly	  where	  they	  can	  maybe	  purchase	  or,	  you	  know,	  kind	  of	  broker	  that	  either	  
piece	  of	  equipment	  or	  service	  from.	  
Third	  party	  provider	  
/	  budget	  holder	  
I	  think	  having	  to	  make	  health	  service	  staff	  think	  about	  the	  actual	  cost	  of	  their	  
services	  per	  head	  has	  been	  quite	  a	  challenge.	  I	  think	  having	  to	  realise	  that	  the	  
disabled	  person	  or	  the	  patient	  might	  be	  the	  expert	  over	  them	  in	  some	  areas	  has	  
been	  a	  real	  challenge	  but	  then	  again,	  a	  very	  positive	  one.	  	  
Operational	  Staff	   Some	  things	  have	  been	  quite	  straightforward…..spot	  purchase	  type	  things.	  Some	  
of	  it’s	  been	  a	  little	  bit	  more	  complex	  to	  organise,	  but	  then	  the	  outcomes	  have	  
been	  good,	  so	  that’s	  been	  worth	  investing	  in	  really.	  
Project	  Lead	   Speaking	  to	  somebody	  else	  who	  has	  been	  using	  direct	  payments	  for	  a	  while,	  also	  
in	  fairly	  difficult	  circumstances,	  went	  some	  way	  to	  reassuring	  the	  family	  that,	  
with	  the	  right	  support	  we	  can	  do	  this.	  And	  they	  have,	  they	  are	  successfully	  now	  
using	  direct	  payments	  and	  are	  employing	  their	  own	  staff,	  with	  an	  understanding	  
that	  it's	  new	  for	  them	  and	  it's	  new	  for	  us	  and	  there	  are	  things	  that	  we're	  learning	  
that	  we	  may	  have	  to	  change	  and	  adapt	  as	  we	  go	  along.	  	  
Health	  Professional	   Through	  my	  own	  experience…..people	  are	  generally	  not	  aware	  of	  what	  statutory	  
services	  are	  available	  to	  them	  and	  the	  health	  and	  social	  care	  makeup	  is	  currently	  
so	  complex.	  People	  have	  to	  navigate	  themselves	  around	  systems	  in	  ways	  that	  
maybe	  aren't	  necessarily	  meaningful	  to	  them,	  and	  very	  often	  I	  think	  some	  of	  the	  
staff	  that	  are	  working	  within	  those	  organisations	  don't	  understand	  the	  full	  range	  
of	  possibilities	  that	  are	  available	  to	  people.	  
Operational	  Staff	   I	  think	  staff	  are	  quite	  frightened	  about	  risk.	  I	  think	  staff	  are	  becoming,	  quite	  
afraid	  to,	  you	  know,	  make	  changes	  to,	  as	  regards	  to,	  personal	  health	  budgets,	  
and	  they’re	  often	  quite	  reluctant	  to	  explore	  other	  ideas.	  
Project	  Lead	   We're	  developing	  some	  kind	  of	  improved	  local	  knowledge	  as	  we	  go	  along	  around	  
providers	  that	  we've	  used	  and	  know	  and	  trust	  and	  have	  got	  the	  appropriate	  





 Questionnaires	  and	  instruments	  Appendix	  E
List	  of	  questionnaires	  and	  instruments	  
	  
Baseline	  outcome	  questionnaire	  
Baseline	  medical	  record	  template	  
Follow-­‐up	  outcome	  questionnaire	  –	  PHB	  Group	  
Follow-­‐up	  outcome	  questionnaire	  –	  Control	  Group	  
Follow-­‐up	  medical	  record	  template	  
Carer	  outcome	  questionnaire	  –	  Control	  Group	  
Carer	  outcome	  questionnaire	  –	  PHB	  Group	  
Month	  3	  budget	  holder	  topic	  guide	  
Month	  9	  budget	  holder	  topic	  guide	  
	  
Month	  3	  topic	  guide	  –	  Project	  Leads	  
Month	  3	  topic	  guide	  –	  Operational	  staff	  
Month	  3	  topic	  guide	  –	  Health	  Professionals	  
Month	  3	  topic	  guide	  –	  Commissioning	  Managers	  
Month	  3	  topic	  guide	  –	  3rd	  party	  budget	  holders	  
Month	  15	  topic	  guide	  –	  Project	  Leads	  
Month	  15	  topic	  guide	  –	  Operational	  staff	  
Month	  15	  topic	  guide	  –	  Health	  Professionals	  
Month	  15	  topic	  guide	  –	  3rd	  party	  budget	  holders	  
Month	  15	  topic	  guide	  –	  Service	  providers	  
Month	  15	  topic	  guide	  –	  managers	  of	  user	  and	  carer	  organisations	  
	  
Set-­‐up	  cost	  template	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